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Abstract 
 
The focus of this thesis is the current policy situation in relation to assisted reproductive 
technologies (ART) in Aotearoa/New Zealand.  I explore how government policies (and lack of 
policy) have shaped access to ART.  I also explore the policy initiatives of funding agencies, the 
National Ethics Committee on Assisted Human Reproduction (NECAHR), managers, healthcare 
professionals, and interest groups.   
 
My investigation into ART policy issues critically examines the various formal mechanisms and 
policies used to regulate and control ART in Aotearoa/New Zealand.  Drawing on my analysis of 
policy-focused documents and material from in-depth interviews with key actors in the policy 
debate, I demonstrate how the ad hoc and contingent approach to ART developments, 
practices, funding, and access has contributed to inconsistent and inequitable access to ART 
services.  I argue that the lack of an ART-specific policy organisation contributes to fragmented, 
and possibly discriminatory, policy decisions.   
 
I examine how the use of restrictive access criteria to manage the increasing demand for 
publicly funded ART services disadvantages certain groups wishing to use these services.  By 
investigating the influence of rationing strategies on the allocation of resources and regulation 
of access, I provide some appreciation of the ‘messy reality’ of policy creation, interpretation, 
and implementation.  I argue that the criteria used to limit access to public ART services 
obscure the use of social judgements and provider discretion.  Likewise, they succeed in limiting 
publicly funded ART treatments to those who conform most effectively to the normative 
definition of family.   
 
My analysis of the ART policy discourse identifies silences and gaps in relation to specific ART 
practices, particularly the use of ART by Mäori.  I highlight the invisibility and marginalisation of 
Mäori within the ART policy debate.  After examining the broader issues concerning Mäori 
access to health services, I explore how these may affect Mäori using ART services to overcome 
infertility.  I argue that the gathering of information about the utilisation of ART services is 
crucial for the accurate identification of the needs of Mäori.  It is also fundamental for effective 
monitoring of state health policy decisions and outcomes. 
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1 
Introduction: 
Framing the Issues 
 
The question is not whether choices are constructed, but how they are 
constructed.  Society, in its ultimate meaning, may be nothing more and nothing 
less than the structuring of choices.             (Rothman, 1984:32) 
1.1 Introduction 
…but you chose not to have children! 
This comment, made by my sister, triggered intense personal reflection about the nature of 
choice and the external constraints on choice in relation to reproduction and parenting.  
Although I have deliberately used methods to prevent conception at different times in my life, I 
do not perceive my present childless
1
 circumstance as a ‘choice’.  As with many aspects of my 
life, a multitude of interconnecting ‘choices’ and decisions have contributed to my current 
situation.  My sister’s comment and my reaction to it highlighted, for me, how the language of 
choice obscures the many social, cultural, political, economic, and historical influences on 
reproductive outcomes.  At the time, I was conducting interviews for an Honours Degree 
project with couples who had used assisted reproductive technologies (ART)
2
 to overcome the 
                                            
1
  I use the word ‘childless’ with reservation as I interpret it as implying a lack or deficiency rather than 
acceptable difference.  Although I have not given birth to or raised children exclusively, I do interact with 
and care for a number of children in a variety of situations.  Therefore, I do not perceive myself (or the 
many other women I know who are similarly situated) as being ‘childless’.  Nevertheless, the decision to 
use this term is a pragmatic one as I identify with Jan Cameron’s (1997) dilemma in finding an 
unproblematic term to describe people without children, especially when reasons for not having children 
are not always a straightforward matter of choice or no choice. 
2
  See Appendix A, Abbreviations and Definitions, for descriptions of the assisted reproductive 
technologies and surrogacy techniques referred to in this thesis.   
  
2
 
consequences of infertility.  At the same time, another research project into aspects of social 
policy relating to ART highlighted inconsistencies and contradictions in the public funding and 
access to ART in Aotearoa/New Zealand.  I became interested in the way that government 
policy (or lack of policy) can constrain or enable the reproductive choices of certain groups, 
principally the choices of those individuals who seek to use ART to conceive children.  My own 
reflections on ‘choice’ were embedded in a wider set of issues about access to reproductive 
technologies. 
 
This thesis explores how reproductive choice is constrained or facilitated by the current policy 
situation in relation to ART in Aotearoa/New Zealand.  I focus on three questions: In the 
absence of specific ART focused legislation, how are ART practices regulated and controlled?  
How are resources allocated and who has access to them?  What are the issues surrounding the 
use of ART by Mäori?  These questions shaped my investigation into the policy issues relating to 
ART in Aotearoa/New Zealand.  My research strategy involved a combination of documentary 
analysis and in-depth interviews, which were used to explore the positions of the key actors in 
the policy debate and to identify what silences and gaps existed in the policy discourse.  
Interviews were undertaken with key actors in the provision of ART services and government 
health policy, as well as interest group representatives and academic commentators.  Analysis 
was carried out on published and unpublished documents produced by both governmental and 
non-governmental organisations.  These included existing legislation, parliamentary bills under 
consideration at the time, discussion papers, reports, public submissions to various reports and 
discussion documents, academic papers, service provision contracts, and service specifications.
3
 
 
Many commentators have observed that the development of social policy relating to ART in 
Aotearoa/New Zealand has been fragmented, unplanned, and reactive.  They have also noted 
that there has been no considered response by the State to the many requests for a more 
proactive approach to ART legislation and policy formulation (Blank, 1990; Caldwell & Daniels, 
1992; Daniels, 1994a; Daniels & Lewis, 1996b; Daniels & Hargreaves, 1997; Blank, 1998; 
Daniels, 1998a; Coney & Else, 1999).  In this thesis, I investigate the consequences of this ad 
hoc and contingent approach to policy in relation to ART developments, practices, funding, and 
access.  I demonstrate that the policy responses to ART developments and practices in 
Aotearoa/New Zealand have contributed to inconsistent and inequitable access to assisted 
                                            
3
  See Chapter Two, The Research Process, for a detailed discussion and analysis of my research 
strategies. 
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reproduction for some individuals and groups.  I also explore how the values and moral 
judgements underlying ART policy decisions continue to emphasise the dominant culture and 
normative family structures, thereby marginalising or silencing certain groups within the ART 
policy debate.   
 
After critically examining the various formal mechanisms and policies used to regulate and 
control ART in Aotearoa/New Zealand, I argue that the lack of an ART specific policy 
organisation contributes to fragmented and, possibly, discriminatory policy decisions.  The 
overlapping and related functions of organisations involved in practical and ethical decision-
making in relation to ART remain uncoordinated and independent, with no public accountability 
for their decisions.  A delay in legislative and/or organisational action in relation to issues of 
information retention and access and cultural safety puts the rights of those involved at risk.  
Similarly, the absence of legislation to prohibit certain potentially unethical ART developments 
means that these developments could be established in practice, making it difficult to withdraw 
or limit their use later on.  While I acknowledge that there is a need for legislative flexibility to 
allow the introduction of beneficial ART innovations and practices, I maintain that there is also a 
need for legislative protection of the rights of those involved in these practices. 
 
The focus on ‘top-down’ policy initiatives, as described in Chapter Three, provides one 
influential arena for policy development and formulation.  However, it can suggest that the 
policy process is linear and progressive.  An examination of the interaction between ‘top-down’ 
and ‘bottom-up’ aspects of policy formulation and implementation provided insight into the 
‘messy reality’ of the policy process (Colebatch, 1998:59-61; Green & Thorogood, 1998:11).  As 
such, an investigation into the influences and effects of health sector controls on the allocation 
of resources and regulation of access provides some appreciation of this ‘messy reality’ and 
identifies another influential arena in ART policy creation, interpretation, and implementation by 
government bodies and providers.  The funding decisions that underlie public access to ART 
practices have been based on historical interpretations of need and access.  Therefore, the 
allocation of these resources in response to the growing demand for ART services has resulted 
in inequitable and inconsistent funding and access throughout the country.  Lack of attention to 
gathering information on the prevalence of infertility, as well as health sector restructuring and 
the introduction of explicit rationing strategies have further embedded these inconsistencies.  
Although the provision of additional public funding and the introduction of national access 
criteria in 2000 were aimed at eliminating regional disparities, I question whether these 
changes will be effective given that they are based on historically determined inequities in 
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funding.  In light of further health sector restructuring, I argue that there is a possibility that 
the status quo will be maintained so that access and funding remain inconsistent throughout 
Aotearoa/New Zealand.   
 
Although restrictive access criteria were introduced to manage the increasing demand and to 
address the inequalities in funding and access to publicly funded ART services, they 
disadvantage certain groups wishing to access these services.  While these criteria provide an 
influential arena for ‘bottom-up’ policy formulation through their interpretation and 
implementation by providers, they also illustrate how ad hoc and reactive policy-making can 
institutionalise inequitable resource allocation.  The access criteria obscure the use of social 
judgements and provider discretion and succeed in limiting publicly funded ART treatments to 
those who conform most effectively to the normative definition of family.  This definition of 
family, as prescribed by the Status of Children Amendment Act 1987, is examined later in this 
chapter.
4
  I acknowledge that the prioritisation of children’s rights over those of donors, 
recipients, surrogates, and intending parents is sometimes necessary in individual cases and 
may influence some access decisions.  However, I argue that marginalising the rights of whole 
groups of people on the basis of protecting the interests of children can lead to discrimination 
and the marginalisation of those who do not conform to the normative definition of family.   
 
The invisibility and marginalisation of Mäori within the ART policy debate is highlighted and 
discussed in Chapter Six.  There is an implicit assumption by various commentators that Mäori 
do not access ART services because they have more culturally acceptable ways of dealing with 
infertility, such as whängai (Daniels & Taylor, 1991; Adair & Rogan, 1998; Dyall, 1999:36-37).  
This assumption is sustained by the lack of data on the prevalence of infertility or the ethnicity 
of those accessing ART services.  While some Mäori may have access to and use whängai to 
manage infertility, the diversity of values and needs within the Mäori population means that 
others may decide to access ART practices.  The lack of quantitative information relating to 
prevalence and ethnicity means that the historically determined demand for services generated 
by the needs of the dominant Pakeha group is used to inform policy decisions.  Such decisions 
may ultimately disadvantage Mäori who wish to access ART services.  I argue that accurate 
quantitative data about who actually accesses ART services is crucial to identify the needs of 
                                            
4
  See Section 1.4, Families & ART, in this chapter for an analysis of the Status of Children Amendment 
Act 1987 and its influence on the definition of family and whänau.  
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Mäori in relation to fertility treatment and to evaluate and monitor state health policy decisions 
and outcomes. 
 
In the following sections of this chapter, I will set the context for the preceding issues by 
discussing the developments in ART that have led many countries to attempt to address the 
rights, responsibilities, and protection of those involved in ART practices.  This discussion will 
include a review of the regulatory approaches undertaken by Britain, Australia, the United 
States of America, and Canada.  As I use the language of rights and choice throughout the 
thesis, I include a brief review of the literature relating to reproductive rights and choice.  
Following this, I examine the Status of Children Amendment Act 1987 (SCAA) and its influence 
on the definition of family in relation to ART policy.  I investigate how changes in social 
acceptance of diverse family arrangements have not yet led to similar changes in legislation or 
policy with regard to ART practices.  Included in this section is a discussion of how the 
definition of family used by the SCAA conflicts with the Mäori concept of whänau.  Finally, I 
provide an outline of the issues addressed in each of the chapters in this thesis. 
1.2 Setting the Context 
Until recently, adoption and artificial insemination were the only options available to infertile 
couples who wanted to become parents.  The first known birth following the medicalised use of 
donated semen occurred in the 1880s and by the second half of the 20
th
 century donor 
insemination (DI) was commonly used to overcome male infertility (Daniels & Lewis, 
1996a:1521).  On 25 July 1978, the first baby to be conceived using a process called in vitro 
fertilisation (IVF) was born in England.  However, the birth of Louise Brown was not the 
culmination of an isolated scientific ‘discovery’.  It took place after years of experimentation and 
research on women’s bodies and reproductive capacities (Spallone, 1989:8-9).  The first 
recorded attempts at IVF took place in 1878 on the ova of a mammal and in 1946 and 1948 
two American scientists claimed to have successfully fertilised human ova in vitro (Fishel, 
1986:13).  Advances in reproductive biology, cryopreservation of sperm and embryos, culture 
techniques, endocrinology, embryology, and laparoscopy all contributed to advances in IVF 
research and, ultimately, the successful conception and birth of Louise Brown (Fishel, 1986:1-
16).  Following the initial success of IVF with human ova, clinics and research centres expanded 
into “almost every country that takes part in the western scientific establishment” (Spallone, 
1989:10).   
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According to Daniels (1999:6), medicalised DI has been practised in Aotearoa/New Zealand 
since the 1940s.  In the late 1970s, the National Women’s Hospital was storing frozen sperm 
and, by the early 1980s, university-based donor insemination clinics had been established in 
Auckland, Wellington, Christchurch, and Dunedin.  In Aotearoa/New Zealand, the first IVF 
programme was established at National Women’s Hospital in 1983 and the following year the 
first child to be conceived through IVF in Aotearoa/New Zealand was born (Coney & Else, 
1999:3; Peek, 1999:18).  In Chapter Four, I discuss how publicity surrounding this event led to 
the increased availability of IVF services and subsequent public funding of these services.  In 
Aotearoa/New Zealand, the growth in the development and use of ART coincided with changing 
social attitudes, law changes that eliminated the distinction between legitimate and illegitimate 
children, and the introduction of the Domestic Purposes Benefit.  These changes facilitated 
more single women being able to keep their babies and led to a decline in the number of 
children being made available for adoption (Else, 1995:216; Adair & Rogan, 1998:264).  
Undoubtedly, increased media attention and availability of ART practices in Aotearoa/New 
Zealand would also have contributed to increased public expectations and demand for such 
services (Blank, 1995:14). 
 
Advances in reproductive technology, IVF, and the use of donated gametes have combined to 
create the potential for new forms of kinship and family relations that challenge conventional 
notions of who can parent.  Consequently, ART has enabled different forms of surrogacy to take 
place and increased the potential for surrogacy to be used to overcome involuntary 
childlessness (English, et al., 1997:31).
5
  Surrogacy is often referred to in relation to ART and 
discussions of surrogacy arrangements are often included in the discourse relating to ART policy 
and practices.  Although it is not within the scope of this thesis to explore the policy issues 
relating to the use of surrogacy in detail, it should be noted that much of the policy and policy 
                                            
5
  The various arrangements known as surrogacy involve a woman who provides the gestation and birth 
of a child for others.  However, this woman may also provide the ova and conception so that she is the 
genetic mother, as well as the birth mother (Blyth, 1993:248).  There are three main types of surrogacy 
arrangement: 1. Insemination by intercourse with the intending father or a donor.  This is usually a 
private arrangement with no medical involvement; 2.  Artificial insemination, using sperm from the 
intending father or from a donor.  This does not technically require the services of an assisted 
reproductive technology provider but may involve health professionals; 3.  Gestational surrogacy, also 
known as ‘full surrogacy’ or ‘IVF surrogacy’.  One or more embryos, created (usually by IVF) from the 
gametes of the intending parents, one of the intending parents plus a donor, or two donors, are 
transferred to the womb of a woman who has no genetic connection to the embryos (Else, 1999a:50).  
See Appendix A: Abbreviations and Definitions for detailed definitions of the various surrogacy 
arrangements that can take place using ART. 
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debate associated with ART practices also relates to surrogacy.  Definitions of the ART practices 
referred to and the abbreviations I have used in this thesis are included in Appendix A. 
 
In Chapter Five, I analyse how the conflation of involuntary childlessness with infertility and the 
emphasis on heterosexual coupledom work to restrict access by lesbian couples and single 
women to publicly funded ART services.  Combined with the continued medical focus on women 
irrespective of whether the problem is male or female infertility, these issues also contribute to 
the marginalisation of men in the discourse surrounding infertility and the desire to parent.  
Albury (1999:176) maintains that representations of ‘man’ and ‘father’ remain largely 
unquestioned in feminist and popular literature about ART.  She believes that the male desire to 
parent is often trivialised, viewed as a form of exploitation of women, or reduced to the legal 
aspects of paternity and inheritance.  Furthermore, she found that there have been few 
challenges to the belief that fatherhood necessarily implies a biological rather than social 
relationship.  Correspondingly, the diagnosis and treatment of male infertility receives little 
attention and is often only investigated after the exclusion of female factor infertility (Purdie in 
Brander, 1991:23).  Although statistical analyses vary on the precise figure, the male partner is 
implicated in 30-50% of all recorded infertility cases world wide (Brander, 1991:9-13;  World 
Health Organisation in Gillett, et al., 1995:14; Cussins, 1998:75; Gupta, 2000:339).
6
  
Reproductive scientists suggest that research into the reproductive functions of men has trailed 
behind research into women’s reproductive functions by at least 15 years (Oudshoorn, 
1999:335).  Although sperm defect/dysfunction is the most common identifiable cause of 
infertility, it remains the least understood and the least treatable of infertility conditions 
(Brander, 1991:2).  Although men do undergo surgery for infertility, women undergo most of 
the ultrasounds, inseminations, surgery, and other invasive procedures, as well as taking most 
of the drugs in relation to treatment (Cussins, 1998:75 & 97 n.23).  Problems with sperm are 
“managed outside the man’s body … and any resultant embryos still need to implant in the 
woman’s uterus, thereby forcing her to become a patient” (Cussins, 1998:97 n.23).  
Consequently, women’s bodies become the focus of attention for ART practices irrespective of 
the causes of the infertility.  The invisibility of men is particularly obvious in relation to the 
                                            
6
  Similarly, the incidence of female-factor infertility is estimated to be between 30%-50%.  Most 
estimates suggest that the causes of infertility are equally divided between female problems and male 
problems, with a approximately 20% of infertility not being attributable to either male or female factors 
(unexplained) (Brander, 1991:9-13;  World Health Organisation in Gillett, et al., 1995:14; Cussins, 
1998:75; Gupta, 2000:339). 
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Clinical Assessment Criteria (CPAC) for treatment of infertility, which focuses almost exclusively 
on women’s bodies and behaviours.
7
 
International Approaches to Regulating ART & ART Practices 
International responses to the ethical, legal, social, and political issues raised by ART and 
surrogacy have been varied.  They have included a combination of legislation, organisational 
policies, reports by commissions and committees, and court decisions that collectively create 
policy and regulate the practices and development of ART and surrogacy (Blank, 1998:139).  
The Ministerial Committee on Assisted Reproductive Technologies (MCART, 1994:16) argues 
that these varied approaches to control and regulation make it difficult to envisage any 
international trends in policy-making.  Despite a lack of uniform policy development with regard 
to issues such as surrogacy, access to information, sex-selection, cloning, or disposal and 
research on embryos, there has been a general movement towards clarifying the legal status of 
children born as a result of ART practices (MCART, 1994:16).  On the other hand, only a few 
countries, such as Sweden, Austria, and Australia, have enacted specific legislation that allows 
adults conceived using donated gametes to access identifying information about their gamete 
donor (Daniels & Lewis, 1996b:66; Tollemache, 1999b:34).  Although other countries, including 
Aotearoa/New Zealand, have moved towards openness and full disclosure, they have not 
enacted specific legislation to ensure the availability of such information.   
 
In Britain, extensive regulation of procedures relating to ART has largely arisen out of the 
Human Fertilisation and Embryology Act 1990.  This Act evolved out of the Committee of 
Inquiry into Human Fertilisation and Embryology and its ensuing report, A Question of Life (the 
Warnock Report) (1985), on the legal and ethical implications surrounding the use of IVF.  The 
Act established the Human Fertilisation and Embryology Authority (HFEA) and required all 
clinics involved in IVF, DI, ICSI, human embryo research, or the storage of gametes and 
embryos to be licensed by this authority.
8
  The first statutory body of its type in the world, the 
HFEA is required to maintain a formal register of information about donors and all licensed 
treatment cycles and outcomes (Health Canada Online, 2001a).  Nevertheless, only non-
identifying information about donors can be made available to persons aged 18 or more who 
                                            
7
  See Chapter Five, Regulating Access, Section 5.4, The Priority Criteria, for a discussion of the CPAC. 
8
 See Appendix A, Abbreviations and Definitions, for descriptions of the assisted reproductive 
technologies and surrogacy techniques referred to in this thesis. 
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were conceived using donated gametes (MCART, 1994:78).
9
  Although liberal in some of its 
approaches, such as permitting research on embryos until the 14
th
 day, the Act facilitates major 
state intervention into ART developments and practices.  As well as regulating and overseeing 
the use and development of ART and surrogacy in Britain, the HFEA also promotes public 
discussion on issues such as sex-selection and the use of foetal tissue (MCART, 1994:24).  In 
December 2000, the British government amended the Human Fertilisation and Embryology Act 
1990 to allow the creation for research purposes of stem cells from early-stage cloned embryos.  
A resolution was also passed requiring that existing legislation be tightened to prevent cloning 
for human reproductive purposes (Health Canada Online, 2001a).  As discussed in Chapter 
Three, the passing of this Act raises questions about how technologies developed as a result of 
this research will be used in Aotearoa/New Zealand if proposals to ban cloning are enacted.
10
 
 
In contrast to the United Kingdom’s national approach to regulating ART and ART practices, the 
Australian constitution delegates responsibility for health legislation to the various states.  
Consequently, the separate states have adopted varying approaches to regulating ART.  As a 
leader in international research into reproductive technology, Victoria became the first state to 
deal with ART through the legislative process by introducing the Infertility (Medical Procedures) 
Act 1984 to regulate the use of IVF and donated gametes.  In 1998, Victoria replaced the 1984 
Act with the Infertility Treatment Act 1995.  This Act prohibits commercial surrogacy, regulates 
the use of IVF, DI, and other fertilisation procedures, regulates the use of human gametes, 
zygotes, and embryos for research, and promotes research into the incidence and causes of 
infertility (Tollemache, 1999b:30).  Access to treatment is confined to married couples or 
heterosexual couples in de facto relationships.  Although access in Aotearoa/New Zealand was 
initially restricted in a similar way, the introduction of the human rights legislation and changing 
social attitudes have resulted in the removal of overt restrictions on the basis of marital status 
or sexuality.  However, as discussed later in this chapter, the only legislation in Aotearoa/New 
Zealand that specifically deals with ART practices positions heterosexual couples as the norm 
                                            
9
  The Human Fertilisation and Embryology Act 1990 also makes surrogacy arrangements unenforceable 
in law, extends the Surrogacy Arrangements Act 1985 to cover all forms of surrogacy, and defines the 
resulting child’s parentage (Blyth, 1995b:4).  Although commercial surrogacy is illegal and surrogacy 
arrangements are unenforceable in Britain, surrogacy does occur under the jurisdiction of licensed 
providers.  There are at least two non-profit organisations in the United Kingdom that facilitate meetings 
between commissioning parents and potential surrogates (Brazier, et al., 1998:ii).  In 1997, Health 
Ministers in the United Kingdom commissioned a review of certain aspects of surrogacy arrangements, 
which concluded that new legislation was necessary to implement its proposals (Brazier, et al., 1998:ii). 
10
  See Chapter Three, Regulating Practices, Section 3.4, Policy Gaps, for a discussion of this issue. 
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for reproduction and parenthood.  In Chapter Five, I explore how this normative definition of 
family influences access restrictions to ART services in Aotearoa/New Zealand. 
 
The Infertility Treatment Act 1995 established the Infertility Treatments Authority to monitor 
and control research, storage, record keeping, licensing and approval, and compliance with the 
Act in relation to all ART.  The Act “makes the welfare of the child the first guiding principle and 
links this to the restrictions on access to infertility services” (Tollemache, 1999:31).  Tasmania 
and Queensland have both passed restrictive surrogacy laws, which apply to both traditional 
and IVF surrogacy (MCART, 1994:22).  South Australia and Western Australia have both 
introduced legislative controls for ART with varying levels of detail and prohibited practices.  
These two states have also established statutory bodies to licence and oversee ART services 
(MCART, 1994:23).  Although New South Wales is in the process of reviewing its position on the 
regulation and control of ART, it currently uses existing legislation to control the activities of 
ART providers and researchers.  There is no specific legislation in the other states (Health 
Canada Online, 2001a). 
 
The United States of America (USA) also regulates ART and ART practices on a state by state 
basis.  Although few states have taken statutory action to control ART (Tollemache, 1999b:29), 
about half have legislated in relation to the status of children born as a result of donor 
insemination (MCART, 1994:20).  Some states have also enacted legislation to deal with specific 
issues such as cloning and surrogacy.  However, the overall approach in the USA is to leave the 
control of ART practices to market forces, in which the courts or consumer and professional 
bodies deal with contested issues.  Although there is a National Advisory Board on Ethics in 
Reproduction in the USA, this body has no regulatory function or power (MCART, 1994:21).  
Unlike Australia and the USA, Canada’s federal government has decided to introduce a national 
level of control over ART practices and to establish a legislative framework that ensures 
consistency in the regulation of assisted human reproduction throughout the country (Health 
Canada Online, 2001b).  In 1993, Canada’s Royal Commission on New Reproductive 
Technologies produced the most comprehensive investigation into the social, ethical, medical, 
political, and legal issues raised by ART developments to date.  The two volume report, Proceed 
with Care (1993b), did not result in the proposed legislation or the recommended establishment 
of the ‘National Reproductive Technologies Commission’ to license, regulate, and oversee ART 
practices and developments.  Although a bill was introduced to the Canadian parliament in 
1996, it contained controversial elements in relation to sanctions, payments, and the regulatory 
structure and lapsed in 1997 because of the federal election (Tollemache, 1999b:33).  In May 
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2001, the Canadian Health Minister presented draft legislation to the Standing Committee on 
Health for consideration and requested that their report be produced by the end of January 
2002.  According to Health Canada (2001b), the draft legislation draws significantly on the work 
of the Royal Commission and is similar to the 1996 bill.  However, the newly proposed 
legislation takes into account recent scientific developments in reproductive technology. 
…it should be noted that scientific methods have developed a great deal since the 
time of the Commission, raising new and complex issues which the draft legislation 
addresses.  Human cloning, for example, seemed only a very distant possibility at 
the time of the Royal Commission's report.             (Health Canada Online, 2001b) 
 
If the proposed legislation is enacted it would “ban cloning and other unacceptable practices, 
regulate treatments to protect the health and safety of Canadians who seek assistance to 
conceive a child, and address research in this area” (Health Canada Online, 2001c).   
 
Britain’s unitary system of government has enabled the relatively easy establishment of a 
consistent national policy and a state regulating authority (Tollemache, 1999b:29).  According 
to Blank (1998:148), countries with federal systems of government often have difficulties in 
establishing consistent national policy for ART services because health policy and licensing is 
often the responsibility of the separate states or provinces.
11
  Consequently, in countries such 
as the USA, Canada, and Australia the fragmentation of power and responsibility between 
federal and state agencies is likely to obstruct the implementation of nationally consistent 
standards and regulations.  Similarly, decentralisation can exacerbate inconsistencies between 
national professional association guidelines and state licensing and regulatory policies.   
 
Although federal systems may hamper the introduction and implementation of consistent 
national ART policies, developments in Australia and Canada demonstrate that national 
consistency is not impossible under such political systems.  Australia’s Reproductive Technology 
Accreditation Committee (RTAC) was established to oversee the practice of IVF nationally and 
has been voluntarily accepted by clinics throughout Australia.  Likewise, Canada’s Federal 
Government has proposed a national legislative framework to regulate and control ART.  As I 
highlight in Chapter Three, the unitary parliamentary system in Aotearoa/New Zealand has not 
                                            
11
  Unitary government systems concentrate political authority in a central government while federal 
systems divide authority between central government and the states, provinces, or other local 
government structures.  Although central government in unitary systems may allocate certain 
administrative responsibilities and services to other institutions, ultimate power remains at the national 
level.  Contrastingly, states or provinces in federal systems are allocated constitutionally based authority 
in areas such as health policy (Blank, 1994:50).  See Blank (1994:49-66) for a description of these 
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advanced the introduction of legislative action or a state appointed authority to control and 
regulate ART developments and practices.  Nor has it always ensured a nationally consistent 
approach to funding and access to ART practices, as I illustrate in Chapters Four and Five.  
Caldwell and Daniels (1992:258) suggest that it is extremely difficult to resolve major moral 
issues such as the control and regulation of ART in a democratic state.  They argue, as does 
Blank (1995:50), that politicians are unlikely to risk their re-election chances by committing 
themselves to strongly contested moral issues that are likely to divide the community.  
Undoubtedly, the lack of international consistency in regulatory approaches has also been 
influenced by the different historical and cultural contexts and the difficulty in establishing 
universally acceptable limits on reproductive rights and choices (MCART, 1994:26). 
1.3 Rights & Choice 
Although originally linked to the “struggle for the right to safe, legal abortion and contraception 
in industrialised countries in the 1970s and 1980s” (Corrêa, 1997), the politics of reproductive 
rights and choice has been expanded to include the use of ART.  Developments in ART have 
generated demands for other reproductive entitlements including ‘the right to parenthood’ 
(Tomasevski in Packer, 1996:54).  Consequently, the rights debate has been extended to 
include contestation of the right to reproduce and to question how such a right would be 
defined in relation to ART (Ruzek, 1991; Rowland, 1992; Cook, 1995; Rowland, 1995; Shanner, 
1995; Di Valentino, 1996; Packer, 1996; Blank, 1997; Steinbock, 1998).  The language of rights 
is included in the discourse surrounding the existing legislation and the policy debate over the 
use and regulation of ART in Aotearoa/New Zealand.  The development of human rights 
instruments and civil rights movements against various forms of discrimination have played a 
central role in influencing value shifts in society, especially in relation to changes in attitudes to 
divorce, remarriage, de facto relationships, homosexuality, the extended family, and solo 
parenting (MCART, 1994:50).  Consequently, the Ministerial Committee on Assisted 
Reproductive Technologies (MCART, 1994:51) asserts that “domestic human rights legislation 
and international instruments are essential touchstones in the development and evaluation of 
policy” and that the Human Rights Act 1993 must be the basis for any discussion of 
                                                                                                                       
contrasting political systems in relation to Aotearoa/New Zealand and the United States of America, and 
the effect this has on health policy. 
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discrimination in the field of assisted reproduction.
12
  Similarly, the Aotearoa/New Zealand 
Family Planning Association (FPA) supports the application of the Aotearoa/New Zealand Bill of 
Rights Act and the Human Rights Act in relation to ART, arguing that it 
…is essential that the regulation of human assisted reproductive technology not be 
used as an opportunity to legalise discrimination against certain groups such as 
lesbians, or single women.           (Family Planning Association, 1997:3) 
 
The Human Rights Commission (1994:2-3) recognises that the rights of those involved in ART 
practices may be in conflict and that attention must be paid to how these rights are balanced 
and prioritised.  Nevertheless, the Commission “considers that fertility treatment services fall 
clearly within the meaning of goods, facilities or services” referred to in section 44 of the 
Human Rights Act.  However, others argue that human rights legislation in Aotearoa/New 
Zealand is inadequate in relation to ART because it focuses on the rights of adults and 
disregards “the rights and best interests of the child” (Coney, 1999c:43).  In Chapter Five, I 
examine how the rights of the child are often used to argue against the use of ART by lesbian 
couples and single women.  Less evident in the policy debate is any discussion on women’s 
reproductive rights and the right to access ART treatments.  In Aotearoa/New Zealand, rights 
based claims are most obvious in relation to the debate surrounding the interests of children 
born through ART practices and access to information about donors by those involved in donor 
ART practices (Atkin, 1995; Else, 1995; Coney, 1999c; Else, 1999b).  Issues surrounding the 
rights of Mäori as Tangata Whenua with respect to assisted reproduction are also marginalised 
in the policy debate and the effect this has on access by Mäori to ART services will be 
addressed in detail in Chapter Six. 
 
The rhetoric and application of rights shift over time.  Similarly, social, political, and 
technological change influences the definition of certain rights and who has a claim to them.  
                                            
12
  The Human Rights Act 1993 replaced previous human rights and race relations legislation in 
Aotearoa/New Zealand.  It added new grounds of prohibited discrimination and increased the penalties 
for unlawful discrimination.  The Aotearoa/New Zealand Government has agreed to be bound by the 
United Nations agreements on human rights and the Human Rights Act 1993 is based on these 
agreements.  Nevertheless, the Government exempted itself from complying with the Human Rights Act 
1993 in relation to its own legislative policies and practices until 1 January 2000 (Human Rights 
Commission, 1998).  The subsequent passing of the Human Rights Amendment Act 1999 extended the 
compliance deadline until 31 December 2001.  Although international human rights treaties have no legal 
status in Aotearoa/New Zealand unless written into domestic law, Aotearoa/New Zealand has a political 
and moral obligation to ensure they are complied with (Coney, 1999c:42).  Henaghan (1995:34) argues 
that the “traditional view that international treaties are not an enforceable part of domestic law unless 
written into that law” has been weakened by judicial practice in Aotearoa/New Zealand.  Recently, family 
court judges have begun using the language of children’s rights to validate decisions about access and 
custody.  Henaghan (1995:45, n.8) cites for example: Neho v Duncan [1994] NZFLR 157; Tozer v 
Newcomb [1992] NZFLR 51; Stove v Stove (Family Court, Hastings, 31 May 1990, FP 020/222/88). 
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Accordingly, the discourse surrounding ‘rights’ must be understood within the particular social 
and historical context in which the rights are being claimed (Blank, 1997:283).  This has 
particular relevance when legislative action is taken to fix policy that cannot be easily changed 
or adapted to accommodate changes in social attitudes and beliefs, as illustrated by the 
analysis of the Status of Children Amendment Act 1987 later in this chapter.  As the language of 
'rights' is more frequently applied to individuals, it is likely to exclude any meaningful 
examination of the “power relations within which the rights are exercised” (Albury, 1999:6).  
Rights discourse presumes individual autonomy and the ability to make "free" choices.  It fails 
to recognise the various social, economic, and political factors that contribute to and exacerbate 
constraints on choice.  Such discourse often presumes equality between those making choices 
(Beveridge & Mullally, 1995:242).  However, Robyn Rowland claims that there is no such 
equality, either in the alternatives offered to people as choices or between those who are 
choosing, as decisions are “constrained and shaped by the forces of economics, social ideology, 
personal psychology and established power structures” (1995:16).   
 
The conferral of rights has often been dependent on a person’s ethnicity, class, age, marital 
status, sexuality, gender, religion, culture, health, and physical abilities and these categories 
commonly form the criterion for access to or exclusion from certain benefits, thereby 
constraining choice.  Rowland (1995:16) argues that these constraints are greater for women 
than for men and that the use of a rights analysis in relation to ART may lead to social decisions 
that fail to consider issues of relationship and caring.  Dion Farquhar (1996:9-10) maintains that 
the opposing discourses surrounding the use of ART reduce the variety of women’s reproductive 
experiences to the binary of free/constrained.  Whether ART are “enabling, constraining, or 
neither and both” is dependant, in part, on the discourses that describe them (Farquhar, 
1996:4).  Accordingly, Farquhar argues that reproductive technologies are “not one entity, nor 
do they play one role, nor have only one fixed set of consequences for users, providers, donors, 
and the larger society” (1996:10).  Similarly, Wajcman (1994) argues that 
…the emphasis placed on women’s right to use these technologies tends to 
obscure the way in which historical and social relations are built into the fabric of 
technologies.  While recognizing the social shaping of women’s choices, few 
participants in the debate acknowledge that the technologies from which women 
choose are themselves socially shaped. 
 
The discourse of rights obscures the way in which choices are highly constrained, as well as the 
manner in which the available technological options are themselves shaped by particular 
political and economic interests (Mackenzie & Wajcman, 1999:275). 
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Recently, reproductive choice has been treated as a consumer good rather than a focus for 
political or moral scrutiny (Albury, 1999:21).  The free-market definition of choice represents 
ART as being “value-neutral, objective high-technology medicine” (Farquhar, 1996:7).  It 
suggests that decisions are limited to choosing one of several comparable outcomes rather than 
being associated with expressions of personal freedom and complex decision-making (Albury, 
1999:21).  Despite low success rates and high costs, the availability of a number of fertility 
treatment options within a market model is celebrated as fostering women’s self-determination.  
The ability to decide which treatment to use from a plethora of technological options and 
provider services is viewed as promoting greater autonomy (Lublin, 1998:93).  However, as 
Franklin and McNeil (1988:553) maintain 
…many early feminist campaigns for abortion on demand were waged in the name 
of “a woman’s right to choose.”  Recently, more complex understandings of the 
context of individual decision making about abortion have led to splits between the 
single–issue abortion campaign and the movement for a broader politics of 
reproductive rights.  …  In short, in all these domains, feminists have learned that 
more choice does not necessarily guarantee more freedom or control. 
 
As such, working through reproductive problems and living with the outcome of numerous 
intersecting decisions is often more involved than the language of choice allows (Albury, 
1999:21).  These decisions, or “reproductive choices”, are influenced by various social, cultural, 
and historical contexts, as well as previous fertility histories and experiences (Farquhar, 
1996:94).  Thus, an individualistic focus on reproductive rights and choices can obscure the 
social, historical, economic, and cultural dimensions of reproduction.  Nevertheless, the purpose 
of modern human rights is to resolve social inequities between the privileged and 
disadvantaged members of society (Dworkin in Cook, 1995).  Steinbock (1998) argues that the 
most important role of rights is their protective function, through the expression of important 
principles of fairness, the empowerment of people against discriminatory practices, and the 
acknowledgment of human dignity and respect for persons.  As these notions of protection, 
fairness, empowerment, and human dignity are so embedded in the language of rights, it may 
be difficult to express them in any other way (Steinbock, 1998).  Therefore, it is with both the 
obscuring and enabling aspects of rights discourse in mind that I use the language of rights in 
this thesis.   
1.4 Families & ART 
As with adoption, ART has enabled biological and social parenthood to be carried out by 
separate individuals, creating potential for new forms of kinship and family relations and 
disrupting the roles and relationships that have traditionally constituted parenthood.  The 
United Nations Convention on the Rights of the Child states that the family is “the fundamental 
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group of society and the natural environment for the growth and well-being of all its members 
and particularly children” (United Nations General Assembly, 1990).  Similarly, the 
Aotearoa/New Zealand Law Commission (2000:2) claims that the family provides security and a 
sense of identity for the child.  However, the boundaries of families, the roles of individuals 
within families, the nature of family relationships, and family members’ expectations and 
responsibilities vary according to the historical, social, and cultural context in which they are 
located.  Although there are a diversity of family structures and formations in Aotearoa/New 
Zealand, the heterosexual nuclear family continues to be promoted as the normative family 
structure and alternative family structures are often depicted negatively in research and policy 
studies (Royal Society of New Zealand & Ministry of Research Science and Technology, 1998:5-
6).  In the past, membership of the nuclear family was established through the practices of 
marriage and subsequent procreation and was based on assumptions about biogenetic and 
marital connections.  Therefore, post-industrial family life came to be accepted as a ‘natural’ 
fact through its connection with the biological fact of procreation (Strathern, 1995:351-353).  
However, the increasing recognition of a variety of family formations, such as ‘reconstituted’ 
families established through divorce, remarriage, death, or sexual preference, has exposed the 
constructed nature of family relationships by separating parenthood into its biological, legal, 
and social aspects.  Similarly, adoption and the development and use of conceptive technologies 
have disrupted the connection between marriage and procreation.  Birth control methods have 
separated sexual intercourse from procreation and enabled people to delay or prevent 
childbirth.  Likewise, a combination of ART practices have enabled single women and lesbians 
to have children and facilitated the separation of the biological aspects of motherhood from the 
social and legal aspects. 
 
Like most countries that allow the use of ART and donated gametes, Aotearoa/New Zealand has 
accepted that the interests of children born from using these procedures are paramount and, 
therefore, has adopted a law that addresses the legal status of these children (Blank, 
1998:142).  However, ART and surrogacy challenge deeply held values and ideals concerning 
family and family relationships.  As is discussed throughout this thesis, the legislation and 
policies enacted in Aotearoa/New Zealand in relation to ART practices are concerned with 
protecting and reinforcing certain kinds of family relationships.  Consequently, the Status of 
Children Amendment Act 1987 (SCAA) is based on the assumption that a ‘normal’ family 
consists of a mother, father, and children and positions heterosexual couples as the norm for 
reproduction and parenthood.  The SCAA legitimises the relationship between the child and the 
parenting (heterosexual) couple by recognising the birth mother and her husband (legal or de 
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facto) as the legal parents.  Providing a woman undertakes an assisted reproduction procedure 
with the consent of her husband, he will be the legal father of any resulting children.  The 
donors of gametes have no rights or responsibilities with respect to the resulting child 
(Tollemache, 1999a:18).  This situation raises concerns in surrogacy arrangements because the 
SCAA provides that 
(1) Where a married woman becomes pregnant as a result of artificial insemination 
and she has undergone the procedure with the consent of her husband,--- 
(a) The husband shall, for all purposes, be the father of any child of the 
pregnancy, whether born or unborn; and 
(b) Any man, not being her husband, who produced semen used for the 
procedure shall, for all purposes, not be the father of any child of the 
pregnancy, whether born or unborn. 
           (Section 5, Status of Children Amendment Act 1987) 
Therefore, any husband who consents to his wife using donor gametes to conceive for the 
purposes of a surrogacy arrangement will become the legal father of the resulting child 
(Henaghan, 1992:179).  Similarly, the woman who becomes pregnant using donor gametes or a 
donor embryo is considered to be the legal mother irrespective of whether she intends to be 
the social mother or not. 
(3) Where a woman becomes pregnant as a result of a donor ovum or donor 
embryo implantation procedure,--- 
(a) The woman shall, for all purposes, be the mother of any child of the 
pregnancy, whether born or unborn; and  
(b) The woman who produced the ovum from which the embryo used in the 
procedure was derived shall, for all purposes, not be the mother of any 
child of the pregnancy, whether born or unborn. 
           (Section 9, Status of Children Amendment Act 1987) 
This situation raises particular concern when the commissioning parents are also the genetic 
parents.
13
  Under present policy the genetic parents have no legal rights or responsibilities with 
regard to the child and would be required to adopt the child in order to become its legal parents 
(Else, 1999a:50-52).  They would be treated as “legal strangers” with regard to the child when 
applying for an adoption order (Caldwell & Daniels, 1992:270).  While the sperm donor can 
become the child’s legal father by marrying the mother, no such provision is made for the egg 
donor to become the child’s mother if she marries the legal father (Tollemache, 1999a:18).  
While pregnancy and birth confer maternal status irrespective of genetic or marital status, 
women who donate their ova are potentially more vulnerable than male donors of sperm in 
relation to attaining recognition as the resulting child’s parent.  Henaghan (1992:187) argues 
                                            
13
  Gestational surrogacy involves a woman gestating a child that has been conceived through IVF, using 
the gametes of the intending social parents.  The resulting child may have no genetic connection to the 
surrogate but would be genetically related to both the intending social parents.  See footnote no.5 in this 
chapter and Appendix A for descriptions of the range of procedures that may be used in a surrogacy 
arrangement. 
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that the SCAA is “concerned with giving particular children a legal father and mother and with 
excluding other people from that legal status”, particularly the donors of gametes, male same-
sex couples, and the partners of lesbian women.
14
 
 
The use of donated sperm by lesbian couples and single women has also raised issues about 
the legal status of the parent-child relationships created as a result of such procedures.  The 
SCAA states that 
(2) Where a woman becomes pregnant as a result of artificial insemination and 
that woman is either a woman who is not a married woman or a married woman 
who has undergone the procedure without the consent of her husband,--- 
(a) Any child of the pregnancy, whether born or unborn, shall not have, in 
relation to the man who produced the semen used in the procedure, the 
rights and liabilities of a child of that man unless at any time that man 
becomes the husband of the woman; 
and 
(b) The man who produced the semen used in the procedure shall not have 
the rights and liabilities of a father of any child of the pregnancy, whether 
born or unborn, unless at any time that man becomes the husband of the 
woman. 
           (Section 5, Status of Children Amendment Act 1987) 
As a result, if a lesbian couple uses donor insemination to have a child, one woman will be the 
biological and legal parent of the child while the other has no legal status.  This woman can 
apply, however, to become an additional guardian (New Zealand Law Commission, 2000:209).  
The donor is relieved of the legal ‘rights and responsibilities’ of paternity and, while the child 
cannot make claims on the donor regarding inheritance and financial support, neither can the 
                                            
14
  At present, in order for male same-sex couples to raise a child genetically related to one of them, they 
would have to rely upon a woman to undertake a surrogacy arrangement with them in which she would 
conceive using one partner’s sperm.  However, they cannot rely on the SCAA to achieve legal recognition 
of their status as co-parents of the child, even if the law was amended to be gender neutral (New 
Zealand Law Commission, 2000:213).  Providing the woman was not married, the sperm-donating 
partner could be identified as the legal father.  However, his partner could not be legally recognised as a 
co-parent.  Similarly, adoption under the current Adoption Act 1955 would only recognise one partner as 
the legal parent.  Because only one adoption order may be in force at any moment in time, two single 
people cannot jointly adopt a child.  Nevertheless, single people can apply to adopt a child (irrespective 
of their sexuality), although a gay male may only adopt a male child (New Zealand Law Commission, 
2000:131-133).  The Adoption Act 1955 does allow two spouses to apply jointly to adopt a child (New 
Zealand Law Commission, 2000:131).  However, differing opinions amongst Family Court judges has led 
to doubt over whether ‘spouses’ includes de facto as well as married couples.  As a result of this 
uncertainty, adoption is presently confined to married couples and single people, excluding same-sex 
couples and de facto heterosexual couples (New Zealand Law Commission, 2000:129-132).  In its review 
of the Adoption Act 1955, the New Zealand Law Commission recommended that “persons are not 
disqualified from eligibility to adopt on account of their relationship status – that is, whether they are 
single, married, in a same-sex, or de facto relationship” (2000:129) and that “the prohibition against a 
single male adopting a female child be removed” (2000:130).  They maintained that the ability to parent 
a child was the important factor when considering “whether adoption by particular applicants is the best 
means of promoting the interests of a particular child” (New Zealand Law Commission, 2000:129).   
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donor make any claims on the child.  In an interview conducted for this project, Rodney Bycroft 
(Scientific Director/Manager, Artemis North Shore Fertility, Auckland) maintains that single 
women and lesbian couples who approach the clinic often have difficulty when it comes to 
registering the birth of the resulting child. 
Does she choose “father unknown” or, with the donor’s permission, can she put his 
name as the father.  Will he be exempt from the Inland Revenue?  Will he be 
exempt from paternity issues?      (Rodney Bycroft, Interview: 13 September 2000) 
 
He suggests that often ‘known donors’ are quite happy to be registered as the father of the 
child but that the women involved do not want them to be financially responsible for the child.  
Single mothers who seek state benefits can be pressured to name a father on the birth 
certificate and if they do not comply their benefit may be paid at a reduced rate (Coney, 
1999c:45).  However, Rodney Bycroft maintains that many of the single women and lesbian 
couples that the clinic treats are financially independent and do not rely on the state or the 
donors for financial support. 
Lesbians will often say, “Well look, one of us works, what is the problem?  You 
know we are no different than a heterosexual relationship.”  I mean you cannot 
argue with that, you cannot argue with the fact that they definitely want this child.  
…  There are definitely some financial situations that are not ideal but as a private 
clinic we have seen single women who are self-sufficient, who do not need to 
work, they have independent income and they ask, “Why can’t I have a child?” 
   (Rodney Bycroft, Interview: 13 September 2000) 
In support of this argument, a recent magazine article profiled two financially independent 
single women who had used ART to achieve their desire to parent (Saunders, 2001).  Similarly, 
Mannis’ (1999) review of research on women who choose to mother alone revealed that these 
women often have financial autonomy, social and family support, education, and a strong, long-
standing desire to mother.  They formed their families without partners and with no expectation 
of ever having a co-parent.  However, in an interview conducted for this project, Sandra Coney 
(Executive Director, Women's Health Action Trust) has questioned whether it is ethically 
reprehensible to allow a child to be born without a father. 
…children are entitled to have a father in their lives and some do set up situations 
where they are having the donation from a gay male friend who is involved in their 
lives.  But, I have difficulty with the idea that these men can avoid a lot of their 
responsibilities towards the child, and do.  
     (Sandra Coney, Interview: 13 July 2000) 
By relieving the donor of rights “rights and liabilities of a father”, the SCAA does not create 
fatherless children.  The SCAA takes away the ‘right’ to apply, as the father, to be appointed as 
guardian of the child and the ‘liabilities’ of maintenance.
15
  The emphasis in the legislation is on 
                                            
15
  Henaghan (1992:182) contends that the legislation is not clear on whether the liabilities extend as far 
as making inheritance provisions. 
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the need for a child to have a legal father.  If there is no other person to be considered for the 
role of the father, then the donor retains the status of father without the rights and liabilities 
(Henaghan, 1992:182).  Although the donor has no legal rights and liabilities, this does not 
preclude individuals involved in donor insemination from negotiating and establishing certain 
rights and liabilities within the terms of their relationships.
16
   
 
Whereas some commentators argue that it is essential to define parenthood by specifying what 
roles take precedence (Blank, 1990:11), others support the deconstruction of such definitions 
and the potential for extending understandings of ‘family’ relationships that ART and surrogacy 
offer (Millns, 1995; Strathern, 1995; Thomson, 1998).  As Strathern (1995) points out, assisted 
conception may introduce individuals who have no genetic or familial relationship into the 
process of reproduction and, as a consequence, provide a model of relations that allows for an 
extended kinship group outside of that offered by the nuclear family model.  Likewise, Barbara 
Katz Rothman (in Thomson, 1998:179) claims that ART practices  
…offer us an opportunity to work on our definitions of parenthood, of motherhood, 
fatherhood and childhood, to rethink and improve our relations with each other in 
families.  Freed from some of the biological constraints, we could evolve better, 
more egalitarian ways of relating to ourselves and each other in reproduction. 
 
Furthermore, Gibson (1992:65-66) claims that some feminists have welcomed alternative 
modes of reproduction because they expand the procreative choices of ‘non-traditional’ families 
and may help to broaden the societal definition of family.  She suggests that a society with a 
broader concept of family might be more open to alternative methods of reproduction and less 
inclined to exclude certain groups of people from such methods.  Nonetheless, there is a danger 
that ART also reinforces the linking of femininity with motherhood and motherhood with 
childbirth, thereby it re-centres ‘normative femininity’ on the maternal body (Sawicki, 
1991:89).
17
  The intent of the legislation in Aotearoa/New Zealand has been to protect the 
‘family’ from the intrusion of third parties and to protect gamete donors from claims of parental 
responsibility.  Consequently, the legislation adds to and reinforces the discourse that 
represents the ‘family’ as being organised around two co-habitating heterosexual parents with 
genetically related children.  Although there are unquestionable benefits to children being raised 
within a family consisting of two parents contributing to the welfare of one another and of their 
children, it should be recognised that many people raise children as single parents and that the 
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 See 'My two mums' (Dickson, 1999) in which a lesbian couple discuss the active role of the sperm 
donor in the lives of their two children. 
17
  Bartky (in Sawicki, 1991:89) defines ‘normative femininity’ as a set of disciplinary practices regulating 
the body, its gestures, appetite, shape, size, movement, appearance, and so on. 
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desire to parent and bring up children extends to those who do not fit the traditional concept of 
‘parent’ (New Zealand Law Commission, 2000:xv). 
 
Haimes (1990:164) argues that some ART procedures are more acceptable than others because 
they reproduce the ideological, structural, and genetic relationships necessary for the ‘normal’ 
family.  Techniques that use the intending parents’ own gametes reproduce all the elements 
necessary for a ‘normal’ family.  However, techniques that use donated gametes only satisfy the 
ideological and structural concepts of such normality.  While resulting children may not be 
genetically linked to one or both parents, the resulting family structure demonstrates and 
reinforces the value of family life (Haimes, 1990:164).  Relationships created by homosexual 
couples and single women or men accessing ART fail to satisfy traditional concepts of family 
and, thereby, challenge the norm more than other ART practices.  Nevertheless, research 
reviewed by the Canadian Royal Commission on New Reproductive Technologies (1993a:457) 
and the New Zealand Law Commission (2000:133-134) suggests that children raised by lesbian 
couples are at no greater risk of harm than those raised by heterosexual couples.
18
   
 
Pool, Jackson, and Dickson (1998:117) argue that, although policy-makers are informed by 
what is reported to them, the use of this information is also influenced and modified by the 
dominant discourse on family formation and structure, as well as public policy strategies.  As a 
consequence, “the norms applied to the formulation of policy are those of the majority, from 
the dominant culture” even though policy-makers come from a variety of family structures and 
ethnic groups themselves (Pool, et al., 1998:121).  This anomaly was substantiated by Theresa 
Wall’s (Senior Analyst, Mäori Health Branch, Ministry of Health) explanation of the use of the 
nuclear family model in policy in an interview conducted for this project.  Although she 
personally recognised and supported the diversity of family formations in society, she suggested 
that policy focused on the nuclear family model because it was easier to manage. 
                                            
18
  According to the New Zealand Law Commission (2000:133), most research concerning the experiences 
of children reared by homosexual parents has focused on children with lesbian parents and there has 
been little significant research published focusing on the experiences of children brought up by gay men.  
Consequently, there is little research to “reliably evaluate either positive or negative influences of gay 
parenting” (New Zealand Law Commission, 2000:133-134).  See Adoption: Options for Reform (New 
Zealand Law Commission, 1999) paragraphs 189-197, for a review of the relevant research.  See also: 
Fitzgerald, B., 1999.  ‘Children of lesbian and gay parents: a review of the literature’, Marriage & Family 
Review, Spring, Vol.29, No.1, p.57 (19).  This paper reviews the research literature concerning the 
development of children with gay and lesbian parents.  The body of literature generally concludes that 
children with lesbian and gay parents are developing psychologically, intellectually, behaviourally, and 
emotionally in positive directions, and that the sexual orientation of parents is not an effective or 
important predictor of successful child development. 
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There are a whole lot of social strictures around the notion that you should have a 
set of parents, a male and a female and your brothers and sisters and you should 
all live in a house together.  That is the way in which society to a large extent has 
been organised but everybody really knows … that families are an extremely fluid 
structure, and they should be because people change.  …  [The nuclear family] is 
just much easier to manage at a policy level, and at an ideological level, if 
everybody is slotted into very nice little patterns that behave in certain ways.  It is 
when you have the diversity of human relationships and the diversity right across a 
whole life span that it becomes difficult for an individual to conceptualise.  So, I 
think that there is just a safety in slotting back into what is popularly identified as 
being the norm.  But, everybody really does know that it is not the norm. 
      (Teresa Wall, Interview: 24 July 2000) 
Nevertheless, this acceptance of the hegemonic nuclear family model in relation to social policy 
contributes to the marginalisation of alternative or non-conforming family formations and fails 
to recognise public acceptance of diversity in the structure of families.
19
   
 
The New Zealand Law Commission (2000:64) points out that there has been an increasing 
acceptance of “familial institutions other than the nuclear family” over the last 45 years, calling 
attention to social changes such as the abolition of the status of illegitimacy, the introduction of 
State financial support for single parents, the increasing use of ART, and the move to open 
adoption arrangements.  Similarly, Fleming and Atkinson (1999:13-14) maintain that since the 
late 1980s there has been a shift away from an ideology that places value on the nuclear family 
as the preferred family unit.  However, they argue that the ‘blood’ relationship between the 
parent and child is taking precedence and this is reflected in changes in policy and in family 
court decisions on custody and access.  Correspondingly, the Adult Adoption Information Act 
1985 and the move towards open adoptions have reinforced the shift from affinal to biological 
links in family policy issues.  However, the SCAA effectively obscures the relationship of the 
person born from a donor or surrogate arrangement to his/her parents, supporting a marital 
definition of family over a biological one (Macklin in Adair & Rogan, 1998:267).  The New 
Zealand Law Commission’s (2000) review of the Adoption Act 1955 was based on the 
recognition of these and other changes in social attitudes and values.  In this review, the 
Commission recommends changes to the SCAA that acknowledge the diversity and validity of 
alternatives to the nuclear family model that can be created through the use of ART (2000:209-
213).  As it stands, the SCAA contributes to the ‘socialisation of procreative behaviour’ by 
positioning the heterosexual couple as the norm for reproduction and parenting.  It works to 
inhibit access to ART by single people and those individuals who are not heterosexual, as well 
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  Robin Fleming and Toni Atkinson’s (1999) research into families established through remarriage 
highlights how policy decisions based on the stereotypical nuclear family can have an adverse affect on 
families that are organised in different ways. 
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as marginalising ethnic groups whose concept of family differs from the ‘norm’.  Therefore, the 
standards and values associated with normality effectively regulate the behaviour of individuals 
and groups (McNay, 1994:95-99).  In Chapter Five I explore how this definition of family and 
issues surrounding ‘worthiness to parent’ have influenced access restrictions to both public and 
private ART services.  Henaghan argues that legislation defining family in relation to ART and 
surrogacy in Aotearoa/New Zealand “seems a very pakeha way of addressing the issue” 
(1992:186, emphasis in original). 
Defining Whänau 
While the Status of Children Amendment Act 1987 (SCAA) focuses on the definition and 
maintenance of the nuclear family, Mäori recognise a broader concept of family that includes 
both the nuclear family and whänau (Durie-Hall & Metge, 1992:60; Henaghan, 1992:186).  
Although the term ‘whänau’ has a range of meanings that apply in different contexts, the 
primary meaning is described as 
…a group of relatives defined by reference to a recent ancestor (tupuna), 
comprising several generations, several nuclear families and several households, 
and having a degree of ongoing corporate life focussed in group symbols such as a 
name, a land base (türangawaewae) and taonga. 
      (Durie-Hall & Metge, 1992:61) 
However, Pihama (1998:195) argues that the contemporary use of the term ‘whänau’ includes 
both biological and non-biological relationships.  Correspondingly, Cram and Pitama (1998:142) 
claim that Mäori family systems are “vital and dynamic and, as such, definitions of whänau are 
being revised within the context of contemporary Mäori realities.”
20
  While nuclear families may 
form the basis of some Mäori households, individuals remain linked through wider cultural 
configurations, particularly through whakapapa (genealogy) (Pihama, 1998:189-190).  Both 
whakapapa and whänau incorporate notions of kinship that allow for relationships, 
responsibilities, and commitment by a range of adult kin in the parenting of Mäori children 
(Pihama, 1998:182).  Mäori children are an inseparable and fundamental part of the whänau 
(New Zealand Law Commission, 2000:82) and sharing the control and care of children with 
other whänau members is generally expected and accepted by parents and caregivers (Durie-
Hall & Metge, 1992:64).  It is possible that this inclusive concept of whänau, combined with the 
concept of whängai, has enabled Mäori to address infertility in the past.
21
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 See Cram and Pitama (1998) for their interpretation and definition of traditional and contemporary 
whänau systems. 
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 The concept of whängai and its relationship to infertility and surrogacy is addressed in Chapter 6, 
Addressing Difference, Section 6.5, Whängai & ART.  
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The SCAA changes the legal status of the child in a similar way to the Adoption Act 1955, and 
the birth certificate reads as if the legal parents are the biological parents (New Zealand Law 
Commission, 2000:210).  This has significant consequences for Mäori, raising issues about the 
child’s right to access information about donors and their genetic background.  As membership 
of whänau, hapü, or iwi is determined by knowledge of whakapapa, which is an integral part of 
being Mäori, it is essential for individuals to know their true whakapapa or genetic connections 
(Dyall, 1999:35).  The use of donated gametes combined with the SCAA undermines an 
individual’s right to knowledge of their whakapapa and their ability to claim access to their 
cultural heritage and other entitlements (MCART, 1994: Appendix E, p.5).  By assuming that the 
protection of children is guaranteed by ensuring parental legal status and the promotion of the 
nuclear family, the SCAA implies that the cultural and social values within Aotearoa/New 
Zealand are homogeneous (Henaghan, 1992:186-187).  Issues surrounding the recognition of 
cultural and social diversity in relation to ART policy are discussed in more detail in Chapter Six. 
1.5 Framing the Thesis 
This thesis consists of seven chapters.  In Chapter Two, The Research Process, I present a 
detailed discussion of the various research strategies used to identify and locate the discourses 
that have informed ART policy.  I provide a definition of ‘policy’ as it is used in this thesis and 
explore the constraints and choices that influenced and guided the selection of and access to 
documentary evidence and interview participants.  My definition and use of a feminist 
perspective is described and I outline how I reached a ‘position’ in the ART policy debate.  I 
provide an explanation of both the access and interview strategies and processes, followed by 
an analysis of the power relations I experienced during the research process.  This discussion 
leads into a consideration of the personal and political conflict I experienced while engaging in 
cross-cultural research.  Finally, I briefly outline the programmes and strategies used to analyse 
the accumulated documents and interview material.   
 
Chapter Three, Regulating Practices, provides a review of the complex situation regarding the 
control and regulation of ART in Aotearoa/New Zealand.  In this chapter, I describe the ‘official’ 
policy responses to ART developments over the last twenty years and present an overview of 
the organisations directly involved in the regulation and control of ART developments and 
practices.  This chapter analyses the ‘formal’ policy background that underlies and influences 
the issues of funding, access, and Mäori use of ART that are discussed in the following 
chapters.  I critically review the two bills currently being considered by a parliamentary select 
  
25
 
committee and consider the policy gaps that will remain irrespective of either bill being passed 
in its current form.  The following sections examine the roles of the two organisations most 
obviously involved in the regulation and control of ART practices in Aotearoa/New Zealand.  I 
analyse the National Ethics Committee on Assisted Human Reproduction (NECAHR) in relation 
to its de facto role in formulating ART policy.  I consider the contribution of professional self-
regulation, through the Reproductive Technology Accreditation Committee of Australia (RTAC), 
to the control and monitoring of ART practices.  Finally, I address issues of public accountability 
in relation to the fragmentation of de facto policy organisations and the lack of an overseeing 
ART policy body.  Throughout this chapter, I comment on the drawbacks of maintaining the 
status quo and delaying legislative action. 
 
Chapter Four, Allocating Resources, outlines the evolution of public funding based on historically 
determined levels of demand and its influence on regional inconsistencies in funding and 
access.  In this chapter, I explore how resource constraints and health sector restructuring 
influenced the introduction of access restrictions for ART treatment.  I describe the funding 
changes and national access restrictions that were introduced in 2000, and I consider how 
recent health sector reforms may affect these attempts at resolving regional inequalities and 
inconsistencies in access and funding.  This chapter sets the context for the analysis of the 
recently introduced national Clinical Assessment Criteria (CPAC) in Chapter Five. 
 
In Chapter Five, Regulating Access, I investigate how access to both public and private ART 
treatment is restricted.  I analyse the values and assumptions that underlie the use of biological 
infertility, age, sexuality, and marital status as limiting factors in the provision of ART treatment.  
Included in this chapter is an examination of arguments based on the interests, rights, or 
welfare of any resulting child.  These arguments are frequently used to justify restricting access 
to ART practices by particular groups of people.  This is followed by an analysis of the national 
Clinical Assessment Criteria (CPAC), which was introduced in 2000 to reduce regional disparities 
in access for publicly funded ART practices.  In this section, I will consider how the various 
criteria rely on social and moral judgements of who is considered worthy of treatment and 
highlight how the CPAC works to limit access by single women, lesbian couples, and older 
women. 
 
Chapter Six, Addressing Difference: Mäori Infertility and ART, explores the invisibility and 
marginalisation of Mäori within the ART policy debate.  I explore the silences surrounding Mäori 
in relation to ART policy and consider the probability of Mäori having existing or future needs to 
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access ART practices.  After considering the broader issues concerning Mäori access to health 
services, I explore how these may affect Mäori using ART practices to overcome infertility.  This 
is followed by my examination of issues relating to the collection of information about ethnicity 
and how the absence of such information affects policy decisions, which may ultimately 
disadvantage Mäori who wish to use ART services.  Within this discussion, I consider the 
difficulties associated with defining Mäori and using ethnicity as a variable in social research.  
Following on from this discussion, I consider whether Mäori use whängai as an alternative to 
accessing ART services.  I explore issues surrounding the protection of whakapapa in relation to 
donated gametes and the retention and availability of culturally relevant information.  Finally, I 
discuss issues arising from the exclusion or marginalisation of Mäori in the ART policy debate.  
Included in this section is a discussion about the necessity for policy to recognise the difference 
and diversity within the Mäori population.  Central to this chapter is an awareness of my 
position as a Pakeha researcher, as discussed in Chapter Two, Section 2.9, Cross-Cultural 
Research. 
 
Chapter Seven, Policy in Practice, concludes this thesis with a discussion of the implications of 
the ART policy situation in Aotearoa/New Zealand and how this situation results in limited 
consideration and analysis of the values and principles underlying any ethical or policy decision-
making.  I illustrate how ad hoc policy development in relation to funding decisions has built on 
historically determined levels of need and neglects to consider any investigation into actual 
demand.  This section explores how the lack of a considered approach to the public funding of 
ART services has contributed to inequitable and inconsistent funding outcomes.  I then explore 
how ad hoc policy approaches, characterised by contingent, incremental, and fragmented 
responses to policy issues, have further embedded inequities in relation to access.  By failing to 
consider the values and principles that underlie restricted access to ART, policy-makers have 
limited the reproductive choices of certain individuals and groups.  I discuss the implications of 
these issues of regulation, funding, and access for Mäori in relation to their marginalisation 
within the policy discourse.  Finally, I consider possibilities for future research and proactive 
policy attention, as well as the implications of this investigation for future policy considerations 
in Aotearoa/New Zealand. 
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2 
The Research Process 
 
…the critical issue for feminists is not so much the content of women’s choices, or 
even the ’right to choose,’ as it is the social and material conditions under which 
choices are made.             (Petchesky, 1990:11) 
2.1 Introduction 
The rationale for this research project is to explore how individuals’ access to assisted 
reproductive technologies (ART) has been shaped by the current policy context in 
Aotearoa/New Zealand.  Many commentators (Daniels, 1994a; Daniels & Hargreaves, 1997; 
Coney, 1999a) have observed that social policy on ART in Aotearoa/New Zealand has been 
created through a combination of existing legislation, professional self-regulation, health service 
controls, and consumer demand.  They have also noted that the recommendations from various 
commissions and committees throughout the late 1980s and early 1990s did not result in 
legislation.  Therefore, policy was often created by default, using these recommendations as 
guidelines.  The Status of Children Amendment Act 1987 (SCAA) is the only piece of legislation 
that specifically addresses ART.  In order to appreciate the current policy situation I decided to 
identify and analyse the discourses that have informed these various ‘default’ policies.  I 
concentrated on documentary evidence produced in relation to the ART policy debate and 
conducted in-depth interviews with representatives of organisations that had been involved in 
producing policy documents or were active in implementing policy.   
 
In this chapter, I will provide a detailed discussion of the research methods and processes used 
to inform this thesis.  Firstly, I will outline the research principles I applied to the research 
process and provide the definition of ‘policy’ as used in this research.  This will be followed by a 
discussion of my subject position in the ART policy arena.  I will then describe the research 
methods and the strategies used to select the documents and participating organisations or 
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individuals.  Next, the procedures used to make contact with and gain access to interview 
participants will be examined, followed by a detailed description of the interview process.  An 
analysis of the power relations encountered during this research will be followed by a discussion 
of the difficulties I experienced when engaging in cross-cultural research.  The chapter will 
conclude with a brief discussion of the programmes and strategies used to analyse the 
accumulated documents and interview material.  
 
In undertaking this research project, I recognised and tried to adhered to the five core 
principles of ethical conduct in social science research; do no harm, voluntary participation, 
informed consent, avoid deceit, and confidentiality or anonymity (Tolich & Davidson, 1999:69-
77).  I acknowledge that my own subjectivity and interest in the subject matter are relevant to 
the research process, from topic selection to dissemination of the findings (Oakley, 1981; 
Harding, 1987; Bishop, 1996; Tolich & Davidson, 1999).  In this chapter, I have attempted to 
place myself in the research process and provide a detailed account of the methods used, 
including the rationale for choices made throughout the process.  Although I identify myself as 
a feminist sociologist, I am aware that “there is not one feminism, but many feminisms: 
feminists across the disciplines work from within a multitude of intellectual paradigms and 
political positions” (Ray, 1996:36).  Therefore, I acknowledge that there is no definitive feminist 
method and that processes used by feminists are often widely divergent and multi-
methodological (Ray, 1996).  Reinharz (1992:6-10) relies on feminists' self-definitions of their 
work because she believes it avoids the danger of applying a one-dimensional definition to all 
feminist researchers and research and allows for the rapid changes in feminist scholarship.  My 
approach to this research was derived from feminist principles and understandings of how 
power differentials impact on all aspects of the research process.  Consequently, my attempts 
at reducing the impact of the power differentials that exist between researcher and participant 
were informed by feminist critiques of research methodology (Oakley, 1981; James, 1986; Cook 
& Fonow, 1990; Stanley, 1990a; Stanley, 1990b; Stanley & Wise, 1990; Fonow & Cook, 1991; 
Reinharz, 1992; Ray, 1996; Wyn, et al., 1996; Casper, 1997).  While I recognise that the 
research participants should be actively involved in the research and reciprocity should be 
encouraged in order to reduce the power differential between the researcher and participants 
(Oakley, 1981; Wyn, et al., 1996), I discovered this was not always practical or welcomed by 
some participants.
22
  Similarly, I recognise that applying feminist ideals to the research process 
does not automatically ensure that power inequities are eliminated (James, 1986:25).  This 
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became apparent when attempting to justify the inclusion of Mäori focused interviews and 
documentary information.
23
  I was also influenced by the belief that feminist-based research 
strives to advance the well-being of women by contributing to political changes that improve 
women’s lives (Cook & Fonow, 1990; Stanley & Wise, 1990; Reinharz, 1992; Stanley & Wise, 
1993).  Although this research is not overtly ‘women focused’, my interest in this topic has been 
shaped by an interest in how gender and the politics of reproduction affect women.  My 
decision to undertake ‘policy-focused’ research was influenced by this interest and the 
knowledge that policy has a profound effect on the “material conditions under which choices 
are made”, especially choices made by women in relation to reproduction (Petchesky, 1990:11). 
 
In this thesis ‘policy’ is used in its broadest sense to include both the private and public 
strategies used to regulate the provision and use of ART.  Acts of Parliament, Ministerial edicts, 
and Government initiated guidelines and strategy documents play a major part in policy 
formulation and implementation.  However, these are not the only contributions to policy.  
Managers, healthcare professionals, patients, and the wider community also establish policy 
through interpretation and implementation of these guidelines and strategies.  This broad 
approach to policy was influenced by Green and Thorogood’s (1998) position on health policy 
analysis. 
To understand how policy is made, and how it impacts on various groups in the 
population, it is not enough merely to look at the decisions of government 
departments.  We also need to examine the more local arenas of decision making 
and action.           (Green & Thorogood, 1998:11) 
 
Therefore, policy analysis in this thesis attends to the positions of various stakeholders, forms 
of legislation, organisational regulation, and debate about regulation and funding.  In the 
context of this research, ‘policy documents’ refers to both published and unpublished 
documentation that has contributed to the policy debate, influenced practices within fertility 
clinics, or affected consumer engagement with ART practices.  Published documents include 
records that have been published or made available to the public such as parliamentary debates 
(Hansard), published reports from committees and commissions, discussion documents, 
submissions on reports and discussion documents, parliamentary bills, academic papers, and 
service provision contracts.  Unpublished documents include records held by organisations or 
individuals that are not generally available to the public but contribute to the policy arena by 
outlining individual and organisational practices and the strategies used to implement policy.  
They may also be specifically written to lobby for official policy changes.  They include 
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submissions to select committees and government organisations, providers’ ‘Conditions of 
Service’ and policy documents, personal correspondence, documents generated by consumer 
and policy orientated lobby groups, service specifications, and clinical access criteria (see 
Appendix B for a list of the documents consulted for this thesis).  Commentary on ART policy 
was sought from representatives of organisations that were involved in the production of these 
documents.  Individuals who had contributed to or authored such documents were approached 
for interviews, as well as those who were actively involved in some aspect of the policy debate.  
As a result, interviewees were located within a variety of organisations including government 
policy agencies, fertility clinics, consumer representative groups, and health activist groups, as 
well as academic contexts (see Appendix C for a list of people interviewed). 
2.2 Taking Sides 
Finch (1986:209) argues that the knowledge created by qualitative policy-orientated research 
cannot be ‘objective’ in the sense of being neutral in relation to the political processes of policy-
making.  She suggests that the nature of the research and the methods used make it likely that 
the political stance adopted by the researcher will be oppositional with respect to the status quo 
and that the researcher is also likely to be ‘visible’ in the research process and its outcome 
(Finch, 1986:10).  Correspondingly, sociology has traditionally positioned itself as an advocate 
for the least powerful in society (Green & Thorogood, 1998:167).  Howard Becker (cited in 
Green & Thorogood, 1998:167) also argues that sociology has a role in challenging the 
‘hierarchy of credibility’ that affords more legitimacy to elite versions of social reality and, as 
such, ‘taking sides’ is inevitable in doing research.  However, Annette Lawson (1991:592) 
questions this assumption and argues that it is not always obvious who the less powerful are in 
health research.  Similarly, Casper (1997:252) found it difficult to identify whose side she was 
on and discovered that, given her dissimilar field of informants, she had to practice 
accountability in different ways.   
 
I began this research with the idea that I should perhaps “take sides”, but with some 
ambivalence towards which ‘side’ I was on.  The literature I reviewed presented compelling 
arguments ‘for’ and ‘against’ ART practices.  Even though Becker (1998:7) warns that such 
reviews can seduce “newcomers” to a field into adopting the ideas of the existing “experts” in 
that field, I was still not completely won over by the petition for unrestricted use of ART or by 
the argument for prohibition based on the negative consequences of these technologies.  I 
could not decisively position myself within what appeared to be a dichotomous debate.  Dion 
Farquhar’s The Other Machine: Discourse and Reproductive Technologies (1996) helped me 
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recognise that this, in itself, was a valid position.  Farquhar argues that reproductive 
technologies are a mixed blessing and there “seems no point in simply opposing them, since 
they are here to stay” (1995:7, emphasis added).  As she goes on to point out, not all women 
experience ART in the same way and, although some women may experience these 
technologies as exploitative and abusive, others may have empowering and satisfying 
encounters with them (Farquhar, 1995).  While public policies can regulate and control the 
exploitative and abusive aspects of these technologies, they can also contribute to the exclusion 
and marginalisation of some women who want to use ART.  It is with this in mind that I 
approached the interviews from an ambivalent subject position.  This position became less 
ambivalent as the research progressed.  I discovered that I could position myself as an 
advocate for those who experience unequal access to publicly funded ART services and for 
those whose reproductive choices are jeopardised by the lack of adequate social policies and/or 
regulations to control the potential for abusive use of ART in Aotearoa/New Zealand.   
2.3 Research Methods 
Research for this project consisted of a literature review, content analysis of a selection of 
original documents that have contributed to policy surrounding assisted reproductive 
technologies (ART), and semi-structured in-depth interviews with representatives of 
organisations involved in the development, interpretation, and implementation of that policy.  
Literature surrounding infertility, rights and choice, the regulation and control of reproduction, 
and ethics in relation to ART was accessed from a variety of disciplines.  These included 
sociological, feminist, political science, psychological, biomedical, and ethical perspectives and 
particularly drew on feminist discussions related to the politics of reproduction (O'Brien, 1981; 
Petchesky, 1990; Farquhar, 1996; Albury, 1999).  This literature informs discussions throughout 
the thesis, particularly, but not exclusively, in relation to discussions about reproductive rights.  
As mentioned earlier, Farquhar (1996) provided an excellent starting point for my own 
positioning in the debate.  She argues that the discourses surrounding ART contribute to the 
construction of “new identities and subjects, along with new expectations, fears, and conflicts” 
and that “both clients and resisters create new normative categories and new relationships to 
the technologies that in turn modify them” (Farquhar, 1996:7).  O’Brien (1981) and Petchesky 
(1990) provided comprehensive theoretical analyses of the feminist politics of reproduction, 
while Albury (1999) explores the different discursive influences on women’s fertility decisions 
and experiences.  She investigates what counts as evidence and who is an authorised expert in 
the political contests surrounding the regulation of fertility (Albury, 1999:2).  Her argument 
“that we need to look beyond the commonsense understandings of motherhood, 
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heterosexuality and family formation which shape policy debates” (Albury, 1999: back cover) 
helped shape the focus and structure of this thesis.  Consequently, this thesis tries to look 
beyond these commonsense debates and investigate their influence on access restrictions to 
ART, the legal recognition of donor-assisted parenthood, and the rights of those involved in the 
formation of families using ART and donor gametes. 
 
Although policy documents are only part of the discourse that surrounds policy formation and 
implementation, they are purposefully written to record or to provoke discussion of a social 
practice.  Recognising the importance of policy documents in this context and, because of time 
and financial constraints, I decided to confine the research for this project to documents 
specifically produced to influence or establish ART policy.  However, documentary evidence only 
represents formal policies and, as such, the philosophies and practices of the actors who shape 
policy ‘on the ground’ could not be accessed solely by an analysis of these documents.  
Therefore, I chose to use a combination of documentary analysis and in-depth interviews to 
explore the influences and motivations of the various commentators and formulators of policy in 
the ART policy debate.   
 
Interviews with state agencies, fertility clinics and health providers, consumer groups, and 
academic commentators were seen as vital sources of information on ART policy.  While I 
identified the documents as representing the ‘public’ account of ART policy, I anticipated that 
in-depth interviews would reveal some of the ‘private’ rationalisations offered by those who 
contributed to the policy debate.  Appreciating that policy is not only influenced by decisions 
and documents produced by government organisations, I chose to include the more local areas 
of policy interpretation and implementation (Green & Thorogood, 1998:11).  Therefore, non-
governmental documents and interviews with non-governmental actors in the policy debate 
were also included.  State produced documents included reports from ministerial committees, 
State commissioned discussion documents, and ministerial policy documents and annual 
reports.  Non-governmental documents included submissions to the Parliamentary Health Select 
Committee, providers’ proposals to the Health Funding Authority (HFA), the New Zealand 
Infertility Society’s magazine, professional codes of practice, and privately produced discussion 
documents such as Protecting Our Future (Coney & Else, 1999).  Interview participants from 
State agencies included representatives of the Ministry of Health, Te Puni Kökiri (Ministry of 
Mäori Development), and the Health Funding Authority (HFA).  Actors who were interviewed 
outside the governmental realm included fertility clinic managers, the New Zealand Infertility 
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Society (NZIS) Executive Officer, the Family Planning Association (FPA) Medical Training Co-
ordinator, health activists, and an academic. 
 
Preliminary analysis of the policy documents had indicated that, while there were explicit 
agendas influencing the documents, there were also less obvious ideologies influencing some 
recommendations and guidelines.  As Green and Thorogood (1998:157) point out, 
Much policy making rests on implicit assumptions, … and each of these derive from 
a particular set of beliefs about the world and will influence the type of action (i.e. 
politics) which are aspired to, if not achieved.  Thus … policies are the result of 
politics, that is, systematic ideas about how society does (or should) function. 
 
Like Luker (cited in Reinharz, 1992:148), I anticipated that a comparison of ‘produced’ interview 
material with ‘found’ archives and organisational literature would enhance my understanding of 
the relation between individual understandings and the public discourses of organisations.  I 
hoped that the in-depth interviews would indicate some of the underlying assumptions and 
beliefs that have contributed to the formulation of ART policy.  However, I also anticipated that 
the interviews would provide an opportunity to gather private and/or unpublished documents 
that I would not otherwise have had access to, as well as providing me with more insight into 
how the policy process works ‘on the ground’.  In addition, I wanted to examine what the 
differently situated organisations perceived to be the important issues, as well as analysing the 
silences and gaps in the policy discourse.   
2.4 Strategies for Accessing Documents 
Initial documents analysed included the Ministerial Committee on Assisted Reproductive 
Technologies (MCART) report, Navigating Our Future (1994), as well as work by Daniels 
(1994b) and Daniels and Hargreaves (1997).  The MCART (1994) report and academic research 
articles (Daniels, 1994a; Daniels & Hargreaves, 1997) had informed an Honours Degree 
research project in 1999 and investigating sources mentioned in these documents through 
library and Internet searches yielded other relevant material.  However, these strategies only 
alerted me to published discussion documents.  Interview participants proved invaluable in the 
search for both published and unpublished literature, including press releases, ‘Conditions of 
Service’, and draft policy changes, as well as submissions made in response to reports and 
discussion documents.  Either these documents had been produced by the participants’ 
organisations and were not published or readily accessible through libraries and the Internet, or 
they were communications between the actors involved in ART policy.  Serendipity, as 
mentioned by Stacey (1991:27), also proved to be a valuable research tool and seemingly 
chance events helped locate some important documents.  Random scanning of the Health 
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Funding Authority’s (HFA) website produced a copy of the funding contract between that 
organisation and Fertility Associates in Auckland.  Similarly, a chance comment to Dianne Yates’ 
(Member of Parliament for Hamilton East) personal assistant led me to the written submissions 
to the Health Select Committee.  These submissions had been ‘tabled’ the previous day and 
were only just available to the public.  As I was due to leave Wellington the next day, this 
information was invaluable.  However, it would not have been brought to my notice if the 
personal assistant had understood my original question.  These situations cannot be planned for 
and serve to reinforce the need to pay attention and follow even the most inconspicuous lead 
when chasing research material.  The regulation and control of ART practices has proved to be 
a fast-changing and dynamic policy arena in which to research.  Therefore, documentary data 
collection has continued throughout the duration of this thesis (see Appendix B for a list of the 
documents consulted for this thesis).   
2.5 Selecting Participant Organisations & Individuals 
I began the process for selecting participant organisations in early March 2000 while compiling 
and refining the research proposal.  The selection process was ongoing and covered several 
months, overlapping with access strategies and the interviews, because selected organisations 
were not always available or willing to participate.  Initially, I developed a flow chart (see 
Appendix D) to assist in the identification of the major actors involved in the ART policy debate 
in Aotearoa/New Zealand.  This device enabled me to categorise these actors into three broad 
organisational groups (state, providers, and consumers/commentators) and provided a 
framework within which to locate selected interview participants.  I positioned Government 
organisations and politicians under ‘state’, fertility clinics and other health service providers 
under ‘providers’, and consumer and political lobby groups, as well as academic researchers and 
commentators, under ‘consumers/commentators’.  However, I anticipated that some of these 
organisations and/or their representatives would belong to more than one category.  Likewise, 
organisations grouped together would not necessarily identify or agree on areas of concern and 
may even have opposing ideas about the ways in which access to ART is constrained or enabled 
by existing policy.  As I was hoping to ascertain some of the underlying assumptions and beliefs 
that have contributed to the formulation of ART policy, it made sense to target organisations 
that were involved in the production of the policy documents.  While I acknowledge that 
specific individuals cannot represent or speak on behalf of all members of a social group 
(Edwards, 1996:169), the interviewees were accessed as representatives of public and private 
organisations and, as such, were speaking as named participants on behalf of their 
organisation.  Once again, financial constraints placed limits on the selection of participant 
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organisations.  Travel and accommodation costs influenced the location and number of 
organisations that could be approached for interviews, as well as affecting the timeframe for 
the interviews.  As most of the targeted organisations were based in Wellington or Auckland 
and my home base is Christchurch, consolidating interviews in these three locations was my 
highest priority.  Similarly, time constraints meant that not all of the initially targeted 
participants could be included in this study.  For these reasons, people and organisations such 
as Wayne Gillett,
24
 the Otago Fertility Service, Paparangi Reid,
25
 Phillida Bunkle,
26
 the Human 
Rights Commission, the New Zealand Medical Association, and the New Zealand Endometriosis 
Foundation were not approached for in-depth interviews. 
 
Some organisations, such as the New Zealand Infertility Society (NZIS), the Ministry of Health, 
and fertility clinics, were obvious targets for interviews.  I decided to speak to representatives 
of the Christchurch Fertility Centre because it was geographically accessible and I had already 
established a working relationship with this organisation.  North Shore Fertility was selected 
because it is a private clinic that does not provide publicly funded treatment and I thought that 
they might provide a divergent perspective on ART policy from the other clinics.  Additional 
organisations were identified through the previously accessed documentation and the Internet.  
MCART’s (1994) report provided lists of organisations and individuals that had made 
submissions to the Ministerial Committee and this helped identify organisations that I believed 
would still have an active interest in ART policy.  I added government organisations to this list, 
such as the Ministry of Women’s Affairs, the Ministry of Health, the HFA, and the National 
Advisory Committee on Health and Disability, because I assumed they would have an interest in 
ART policy.  Individuals who had a high profile in the policy debate and/or had participated in 
the authorship of policy documents, such as Sandra Coney, Dianne Yates, Ken Daniels, and 
John Peek, were also included.  I continued the selection process while carrying out the 
interviews in Auckland and Wellington, as participants frequently provided names and contact 
information of people they considered were important in the ART policy debate and who were 
likely to make a valuable contribution to the research.  Although I tried to contact some of 
                                            
24
  Wayne Gillett is an Associate Professor with the Department of Obstetrics and Gynaecology at the 
University of Otago and a co-author of Costs and effectiveness of infertility services in New Zealand: a 
decision analysis (Gillett, et al., 1995) and Access to Infertility services: development of priority criteria 
(Gillett & Peek, 1997).   
25
  Dr Paparangi Reid was a member of the two-person Ministerial Committee on Assisted Reproductive 
Technologies and co-authored their report, Navigating Our Future (MCART, 1994). 
26
  Phillida Bunkle is a Member of Parliament and a member of the Health Select Committee considering 
the two bills on ART. 
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these people, they were often unattainable or unavailable because of time constraints or other 
commitments.  
2.6 Making Contact & Gaining Access 
The access process proved to be the most time consuming and, at times, frustrating aspect of 
the research.  I began approaching organisations and individuals in May 2000 to request the 
contact names and addresses for recipients of introductory letters.  In most cases I selected the 
manager, chief executive, or director of the targeted organisations as the initial contact and 
possible interviewee.  In some cases, however, the organisation and/or representative were 
selected because of their high profile in the policy debate and/or authorship of policy 
documents.  Once again, the Internet proved to be a valuable resource and I was often able to 
access names, phone numbers, and addresses via the targeted organisation’s website.  I 
identified additional participants by phoning the organisation in question and requesting the 
name of someone who could be contacted in relation to my research.  Occasionally, I was 
redirected to people in a variety of positions before locating someone who was willing to be 
identified as a contact and/or was conversant with the topic.  Sometimes this course of action 
would lead nowhere and I would have to begin the process again.  On one occasion, I was 
redirected to the Executive Officer of a consumer organisation who was more than willing to 
participate in the research, as well as provide additional documentary information.  This 
circumvented sending the introductory letter and I was able to make an interview appointment 
straight away.  Once a contact name was provided or located, this person was sent a letter of 
introduction or contacted by telephone.  Sixteen organisations and two individuals were initially 
contacted for interviews.  Of these initial contacts, twelve organisations and the two individuals 
agreed to participate in the research project. 
 
On 8 June 2000, I sent fourteen letters to the selected interview participants or institutional 
contacts in Wellington and Auckland.  These letters described the research and asked for the 
recipients’ participation or that of a nominated representative (see Appendix E for a copy of the 
letter).  Potential interview participants in Christchurch were initially contacted by telephone and 
the first telephone access was made on the 9 June 2000.  I used this approach in Christchurch 
because I had established a previous research relationship with some of the targeted 
organisations.  I also wanted to shorten the access process so that I could commence the local 
interviews prior to starting those in Wellington or Auckland.  These initial interviews helped me 
refine the interview process and indicated some additional interview topics to include on the 
  
37
 
subsequent interview guides.
27
  However, access to contact names and possible interview 
participants continued to be a complicated and time-consuming process. 
 
The original strategy was to follow the introductory letters with a telephone call within the 
ensuing two weeks to establish the recipients’ and/or organisations’ willingness to participate, 
and to organise interview times if appropriate.  However, one of the targeted recipients 
contacted me the day he received the letter to arrange an interview date and time.  Another 
emailed me to inform me that she was leaving the organisation and that her position would 
cease to exist.  However, she had passed my letter on to her manager had undertaken to 
contact me with an alternative representative.  The enthusiastic response by these two people 
was reassuring and I was encouraged to hope that gaining access to interviewees would be 
easier than I had originally anticipated.  This confidence was short-lived and I managed to 
confirm only three interviews after contacting eleven organisations with the follow-up phone 
calls on the 14 June 2000.  One of the confirmed interviews was with the person who had rung 
me two weeks earlier and another was with a provider representative who would be overseas 
when I was intending to be in Auckland.  Fortunately, this representative agreed to a telephone 
interview when he returned to Aotearoa/New Zealand.  One contact for a government 
organisation declined an interview because he felt the organisation did not have anyone 
currently working in the ART policy arena and, therefore, did not have anything to contribute to 
the debate.  The remaining contacts were not available or had referred my letter to someone 
else, who had not had an opportunity to read it.  I noted the new contacts’ names and 
arranged to make another set of calls the following week.  
 
My first experience of ‘gatekeeping’ involved the information officer of a government 
organisation who refused to provide me with a direct contact when I phoned that organisation 
in May 2000.  She suggested that I email the introductory letter directly to her and she would 
then pass it on to those she thought were appropriate.  I had hoped to avoid such tactics by 
targeting those at top of the ‘institutional hierarchy’.  Although I recognised that all my contacts 
were gatekeepers to some degree, I reasoned that it would save time to target those people 
whom I assumed would have the ultimate responsibility for approving their organisation’s 
participation in the research.  This strategy did not work in all cases as personal assistants or 
secretaries often vetted the recipients’ mail and proved to be gatekeepers in their own right.  
One state organisation, with which I negotiated access through a gatekeeper, refused to 
                                            
27
  See Section 2.7, The Interviews, in this chapter for a discussion of interview strategies. 
  
38
 
participate after I had sent the introductory letter to the nominated representative.  I had not 
been able to talk directly to the targeted participant and I was suspicious of this decision, 
speculating that my request was considered a low priority and I was being ‘fobbed off’.  This 
proved to be a valid suspicion when, a month later, the Chief Executive of the organisation 
contacted me after she finally received my letter.  She expressed concern that I had not 
received a reply.  However, she justified the decision not to participate by arguing that her 
organisation performed an advisory role rather than an active policy-making role and she 
believed that the organisation would not have anything further to contribute to the debate.  I 
was left with the impression that the outcome may have been different if my letter had reached 
her desk first and I had been able to talk directly to her when I made the follow-up phone call.   
 
Gatekeeping occurred more frequently in relation to government organisations, where initial 
contacts appeared to be far more wary about participating in the research than those in non-
governmental organisations and private enterprise.  Nevertheless, some of the larger private 
organisations also refused to take part in my research project.  Again, my contact with these 
organisations was with gatekeepers and I suspected that the request had not reached the 
intended participants.  However, this reticence may have been a consequence of the contact’s 
position in a hierarchically structured institution that requires the employee to operate within a 
context of loyalty and formal procedures (Green & Thorogood, 1998:163).
28
  Furthermore, it 
may have reflected the lack of priority given to ART matters by some organisations, as well as 
institutional resource and time constraints that preclude employees spending time on projects 
outside their own organisational responsibilities.  People were being approached as named 
commentators and were required to make public statements on behalf of their organisations on 
a controversial topic and this may have acted as a disincentive to involvement in the project. 
 
In order to establish a timeframe in which to schedule the interviews I verified air travel times 
and availability before contacting potential participants.  As it was necessary to confirm the 
interviews before finalising travel arrangements, the delay in contacting people meant that the 
window of opportunity in which to book airfares was closing.  Finally, through a combination of 
repeated phone calls and email messages I confirmed one more Auckland interview and three 
more Wellington interviews.  Consequently, I had scheduled only two face-to-face interviews in 
Auckland.  While this gave me time to follow the additional leads that I had been given while 
                                            
28
  See Section 2.7, The Interviews, in this chapter for a discussion of how the interview participant’s 
position in the organisation may also have affected the interview process. 
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trying to access participants, these proved fruitless as the people and organisations involved 
could not see me within the timeframe I had allowed or they were not available.  I had 
managed to arrange five interviews in Wellington over a period of three days.  However, this 
meant doing two interviews a day and left little latitude for changes in schedules.  Before 
leaving for Wellington I had to reschedule two of these interviews because of changes in the 
participants’ schedules.  This proved a complicated process as I had allowed little time within 
which to negotiate changes and I was unable to change flight bookings because of the financial 
consequences and the availability of seats.  There was less urgency in arranging or changing 
interview times in Christchurch and, although I had arranged and completed two interviews 
before leaving for Auckland, I continued the access process for these interviews once I returned 
from the North Island.  An additional interview in Dunedin was scheduled when the participant 
contacted me after being notified of the research project by another contact. 
 
Initially, methodological procedures for gaining access worked well.  Nonetheless, it became 
obvious that accessing participants is time consuming and not as straight forward as my initial 
success suggested.  Difficulties in contacting gatekeepers and their inability to access potential 
participants meant that timetables were disrupted and access strategies needed to be revised 
or adjusted.  In retrospect, excluding obvious financial and time constraints, the snowball 
method of gaining potential participants would have worked well in this project.  As mentioned 
earlier, many of the interview participants provided names of organisations and individuals that 
could have made valuable contributions to the research.
29
  Although I tried to contact some of 
the people recommended by other participants, only one responded to my overture and was 
available for an interview.  Furthermore, the tightly constrained interview timeframes in the two 
North Island locations meant that the interview schedule was somewhat inflexible, particularly 
in Wellington.  Consequently, interview opportunities were missed as information on additional 
commentators or participants in the ART policy arena could not be followed up and one 
cancelled interview could not be rescheduled.  As with the selection process, access initiatives 
continued over several months, overlapping with interviews and the transcription process.  The 
final interview participant was confirmed on 11 August 2000, three months after the first 
contact was initiated.  In general, gaining access was far less troublesome with private 
organisations than with government organisations, where I had to negotiate with gatekeepers 
and encountered hierarchical decision-making processes.  One positive outcome of locating 
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  In some cases, potential interviewees were recommended by more than one person and others had 
already been approached or considered for interviews.  
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potential participants via a range of intermediate contacts was that I gained information on the 
structure of the organisations I was trying to access, as well as insights into the policy process 
‘on the ground’.   
2.7 The Interviews 
The interviewing process began on 14 June 2000 and the final interview was undertaken on the 
31 August 2000.  Fourteen interviews were carried out, consisting of twelve face-to-face 
interviews and two telephone interviews (see Appendix C for a list of the organisations and 
individuals involved in the interview process).  Two of the face-to-face interviews were 
undertaken in Auckland, five were situated in Wellington, one in Dunedin, and the remaining 
four took place in Christchurch.  Both of the telephone interviewees were located in Auckland.  
Before each interview commenced, the participant or participants were given an information 
sheet and asked to complete a consent form (see Appendix F for examples).  The information 
sheet explained the focus of the interviews and reminded the participants that they were being 
interviewed as representatives of the organisation for which they worked.  All of the 
interviewees were interviewed in their professional capacity as representatives of organisations 
or as academic researchers/commentators who have made public contributions to the ART 
policy debate and, as such, it was not considered necessary to offer anonymity.  Thirteen of the 
interviews were audiotaped to allow the interview to be transcribed verbatim and to ensure the 
information collected was accurate.  Although permission to tape the interviews was sought 
during the access process, I repeated this request before commencing the interviews.  Where 
possible, hand written notes were taken.  However, note taking proved difficult when I 
considered it necessary to concentrate fully on the participant’s conversation.  This was 
particularly necessary in two cases when there was significant background noise and the 
participants were very softly spoken.  An interview with Dianne Yates (Member of Parliament 
for Hamilton East) was so constrained by time that it was not feasible to set up the tape 
recorder and only hand written notes were taken.  Although this severely limited interview did 
not provide any information I could use in the final analysis, it did provide an unplanned 
opportunity to access invaluable documentary information in the form of the written 
submissions to the Health Select Committee.
30
 
 
                                            
30
  This serendipitous event is described in Section 2.4, Strategies for Accessing Documents, in this 
chapter. 
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Eleven of the face-to-face interviews were conducted in the participants’ workplaces and one 
interview was conducted in the participant’s home.  The two telephone interviews were 
conducted at a time the participant nominated.  One provider representative consented to 
material from an interview for an earlier research project being included in this thesis.  
Consequently, material from both interviews has been used in this thesis and is differentiated 
by the dates on which the interviews took place.  The length of the interviews ranged from 10 
minutes to 105 minutes.  This variation in length was dependent on the participant’s personal 
and professional involvement in and knowledge of the policy debate, as well as other 
commitments.  All the interviews were undertaken using a semi-structured, in-depth approach.  
This meant that, although the interviews were focused on ART policy and what the participant 
perceived to be the enabling or constraining aspects of this policy, standardised questions were 
not used.  This approach allowed the interview participant/s to engage with the topic and 
address issues they thought were important.  However, as I was interested in the policy ‘gaps’ 
and the marginalisation of certain groups within current policy discussions, I would introduce 
these topics if the participant/s had not addressed them during the course of the interview.  
Accordingly, interview guides were used to help keep the interview focused and to ensure these 
issues were addressed (see Appendix G for an example of the interview guide).  These guides 
varied between the three categories of participating organisations to allow for the different 
institutional contexts and perspectives.   
 
On three occasions, considerable prompting and probing were necessary to generate 
engagement with the topic.  This occurred in interviews with representatives of state 
organisations.  Participants in two of these interviews had been nominated by a gatekeeper to 
represent their organisation and were accompanied by a more senior work colleague.  These 
representatives tended to have little accumulated knowledge of ART practices and policy.  
Restructuring, changing administration, and staff retrenchment have meant that staff with 
institutional and historical knowledge of the issues have moved on and those interviewed were 
new to the area and had a limited work-related knowledge of ART policy issues.
31
  This would 
have influenced their ability to engage with the topic without prompting and could explain why 
some individuals and organisations would not agree to an interview.  The responses of 
participants working within government organisations may also have been influenced by their 
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  See Chapter 3, Regulating Practices, Section 3.7, Accountability, for a discussion of how the depletion 
of institutional knowledge and experience within government agencies has affected consumer trust in 
these policy organisations. 
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position within an “institutional context of hierarchy, loyalty and formal procedures” (Green & 
Thorogood, 1998:163).  This was sometimes evident when the interviews were completed and 
the tapes were turned off, as the participants relaxed and were more open about their personal 
and professional views.  Although employees of private organisations may also be influenced by 
their position within the institutional context, those interviewed within the provider and 
consumer/commentator categories appeared to be less constrained and guarded in their views 
and were more inclined to blend their personal and professional opinions.  The organisations 
targeted in these groups were smaller than the state organisations and were represented by a 
manager, chief executive, or director who had more institutional authority to speak on behalf of 
their organisation than the state employees did.  Their confidence and candour when discussing 
the issues could have been due to the senior positions they held in their organisations.  
Furthermore, the provider and consumer/commentator organisations that participated in the 
research generally specialised within the ART area and were directly affected by the policy 
debate.  Therefore, they may have been more informed and more capable of discussing the 
issues in depth.  However, it was evident that all the interviewees engaged in strategic 
representation of their organisations and their policy positions. 
 
One state organisation initially declined my request to tape-record the interview and hesitated 
about signing a consent form.  Although the organisation had previously contributed to the ART 
policy discussion, this input was limited, and those who had been involved in this work were no 
longer part of the organisation.  Understandably, the representatives were wary of discussing 
something about which they had only limited knowledge.  Although an interview strategy was 
negotiated that enabled the interview to proceed and gave the participants more control over 
the eventual use of the interview material,
32
 they were generally very cautious with their 
responses throughout the interview.  Although copies of relevant published information from 
the organisation were made available, I was informed that I would have to use the Official 
Secrets Act to gain access to unpublished material related to their policy involvement (this 
related to submissions, guidelines, and recommendations).  Hornsby-Smith (1993:54) argues 
that some organisations approach participation in research with caution because they “see 
research as a threat because … there are fears of exploitation or it may result in damaging 
disclosures….”  Although the organisation did not restrict physical access to the research 
setting, access to information was restricted through discursive strategies, such as reluctance in 
responding to questions and an unwillingness to provide access to unpublished documentation. 
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  See Section 2.9, Cross-Cultural Research, in this chapter for a discussion of this negotiation process. 
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These were tightly focused interviews with representatives of public or private organisations 
reflecting on their organisations’ role in the ART policy debate.  As such, participants were 
interviewed in their official capacity and were not required to share personal information or 
experiences.  The more formal nature of the interviews precluded the use of a conversational 
style and equal sharing to reduce power differentials between the participants, as advocated by 
Anne Oakley (1981).
33
  Although I occasionally employed conversational interaction, I preferred 
to limit my spoken involvement in the interviews.  Rather than positioning myself as distant and 
impartial, I was attempting to remove any influencing or disrupting elements while maintaining 
an involved presence.  The first transcription made it obvious that even my restrained presence 
could disrupt the participants’ focus or train of thought.  My murmured agreement could also 
prevent the speaker from finishing what they were saying, as they obviously assumed I 
understood or knew what they intended to say.  I tried to be more aware of the impact of my 
own participation in the subsequent interviews.  Although I would intercede to clarify a point, 
direct the discussion towards certain issues, or answer direct questions, I tried to limit my own 
participation so that I was not interrupting the participants or preventing them from completing 
what they were saying.  Nevertheless, some interviews were more informal than others and it 
was not possible to sustain this strategy of limited participation.  Increased participation on my 
part was also necessary in the interviews that required more prompting and consistent follow-
up questions.  By necessity, the telephone interviews were more focused and formal than the 
face-to-face interviews.  These variations in procedure highlighted the unpredictable nature of 
interviews and the need for flexibility in interview techniques.   
 
Scheduling five interviews over three days while in Wellington was tiring, with little time to 
refine and reflect on the process.  Ideally, more time between interviews would have enabled 
me to transcribe and absorb what was discussed in each interview before carrying out the next 
interview.  Although I had allowed five days between the Auckland and Wellington trips to 
review the interview process, this time was taken up with access issues and reorganising 
scheduled interviews.  Time constraints in Wellington also caused problems when two interview 
participants needed to reschedule at short notice.  My inability to reschedule within the time I 
had allowed meant that one interview was severely constricted by time and the other had to be 
carried out with a replacement representative who was less informed than the original 
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  See Section 2.8, ‘Studying Up’ & Discrepancies in Power, in this chapter for a discussion of the 
strategies used to diminish power inequities  
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participant.  All the participants agreed to further contact if the transcription and analysis 
process highlighted any issues or questions that needed clarification.  Both telephone interview 
participants were forwarded consent forms to complete. 
2.8 “Studying Up” & Discrepancies in Power  
While the more common research relationship involves the subjects of the research having less 
power than the researcher, this is not always the case.  In some research situations, those 
being studied have considerably more institutional power than the researcher.  Monica Casper 
(1997:245) describes this as “studying up”.  She suggests that interviewing people in elite 
settings and as part of elite social networks has important implications for the nature of the 
research and “may affect everything from the feelings of the researcher to how we represent 
ourselves in research sites to issues regarding access” (Casper, 1997:245).  During most of the 
interviews I was aware that I was “studying up” and that certain interview participants had 
more institutional or reputational ‘power’ than I did as a female student researcher.  For the 
most part the interviewees were managers, directors, or executive officers within the 
participating organisations and some of the interviewees were medical specialists.  Casper 
(1997:247) suggests that the elite nature of specialised knowledge within medical and techno-
scientific settings also contributes to power inequities.  Nonetheless, I did not feel intimidated 
or disadvantaged by this lack of specialised knowledge, even though I often had to ask for 
clarification of clinical and scientific terms and practices.  Like Casper (1997:247), I discovered 
that the participants’ answers often produced useful information or insights.  However, the 
participants’ institutional knowledge and position were not the only factors influencing the 
power relationship between researcher and participant.  I contributed to the power imbalance 
by conferring on some participants what Weber called “charismatic authority” (Ritzer, 
1996:132).  These participants had gained status via their reputations in academia or the 
popular media and my deference to their experience and knowledge added to my perception of 
“studying up”.  One participant’s seemingly aggressive response to my request for an interview 
certainly accentuated my own insecurities about the validity of my research and the questions I 
wanted to ask.  I approached this interview with some trepidation, expecting impatience and 
condescension.  Although I was consciously aware of my perceived ‘inferior’ position, the 
participant’s responsiveness and hospitality during the interview diluted any discomfort and 
nervousness.  This situation revealed how power differentials can be misinterpreted or 
exaggerated by the researcher’s own subjectivity.   
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Although I felt it was not appropriate to use the feminist interview techniques advocated by 
Oakley (1981), I did try to reciprocate or ‘give back’ during the interviews.  While I did not 
volunteer information about my position in the policy debate, I was willing to answer any 
questions about this position.  However, I was rarely asked where I stood on any of the topics 
discussed and, in general, the participants showed no curiosity about my political position in 
relation to ART.  On occasion I would ‘share’ personal information or the motivations behind my 
research involvement in the ART field with the participants but this was generally during the 
more informal or less focused discussions towards the end of the interviews and the ‘sharing’ 
was usually initiated by me.  Jane Ribbens (1989:584) observes that interview participants may 
interpret the research situation as giving them permission to talk about themselves or their 
opinions at length.  Consequently, they may perceive any unasked for interruptions or 
contributions by the researcher as a nuisance and not part of the original research agreement.  
Similarly, Gayle Letherby (Cotterill & Letherby, 1993:6) discovered that her involvement and 
presence in the interviews was partly structured by her respondents’ interest or lack of interest 
in her personal history.  It is likely that the participants made certain assumptions about my 
position in the ART policy debate.  However, only two interviewees articulated their opposing 
assumptions.   
 
A participant’s assumption that I was politically aligned with her organisation, combined with 
my own feelings that I was obliged to ‘give back’ in some way, created a situation where I felt 
unable to refuse a request.  Directly after one interview I was asked to “return the favour” by 
performing a small task at a function the organisation was arranging.  I felt obligated to agree 
and I was left wondering how I would have handled this situation had the request been for 
something that I was uncomfortable with or opposed to doing.  I can only assume I would have 
negotiated some other way of ‘repaying the debt’.  This situation accentuated the fact that 
participants may have expectations about continued involvement and assistance from the 
researcher and why strategies need to be in place for dealing with such requests.  It also re-
emphasised the complexities of power in research; the researcher and participants may occupy 
shifting positions in the relationships of power and this relationship may not be completely one-
sided (Cotterill, 1992; Cotterill & Letherby, 1993).   
 
Finch (1986:206-207) argues that discussions of research ethics often distinguish between the 
relative power of different research subjects.  She also suggests that considerations of privacy 
and protection can be partially suspended in research on the ‘powerful’.  However, participants 
in policy research can be officials who themselves are relatively powerless within the setting 
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being researched and, therefore, ethical issues may not be particularly different from research 
on less powerful groups (Finch, 1986:206-207).  As noted earlier, the participants working 
within the government organisations I targeted were more likely to have been in this position 
than the managers and directors of the private organisations.  Nevertheless, these participants 
were in some sense powerful relative to the researcher, as I was reliant on their ability and 
willingness to provide access to organisational literature and information. 
 
While I experienced power inequities within the access process and research setting, I also had 
significant power as researcher.  I decided what research topic to address, what methods to 
use, whom to interview, when to probe, as well as how to interpret, analyse, and present the 
information the participants gave me.  Like Bev James (1986:30), I justified such decisions in 
terms of what she calls “necessary power”.  Although those with more institutional power may 
have the means by which to protect themselves from exploitation, I agreed with Finch’s 
(1986:207) argument that the ethical issues of doing no harm and maintaining privacy were still 
valid.  In order to reduce the likelihood of doing harm and to ensure that none of the 
participants felt disempowered by the interview process, consent forms were introduced before 
the interviews began.  As Green & Thorogood (1998:169) suggest, confidentiality is an 
important ethical consideration within health care settings because “individual professionals 
may be providing information that could damage their relationships with others if made public, 
or damage the reputation of their organisation.”  For this reason, the consent forms provided 
the participants with the opportunity to specify how they wished to be represented in the 
research (see Appendix F).  Two organisations also chose to use the consent forms to impose 
limitations on the use of the information they gave me.  However, only one of these interviews 
was used in the final analysis as the other interview provided little information relevant to the 
research topic.
34
   
 
In conjunction with the consent form, the participants were given an information sheet prior to 
commencing the interview (see Appendix F).  As mentioned earlier, the information sheet 
outlined the research project and reminded the participants that they were being interviewed as 
                                            
34
  This interview was with a women’s health collective, which provided free health related information 
and advice.  Most of their work, at the time of the interview, involved contraceptive advice and 
pregnancy tests for teenagers.  If they were asked for advice on fertility problems their policy was to 
refer the person on to a doctor or the Family Planning Association.  I decided not to transcribe the tape 
as there was little information I could use directly.  However, the interview was the first one I undertook 
and it provided an opportunity to develop and extend my interview skills. 
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representatives of the organisation they worked in.  It also contained the names of my 
supervisors and university contact information to allay any concerns they might have about 
participation in the project.  Furthermore, a ten-page summary was offered to their 
organisation upon request at the completion of the thesis and information on accessing the 
completed document was provided.  Although this provision was made in order to provide some 
feedback and reciprocity for participation in the project, only two participants requested a copy 
of the summary for their organisation.   
2.9 Cross-Cultural Research 
Feminist-based research methods acknowledge the inherent power imbalance between the 
researcher and the participants, as well as the researcher’s subjective influence on research 
decisions.  Such methods seek to address and reduce this power imbalance by actively involving 
participants in the research process and by informing participants of the results of the research 
(Wyn, et al., 1996: 166-169).  However, these strategies cannot completely eliminate ethical 
dilemmas within the research process, especially the dilemmas posed by undertaking cross-
cultural research. 
A Pakeha researcher neither can nor should speak for women of another culture.  
With her different personal experiences and social position a Pakeha woman must 
acknowledge her perspective is imbued with assumptions based on her own 
ethnicity.          (James, 1986:26) 
 
With this in mind, it was with some trepidation that I approached the idea of including Mäori 
and conducting interviews with representatives of Mäori focused organisations.
35
  An awareness 
of the ethical issues of marginalisation, exploitation, and power inequality surrounding the 
inclusion of Mäori created a twofold tension.  If I wanted to examine the policies and practices 
surrounding ART in Aotearoa/New Zealand, how could I justifiably refrain from addressing these 
issues in relation to Mäori?  Conversely, how could I, as a Päkehä researcher, attempt to 
explore and write about these issues in relation to Mäori?  Although I ultimately decided to 
include a chapter focusing on Mäori infertility and ART, this complicated and troubling tension 
continued throughout the research, as well as during the writing stages.  It highlighted the 
ethical responsibilities I had as a feminist researcher.  Nevertheless, the most significant reason 
for including Mäori in this research project was based on the unique status that Mäori occupy as 
tangata whenua and as partners to te Tiriti o Waitangi (the Treaty of Waitangi).   
 
                                            
35
  Even though I recognise that other ethnic and cultural groups may have similar or divergent issues 
relating to ART, it was beyond the scope of this thesis to address these issues. 
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The decision to request and carry out interviews with representatives of Mäori focused 
organisations was grounded in an awareness of my own limited knowledge of Mäori culture, 
difficulties with cross-cultural research practices, possible access difficulties, and an 
unwillingness to exploit Mäori perspectives.  An appreciation of the basic principles of Kaupapa 
Mäori research and Mäori-centred research (Bishop, 1996:11-19; Cunningham, 1998:399-402) 
added to the personal and political unease I was experiencing.  I acknowledge and accept the 
reasons behind the growing resistance to non-Mäori research into the lives of Mäori,
36
 as well as 
the wishes of groups who believe that “Mäori research should be led and undertaken by Mäori 
people only” (Bishop, 1996:17).  However, I believe that if I had omitted an analysis of ART 
policy in relation to Mäori I would be contributing to the marginalisation and invisibility that 
Mäori already experience in many areas of Aotearoa/New Zealand society.  Correspondingly, I 
agree with James (1986:26-27), who argues that Päkehä researchers have a responsibility to 
address ethnicity in relation to their own membership of a powerful cultural group.  They should 
investigate how that group constructs and maintains unequal power relations, as well as 
acknowledge how their own experiences are influenced by the practice of power and privilege 
in particular contexts (James, 1986:26-27).
37
  Consequently, I recognise that within the 
limitations of this research project I can only offer a Päkehä perspective of ART policy in 
relation to Mäori.  However, rather than speak for members of an ethnic and/or cultural group 
that I do not belong to or attempt to present a Mäori perspective, my intention is to present a 
Päkehä interpretation of the marginalisation of Mäori with regard to access to and use of ART.   
 
Given the importance of whakapapa and genealogical knowledge to Mäori culture, I wanted to 
understand how policy relating to ART might have an effect on Mäori.  The interviews with 
representatives of Mäori organisations were intended to inform me and to offer some insight 
into what the ART policy issues might be for Mäori and how these issues could be addressed in 
a culturally acceptable way.  Nevertheless, I recognised that Mäori are not a homogeneous 
group and specific individuals or organisations cannot represent or speak on behalf of all 
members of a social group (Edwards, 1996:169).  As one interviewee put it,  
                                            
36
  For most of the twentieth century research into Mäori lives and society has been dominated by a 
“Pakeha world-view.”  This style of research has often been carried out for the sole benefit of the 
researcher, who has also decided what to research, controlled the research methods, analysed the results 
from a Päkehä perspective, and taken control of reporting the outcomes.  This process has often 
“proscribed and belittled certain Mäori knowledge gathering and information processing methods and 
contexts” (Bishop, 1996:15).   
37
  Although Päkehä currently occupy the dominant social position in New Zealand, I recognise that 
individuals within this group occupy varied positions in their relationship to power and privilege.  
Similarly, individual Mäori occupy varied subject positions in relation to marginalisation and subordination. 
  
49
 
…it is expected in the world of Mäori that two, ten, twelve different tribes will have 
two, ten, twelve different [perspectives].  It is expected by Mäori that they do have 
a different opinion. 
(Naida Glavish, Chief Advisor - Tikanga, Mäori Health Development 
Service, Auckland Healthcare Services Limited, Interview: 9 August 2000) 
 
As this thesis focuses on the analysis of policy surrounding ART, it was logical to start with 
organisations that are involved in Mäori policy development.  These organisations were selected 
and approached using the same methods as previously described.  Although several other Mäori 
contacts and organisations were approached to participate in the project, those that finally 
agreed to participate included two state organisations and one provider/consumer organisation.  
The Mäori Health Branch of the Ministry of Health was selected because I felt that, given the 
Ministry’s involvement in the ART policy arena, it would be the most conversant with the issues.  
Similarly, the role of Te Puni Kökiri (Ministry of Mäori Development) in providing policy advice to 
the Government and other agencies, as well as providing services to assist Mäori achieve their 
development aims, influenced their selection.  As there are no official Mäori providers in the 
ART domain, I contacted the Mäori Health Development Service (He Kamaka Oranga) located 
within Auckland Health Services.  This group provides Mäori corporate support on policy issues, 
systems and processes, and supplies information about how to apply aspects of tikanga
38
 within 
the organisation.   
 
The two state organisations had no policy per se on the use of ART and this significantly 
affected the final analysis and presentation of the research findings.
39
  The representative of He 
Kamaka Oranga was not available while I was in Auckland and was one of the two participants 
with whom telephone interviews were organised.  As she used Mäori language to describe 
certain concepts and relationships, she agreed to edit the transcript to ensure accuracy in 
spelling and context.  Her involvement in this task gave her a chance to veto or change the 
interview transcript.  As mentioned earlier, the representatives of one state organisation initially 
would not agree to the interview being taped and resisted signing the consent forms.  Along 
with concerns about a lack of institutional knowledge regarding ART policy, one of the 
interviewees indicated that this wariness was also motivated by the organisation’s desire to 
maintain control over research information so that it was not used to portray Mäori in a 
negative way.  We negotiated to proceed with taping the interview and upon completion, if 
                                            
38
  Tikanga can include law, customs, values, traditional behaviour, and philosophy (New Zealand Law 
Commission, 2000:75 n.247).  According to Naida Glavish (Chief Advisor - Tikanga, Mäori Health 
Development Service, Auckland Healthcare Services Limited, Interview: 9 August 2000), “tikanga are the 
customs and protocols of spirituality that Mäori require to be included in the delivery of services.” 
39
  See Chapter 6, Addressing Difference: Mäori Infertility and ART.  
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satisfied with the content, they would then sign the consent forms.  If they were not 
comfortable with the outcome, I agreed to return the tape to them.  This strategy worked well 
and both participants eventually signed the consent forms with the proviso that they (or 
representatives of their organisation) could review and approve any mention of their 
organisation in the final analysis.  As their participation in the research was conditional on my 
acceptance of this constraint, I was more than happy to agree.  This provision also gave the 
participants and organisation some control over how their interview material was analysed and 
presented.  In order to give both the organisation and interviewees a chance to review their 
contribution to the research project in context, I supplied them with a complete chapter on 14 
November 2001.  As the original interview participants were no longer available, I forwarded 
the draft chapter to another ‘Policy Manager’ whose name I had been given by my original 
contact with the organisation.  This person did not respond to my repeated attempts at contact 
and, in late December 2001, I sent an email suggesting that if I did not hear from her I would 
assume that the organisation was happy with the inclusion of the interview material and 
proceed with submission of the thesis. 
 
Having determined that it was important to include interviews with individuals knowledgeable 
about issues relating to ART and Mäori, the question then became “how?”  I was hesitant to 
begin the analysis because I was aware that I had undertaken “Research Involving Mäori” 
(Cunningham, 1998:397).  While this style of research includes Mäori as participants and 
subjects and includes secondary sources of Mäori knowledge and culture, it does not allow for 
Mäori involvement in all levels of the research process or for the production of Mäori 
knowledge.
40
  Although I attempted to minimise the power differentials by observing the 
necessary research ethics and employing a feminist methodology, I was conscious of the fact 
that the analysis and presentation of the information gathered would be mine.  While financial 
and time constraints, my own ethnicity, and the requirements of Master’s (MA) thesis research 
made it impractical to engage in “Mäori-centred Research” as described by Cunningham 
(1998),
41
 I have attempted to pay attention to the effects of my ethnic position on my analysis 
                                            
40
  Cunningham describes such research as typically “involving Mäori as participants, subjects and /or 
researchers.  It may also involve Mäori ‘data’, possibly in written or oral form, such as statistics and 
interviews.  It will frequently refer to secondary sources, such as accounts of traditional knowledge and 
beliefs.  …  It is likely that a mainstream analysis will have been applied.  …  This analysis will not, 
however, produce Mäori knowledge – it will produce mainstream knowledge of Mäori” (1998:397-399; 
emphasis in original). 
41
  In “Mäori-centred Research”, Mäori are involved at all levels of the research process, such as 
participants, researchers, and analysts.  Mäori data will be gathered and Mäori analysis will be applied so 
that the resulting knowledge will be Mäori knowledge (Cunningham, 1998:399).  
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of the data collected.  I did not want to objectify Mäori as the ‘other’ but hoped to address 
‘difference’ in a positive and informative way.  However, I avoided engaging in an analysis of 
the information collected until late in the writing-up stage.  This was partly due to ongoing 
tensions in relation to being a Päkehä and researching Mäori, and a related avoidance of having 
to decide how to include Mäori.  Although I originally considered incorporating this information 
into the existing chapters, it soon became evident that I could not just ‘add in’ Mäori to my 
analysis of the policy situation surrounding ART.  Embedding discussion of Mäori issues relating 
to ART in the other chapters would have contributed to the marginalisation that Mäori 
experience on a daily basis and may have presented issues out of context.  The proposed 
sections eventually evolved into a separate chapter as I considered the inequalities of Mäori 
access to a predominantly Päkehä focused health sector, as well as the conditions that may 
preclude Mäori from experiencing health services, including ART services, in the same way as 
Päkehä New Zealanders.  Nevertheless, some issues relating to Mäori use of ART, such as the 
definition of whänau, have been included in other chapters where I considered it contextually 
appropriate.
42
 
2.10 Analysis of the Research Material 
The first interviews were transcribed verbatim including pauses and interruptions.  However, as 
the transcription process developed, certain shortcuts and abbreviations were employed to 
hasten the process.  Eventually, non-relevant data such as telephone interruptions were 
excluded and a note was made in the transcription to indicate this.  Information was also 
excluded when informants indicated they were speaking ‘off the record’, ensuring that such 
information was not available to tempt me during the coding and writing-up stage.  Documents 
and interviews were analysed to determine common themes, such as what groups are granted 
authority to speak and whose voice is ignored or erased, as well as to uncover any 
contradictions that existed within them.  The texts and interviews were then compared to 
ascertain what contradictions existed between them and to highlight the gaps, marginalisations, 
and resistant strategies that are part of the policy situation surrounding ART practices.  
Although the portions of the interviews that were included in the thesis were edited as 
necessary, the meaning was not changed.  Only words such as “um” and other peculiarities of 
spoken narratives were omitted from quotations.  Brackets have been used to indicate where a 
word has been changed or inserted to clarify what the interviewee is talking about. 
                                            
42
  See Chapter 1, Introduction: Framing the Issues, Section 1.4, Families & ART. 
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The ‘Non Numerical Unstructured Data Indexing, Searching and Theorizing’ (NUDIST) computer 
programme was used to code, retrieve, and organise the transcribed interviews.  The 
transcripts were studied carefully and recurring themes were noted.  A coding framework was 
developed
 
from the recurring themes and the aims of the research, and the transcripts were 
coded according to the codes using NUDIST (see Appendix H).  During the analysis of the 
interview material I kept in mind Foucault’s claim that silence is not the opposite of discourse 
but a facet of it and what is excluded or marginalised within the discourse is relevant to what is 
accepted as legitimate knowledge and truth (in Armstrong, 1997:27).  Analysis of the coded 
interview material allowed for exclusions and marginalisations, as well as inconsistencies and 
contradictions, to be identified.  Although the coding and analysis of the interview material was 
a laborious and time-consuming task, it facilitated a sound knowledge of the content of the 
interviews.  The small size and tight timeframe of the project undoubtedly prevented me from 
learning and using the programme to its fullest potential.  However, the time taken to code and 
analyse the data ensured that it was easily accessible and retrievable.   
 
This chapter has outlined an apparent linear progression in research activity, from identifying 
and accessing participants and documentation to analysing and presenting the interview 
material.  However, the process itself has been one of negotiation and adaptation, emphasising 
the emergent nature of the research process and the need to be versatile and resourceful.  
Similarly, the information collection and analysis continued throughout the writing-up stage, 
highlighting the unfinished nature of policy and policy analysis.  The thesis was completed at a 
time when there was significant and increasing attention being paid to the two bills relating to 
assisted reproduction.  These two bills have been at the select committee stage for more than 
five years and a report is due 31 May 2002.  The decision to conclude discussion and research 
endeavours at the end of 2001, a seemingly arbitrary point in the policy debate surrounding 
ART, was shaped by the timeframe for thesis submission rather than any closure in the topic 
addressed. 
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3 
Regulating Practices 
 
And so, it has been an ad hoc historical thing as opposed to a planned policy 
moving forward to providing a service. 
(Helen Williams, Policy Analyst, Elective Services 
Project, HFA, Interview: 29 August 2000) 
3.1 Introduction 
As highlighted in Chapter One, different countries have responded to the ethical, legal, and 
political issues raised by assisted reproductive technologies (ART) in a wide variety of ways.  
These have included a combination of legislation, governmental and organisational regulations, 
court decisions, and reports by government appointed commissions to create policy and 
regulate the practices and development of ART (Blank, 1998:139).  In Aotearoa/New Zealand, 
public policy surrounding ART and surrogacy has been shaped by an assortment of existing 
legislation, professional self-regulation, health service controls, and consumer demand and ART 
practices have been dominated by a medical model of control and regulation (MCART, 
1994:11).  However, a network of relationships between consumers, providers, and government 
institutions, as well as cultural and structural factors, have also influenced policy issues 
surrounding the public funding, access, utilisation, and culture of ART services.  These policy 
issues are debated within a variety of public institutions and arenas, including academic 
publications, newspapers, magazines, television, radio, Internet, public conferences, and 
workshops.  Those who participate in these debates shape the language, as well as influence 
the issues that are considered.  They also have an effect on the timeframe and manner in 
which the issues will be resolved (Albury, 1998:130).  Although governments are expected to 
provide the formal policy solutions in relation to ART, there are many other actors and 
institutions involved in the development and formulation of policy.  As Blank (1998:148) 
acknowledges, it is important that the policy-making process includes an ongoing public 
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discussion of the goals of ART technologies and the social concerns surrounding the provision of 
these technologies.  Consequently, the ART policy debate should include consideration of issues 
relating to who has access to ART services, public funding priorities, and the protection of those 
involved.  While this chapter will focus on issues surrounding the regulation and control of ART 
practices, the following chapter will investigate how public funding provisions for ART have 
developed in an unplanned and contingent fashion, and how this has influenced the restriction 
of access to publicly funded ART practices.  Chapter Five will explore how the access restrictions 
imposed on those wanting to use ART practices are used to regulate and control family 
formation by relying on social judgements of ‘worthiness’ to parent.  The implications for Mäori 
of these issues of regulation, funding, and access are the focus of Chapter Six. 
 
This chapter sets the context for the ART policy issues discussed in the following chapters.  I 
highlight the sometimes arbitrary and fragmented nature of ART policy development and argue 
that there is a need for a more cohesive oversight and control of both ART practices and policy 
development.  I begin by detailing the ‘official’ responses to the introduction and expansion of 
ART practices in Aotearoa/New Zealand.  Although presented in a chronological and linear 
fashion, it is important to note that the ‘messy reality’
43
 of policy-making is far less orderly and 
systematic, and several policy initiatives may be under consideration at the same time.  
Similarly, while this analysis of ART policy development focuses primarily on ‘top-down’ policy 
initiatives, I acknowledge the need for attention to the ‘bottom-up’ elements of the policy 
process, some of which will be discussed in the following chapters.  While early reports 
established a reactive approach to ART developments in Aotearoa/New Zealand, the Ministerial 
Committee on Assisted Reproductive Technologies (MCART, 1994) proposed a far more 
proactive response.  This report has influenced public debate and commentary relating to ART 
over the last eight years, particularly the two bills on reproductive technologies currently being 
considered by the Health Select Committee.  I will present a review of these bills, the content of 
which proposes legislative control and regulation of certain ART practices and research 
developments.  This is followed by an analysis of the gaps in ART policy that are likely to 
remain, irrespective of either of the bills being passed in their current form.  The role of the 
National Ethics Committee on Assisted Human Reproduction (NECAHR) in relation to ART policy
                                            
43
  This phrase was used by Martin and Salmond (2001:44), Policy Making: The ‘Messy Reality’, in their 
consideration of how history and context affect the policy process in the health sector.  They borrowed 
the phrase from Peter John, Analysing Public Policy (1998), London: Printer, p.7. 
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formulation is then examined and this is followed by an analysis of the use of professional self-
regulation to control and monitor ART practices.  Finally, I explore issues of accountability in 
relation to government officials, the fertility clinics, NECAHR, and the Reproductive Technology 
Accreditation Committee of Australia (RTAC). 
3.2 Policy Background 
From the mid-1980s to the mid-1990s, several commissions and committees, both public and 
private, were formed to address issues of regulation and control surrounding ART and 
surrogacy in Aotearoa/New Zealand.  The first child in Aotearoa/New Zealand to be conceived 
through IVF was born in 1983.  In 1984, a group representing the Royal Society of New 
Zealand, the New Zealand Law Society, the Medical Council of New Zealand, and the New 
Zealand Medical Association requested that the government appoint a standing committee to 
consider the legal, moral, and social issues surrounding IVF, artificial insemination, and related 
problems of biotechnology (Daniels, 1998a:79; Coney & Else, 1999:3).  The following year the 
Law Reform Division of the Department of Justice published New Birth Technologies: An Issues 
Paper on AID, IVF, and Surrogate Motherhood (1985).  Although this document was intended 
to “promote public debate on the issues raised by the new reproductive methods”, it set the 
precedent for a ‘wait and see’ approach by Government in relation to ART and surrogacy 
(Department of Justice, 1985:7).  One hundred and sixty-four submissions were received in 
response to the issues paper, a quarter of which referred to the need for a committee to 
oversee assisted reproduction developments in Aotearoa/New Zealand and ninety-nine of which 
made reference to surrogacy.   
 
In response to the requests for an overseeing body, the Department of Justice established the 
Interdepartmental Monitoring Committee on Assisted Reproductive Technologies (IMCART) to 
collect information, monitor developments, and advise ministers on ART.  This committee was 
comprised of representatives from the Departments of Justice, Health, Women’s Affairs, Social 
Welfare, Manatu Mäori, and Pacific Islands Affairs and it maintained the reactive stance initiated 
by the Government in dealing with ART issues.  In 1987, the only piece of legislation that 
specifically deals with ART was passed by parliament.  The Status of Children Amendment Act 
1987 (SCAA) was enacted in order to clarify the status of the children, donors, and legal 
parents where donated gametes are used.  It legitimises the relationship between the child and 
the parenting couple by recognising the birth mother and her husband (legal or de facto) as the 
legal parents.  Providing a woman who undertakes an ART procedure using donated gametes 
has the consent of her husband, he will be recognised as the legal father of any resulting 
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children.  The SCAA ensures that the donors of gametes have no rights or responsibilities with 
respect to the resulting child (Tollemache, 1999a:18).
44
 
 
In 1990, several providers of ART in Aotearoa/New Zealand invited the Reproductive 
Technology Accreditation Committee of Australia (RTAC) to oversee developments and practices 
of ART within their clinics.  This move was motivated by the providers’ concern over the lack of 
a system of accountability and, consequently, RTAC became the accrediting body for 
Aotearoa/New Zealand clinics (Daniels, 1998a:79-80; Coney & Else, 1999:3-5).  Although many 
commentators have acknowledged the logic of using RTAC as an accrediting body (Helen 
Williams, Interview, 29 August 2000; John Peek, Interview: 12 July 2000; Rodney Bycroft, 
Interview: 13 September 2000), others have raised concerns regarding the use of Australian 
standards to accredit Aotearoa/New Zealand clinics (Sandra Coney, Interview: 13 July 2000; 
Ken Daniels, Interview: 31 August 2000; Dyall, 1999:37).  Although many accept that the local 
ART industry is too small to warrant the establishment of an independent Aotearoa/New 
Zealand based accrediting committee, there is some unease concerning the absence of 
Aotearoa/New Zealand specific guidelines within RTAC’s ‘Code of Practice’,
45
 particularly in 
relation to cultural safety issues for Mäori consumers,
46
 accountability issues, and access to 
information.   
 
The Medical Council of New Zealand commissioned the University of Otago Bioethics Centre to 
review the whole area of ART in 1991.  The resulting report, Biotechnology Revisited, raised 
concerns about the lack of statutory regulation of infertility services (The Bioethics Research 
Centre, 1991:3) and concluded “that the field of human reproduction is too sensitive an area to 
be left to individual initiative or voluntary self-regulation” (The Bioethics Research Centre, 
1991:5).  It recommended the “establishment of a licensing authority for continued oversight of 
the practice of reproductive technology and related research in New Zealand”, as well as “an 
expert advisory panel be set up to assist in the drafting of legislation which would take into 
account the rights of all parties, but in particular the safeguarding of the welfare of all children 
born by means of assisted reproduction” (The Bioethics Research Centre, 1991:5).  
                                            
44
  See Chapter One, Introduction: Framing the Issues, Section 1.4, Families & ART, for an analysis of the 
SCAA and its impact on family formations produced through the use of ART. 
45
  Section 3.6: Professional Self-Regulation in this chapter addresses the use of RTAC to regulate ART 
practices in New Zealand. 
46
  See Chapter Six, Addressing Difference: Mäori Infertility & ART, for a discussion of these issues, as 
well as issues relating to access to treatment, whängai, and protecting whakapapa. 
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Responding to growing tensions between the legal and medical professions surrounding the 
regulation and control of ART and surrogacy in Aotearoa/New Zealand, the Minister of Justice 
established the Ministerial Committee on Assisted Reproductive Technologies (MCART) in 1993.  
The two-person committee was commissioned to review policy and legislation from overseas 
that might be adopted in Aotearoa/New Zealand and they published their report, Assisted 
Human Reproduction: Navigating Our Future, in 1994.  A majority of the submissions received 
by MCART supported a licensing process for providers within an Aotearoa/New Zealand-specific 
framework (Coney & Else, 1999:6).  MCART (1994) recommended that a policy focused ‘Council 
on Assisted Human Reproduction’ be set up to advise and monitor the field of ART.  After 
regional ethics committees expressed concern over inconsistent decision-making with regard to 
ART practices, the Minister of Health established the Interim National Ethics Committee on 
Assisted Reproductive Technologies (INECART) to manage this area on a national basis 
(Daniels, 1998a:80).  In 1995, the Minister of Health reconstituted INECART as the National 
Ethics Committee on Assisted Human Reproduction (NECAHR) to monitor new and innovative 
practices (Coney & Else, 1999:7).  That same year, the Department of Justice assigned an 
officials’ committee to investigate MCART’s proposals and provide advice to the Government.  
Although the committee supported some of MCART’s recommendations, it did not support the 
establishment of a ‘Council on Assisted Human Reproduction’ to oversee ART practices and 
policy.  Instead, the officials’ committee recommended that the NECAHR undertake some of the 
suggested tasks of the proposed council, effectively “taking NECAHR beyond the domain of 
ethics and into the policy arena” (Daniels & Hargreaves, 1997:4).   
 
Dianne Yates introduced the ‘Human Assisted Reproductive Technology Bill’ as a Private 
Member’s Bill in 1996 (Yates Bill; see Appendix I).  After its second Parliamentary reading in 
April 1997, the bill was sent to the Justice and Law Reform Select Committee for consideration 
(Hansard, 1997).  However, it was moved to the Health Select Committee sometime later.  In 
November 1998 the National-led Coalition Government introduced the ‘Assisted Human 
Reproduction Bill’ (Graham Bill; see Appendix J),
47
 which seeks to prohibit certain unethical 
techniques, provide rights of access to information for gamete donors and children born 
through donated gametes, and affirm and expand the role of NECAHR.  As a consequence of 
the Graham Bill, it would appear that the National-led Coalition Government made a policy 
decision (or non-decision) to refrain from ‘officially’ regulating surrogacy arrangements.  The 
                                            
47
  This bill was introduced by Sir Douglas Graham, who was the Minister of Justice for the National/New 
Zealand First Coalition Government in 1998. 
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Graham Bill mentions surrogacy as part of the interpretation but does not address any of the 
contentious issues surrounding payment and the rights of those involved in surrogacy 
arrangements (Else, 1999a:52).  In 2000, the New Zealand Law Commission addressed the 
issue of surrogacy in its report on adoption law reform, Adoption and Its Alternatives: A 
Different Approach and a New Framework (2000:60, 186-207).  The Law Commission makes 
some suggestions about placing surrogacy within its own regulatory framework, but contends 
that there has not been enough public consultation for their proposals to be considered as firm 
recommendations (2000:60).  The inclusion of surrogacy within the Law Commission’s terms of 
reference for adoption law reform has taken the consideration of issues over the legal status of 
those involved in such arrangements out of the medical context and placed them in a legal 
context.  However, the issue of restricting access to ART practices that enable some surrogacy 
arrangements to take place is still within the jurisdiction of NECAHR and the fertility clinics. 
 
Although the Status of Children Amendment Act 1987 (SCAA) remains the only legislation that 
specifically deals with ART, it is not the only legislation or common law that could be used to 
resolve any legal issues arising from ART practices.  Some of the existing regulations and 
statutes that could have particular relevance to ART include the Adoption Act 1995, the Adult 
Adoption Information Act 1985, the Contraception, Sterilisation and Abortion Act 1977, the 
Human Rights Act 1993, the New Zealand Bill of Rights Act 1990, the Human Tissue Act 1964, 
and the Privacy Act 1993.  Similarly, the current legal framework governing medical practice has 
an effect on the provision of ART services and the protection of patients’ rights, including the 
following acts and their amendments: the Health and Disability Commissioner Act 1994, the 
Code of Health and Disability Services Consumers’ Rights, the Health Information Privacy Code, 
the Health Act 1956, the Health (Retention of Health Information) Regulations 1996, the Health 
and Disabilities Services Act 1993, the Medical Practitioners Act 1995, the Medicines Act 1981, 
and the Nurses Act 1997-1994 (MCART, 1994:11; Tollemache, 1999a).  For example, the Adult 
Adoption Information Act 1985, the Health Information Privacy Code, the Health Act 1956, and 
the Health (Retention of Health Information) Regulations 1996 give individuals access to 
records and information if they exist.  However, these Acts do not necessarily require such 
information to be recorded and access to information in relation to ART procedures is 
dependent on what records providers are currently obliged to keep according to their RTAC 
accreditation requirements (Tollemache, 1999a:20).  The Human Rights Act 1993 makes it 
unlawful to discriminate based on characteristics such as sex, disability, marital status, family 
status, sexual orientation, ethnic or national origins when providing goods, facilities, or services.  
The Human Rights Commission (HRC) has previously received complaints in relation to the 
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provision of ART services on the grounds of disability, marital status, and sexual orientation 
(Hamed, 1997).
48
   
 
Blank argues that existing statutes are often poorly suited to ART practices and frequently 
require new interpretations in their application to such practices.  He maintains that the 
“divergent and potentially conflicting combination of private and public actions results in 
ambiguous policy” (1998:147).  Over the past twenty years, there have been a profuse and 
diverse number of government agencies and individual actors involved in ART policy discourse 
and decision-making in Aotearoa/New Zealand.  Combined with the lack of a dominant policy 
relating to ART or an agency specifically responsible for ART issues, this means that more 
discretionary power is likely to be given to those involved in implementing the guidelines and 
controls that do exist (Sabatier, 1986:30-31; Blank, 1994:7). 
 
While policy formulation and implementation is often theorised as progressing through a distinct 
set of phases,
49
 most analysts acknowledge that the process is not as linear or straightforward 
as set out by the models.  However, they see such normative models as a useful tool in the 
analysis of the policy process as a whole (Blank, 1994:6; Colebatch, 1998:105).  Top-down 
policy models focus on a central authority which initiates, selects, and then implements policy 
directives through “the development of rules, regulations and guidelines essential to the 
carrying out of the decision” (Blank, 1994:7).  Such policy models are often criticised for 
focusing on central decision-makers as the key actors in policy formulation and failing to 
acknowledge the important initiatives of “street level” groups, workplace managers and 
workers, as anything other than complicating factors in the policy process (Sabatier, 1986:30; 
Colebatch, 1998:58).  Others argue that the process also works from the ‘bottom-up’ in that the 
                                            
48
  A lesbian woman made a complaint under the previous Human Rights Commission Act 1977, when 
she was denied access to services on the basis of marital status and the HRC supported the woman’s 
complaint.  Since the new Human Rights Act 1993, the HRC has received many enquiries.  The most 
notable complaint has been on the basis of disability.  The HRC successfully resolved the situation 
through a consultative approach, in which the Commission facilitated a meeting between the couple and 
various specialists in the field, such as fertility practitioners, an ethics committee member, an RHA 
disability manager, representatives from the Children's Commissioner, and home help providers (Hamed, 
1997).  See also Chisholm, D. & L. Umbers, 1994.  ‘Scientist quits over Lesbian Ruling’, The Press, 29 July 
1994, p.2. 
49
  Brewer and deLeon (in Blank, 1994:6-7) outline this process as involving six stages; initiation, 
estimation, selection, implementation, evaluation, and termination.  Similarly, Howlett and Ramesh (in 
Colebatch, 1998:105) developed “a model of policy as a cycle of applied problem solving” which includes 
agenda setting, policy formulation, decision-making, policy implementation, and policy evaluation. 
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…range of grounded practices that arise from day-to-day work in the health care 
sector constitute policy in themselves: they both contribute to the policy agenda 
and also mould its operation.         (Green & Thorogood, 1998:11) 
 
While acts of parliament, ministerial edicts, and government initiated guidelines and strategy 
documents play a major part in policy formulation and implementation, they are not the only 
contributors to policy.  Bottom-up analysts argue that policy develops through a constant 
interaction between ‘top’ and ‘bottom’, as well as insiders and “relevant others” (Colebatch, 
1998:61).  Accordingly, managers, healthcare professionals, patients, interest groups, and the 
wider community create and establish health policy through interpretation and implementation 
of guidelines and strategies.  ART providers and consumers of ART practices were crucial in 
formulating and putting into practice policy initiatives relating to donors being identifiable and 
the technical oversight of ART practices.
50
  The formulation, interpretation, and implementation 
of policy from this bottom-up perspective is always more unstable, intuitive, informal, and 
“messy” than the more normative model would allow, involving a variety of participants with 
their own distinct understanding and expectations surrounding the issues (Colebatch, 1998:59).  
Colebatch (1998:60) argues that both perspectives play an important part in the policy process 
and that the policy process involves a combination of both top-down and bottom-up elements, 
including both horizontal and vertical dimensions,
51
 empirical and normative frameworks, and 
language that is used as part of the action.  Correspondingly, the publicly funded provision of 
ART services through negotiated purchase agreements and the subsequent allocation and 
management of public funds by service providers introduces another influential arena for the 
creation, interpretation, and implementation of policy by government bodies and providers.  
While the implications of public funding decisions relating to ART will be considered in the next 
chapter, the following section will consider the ‘top-down’ initiatives in policy formulation 
concerning ART and ART practices that have been under consideration in Aotearoa/New 
Zealand for more than five years. 
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  As mentioned earlier, concern over the lack of a system of accountability motivated several 
Aotearoa/New Zealand fertility clinics to invite the Reproductive Technology Accreditation Committee of 
Australia (RTAC) to oversee developments and practices of ART within Aotearoa/New Zealand clinics by 
becoming the accrediting body for their clinics (Daniels, 1998a:79-80; Coney & Else, 1999:3-5).  
Similarly, ART providers and consumer representative bodies have been active in promoting openness 
between parents and children in relation to donated gametes, as well as collecting and storing donor 
information. 
51
  The vertical dimension is concerned with authority and hierarchy, where policy is seen as being about 
choice and the pursuit of objectives.  The horizontal dimension is concerned with the way the policy 
process moves outside any particular organisation and includes people who “share an interest in the 
policy question, but have a distinct perspective on it and whose cooperation cannot be taken for granted” 
(Colebatch, 1998:61-62).  Within the horizontal dimension, the policy ‘problem’ does not appear 
automatically but is recognised as the disparate participants introduce their different perspectives.   
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3.3 Proposed Legislation 
As mentioned earlier, social policy surrounding ART and surrogacy in Aotearoa/New Zealand 
has been created in an ad hoc manner, combining and adapting to the interactions between 
existing legislation, professional self-regulation, health service controls, and consumer demand.  
The policy development has also been significantly influenced by the reports of various 
commissions and committees that have been established to address the issues of regulation 
and control of ART over the last 20 years.  The New Birth Technologies: An Issues Paper on 
AID, IVF, and Surrogate Motherhood (Department of Justice, 1985) was intended to promote 
public debate on the issues surrounding ART and surrogacy.  However, it also contributed to 
the ‘wait and see’ approach adopted by successive governments (Department of Justice, 
1985:7).  The Ministerial Committee on Assisted Reproductive Technologies (MCART) report, 
Assisted Human Reproduction: Navigating Our Future (1994), has probably been more 
influential with respect to public debate and policy matters relating to ART.  Consequently, most 
of the people interviewed for this study mentioned this report as having some influence on 
organisational policy positions.   
 
The MCART (1994) report has also influenced the instigation of legislative action in the form of 
the Yates and Graham Bills (see Appendices I & J).  While both bills propose bans on certain 
unethical practices, such as the cloning of humans and the sale of human gametes and 
embryos, they differ on how ART practices should be regulated and controlled.  The Yates Bill 
follows the recommendations of MCART more closely, setting out to license clinics, establish a 
central register for children born through ART, and ban commercial surrogacy.  This bill also 
places restrictions on the use of sex selection techniques and mandatory genetic screening.  It 
aims to establish a licensing authority (the Human Assisted Reproductive Technology Authority) 
to “regulate and ensure proper monitoring of services” (Yates, 1997: see Appendix I).  The 
Graham Bill bans the implantation of animal embryos in humans or the implantation of human 
embryos in animals.  It also bans the use of human cells to develop procedures or techniques 
for undertaking any of these activities.  While the National Ethics Committee on Assisted Human 
Reproduction (NECAHR) is given statutory recognition and has its role expanded, it appears that 
it will remain under the control and oversight of the Ministry of Health and its Minister.  
NECAHR’s extended responsibilities remain ambiguous as the Graham Bill states that the 
committee’s functions are dependent on the Minister of Health’s discretion.  This bill also 
establishes a legislative requirement for a centralised system that retains and stores information 
about donors of gametes and embryos, as well as the children born through such donations 
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(Graham, 1998: see Appendix J).  However, the Graham Bill only mentions surrogacy as part of 
the interpretation and does not address any of the contentious issues surrounding payment and 
the rights of the parents (Else, 1999a:52).  The Graham Bill does not include any mention of 
the Treaty of Waitangi (te Tiriti o Waitangi) or its provisions for the protection of Mäori as 
Tangata Whenua (Coney, 1999a:26-27; Dyall, 1999:35).  Nor does it advocate a separate policy 
body to oversee and monitor ART practices and to consolidate the fragmented formulation of 
policy that has occurred in this area.  The proposed legislation does not deal directly with 
access issues and it is unclear whether the functions of the proposed Council in the Yates Bill or 
the increased jurisdiction of NECAHR proposed by the Graham Bill will address such issues.  
Therefore, these issues may continue to be shaped by the rationing of publicly funded 
treatment, the Human Rights Act, and the policies and practices of individual clinics.
52
 
 
Both bills emphasise the rights of people conceived through ART practices to information about 
their genetic heritage.
53
  The Human Assisted Reproductive Technology Bill (Yates Bill) 
specifically states that the aim of the bill is to 
…protect the rights of children, and the rights of women (birth mothers) as well as 
donors (men and women).            (Yates, 1997: see Appendix I) 
 
Although both bills place legal requirements on the collection and storage of information and 
provide for a centralised system for recording and storing this information, neither fully 
addresses what genetic information should be recorded or specifies how it will be collected and 
stored.  All the provider representatives interviewed supported the introduction of legislation 
                                            
52
  See Chapter 4, Allocating Resources, and Chapter 5, Regulating Access, for discussions of funding and 
access issues in relation to ART practices. 
53
  At present, there is no statutory requirement for the collection and storage of information about 
gamete and embryo donors, surrogates, and any people born from the use of donated genetic material.  
Nor is there any provision for these people to access identifying or genetic information about donors or 
surrogates (Henaghan, 1992:184).  Until the early 1990s, it was the policy within clinics to guarantee 
anonymity to gamete donors.  However, New Zealand’s position on access to identifying information has 
been influenced by the Adult Adoption Act 1985, which recognised the need for information by adopted 
people, and accredited clinics no longer provide the option of anonymity to donors.  Although this is not a 
legal requirement, Aotearoa/New Zealand fertility clinics encourage donors to agree to contact should the 
person conceived using their gametes wish it (Adair & Rogan, 1998:268-270).  RTAC’s ‘Code of Practice 
for Centres using Assisted Reproductive Technologies’ (1999) ensures that some records are kept by 
accredited clinics.  Accredited clinics are required to keep permanent records of “ART procedures, 
identifying patients, gamete or embryo donors and recipients, and outcomes of attempted fertilisation 
and conceptions” and clinics are advised that they “should allow all donors and patients access to their 
records” (RTAC, 1999).  The ‘Guidelines for Screening for Gamete Donation’ (RTAC, 1999: Attachment J) 
sets out what information about the donor’s social history is “considered to be appropriate” and “which 
may be of assistance to parents of children at a later date”.  However, the guidelines do not specify who 
may have access to what information, and it appears that these issues are decided by the clinics in 
question.  Furthermore, access to any retained information is limited by whether or not the parents tell 
their children of the circumstances of their conception. 
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that would formalise the collection and storage of information about gamete and embryo 
donors, surrogates, and any people conceived using donor gametes.  John Peek (Clinical 
Manager/Group Operations Manager, Fertility Associates Auckland) maintains that such a move 
would only be reinforcing what was already happening within clinics. 
…I think in a way any bill that is enacted will just be codifying what is general 
practice for most people.            (John Peek, Interview: 12 July 2000) 
 
Peek is supportive of the benefits the proposed legislation will have in relation to removing 
some of the barriers to openness. 
…there are some people who still want to maintain secrecy so the bill could make 
maintaining that secrecy difficult because there would be a register and everybody 
could look up and see whether they were conceived from donor insemination and 
be able to contact their donor.  And, I think that would be good really.   
          (John Peek, Interview: 12 July 2000) 
Nonetheless, access to this information is limited by whether or not the parents tell their 
children of the circumstances of their conception.  Robyn Scott (Executive Officer, New Zealand 
Infertility Society [NZIS]) acknowledges the diversity in people’s willingness to be open about 
the circumstances surrounding their child’s conception and/or birth. 
…we support openness of information.  All the NZIS policy statements support 
openness of information. … We certainly believe that children are entitled to 
correct genetic information.  That is a stated policy of the NZIS.  However, you 
would find amongst our membership a huge variation in [individuals’] 
preparedness to implement that policy.   
      (Robyn Scott, Interview: 26 July 2000) 
Similarly, John Peek concedes that there is no guarantee that donors will continue to be 
available or identifiable even if they initially intend to be. 
In New Zealand, we are different from overseas because basically the clinics and 
the consumers have voluntarily moved towards having identifiable donors.  It does 
not guarantee that a donor is going to be identifiable but they go in with that 
intention.              (John Peek, Interview: 12 July 2000) 
 
 
Although generally supportive of legislation that would formalise the information storage and 
collection process, providers are less inclined to support the establishment of a central donor 
register that would be controlled and monitored by a body other than the clinics.  Mark Leggett 
(Business Manager, The Fertility Centre, Christchurch) is wary of trusting sensitive information 
to a central register maintained by a government department.  
It is a relationship thing.  If we go through a central register, that is not a problem, 
but … you have got to have the same trust that you have with the clinic … and 
some of the government departments have not generated a whole lot of trust in 
recent years, in relation to privacy act issues.  And, it is a very strong privacy 
issue. 
       (Mark Leggett, Interview: 22 September 1999) 
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Similarly, Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) 
emphasises privacy issues and the unreliability of public officials in handling sensitive 
information. 
[I support a central donor register] on the condition that it is handled properly.  
That is going to be the hard one because as soon as you get a social agency 
involved you end up with the possibility of horrendous mistakes.  [Whereas] clinics 
are under enormous constraint, such as professional pressure, confidentiality 
issues, and privacy issues to do with preserving the rights of the parents and the 
child.  The bar is not as high for social agencies.  …  I do not believe that many 
mistakes occur at the moment where the clinics have responsibility for that 
information.  …  If that data then goes to Birth, Deaths, and Marriages and you 
end up with a junior clerk making a [mistake] and sending someone the wrong 
information … so I support it but it has to be a system that has very little chance 
of disaster.        (Rodney Bycroft, Interview: 13 September 2000) 
 
Both Leggett and Bycroft suggest that systems managed by the medical professional are more 
reliable than government bureaucracies.  However, this position fails to take into account the 
possibility that information may not be retained because of individual clinic discretion or it may 
be lost when clinics close or merge.  Lack of consistency over information retention and 
individual clinic discretion over what information to disclose and who has access to it may 
impinge on the rights of donors and those conceived from donated gametes.  John Peek points 
out that it is not just the issue of a central register that is important.  The issue of guidelines 
and rules about the use of and access to the information gathered should also be included in 
the debate. 
[You need] instructions on what to do and not how to do it.  To say there is going 
to be a register in this sort of information is one thing but not to say how you 
access it and how you look after people in the process is, I think, a very big 
deficiency.  …  But, the whole thing … at the moment is not about keeping the 
information but how do you facilitate and look after people using the information.  
I do not think the Bills address that at all. 
          (John Peek, Interview: 12 July 2000) 
Concerns for the security of information appear to be premised on the idea that increases in the 
amount of information kept will jeopardise the right to privacy by those individuals undertaking 
ART treatments.  
Given that every extra record of donor or treatment information increases the risk 
of a breach of security or privacy, couples in treatment programmes have the right 
to maximum privacy and to control who knows what, and when. 
     (New Zealand Centre for Reproductive Medicine (The Fertility Centre, 1997:14) 
However, protecting the ‘couples’ right to privacy may restrict and marginalise the rights of 
donors, as well as the rights of people conceived using donor gametes or surrogacy 
arrangements to information about their genetic background.  The same provider had earlier 
argued for the primacy of the interests of the children in relation to who has access to ART.  
The apparent shift in focus highlights how a rights focused debate continually places the 
interests of those involved in conflict with each other.  Considering the rights of all those 
  
65
 
involved in ART practices, the donors, recipients, surrogates, intending parents, and those 
individuals conceived through donated gametes, is particularly important and complex when 
addressing who should have control and access to information regarding genetic origins. 
 
The Health Select Committee is considering both bills and it is unlikely that any report on either 
of them will be released before this thesis is submitted.  Ministry of Health representatives, 
Helen Lockyer (Senior Policy Analyst) and Matthew Soeberg (Policy Analyst), suggest that the 
Yates Bill has been interpreted as too “prescriptive” and support is leaning towards the more 
“flexible” approach to regulating ART practices and future developments as outlined by the 
Graham Bill.   
We cannot pre-empt what [the] Health Committee will ultimately decide, and what 
the views of the Ministers of Justice and Health will be, but the bit of analysis that 
we have done to date, and Justice has done to date, tends to be steering us more 
towards Sir Doug Graham’s bill.  Taking into account some of Dianne Yates' ideas 
as well because some of them are very similar … and tweaking that.  So we are 
almost merging them together, the merge will in a sense be based primarily on Sir 
Doug Graham’s bill, we think.  We cannot pre-empt… 
   (Helen Lockyer, Interview: 24 July 2000) 
Also the submissions that we have had a quick look at have indicated that the 
Graham Bill is the preferred one rather than the Dianne Yates’ one. 
          (Matthew Soeberg, Interview: 24 July 2000) 
This perceived preference might be influenced by the significant power of the biomedical 
community and the fact that any successful policy must have at least implicit backing by those 
being regulated (Blank, 1995:178).  The continuing and rapid advances in ART innovations and 
applications, as well as their rapid inclusion into acceptable practice mean that any decision in 
ART policy is in danger of being outdated and obsolete within a very short timeframe.  
Therefore, the ART policy-making process is never finished and, according to Blank (1998:135), 
fixing policy through government legislation may limit the use of technology and inhibit the 
flexibility needed to adapt to new applications.  This view is supported by Rodney Bycroft 
(Scientific Director/Manager, Artemis North Shore Fertility, Auckland) who advocates a more 
flexible system of control through which biomedical progress can be accommodated more 
readily. 
Looking at models overseas, I think that an official government appointed body 
that had the job of reviewing, from time to time, reproductive practices and 
technology is a far better way of doing it than having tight legislation.  That is 
more to do with the speed of change and the ability to accommodate that change 
in a timely way that does not actually end up prejudicing and disadvantaging New 
Zealand citizens.  The problem with legislation is that it quite often does not 
foresee the future and by not foreseeing the future, it then becomes a mammoth 
exercise to amend it and change it through the parliamentary process.  
   (Rodney Bycroft, Interview: 13 September 2000) 
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Similarly, NECAHR’s submission to the Health Select Committee on the Assisted Human 
Reproduction Bill requested that any new legislation allowed for flexibility. 
NECAHR is of the view that there is a gap in the law with regard to assisted human 
reproduction.  …  However, NECAHR urges legislation that allows for flexibility in a 
rapidly developing technological field.              (NECAHR, 2000a:3) 
 
Nevertheless, too little state intervention can expose vulnerable groups and individuals to 
exploitation and discrimination, especially given the decreasing amount of time between the 
initial research into a technique and dissemination into widespread use (Blank, 1995:10).
54
 
 
Ministry of Health representatives (Matthew Soeberg and Helen Lockyer, Interview: 24 July 
2000) explained the lack of progress on either bill as a consequence of parliamentary progress, 
procedural issues, and the complexity of reviewing over 150 submissions.  However, others 
interviewed believe the delay is due to the lack of governmental prioritisation and importance 
placed on ART issues and a belief that the present system of medical control is adequate, as 
well as the inherent difficulties in resolving moral and ethically contentious issues (Sue 
Bagshaw, Interview: 21 August 2000; Sandra Coney, Interview: 13 July 2000; Ken Daniels, 
Interview: 31 August 2000).  Blank (1995:50) suggests that elected officials find ART issues 
politically risky and are therefore hesitant to formulate national policy or specific legislation.  He 
argues that, as public officials are not re-elected based on their efforts to resolve future 
problems, they refrain from making “hard choices” in politically volatile areas until a crisis is 
obvious.  This argument is supported by Ken Daniels (Associate Professor, Department of Social 
Work, University of Canterbury) 
...the area of assisted human reproduction is like a graveyard for politicians.  It is 
fraught with problems.  It is one of those moral issues like abortion and 
contraception and so on.  You have got strongly divided opinions, Parliaments, as a 
whole, never handle moral issues very well, and this is seen as a moral issue.  So, 
I think there has been some general reluctance to get involved in it. 
  (Ken Daniels, Interview: 31 August 2000) 
Sue Bagshaw (Medical Training Co-ordinator, Family Planning Association, Christchurch) 
suggests that, while assisted human reproduction is a politically difficult issue to resolve, it is 
the responsibility of elected officials to make the “hard choices”. 
…that is why we have parliament and we elect people to make judgements for the 
good of society.     (Sue Bagshaw, Interview: 21 August 2000) 
 
Although it may appear that successive governments have been reluctant to intervene in what 
has traditionally been accepted as a matter of individual privacy, there are many statutes within 
the Aotearoa/New Zealand legal system that do intervene in issues relating to human 
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  This issue is discussed in more detail later in this chapter; see Section 3.5, NECAHR. 
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reproduction and parenting, illustrating that past governments have addressed the difficulties 
associated with legislating moral issues in the past.
55
  While the lack of specific legislation in 
relation to ART does not mean that these services and practices are completely unregulated, it 
does contribute to the fragmentation of ART policy and regulation.  It also adds to the 
vulnerability of those involved in ART practices using donated gametes, especially in relation to 
access to information, and may allow exploitive and socially unacceptable uses of ART to 
become embedded into practice before the negative consequences can be assessed (Blank, 
1994:10-13).  Furthermore, by avoiding legislation and delegating decision-making for specific 
ART related issues (both ethical and policy related) to NECAHR, the Government can effectively 
evade direct accountability and controversy. 
 
Although the two ART bills being considered by the Health Select Committee address a range of 
important issues and coincide in banning certain unethical practices, they diverge with respect 
to the levels of state regulation they prescribe.  According to Blank (1995:16), those who 
support biomedical technologies tend to concentrate exclusively on “clinically indicated 
applications” (infertility, genetic screening for inheritable diseases, screening for sex-specific 
inherited diseases) and down-play the possibility of coercive uses, while those who oppose 
them often give more attention to the potential coercive or abusive aspects of specific 
techniques (compulsory genetic screening, embryo harvesting, foetal experimentation, eugenics 
programmes, and sex-selection techniques).  This polarisation of attention is reflected in the 
two bills under discussion.  The Graham Bill tends to focus on those issues that already have 
wide support from health professionals, such as banning cloning, data collection and storage, 
and access to information by those involved in ART practices using donated gametes, as well as 
a non-regulatory form of policy review.  On the other hand, the Yates Bill takes a more 
interventionist approach to a wider range of potentially coercive and abusive applications of the 
technologies and, unlike the Graham Bill, it addresses some aspects of surrogacy.  Blank 
(1995:16) suggests that the ambiguity often encountered in the debate surrounding biomedical 
technologies is caused by a failure to distinguish between the techniques and the uses to which 
they are put.  Therefore, while the current debate is polarised around these two interpretations 
of the issues, many social and ethical issues remain unresolved. 
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  For example: the Contraception, Sterilisation, and Abortion Act 1977 and its subsequent amendments; 
the Adoption Act 1955 and its subsequent amendments; the Adoption (Intercountry) Act 1997; 
Guardianship Act and its subsequent amendments; the Births, Deaths, and Marriages Registration Act 
1995 and its subsequent amendments. 
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3.4 Policy Gaps 
While there is no specific legislation to control and regulate ART developments and practices, 
this does not mean that they exist within a policy vacuum or that they are unregulated.  As 
discussed earlier, a combination of Acts, regulations, and professional guidelines controls and 
regulates the medical profession, as well as specialist ART providers.  However, even if the 
previously discussed Graham or Yates Bills are passed as they currently exist, there will remain 
several areas of concern where no or very little official policy exists.  Surrogacy, sex-selection, 
embryo donation, embryo experimentation, property rights for genetic material, and stem cell 
cloning have either been ignored or only partially addressed in either bill.  Although it is not 
within the scope of this thesis to discuss all these issues, it is important to acknowledge that 
issues surrounding these procedures are likely to intensify in the near future and there is little 
or no policy to address the introduction and acceptability of these practices in Aotearoa/New 
Zealand.   
 
All the provider representatives interviewed (Mark Leggett, Interview: 22 June 2000; John Peek, 
Interview: 12 July 2000; Rodney Bycroft, Interview: 13 September 2000) affirmed that they 
were considering embryo donation as a strategy for patients who had 'surplus' embryos in 
storage after completing or ceasing their own treatment.  They all saw embryo donation as a 
natural progression, although they did acknowledge that it required certain 'constraints' and 
that NECAHR approval would have to be sought before proceeding.  All three provider 
representatives equated embryo donation to the adoption process in some way.  Mark Leggett 
(Business Manager, The Fertility Centre, Christchurch) in particular saw the difference as being 
a matter of timing.  However, he was specific about differentiating between an embryo created 
from donated gametes and an embryo created for use by a "couple" from their own gametes.   
Embryo donation is very similar to adoption, just nine months earlier.  You are not 
donating one gamete … therefore, one of the parents is at least a biological 
parent.  These are two non-biological parents to a baby that has come from [these 
people] over here.  [A] donor embryo is completely from another couple’s 
gametes.  If they had [embryos] replaced and got pregnant … and then passed 
the baby on that would be an adoption process.  …  I think there should be some 
connection to recognise what is going on because you are handing over a baby or 
a potential baby as opposed to just a gamete. 
                (Mark Leggett, Interview: 22 June 2000) 
This quote highlights the difficulties involved for clinics in conceptualising the relationships that 
are enacted through the use of ART.  It appears to be important for this provider to 
differentiate between embryos created for people who intend to co-parent the resulting child 
and embryos created from the gametes of donors who do not intend to parent the resulting 
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child.  Similarly, John Peek (Clinical Manager/Group Operations Manager, Fertility Associates 
Auckland) is specific about not creating embryos for donation.  
Basically, these are from people who have stored embryos.  We would not be 
creating embryos for donation.  They are people who had twins and then another 
child or whatever and decided they do not want to have any more and who prefer 
to donate than to discard [the remaining embryos].  …and we would say that it 
had to go like adoption.  It had to be open and people probably had to meet 
beforehand.              (John Peek, Interview: 12 July 2000) 
 
However, in cases where donated gametes are used, the resulting embryo is at least partially 
donated and in a small number of cases may even be completely created from donated 
gametes.  It would appear that the donating ‘couple’ are conceptualised as the potential 
parents, whether or not they both have contributed the gametes for the creation of the embryo.  
The gamete donors are seen only as altruistic gift givers with no future responsibilities or rights.  
Therefore, it would seem that the relationship of the ‘couple’ is what differentiates embryo 
donors from gamete donors.  Interestingly, it appears that in relation to embryo donation a 
woman who receives the embryo and consequently experiences pregnancy and labour, can only 
be conceptualised by the providers as the ‘mother’ through the adoption process.
56
  This is in 
contrast to gamete donation as outlined by the Status of Children Amendment Act 1987 
(SCAA),
57
 where the gestating woman and her husband are considered the legal parents 
regardless of the origin of the gametes.   
 
Ken Daniels (Associate Professor, Department of Social Work, University of Canterbury) also 
sees embryo donation as a logical development.  However, his justification is slightly different 
to that of the providers, as he sees embryo donation as an acceptable and incremental 
extension of donating gametes, rather than conceptualising it as the donation of a potential 
child. 
I am not surprised that it is going to come and I think it is a logical development.  
I cannot see how you could say we allow sperm and we allow egg, but we do not 
allow the combined.  A number of people have talked about this as pre-
implantation adoption.  I think there are some different issues involved that will 
need to be looked at very carefully.  But, I personally, from an ethical point of 
view, cannot see any ethical objections to it, having gone as far as we have….  I 
mean if in fact you say no assisted reproduction at all, no donation of gametes, 
then that is fine but as soon as you start opening it up, you have to say, “Well if 
we approved that, what is different about this that makes us take a different stand 
than what we did before?”  In other words, we debated the ethical arguments at 
                                            
56
  Although marginalised in the discourse surrounding parental, embryonic, and foetal rights, pregnancy 
and birth is an embodied experience for women and is dependant on a biological relationship between 
both entities, irrespective of who donates the gametes.   
57
  The Status of Children Amendment Act 1987 is discussed in Chapter One, Introduction: Framing the 
Issues, Section 1.4, Families & ART. 
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that time and we approved this, what additional ethical issues emerge from this 
development.  That is the only way the Ethics Committee can really look at it. 
  (Ken Daniels, Interview: 31 August 2000) 
Other commentators (INECART, 1995:21; Brazier, et al., 1998:36) argue that it is questionable 
whether it is in the interests of children to be born from donor ART or surrogacy arrangements.  
Sandra Coney (Executive Director, Women's Health Action Trust) also argues against embryo 
donation because of its potentially negative effect on children. 
…I do not agree that some services should be provided at all.  I am particularly 
concerned about the ones involving donation.  …  Embryo donation is like egg or 
sperm donation only a lot worse.  I mean it is that couple’s completely genetic 
child.  …the idea that a child would have no genetic connection to the mother that 
carries them and to the people bringing them up but have genetic connections to 
somebody else.  A whole family that they might really belong to and not be with 
them … this is deliberately creating a disjointed, fractured family where the genetic 
connections are completely severed.      (Sandra Coney, Interview: 13 July 2000) 
 
When arguing against the use of donated gametes and embryos, Coney fails to acknowledge 
that such circumstances are not particular to donor or surrogacy assisted reproduction and that 
adoption, death, divorce, abuse, and abandonment can create similar situations (Robertson, 
1994:121).  Adair (1998:270-271) refers to studies that have investigated the psychological 
development of children conceived using ART and donor gametes and found no evidence of 
psychological or emotional disorder.
58
  Similarly, drawing on the experiences of individuals who 
have been adopted, Baran and Pannor (in Blyth, 1995a:193) propose that more harm is likely to 
result from past practices of secrecy and anonymity.  Societal responses and the stigmatisation 
of donor and surrogacy arrangements may pose the greatest threat of harm to the child (Blyth, 
1987:24).  Nevertheless, the impact of such arrangements on children is an important concern 
and any risk of harm should be minimised.  These practices, however, should occur only under 
conditions that attempt to protect the welfare of all those involved, especially those conceived 
from donated gametes, the donors, recipients, and surrogates.  Concerns about the use of 
donated gametes and embryos also raise issues surrounding the ownership of biological 
material and the rights of embryos.
59
  The New Zealand Law Commission (2000:188, n.534) 
                                            
58
  These studies include: Brewaeys, A., 1996.  ‘Donor Insemination, the impact on the family and child 
development’, Journal of Psychosomatic Obstetrics and Gynaecology, Vol.17, pp.1-13; Golombok, S., A. 
Brewaeys, R. Cook, M.T. Giavazzi, D. Guerra, A. Mantovani, E. Hall, P.G. Crosignani, & S. Dexus, 1996.  
‘The European study of assisted reproduction families: Family functioning and child development’, Human 
Reproduction, Vol.11, No.10, pp.2324-2331; Golombok, S., R. Cook, A. Bish, & C. Murray, 1995.  
‘Families created by the new reproductive technologies: Qualities of parenting and social and emotional 
development of the children’, Child Development, Vol.66, pp.285-298. 
59
  The framework and language of rights is used within competing discourses to promote and protect 
the interests of embryos/foetuses, as well as to promote and protect women’s rights to reproductive 
choice.  While the conflict between two rights-bearing entities has often been the focus of legal, religious, 
and ethical discourses in relation to abortion and birth, reproductive technologies have increasingly 
removed the woman carrying the baby from consideration.  The increasing use of foetal imaging 
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claims that both the Yates and Graham Bills do not sufficiently address the issue of the “rights 
of the child and of the unborn or yet to be conceived child”, suggesting that these issues will be 
a continuing source of concern.  By focusing solely on the rights and interests of children in the 
policy debate, the rights and interests of the donors, recipients, surrogates, and intending 
parents are in danger of being undermined and/or marginalised, especially if these people do 
not conform to the normative definition of family.
60
  Similarly, such a narrow focus fails to 
acknowledge that children conceived through ART practices will eventually be adults and, as 
such, their rights and interests are in danger of being overlooked.  Although it is not within the 
scope of this thesis to discuss all these complex issues in detail, it is important to note that 
these topics need to be considered within the ART policy framework. 
 
Blank (1995:51) claims that there is increasing evidence in the United States of America (USA) 
that people are willing to use technologies that offer control over the characteristics of their 
children.  Although he acknowledges that gender preferences are “less clear” in the USA, Blank 
(1995:45-46) maintains that the availability of sex-selection procedures and the tendency for 
one or two-child families will combine to create a widespread demand for such procedures.  A 
recent newspaper report indicates that sex-selection techniques are also increasing in demand 
in the United Kingdom (UK).  Despite restrictive legislation in the UK, the report claims that the 
“procedure is reportedly available at a number of licensed clinics which operate as a result of a 
loophole in the law” (The Press, 5 November 2001, p. 12).  Although John Peek (Clinical 
Manager/Group Operations Manager, Fertility Associates Auckland) claims that most sex-
selection methods do not work, he does acknowledge that there is an increasing demand in 
Aotearoa/New Zealand for these techniques to be used for social reasons. 
                                                                                                                       
technologies, such as ultrasound, sonogram, and endoscopy, contributes to the illusion that the embryo 
is disconnected and independent of the woman in whose body it exists (Terry, 1989:22; Shildrick, 
1997:201-202).  Correspondingly, ART has added to the increasing invisibility of the women in the 
reproductive process by enabling conception to take place outside the body and dividing the female body 
into its component parts.  By concentrating on the separate roles and functions of these component parts 
in relation to conception and pregnancy, ART potentially contributes to the effacement of pregnancy as 
an embodied experience by women.  It also obscures the embryos’ dependence on women’s bodies and 
enhances the ability to identify embryos as individuals with rights.  The manifestation of foetal rights 
positions pregnant women’s rights as competing and therefore, hostile to those of the embryo/foetus 
they are carrying because the pursuit of women’s rights to choose not to parent are at the expense of 
the life of the foetus.  Furthermore, by assuming that the foetus has equal rights within the mother, the 
rights of the foetus are effectively prioritised (Terry, 1989:22-23).  Accordingly, the interests of the 
embryo are not necessarily placed in conflict with those of the mother; rather they are given precedence 
over them. 
60
  See Chapter 5, Regulating Access, Section 5.3, Access & Rights, for a discussion of how focusing 
solely on the rights of children can impact on those seeking access to ART services. 
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Well, fortunately none of the sex-selection methods actually work.  ….  The only 
thing that is reliable is sorting sperm and then using IVF, and I think that there is 
only one clinic in the [USA] that I know of that does that and even then you have 
only got like a 70% or 80% chance of having a child of the right sex.  All the other 
methods do not work.  …  A lot of people ask about sex-selection.  I must get one 
or two calls a week but it is usually European people with one or two children who 
want a child of the other sex and I [wonder] what the expectations for children 
are.               (John Peek, Interview: 12 July 2000) 
 
Subsequently, it was reported in March 2001 that Fertility Associates had received limited 
approval from NECAHR to conduct a feasibility study into Fluorescent In-Situ Hybridisation 
(FISH) (Philp, 2001).  This technique enables the detection of abnormal chromosomes in 
embryos before they are implanted using IVF.  While intended to “reduce miscarriages for 
women trying to get pregnant through IVF by screening out the weakest embryos”, the 
technique can also detect chromosome anomalies associated with Down’s Syndrome and 
Turner’s Syndrome
61
 and can be used to determine the sex of an embryo (Philp, 2001:19-20).  
These capabilities raise questions about the eugenic applications of such techniques and who 
has the authority to make the decisions and choices associated with them.  While the use of 
sex-selection techniques is often justified in terms of therapeutic use, such as a sex-linked 
genetic predisposition to a disease, it is often unclear what the definition of ‘therapeutic use’ 
might include.   
My own view is that I have no difficulties with sex-selection where there is a 
medical reason for it.  I would take a lot of persuading, in fact, I am not quite sure 
that I could be persuaded, I just do not think that for social reasons that it is 
acceptable.       (Ken Daniels, Interview: 31 August 2000) 
 
ART techniques make a diverse range of clinical and eugenic applications possible, depending 
upon the motivation of the people using them (Blank, 1995:47).  Similarly, the manner in which 
they are applied can be either enabling or constraining of reproductive choice and rights.   
 
As mentioned earlier, the speed at which ART innovations and applications advance has been 
used by some commentators as a justification for resisting legislative control.  Others stand by 
the ‘slippery-slope’ argument as defined by Mendeloff (1985:83, emphasis in original); “the 
principles used to justify current decisions tend also to justify in advance future decisions that 
may be much more troubling.”  Sandra Coney (Executive Director, Women's Health Action 
Trust) is particularly concerned about the effects such procedures will have on the vulnerable in 
society.  She implies that allowing the use of certain procedures will undoubtedly lead to more 
questionable procedures in the future. 
                                            
61
  Turner’s Syndrome can cause infertility, as well as heart and lung problems. 
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The whole history of scientific experimentation is that things barge ahead without 
enough consideration of the ethical issues and then you find out a lot later that 
you have got some ghastly dilemma on your hands.  I cannot see any advantage 
in cloning what so ever … and I even think that things like sex-selection for genetic 
[linked disorders] have to be thought about really carefully.  I know that some of 
the groups, [such as] Cystic Fibrosis, are very keen on some of these things, 
[those] who have got it in their families.  You can be very sympathetic to that but 
that has to be balanced against the effect on the whole of society … because then 
the flow on effect of that can be that people who have a child who is imperfect get 
blamed or will not get social support.  So, there are big social effects of going 
down some of these routes.  …  I can see there may be some value of research on 
embryos that have been miscarried or aborted and people consent to that 
occurring.  I do not at all like the concept of creating embryos for the purpose of 
research.  The reason for that is the same reason as, “If you can do that, what 
else can you do?  Can you create human beings so you can get their kidney?”  If 
you treat human life as objects and as commodities then it is very easy for that 
approach to just spread.       (Sandra Coney, Interview: 13 July 2000) 
 
Mark Leggett (Business Manager, The Fertility Centre, Christchurch) acknowledges that at 
present there are no regulatory controls in Aotearoa/New Zealand to stop scientists 
experimenting with procedures such as cloning.  However, he is convinced that scientists in 
Aotearoa/New Zealand would not participate in such research. 
The fear of the people in white coats who will do anything they like if we do not 
control them.  That might happen overseas but I doubt it happens in New Zealand 
or Australia so much.  As I say, someone is bound to be, at the moment, working 
on human cloning.  Simple as that.  [There are] plenty of private laboratories 
around.  The technology has existed for a little while now so somebody is doing it.  
…  Well it could happen in New Zealand, you could do anything you like.  …  I do 
not think we have got the actual technology to do it but theoretically, we could do 
it.  …  There is nothing to stop us doing it because the legislation is not in place 
yet!  So, it could be done, but knowing the industry in New Zealand… we certainly 
have not done anything with humans.  New Zealand is so small you would never 
get away with it.         (Mark Leggett, Interview: 22 September 1999) 
 
Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) is also 
convinced that research into as yet unsuccessful procedures will continue and will eventually 
succeed. 
I think we can expect the unexpected in this area of medicine.  ...  I think you 
would be naive to think that just because it has not worked right at the beginning 
it is not going to ever work.  You only have to look at the automobile and people 
who said there that the car would never take off.  ….  It is a very naive approach.  
I think you have to deal with the issue that most things that are theoretically 
possible will probably become practically possible. 
   (Rodney Bycroft, Interview: 13 September 2000) 
However, he also cautions against what he calls “knee-jerk” reactions and “scare mongering”.  
Like Mark Leggett, he believes that there are enough social controls in Aotearoa/New Zealand 
to prevent scientists and doctors overstepping social boundaries in relation to genetic 
experimentation and manipulation. 
I subscribe to the view that most scientists are responsible and ethical.  Most of 
the ones I have spoken to are.  There might be some nutters out there.  There is a 
popular myth that scientists are all mad.  I have not seen that.  I have seen 
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scientists and doctors holding meetings in their own time at their own expense, to 
explore the social and ethical issues that they are dealing with. 
   (Rodney Bycroft, Interview: 13 September 2000) 
Nevertheless, recent media coverage of claims by Italian scientists that they will be the first to 
clone a human highlight the fact that there are scientists and doctors who are willing to push 
boundaries in relation to what is considered socially acceptable scientific and medical practice 
(McCurdy, The Press, 12 March 2001, p.1; Robson, The Press, 9 August 2001, p.11; McKie, The 
Press, 14 August 2001, p.5).  It also raises questions about the future use of technologies 
developed overseas as a result of these genetic experimentation and manipulations.  As the 
proposed legislation in Aotearoa/New Zealand bans human cloning, does this mean that any 
advances in reproductive science generated from such research will not be used here?  Would it 
be ethically or morally appropriate for Aotearoa/New Zealand to ban such experimentation and 
then benefit from its development in other countries?   
 
While there is currently very little research done into infertility and ART techniques in 
Aotearoa/New Zealand, clinics do develop and refine techniques developed internationally.  
John Peek maintains that there is  
…developmental work when we start using a technique but [they are] nearly 
always techniques that already exist overseas.  It is just us trying to get them to 
work locally.              (John Peek, Interview: 12 July 2000) 
 
Although supportive of legislative control over certain practices, Rodney Bycroft is wary of a 
complete ban on cloning or embryonic research without careful consideration of what the 
procedures include or how they may benefit society. 
I think that there definitely needs to be control over certain practices that people 
find abhorrent.  Cloning humans and human hybrids and things like that.  I think 
the bill is correct there to make some of those processes illegal.  …  
Experimentation on human embryos is one area that really should be handled 
intelligently because if we are going to learn more on how to help people to 
perform safer pregnancies through the technology then certain controlled research 
needs to be done there.  But certainly some things like forming human/ animal 
hybrids, cloning issues, although you have to be very careful how you define 
cloning because cells have been cloned for years.  …  There are clearly things 
involved in cloning that could be sensible and ethical and morally defensible and 
yet there are some things that are clearly unethical. 
   (Rodney Bycroft, Interview: 13 September 2000) 
Similarly, Mark Leggett argues that there needs to be some consideration of the issues involved 
and a general ban is unrealistic and prohibitive for future advances in reproductive medicine. 
It needs to be thought through more.  As scientists will tell you, there are aspects 
of cloning technology that are useful in reproductive medicine.  Not that they 
actually do cloning but that there are parts of it that could be used to assist 
average couples in reproductive life.  While you are not actually doing cloning 
there are parts of the process that are useful or that could be useful.  So, [I] feel 
that on the whole disallowing cloning all together is a stupid thing to do. 
       (Mark Leggett, Interview: 22 September 1999) 
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The nature of fertility clinics’ work and their experience and interest in embryology is likely to 
place them at the forefront of any new developments in genetic manipulation and/or 
experimentation.   
 
Policy gaps exist in two key areas relating to ART developments and practices; the control and 
oversight of innovative applications of existing technologies and the rapid expansion of new 
biomedical technologies that are potentially applicable to human fertility.  As it stands, it is 
NECAHR’s role to approve and provide guidelines for any innovative practices or research 
strategies in the use of ART in Aotearoa/New Zealand. 
3.5 NECAHR  
There is nobody else making policy decisions though.  Who is making policy 
decisions?  Should that be a Ministry of Health area or should policy be enshrined 
in legislation or should legislation be enacted and then policy developed?  What 
should the process be? 
       (Robyn Scott, Executive Officer, NZIS, Interview: 26 July 2000) 
The National Ethics Committee on Assisted Human Reproduction (NECAHR) was established 
under section 46 of the Health and Disability Services Act 1993 and reconstituted under section 
11 and 16 of the New Zealand Public Health and Disability Act 2000 (NECAHR, 2001b).  In April 
1993, the Minister of Health established the Interim National Ethics Committee on Assisted 
Reproductive Technologies (INECART) to provide specialist advice in the area of assisted human 
reproduction.  INECART was established in response to regional ethics committees expressing 
concern over “proposals and protocols from providers of assisted human reproduction (“AHR”) 
services” (NECAHR, 2001c).  In March 1995, INECART was reconstituted as the National Ethics 
Committee on Assisted Human Reproduction (NECAHR) under section 46 of the Health and 
Disability Services Act 1993 and, in 2000, was re-established under section 11 of the New 
Zealand Public Health and Disability Services Act 2000 assuming the same role as it had 
previously (NECAHR, 2001c).   
 
NECAHR's terms of reference (2001a:1) outline the functions it is required to perform.  These 
functions include the evaluation of new, experimental, or innovative ART applications and 
research “to ensure that the ethical aspects are considered and that participants in research 
and innovative treatment are protected” (NECAHR, 2001c).  NECAHR is also required to develop 
protocols and guidelines relating to the ethical issues involved in aspects of assisted human 
reproduction to assist providers and researchers in their applications for ethical approval.  
However, in the absence of legislative guidance or a broadly focused policy organisation to 
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make decisions on the social implications of ART practices and procedures, NECAHR has found 
itself in this role.   
From time to time, it has felt that it has been forced inappropriately to take an ad 
hoc role in policy formulation in the vacuum that exists.           (NECAHR, 2000a:3) 
 
In its submission to the Health Select Committee, NECAHR argues that this gap in the ART 
legislative or policy framework has compromised its ability to maintain an autonomous role in 
ethical decision-making. 
Accredited ethics committees in New Zealand operate in accordance with the 
National Standard for Ethics Committees which provides for independence of 
decisionmaking in regard to ethical review.  Currently, NECAHR is more or less 
autonomous in its application of ethical review.  In the absence of a contextual 
framework NECAHR has, by default, become involved in major decisions with far 
reaching social implications and also policy formulation in the area of assisted 
human reproduction.  NECAHR has become aware of difficulties in exercising the 
kind of autonomous role that its current terms of reference seem to imply. 
     (NECAHR, 1999:4) 
John Peek (Clinical Manager/Group Operations Manager, Fertility Associates Auckland) agrees 
that the two roles of policy and ethical decision-making should not be handled by one 
organisation and is critical of the Graham Bill’s proposal to extend NECAHR’s functions to 
include policy and monitoring roles. 
The alternative also has some weaknesses in that they were going to give all the 
functions of monitoring what is happening to the ethics committee, the National 
Ethics Committee on Assisted Human Reproduction.  I think you cannot give those 
two roles to one organisation because the organisation which monitors should also 
be monitoring the ethical decisions in the way those functions are handled whereas 
I do not think [NECAHR] can really monitor itself.   
          (John Peek, Interview: 12 July 2000) 
Similarly, Ken Daniels (Associate Professor, Department of Social Work, University of 
Canterbury) sees the role of ethics and policy formulation as complementary but distinct. 
…my contention would be that when you develop a policy you take into account a 
whole lot of factors of which ethics is a very important one.  But, if the ethics is 
determining the policy, then we have got something wrong in the system. 
  (Ken Daniels, Interview: 31 August 2000) 
Beauchamp and Childress (1994:10) argue that policy formation and evaluation “involve more 
complex forms of judgment than merely invoking ethical principals and rules.”  Although such 
principles and rules should provide the moral context for policy decisions, policy formulation 
requires empirical evidence and attention to relevant fields, such as medicine, economics, law, 
psychology, and sociology (Beauchamp & Childress, 1994:10).  Although NECAHR has made 
some general policy decisions, such as allowing the practice of altruistic IVF surrogacy, it 
continues to make decisions about the application of such policies using a case-by-case process. 
 
Rather than taking the reactive stance of NECAHR, John Peek believes that there should be a 
policy body that is proactive in looking at ART policy issues.  He highlights the necessity for 
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urgent decision-making in some situations and argues that a policy organisation with the role of 
investigating and consulting on new or unusual developments could give providers some 
guidance in these circumstances. 
At the moment, there is no body that formulates those policies.  It is only if 
somebody thinks of an idea and passes it to an ethics committee.  [NECAHR] is 
taking on a little bit of a role of trying to have some guidelines, policy guidelines, 
but usually it is reactive.  Somebody comes to them and that triggers their mind 
that perhaps there should be something more uniform.  …  I think it should be 
some [organisation’s role] to think about what might be needed and put it up for 
debate.  I think what is coming out of the ethics committee is quite useful.  …  
[NECAHR] came up with some suggested guidelines about how to approach [using 
men’s sperm after they have died].  …  I think to have some policies along those 
lines is good because otherwise what happens [is that] the clinics are caught when 
the pathologist rings up and says, “I am doing an autopsy and the family have 
mentioned this.  What shall we do?” and there is no time to really think about it so 
you do it and then you have got it in the [sperm] bank and then you have a 
precedent and what do you do with it?  So, to have some policies would be really 
good.               (John Peek, Interview: 12 July 2000) 
 
However, according to Blank (1994:12-13), the inability to predict the long-term consequences 
of new technological practices in medicine combined with short-term political pressures 
concentrates technological assessment on the immediate future.  The case-by-case approach to 
decision-making, as practiced by NECAHR, is easier to manage politically because it focuses on 
cases in which the benefits and beneficiaries are easily identifiable and avoids having to reach 
agreement on criteria and principles that may be politically contentious.  This approach enables 
decision-making without having to justify an overarching policy through particular ethical 
principles or rules and simplifies the search for political resolution.  Mendeloff (1985:87) argues 
that it is easier to obtain group consensus on individual cases than to get agreement on general 
principles and particular policies.  Not having to justify decisions on a general basis also allows 
policymakers to be flexible in their responses to individual cases (Mendeloff, 1985:83 & 89).  
The ‘muddling through’ method of policy-making and ethical decision-making can be 
rationalised by the need to allow for limited timeframes, information, and reasoning ability 
(Mendeloff, 1985:85).  Although the future impact of technology is difficult to predict because it 
is reliant on a number of social and practical factors, not just the existence of the technology, 
inattention to long-term consequences may prove harmful (Blank, 1994:13).  The use of certain 
unethical ART practices may become widespread through the acceptance of practices that 
individually do not indicate the potential for harm (Blank, 1994:13).  Blank (1995:10) suggests 
that the potentially negative consequences of biomedical technology are not likely to be 
apparent until the technology has been “frozen” into technical, institutional, and social patterns.  
Once this has happened he predicts that controls will be both costly and difficult to put into 
practice. 
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Those interviewed raised concerns about the absence of a consumer representative on 
NECAHR.  NECAHR’s terms of reference state that 
NECAHR shall consist of not more than 10 members appointed by the Minister of 
Health (“the Minister”).  NECAHR’s membership shall include members with 
specialist knowledge of and experience in assisted human reproductive procedures.  
NECAHR shall have at least two Mäori members.  At any time, at least half the 
members of NECAHR shall be lay members.  For the purposes of appointments to 
NECAHR, a lay member is defined as anyone who: 
• is not a registered health professional engaged in health care delivery or 
employed in the provision of health or disability services 
• is not involved as a researcher in health and disability research in the field of 
assisted human reproduction 
• may not be construed by virtue of current or previous employment to have a 
potential conflict or professional bias in assessing a majority of applications 
presented to NECAHR for ethical review. 
The Director-General of Health will appoint one person to represent the Ministry of 
Health.  It will be the responsibility of that person to provide NECAHR with 
information regarding government policy and ministerial views. 
      (NECAHR, 2001a) 
Both consumer and provider representatives believe that the voice of the consumer is 
marginalised within the policy debate because of their exclusion from NECAHR.  MCART 
(1994:39) recommended that the membership of NECAHR should be carefully chosen and 
balanced with respect to gender, ethnicity, and professional background.  However, Ken Daniels 
(Associate Professor, Department of Social Work, University of Canterbury) claims that the 
Minister of Health does not see NECAHR as a representative body for interest groups and, 
expresses his own reservations about having consumer representation on an ethics committee. 
Well I actually believe that we need a policy body in New Zealand and I think 
consumers should be on the policy body.  I must admit that I have got some 
uncertainties, and that is all they are, about the role of consumers in an ethics 
committee.  Now, if we had been a policy committee looking at surrogacy we 
needed the consumer voice there.  But, ethics is a highly specialised area, and 
people are supposed to be appointed because they have got some knowledge in 
that area.  And I mean I would not want to come out strongly and say one way or 
the other that there should not be [consumer representation] but I think if we had 
a different system there would be no question that consumers would be involved 
in that.  …  Various Ministers have made clear on a number of occasions that this 
is not a representative body.  You do not have somebody there to present a 
particular viewpoint; everybody is focusing on the ethics of the issue.  Now I think 
that is a bit blurry as well.  I can see it from both points of view. 
  (Ken Daniels, Interview: 31 August 2000) 
Nevertheless, Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, 
Auckland) believes that there should be a consumer representative on NECAHR.   
I definitely support the consumer’s desire to be represented on NECAHR.  
Definitely!  …I feel that the voice of the consumer on the Committee is only heard 
through those people who are working in the industry and most of the Committee 
will have access to some consumer information if you think about it.  Some of the 
GP's on the committee will have access to their patients.  I will have access 
through my advisory role because I am seeing patients all the time.  Ken Daniels 
knows patients because he has talked to them for years.  Rosemary De Luca 
through her chairpersonship and through her interests in informed consent will 
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have a view on consumers’ interests.  So, I think it is probably naive to say that 
the consumer is not represented.  The consumer is not represented directly with a 
consumer with a particular bandwagon.  I guess the issue is that you end up with 
someone who has a barrow to push but then I believe [the consumer] should be 
there because it is fair.  It just seems fair that [the consumer] voice is heard.   
        (Rodney Bycroft, 13 September 2000) 
Bycroft displays some disquiet over the possibility that a consumer member would have a 
particular bias with regard to ART practices.  He suggests that the ‘experts’ already represented 
on the committee would adequately represent consumer concerns but continues to support 
consumer representation in the interests of fairness.  However, while suggesting that a 
consumer representative may have a “barrow to push”, he fails to recognise that the existing 
NECAHR members may have their own agenda regardless of their professional position and that 
‘expert’ status does not necessarily confer objectivity. 
 
Edwards (1998:154) argues that it is difficult to uphold the separation between ‘lay’ and ‘expert’ 
opinion because members of both categories are “cultural beings” who draw on specific 
“cultural ideas to order and make sense of social phenomena of which they need not … have 
direct experience.”  As such, both lay and expert representatives on the ethics committee will 
draw on their own experiences, including their cultural expertise and personal understandings 
of kinship, to understand and evaluate of new ART practices or techniques (Edwards, 
1998:154).  Correspondingly, Mendeloff (1985:88) suggests that bioethical committees may 
under-represent the perspective of society because their membership is often chosen from the 
educated elites.  He speculates that specialist members of bioethical commissions are likely to 
be more supportive of medical research than other groups.  Robyn Scott (Executive Officer, 
NZIS) argues that academic representation and support for medical research is not enough and 
that the voice of the consumer is being silenced in relation to decisions that affect their 
reproductive choices. 
We have some reservations about NECAHR.  Firstly, there is no consumer 
representation on the ethics committee that is making decisions on behalf of 
consumers.  …  So, we have a lot of concerns that there are a lot of academic 
people making decisions on behalf of infertile people in New Zealand with no broad 
based opinion ever presented to them.  …  There is no provider representation and 
there is no consumer representation.        (Robyn Scott, Interview: 26 July 2000) 
 
In 1988, the Cervical Cancer Committee of Inquiry produced guidelines for research involving 
humans, which recommended that “lay representation on the ethical committee approximates 
one half of the membership” (Cervical Cancer Committee of Inquiry & Cartwright, 1988:214).
62
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  The Cervical Cancer Inquiry into questionable research ethics had considerable influence on the 
establishment of guidelines for all research involving human beings, including social research (Tolich & 
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By continuing to reject membership nominations from the New Zealand Infertility Society 
(NZIS),
63
 the Minister of Health is in danger of subjugating ‘lay’ knowledges, concerns, and 
experiences beneath the more dominant ‘scientific’ or ‘expert’ discourses represented by the 
current membership of NECAHR (Lupton, 1997:104).
64
   
 
Until recently there was no provider input on NECAHR.  However, a specialist scientific officer 
nominated by the clinics is now present at NECAHR meetings.  This person does not have a 
voting role but is available for clarification of issues in relation to ART practices and technology. 
From time to time, fertility clinics have been critical of the level of specialized 
scientific expertise on the Committee to inform its discussions.  In response to 
these criticisms, meetings are now attended by a clinic’s representative with 
scientific expertise who has been nominated by the clinics to advise NECAHR on 
specialized scientific matters.  NECAHR also seeks expert advice from time to time. 
       (NECAHR, 2000a:2-3) 
Although John Peek (Clinical Manager/Group Operations Manager, Fertility Associates Auckland) 
perceives the overall composition of NECAHR as flawed, he acknowledges that this development 
makes the ethics committee more responsive to consumer and provider requirements in terms 
of timeliness and approachability. 
I think it has great holes in it.  I think most of the people there are fine except that 
it has lots of representation from government organisations, from the health 
profession, although the people on it from the Health profession are generally not 
very knowledgeable about ART because the field is relatively small.  Anybody that 
has knowledge about ART is likely to be someone submitting stuff to the 
committee.  They have a system now where they rotate expert opinion from each 
of the clinics, which is a bit of an advantage.  So, I think that they lack a lot of 
information about ART and there is no consumer representation. … The committee 
is quite a lot more open than it used to be.  …they welcome people to come along 
and answer the questions at the time of the committee meeting whereas before 
they would have the meeting and you would have to wait three months to have an 
opportunity to answer the questions and then there would be more questions from 
those questions.             (John Peek, Interview: 12 July 2000) 
 
Expert knowledge in a technical field does not guarantee that the social implications of 
technology are considered and in some cases, these implications may even be obscured by 
attention to the technical aspects (Blank, 1998:138).  However, successful health policy is 
dependent on some level of specialised medical knowledge (Blank, 2001:149).  Therefore, 
                                                                                                                       
Davidson, 1999:83-84).  It concluded that ethical standards "must be applied rigorously to research and 
treatment protocols on behalf of the patients" (Cervical Cancer Committee of Inquiry & Cartwright, 
1988:152) and lead to the established of regional ethics committees under Area Health Boards in the late 
1980's (NECAHR, 2001c). 
63
  The New Zealand Infertility Society (NZIS) has repeatedly canvassed the Minister of Health and 
NECAHR for consumer representation on the committee. 
64
  See Appendix N for a list of the members of NECAHR and their professional and/or academic status. 
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although the specialised knowledge of experts is not solely adequate to deal with the distinctive 
ethical and moral issues associated with ART practices, technical experts should be included in 
the debate over “social priorities” (Blank, 1998:138).  Although such experts may initiate and 
direct public debate on biomedical issues, extensive public involvement is critical if democracy is 
to be maintained (Blank, 1998:138). 
 
For Sue Bagshaw (Medical Training Co-ordinator, Family Planning Association, Christchurch) the 
issue of consumer representation is connected to the lack of public consultation undertaken by 
NECAHR.  
NECAHR is not really representative of society and I find that really worrying.  …  
[They] do not have the time and they are not asked to really.  …  If you actually 
said that NECAHR needs to be representative and put in its constitution that you 
must go away and consult and you must take into account all these groups’ 
opinions, then at least they would have to try to do that.  I mean it is a pretty hard 
task but at least they would have to try to do that.  To me that would be a much 
more democratic way of deciding what happens. 
 (Sue Bagshaw, Interview: 21 August 2000) 
Although NECAHR acknowledges the importance of public consultation in making its decisions, 
it argues that the pluralistic nature of society in Aotearoa/New Zealand, the specialised 
knowledge relating to ART practices, and the “private and personal aspects of most requests for 
ethical review” often make public consultation difficult (NECAHR, 2000a:2).  Consequently, the 
ethics committee relies on a diverse range of media to keep its members informed of public 
debate in the area of ART. 
When possible, the Committee uses opportunities that offer good investigative 
journalism to engender public discussion.  It also consults about proposed 
guidelines.  For example, the guidelines for non-commercial altruistic surrogacy 
using IVF as treatment will be distributed shortly for public consultation.  NECAHR 
also informs itself about public debate by reading relevant reports and submissions 
in the field that have been called for by groups other than itself, and follows media 
reports, published correspondence and radio ‘talk-back’ programmes.  
Arrangements are being put in place to make NECAHR's work public via a website. 
        (NECAHR, 2000a:2)
65
 
The avenues of public expression identified above are in themselves specific discourses that 
give authority to certain voices, controlling what is said, who can speak, and when (Foucault 
cited in Campbell, 1993).  Although useful in the contribution to public debate, some of these 
avenues for public discussion are arbitrary in their attention to issues relating to ART and 
should not be a substitute for direct consultation with interested or concerned publics.  A wide 
                                            
65
  This website is now operational and appears to have been created on the 21 September 2001.  It 
provides online access to NECAHR’s annual reports, submissions to the Health Select Committee and the 
Law Commission, Terms of Reference, membership, and links to other relevant sites (Available: 
http://www.newhealth.govt.nz/necahr.htm [6 November 2001]). 
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range of interested individuals may be excluded from having their views considered in the 
debate because they lack the information, social capital, or cultural knowledge to engage in 
these forums for discussion.  While public consultation can be difficult and time consuming, it is 
a far more inclusive method of gathering information and opinion than relying solely on ‘expert’ 
advice or ‘popular’ media presentations.  Blank (2001:148) argues that there is a strong belief 
in Aotearoa/New Zealand that the public should have a participatory role in deciding ‘public 
policy’.  However, he suggests that in recent years Aotearoa/New Zealand has moved away 
from participatory democracy towards ‘thin’ democracy in which health care decisions are being 
primarily made by the health providers and public administrators.  Accordingly, there has been 
a move towards reducing the control of medical professionals and limiting the amount of public 
consultation in health policy (Blank, 2001:150).  Therefore, NECAHR’s position as the only 
government appointed group with direct responsibility for ART policy decisions and guidelines, 
strengthens the need for it to undertake public consultation in relation to ART developments.   
 
Although providers are required through their professional codes of practice and the 
Reproductive Technologies Accreditation Committee (RTAC) to submit research and new 
treatment proposals for ethical review to NECAHR, there is no regulatory framework to enforce 
NECAHR’s findings.  However, NECAHR stresses that fertility clinics currently comply with 
accreditation and ethical requirements despite the lack of regulatory enforcement. 
Although the Committee has no legislative powers, fertility clinics currently 
demonstrate a due regard for and compliance with its ethical review findings.  …  
There has been an informal undertaking by RTAC to make compliance with 
NECAHR's guidelines a requirement of accreditation for New Zealand clinics.  This 
undertaking will be pursued when public consultation on the surrogacy guidelines 
is completed and the guidelines formalised.     (NECAHR, 2000a) 
 
Coney (1999a:22) contends that in the past some ART research proposals have not been 
referred to NECAHR but have been dealt with by university ethics committees.  She also 
speculates that, under NECAHR’s terms of reference, practices that have been long established 
internationally, but are new to Aotearoa/New Zealand, may not need to be submitted for ethical 
approval.  NECAHR also notes that the only incentive for clinics to submit proposals comes from 
their accreditation commitments. 
The RTAC guidelines require accredited clinics to submit research and new 
treatment proposals for ethical approval before adopting new procedures.  This 
ethical review is undertaken by NECAHR.  In the absence of any overarching 
statutory body, RTAC accreditation provides the only impetus for clinics to submit 
proposals for review.       (NECAHR, 1999:2) 
 
However, Rodney Bycroft argues that the clinics’ statutory requirements to comply with RTAC 
are a sufficient motivation for clinics to comply with NECAHR’s findings and judgments. 
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NECAHR will say that they do not have the authority to compel clinics to do things 
but the clinics through their registration process are required to do or to act on the 
advice of their ethics committee.  So, for us here at the clinic, we would be stupid 
to run against the advice and recommendations of NECAHR because it would be in 
breach of our statutory requirements to be registered and to take notice of [them].  
From time to time, some clinics have contested NECAHR’s recommendations. 
   (Rodney Bycroft, Interview: 13 September 2000) 
Nevertheless, there are no penalties in place if a clinic does not comply with NECAHR’s decision 
and carries out a procedure that does not have ethical approval.
66
  The Assisted Human 
Reproduction Bill (Graham Bill) does not make any recommendations regarding this issue. 
The Bill is silent on the situation where the ethics committee decides that a 
procedure should not be given ethical approval.  Currently the only mechanism 
preventing the implementation of such a procedure is the requirement under the 
RTAC accreditation guidelines.      (NECAHR, 1999:4) 
 
Consequently, NECAHR and RTAC remain the only two organisations in Aotearoa/New Zealand 
with specific control over ART at present and, as explained in the following section, they remain 
independent and are not accountable to each other. 
3.6 Professional Self-Regulation 
Professional self-regulation has a principal role in the control and regulation of ART in 
Aotearoa/New Zealand.   
In 1992, the RNZCOG [Royal New Zealand College of Obstetricians and 
Gynaecologists] formulated a policy that all providers of ART, including DI services, 
in New Zealand, be accredited with the Australian Reproductive Technologies 
Accreditation Committee to set minimum professional standards and allow peer 
review.        (MCART, 1994:11) 
 
The Australian based Reproductive Technologies Accreditation Committee (RTAC) is one of two 
bodies with specific control over ART and surrogacy in Aotearoa/New Zealand.  RTAC monitors 
the practical aspects of ART provision and provides procedural guidelines for the professional 
qualifications of clinic staff, the prevention of diseases, the collection of information, informed 
consent, the provision of laboratory facilities, ethics and research, and the provision of support 
services including counselling (MCART, 1994:11; RTAC, 1999).  Nevertheless, commentators 
have expressed concern about the use of an Australian based organisation to oversee 
Aotearoa/New Zealand clinics. 
Standards for recognition or accreditation of ART clinics in New Zealand are 
currently based on Australian standards.  The values and perspectives of Australia, 
however, are not necessarily appropriate for New Zealand.     (Dyall, 1999:37) 
 
                                            
66
  Clinics may lose their accreditation with RTAC if they do not comply with NECAHR’s findings.  The 
consequences of this are discussed in the following section of this chapter. 
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Similarly, Ken Daniels (Associate Professor, Department of Social Work, University of 
Canterbury) expressed concern about the lack of accountability or sanctions provided by relying 
on an offshore accreditation committee that has no regulatory obligations to the Government of 
Aotearoa/New Zealand. 
RTAC is in no way answerable to the New Zealand Government.  So, there is an 
accountability issue and if the Government is interested in protecting the interests 
and welfare of children and of families and so on, how do they actually monitor 
that?  And, there is no process for any input into RTAC standards or for RTAC to 
report back to anybody in New Zealand.  So it is very much a self-regulatory 
system and while that has quite a lot going for it, it also has weaknesses.  How 
does it actually tie in?  I mean if the professional group says, “This is what we are 
going to do” and the Government does not like it, then what can they do about it? 
  (Ken Daniels, Interview: 31 August 2000) 
Others involved in the policy debate argue that disparate health systems and cultures make it 
inappropriate for an Australian-based organisation to oversee ART practices in Aotearoa/New 
Zealand.   
It is not appropriate.  I do not see how they can.  I think there are several issues.  
One is around differences in the structure of the health system and the other is in 
cultural differences that they would not be able to deal with and the third is just 
the practicalities of being able to perform as an accreditation body. 
(Sandra Coney, Executive Director, Women's 
Health Action Trust, Interview: 13 July 2000) 
 
 
All Aotearoa/New Zealand ART providers are presently accredited through RTAC, as originally 
required by the RNZCOG (Ministry of Justice & Ministry of Health, 1997).  However, there is no 
legal requirement for the clinics to be accredited.  As a self-regulatory organisation, the 
RNZCOG and, latterly, the RANZCOG
67
 has no power to enforce their members to comply with 
their standards and guidelines (MCART, 1994:12).  Similarly, there are no legal sanctions in 
place if providers fail to comply with RTAC’s guidelines or lose their accreditation. 
There are [no sanctions] in New Zealand.  It is the stigma really.  In Australia if 
you are not accredited you are not eligible to get the drugs from the federal 
government which means that your patients would be severely disadvantaged so 
[they would go somewhere else].  (John Peek, Interview: 12 July 2000 
 
Mark Leggett (Business Manager, The Fertility Centre, Christchurch) suggests that market 
forces would ensure that clinics maintained their accreditation, as loss of reputation would be a 
consequence of not being accredited by RTAC. 
Reputation probably more than anything else.  No one would recommend you I 
would think.  ...  If we do not provide a very good service people would not come 
back.  They will go somewhere else, out of town. 
       (Mark Leggett, Interview: 22 September 1999) 
                                            
67
  In 1998, the Australian and New Zealand Colleges amalgamated to form the Royal Australian and New 
Zealand College of Obstetricians and Gynaecologists (RANZCOG). 
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This observation fails to take into account the small number of clinics and geographical 
limitations that restrict the options available to consumers.  MCART (1994:12) argues that those 
providers who negotiate purchase agreements for publicly funded ART services would be 
disadvantaged if they did not hold RTAC accreditation.  As Helen Williams (Policy Analyst, 
Elective Services Project, HFA) maintains 
If you were not accredited I do not think the HFA would purchase from you. 
      (Helen Williams, Interview: 29 August 2000) 
However, this is only effective as a sanction if the clinic is involved in applying for government 
contracts.  The smallness of the ART community and the role of the NZIS and affiliated regional 
infertility societies in educating and informing consumers about the standards of services they 
can expect may work to ensure that non-accredited clinics are disadvantaged.  On the other 
hand, the small number and geographical location of clinics may offset any disadvantages by 
limiting consumers’ options for treatment.  Helen Lockyer (Senior Policy Analyst, Ministry of 
Health) sees the lack of effective sanctions as one of the reasons for making accreditation 
mandatory. 
…that would be one of the advantages of making such accreditation or something 
similar mandatory and actually having some sanctions.  Penalties [is] one of the 
issues that [is] covered by both of the bills. 
   (Helen Lockyer, Interview: 24 July 2000) 
 
 
All of the provider representatives interviewed supported the use of RTAC as their accrediting 
agency, suggesting that setting up an independent Aotearoa/New Zealand accrediting 
organisation would be extreme and costly considering the small number of clinics in this 
country. 
RTAC is pretty good.  The industry is not so huge and diverse in New Zealand and 
Australia that people would get away with anything, really.   
                (Mark Leggett, Interview: 22 June 2000) 
Similarly, Helen Williams (Policy Analyst, Elective Services Project, HFA) identifies the size of the 
Aotearoa/New Zealand ART ‘industry’ as too small to warrant setting up its own self-regulating 
organisation. 
Because we are too small a country to have a New Zealand based one and that 
happens with a lot of specialities.  I think it is absolutely fine for it to be an 
Australian based; it has New Zealand input as well. 
         (Helen Williams, Interview: 29 August 2000) 
John Peek agrees that, as far as overseeing the technical aspects of ART practices is concerned, 
RTAC is a prudent choice.  However, he argues that there is a need for local guidelines to be 
added to RTAC’s ‘Code of Practice’ to take into account the cultural differences between 
Aotearoa/New Zealand and Australia. 
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I think that RTAC was mainly to look at technical things and especially at the 
tradition of counselling and looking after people from that aspect and that you 
went through ethics committees and all that sort of stuff.  So, I think those are 
similar enough that probably makes no difference.  I think it is really good to have 
an offshore body in one way, in that New Zealand is pretty small, in terms that 
trying to cobble together something that can look after five or six clinics, whereas 
in Australia there are 25 or 30.  I think is really sensible.  …  [There are] definitely 
New Zealand dimensions that should be looked after.  New Zealand cultural things, 
not just Mäori, but New Zealand’s culture of openness about donor insemination….  
So, I think it should have some New Zealand guidelines.  At the moment, it has 
New Zealand participants in that a member of the local Infertility Society is the 
local person, counsellors are local, one of the doctors is local, but there are no 
actual New Zealand guidelines or part to it 
          (John Peek, Interview: 12 July 2000) 
Although there are two Aotearoa/New Zealand representatives on RTAC, a 
gynaecologist/obstetrician and a consumer (Ministry of Justice & Ministry of Health, 1997), the 
RTAC ‘Code of Practice for Centres Using Assisted Reproductive Technology’ (1999) contains no 
Aotearoa/New Zealand-specific guidelines.  In 1994, MCART (1994:37 & 40) acknowledged that 
accreditation of Aotearoa/New Zealand clinics by RTAC served “a vital purpose in ensuring that 
appropriate standards are set at an international level”.  However, they recommended that an 
Aotearoa/New Zealand supplement to the guidelines be given priority.   
 
MCART (1994:40) recommended that the Royal College of Obstetricians and Gynaecologists 
(RNZCOG) undertake this task in “consultation with providers, consumers, public officials”, and 
their proposed overseeing body (Council on Assisted Human Reproduction).  Although there 
have been repeated calls for the development of a Aotearoa/New Zealand supplement to the 
RTAC guidelines, this supplement has not eventuated.  While acknowledging the need for such 
a supplement, Ken Daniels (Associate Professor, Department of Social Work, University of 
Canterbury) suggests the difficulty of the task may have been the reason for the delay. 
The job of drawing up that supplement has been pushed from pillar to post.  But, 
it was given to the Royal College of Obstetricians and Gynaecologists to do and, to 
my knowledge, they have never done it, although they have been pushed by 
Ministers and they have been pushed by NECAHR.  I mean it is a very difficult 
thing to do; it is an extremely difficult thing to do.  …  But, there is still no  
standard; no specification as to what should be looked at in terms of determining 
whether New Zealand clinics are operating in an appropriately culturally sensitive 
way.  That supplement is the missing part…. 
  (Ken Daniels, Interview: 31 August 2000) 
However, MCART (1994:40) did not foresee the task as being too difficult and claimed that 
RTAC was willing to include an Aotearoa/New Zealand-specific supplement developed by New 
Zealanders.  It appears that, while it is still the intention of the Ministry of Health to include the 
proposed supplement, the timing and form that this inclusion takes is dependent on the 
outcome of the Health Select Committee’s consideration of the two bills. 
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The NZ (sic) supplement to the RTAC guidelines has not been completed.  This is 
primarily because we are awaiting the outcome of the select committee's 
deliberations on the two assisted human reproduction bills.  The legislation may 
have implications for the content of the guidelines.  The Health Select Committee 
hopes to consider the bills in April or May of this year. 
     (Personal Communication, 21/01/01)
68
 
In the meantime, gamete donors, surrogates, commissioning parents, and individuals conceived 
with donor gametes are offered few assurances that practices will be monitored and regulated 
in a way that best suits the historical, cultural, or political environment of Aotearoa/New 
Zealand.  These issues will be discussed in more detail in Chapter Six. 
 
As the sole method of regulation and control, professional self-regulation excludes or 
marginalises people outside the profession from having any input into the development or 
enforcement of policies and codes of practice.  Medical codes that are generated without public 
or patient consultation rely on the traditions and judgements of the medical profession and 
“may do more to protect the profession’s interests than to introduce an impartial and 
comprehensive moral viewpoint” (Beauchamp & Childress, 1994:8).  The Canadian Royal 
Commission on New Reproductive Technologies (1993a:57) argues that “a self-regulating 
profession is not necessarily best equipped to assess the social, ethical, and economic 
implications of the technologies and may be insufficiently accountable to those whose needs 
they are meant to serve, particularly in the absence of a broader regulatory system.”  
Correspondingly, Beauchamp and Childress (1994:7-8) argue that professional codes sometimes 
take too broad a view with regard to ethical requirements or claim to be more comprehensive 
or authoritative than they are entitled to.  This approach often leads professionals to mistakenly 
assume that, by following the rules of the code, they will satisfy all the moral requirements.  
Although medical codes pay attention to general principles and rules such as ‘do no harm’ and 
confidentiality, only a few comprehensively address issues of honesty, openness, autonomy, 
and justice (Beauchamp & Childress, 1994:8).   
 
Daniels and Taylor (1993:1474) claim that fertility specialists are not resistant to government 
intervention and “would prefer to operate within a set of clearly specified guidelines determined 
by a publicly appointed and/or approved body.”  However, the preference for guidelines is 
undoubtedly influenced by an unwillingness to support regulatory interference with their 
professional autonomy when exercising clinical judgement (Daniels & Taylor, 1993:1474).  
                                            
68
  Email communication with Helen Lockyer, Team Leader, Professional Regulation & Quality, Personal & 
Family Health Directorate, Ministry of Health, 21 January 2001. 
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While fertility specialists in Aotearoa/New Zealand may be resistant to regulatory controls, they 
do not appear to be totally opposed to mandatory accreditation or to the establishment of some 
form of policy body to oversee ART practices and developments.  Notably, in the early 1990s 
Fertility Associates in Auckland requested that the Minister of Justice establish some form of 
regulatory authority to supervise ART practices in Aotearoa/New Zealand.  As mentioned earlier, 
Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) would 
prefer to have a government appointed committee to review reproductive practices and 
technology than controlling legislation. 
I guess my personal opinion is that I would like to see a separate body but, in the 
absence of that, I think somebody has to do it and NECAHR is probably in the best 
position to do that at the moment.  If the Government clearly do not want to set 
up a body that regulates the industry then NECAHR [is probably the next best 
thing].       (Rodney Bycroft, Interview: 13 September 2000) 
 
Similarly, John Peek is not opposed to some form of government regulation of ART but is wary 
of the costs of setting up a specifically ART focused policy organisation being passed on to 
consumers and providers. 
You can have government regulation that does not cost too much.  It is just what 
sort of bureaucracy you put with it.  I do not mind having an external thing but … 
it should be done very cheaply and … rely on trying to use existing laws and 
mechanisms as much as possible.  … You would have some sort of committee just 
to hold it all together rather than making a new committee to do it all. 
          (John Peek, Interview: 12 July 2000) 
The MCART (1994) report recommended the establishment of a body to oversee and coordinate 
policy decisions in ART and Ken Daniels supports this model of policy formulation and control. 
If you had an umbrella organisation that was responsible for looking at things like 
ethics, standards, accountability, public education … I guess those are the main 
areas.  Bill Aitkin and Paparangi Reid [MCART] actually made some comments 
about that in their report; that there needed to be a group that took a much 
broader brief.       (Ken Daniels, Interview: 31 August 2000) 
 
As indicated previously, there has been no progress towards establishing a policy body that 
would take an overseeing and policy formulating role, as well as co-ordinate the intersecting 
and related functions of NECAHR and RTAC in relation to ART.  Consequently, issues of 
accountability and decision-making transparency are the central concerns for some ART 
commentators.  
3.7 Accountability 
According to Blank (1998:135), the relationship between the number of reports by government 
committees and the paucity of government action in response to them may reflect the political 
use of ad hoc bodies as a deflective mechanism by elected officials.  It may also be a 
recognition that the issues raised by ART are too complex or politically sensitive for decisive 
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action.  As a consequence, Daniels (1998a:80) contends that ethical and professional practice 
decisions are likely to dominate when there are gaps in public policy.  As there is no overseeing 
body to co-ordinate the contributions of the various groups and organisations already involved 
in the ART policy arena, Ken Daniels (Associate Professor, Department of Social Work, 
University of Canterbury) defines organisations such as NECAHR, RTAC, and the HFA, as the 
…de facto policy groups in New Zealand at the moment because of the policy 
vacuum and decisions are being made in lots of different areas by different groups. 
  (Ken Daniels, Interview: 31 August 2000) 
As mentioned earlier, he would like to see these groups brought together under the auspices of 
a body dedicated to formulating policy and overseeing the diverse range of participants in the 
field.  This body would be responsible for making policy within a regulatory framework. 
That is where I think there is a role for a policy group.  If you had an umbrella 
organisation that was responsible for looking at things like ethics, standards, 
accountability, and public education.    (Ken Daniels, Interview: 31 August 2000) 
 
Robyn Scott (Executive Officer, NZIS) also sees the current fragmented policy situation as 
contributing to a lack of accountability on the part of government agencies. 
The process of decision-making is not transparent and nobody is held accountable 
for the decisions they make.  The letters that we write, the letters to the Minister, 
the letters to the HFA, the HFA meetings we have, nobody is ever accountable for 
anything, never.  It is always somebody else’s problem and somebody else’s fault 
… there is no transparency….         (Robyn Scott, Interview: 26 July 2000) 
 
She partly attributes the lack of accountability and transparency within the present policy 
situation to the depletion of involvement and historical knowledge (of the ART policy debates 
and developments) within the government sector.
69
  Correspondingly, she sees this as a 
consequence of high staff turnover and the continuing health sector restructuring. 
There is no way of tracking who is [responsible] as somebody who is working in 
[the field] today might be gone in two months or three months.  We are into our 
fifth Health restructuring in nine years so the system is being restructured all the 
time as well.  There is an awful amount of time, energy, and money that is taken 
up by that change.  So, it is like a constant change process really. 
       (Robyn Scott, Interview: 26 July 2000) 
 
In 1998, statistics showed there had been large staff turnover levels in forty-six government 
departments and agencies over the previous five years (Lilley, 1998).  The inability to retain an 
experienced and committed policy skill base within government organisations means that those 
with the most consistent and historical knowledge of ART policy debates and developments are 
those people who have been directly or indirectly involved in the provision of services over the 
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  See Chapter 2, The Research Process, Section 2.7, The Interviews, for how the depletion of 
institutional knowledge and experience in this area influenced the research process. 
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past two decades.
70
  Martin and Salmond (2001:55) suggest that the recent integration of the 
Health Funding Authority (HFA) into the Ministry of Health is highly likely to result in a loss of a 
“valuable source of specialised and contestable advice to the Minister”, even though the process 
“was designed to avoid overlapping jurisdictions and to reduce costs”.  In contrast, Devlin et al 
(2001) maintain that a conscious effort is being made “not to lose institutional knowledge and 
experienced staff during the transition.”  Nevertheless, the NZIS’s past experiences with health 
sector restructuring has contributed to their scepticism regarding the current restructuring 
process and the loss of institutional knowledge and continuity. 
…this is a problem that we have always had, this lack of continuity.  The minute 
we network and make contact with somebody, they are gone, and it changes and 
it is just this continual process.  And, that must be replicated by many areas of 
Health in New Zealand.          (Robyn Scott, Interview: 26 
July 2000) 
 
The perceived lack of accountability and transparency in the present system of official policy-
making and negotiation means that the NZIS suspects conspiracies within the current 
arrangement, as they have no way of verifying why and how decisions are made and there is a 
lack of continuity in official contacts. 
 
Ken Daniels (Associate Professor, Department of Social Work, University of Canterbury, 
Interview: 31 August 2000) sees accountability as an issue in relation to RTAC and the 
Aotearoa/New Zealand Government.  He believes one of the dangers with self-regulation is its 
lack of transparency.  As explained in the previous section, RTAC is not required to report to the 
Aotearoa/New Zealand Government and, although there are professional requirements, there 
are no legal requirements for clinics to belong to RTAC.  Ken Daniels does not see the need to 
establish an independent Aotearoa/New Zealand based accreditation committee, but does 
believe that RTAC should have some responsibility to an Aotearoa/New Zealand based policy 
group. 
So, I think we need some kind of legislation that sets up a policy group and that 
that policy group has responsibility for those different areas that I mentioned 
before [ethics, standards, accountability, and public education].  I do not see it 
needing to set up a whole lot of regulations.  For example, when it came to the 
issue of standards and accountability, there is no reason why it could not 
subcontract that to RTAC.  But, that RTAC then reported to that group on the visits 
that it made.  At the moment, RTAC comes, makes a visit to [the clinics], who 
                                            
70
  According to Robyn Scott (Executive Officer, NZIS, Interview: 26 July 2000) “…many of them have 
worked in the industry for a long time.  It is not an industry where the staff changes a lot.  You have still 
got your original group of Freddie [Graham], Richard [Fisher], Joy Ellis, and John Peek that started up 
IVF at National Women’s [and] all still work at Fertility Associates and still work in infertility.”  See 
footnote no.73 in Chapter 4, Allocating Resources, Section 4.2, Funding Issues, for a summary of John 
Peek’s involvement in this area. 
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knows what goes in those reports?  I mean all that is known is, “Is this clinic given 
a one year extension, a 3 year extension, or what?” 
             (Ken Daniels, Interview: 31 August 2000) 
However, as mentioned earlier, NECAHR is the only government body that has direct 
responsibility for making decisions in relation to ART.  As a result, they have been charged (by 
default) with making policy decisions on a case-by-case basis.  There is no contact between 
RTAC and NECAHR so clinical and ethical decisions are made in isolation of each other.  
Moreover, some decisions regarding public education and accountability are not made at all or 
are left to the initiative of clinics and consumer groups. 
Well no, you see we do not have any contact with RTAC.  There was an interesting 
phase when RTAC were over here doing a visit [and] we invited them to come to a 
NECAHR meeting.  We sat down and had a very profitable discussion and lunch 
together and one of the results of that was that somebody from NECAHR was 
going to be invited to visit clinics whenever it took place in New Zealand.  And, 
somebody from RTAC, one of the New Zealand representatives, was to be on 
NECAHR.  Well I do not know what happened to that.  We certainly were invited … 
but I do not think that is happening now but maybe that was because there was a 
change of personnel in RTAC.  …  But, that would have actually facilitated some 
communication between the two groups.  Not that RTAC were responsible to 
NECAHR or vice versa but we did share certain things in common.  For example, 
our commitment to wanting to provide for the safety and welfare of children meant 
that we needed to know what clinics were doing, what kinds of forms they were 
using, etc.  But, short of us going and visiting the clinics, which would have been 
duplicating RTAC’s work, there was no way we could really do that efficiently.  
Therefore, that is the bit that is missing in the total picture, it seems to me.   
             (Ken Daniels, Interview: 31 August 2000) 
Sue Bagshaw (Medical Training Co-ordinator, Family Planning Association, Christchurch) also 
argues for a national body that would be responsible for overseeing and formulating ART policy, 
maintaining that such a body would also enable issues of differential access and funding to be 
addressed.  These issues are presently left to individual clinics and consumer groups to canvass 
the Health Funding Authority.
71
 
If you had a national body that was a bit more democratic than NECAHR it could 
look at the ethics of discriminatory access, and I think that should be one of the 
things that they look at and it should be at a national [level].  …  There needs to 
be lay input into it definitely.  I think there needs to be the influence of people who 
are sub-fertile because then they understand the pressures that drive the market, 
if you like, as well as people who are fertile and maybe have a more objective 
view.                 (Sue Bagshaw, Interview: 21 August 2000) 
 
As there is no organisation solely responsible for co-ordinating overlapping interests or 
concerns, issues regarding future research developments and utilisation are left until they 
become immediate.  Therefore, RTAC continues to focus on the standards and clinical 
application of procedures, while NECAHR concentrates on making case-by-case decisions with 
                                            
71
  See Chapter 4, Allocating Resources, and Chapter 5, Regulating Access, for discussions about funding 
and access to ART practices. 
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regard to surrogacy, producing guidelines on the use of certain procedures, and responding to 
applications from providers when they seek approval for new innovations in the use of ART. 
3.8 Conclusion 
Underlying the discussion in this chapter is the understanding that health policy formulation and 
implementation is influenced and shaped by the interactions between state controlled funding 
and policy agencies, managers, healthcare professionals, patients, interest groups, and the 
wider community.  Consequently, elements of both ‘top-down’ and ‘bottom-up’ policy 
development need to be acknowledged in any analysis of the policy process in the field of ART. 
 
ART policy in Aotearoa/New Zealand has been formulated using an ad hoc, reactive, and case-
by-case approach as new or challenging issues have arisen over ART service provision.  Many 
reports from various committees and commissions have called for public debate and an 
overseeing organisation to advise and monitor ART practices and developments.  However, no 
such administrative body has been created and the only official bodies involved in the control 
and regulation of ART practices are the Reproductive Technology Accreditation Committee of 
Australia (RTAC) and National Ethics Committee on Assisted Human Reproduction (NECAHR).  
These two committees operate independently and are not accountable to each other.  Although 
the Status of Children Amendment Act 1987 (SCAA) remains the only piece of legislation that 
explicitly deals with ART, there are many existing regulations and statutes that could be used in 
relation to legal issues arising from ART practices.  These include professional codes of practice 
and legislation specific to the health and medical sector, as well as legislation relating to 
adoption and human rights.   
 
During the last five years, two bills have been introduced to Parliament that propose varying 
degrees of legislative regulation and control over currently practiced assisted reproductive 
techniques, as well as potentially harmful ART developments.  Although these bills have been 
considered by Parliamentary Select Committees for a combined total of five years, they have 
had the due date for their report/s extended on numerous occasions and there is no guarantee 
that they will be tabled before this thesis is submitted.
72
  Delays in reporting on the two bills 
                                            
72
  A check of the Office of the Clerk of the House of Representatives’ website ‘Bills before the Select 
Committees’ (http://www.gp.co.nz/wooc/npaper/select-committee-bills.html), prior to submitting this 
thesis, indicated that the due date has again been extended and the report is now due on the 31 May 
2002. 
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have been explained as systemic and procedural.  However, it is more likely that the delays 
have been influenced by the fact that the issues are politically contentious and involve state 
interest in matters that are generally considered private.  Although issues surrounding the use 
and development of ART may be politically difficult to resolve, the lack of action by successive 
political parties and coalitions has meant that the resolution of many social and ethical concerns 
remain dependent on the attention and discretion of providers, NECAHR, and RTAC.  Embryo 
donation, sex-selection, and surrogacy are all areas that require further public debate and 
consideration.  Controlling the introduction and application of these practices currently remains 
dependent on providers applying to NECAHR for approval of their use and then complying with 
NECAHR’s decisions. 
 
While both the Yates and Graham Bills propose the banning of certain unethical procedures, 
they differ over the level and structure of oversight for ART practices.  The Yates Bill proposes 
that fertility clinics be licensed and aims to establish a licensing authority which will control and 
monitor the provision of ART services.  However, the Graham Bill proposes a policy structure 
similar to the one currently in effect and, although NECAHR is given statutory recognition and 
its role is expanded, the committee remains under the control of the Minister of Health.  The 
bills differ over the level of attention they give to surrogacy and the recognition they give to the 
Treaty of Waitangi (te Tiriti o Waitangi).  They also reflect the polarisation of issues around the 
clinical applications and the potentially harmful aspects of specific techniques.  Some 
commentators have expressed concern that prescriptive legislation would restrict the use and 
development of any technological advances in assisted reproduction.  They have suggested that 
the establishment of a government appointed organisation to oversee and monitor such 
developments and ART practices would provide a more flexible and timely form of control.   
 
Although not established as an ART policy organisation, NECAHR has taken on this role by 
default.  Consequently, ethical decisions, which should form the basis of policy in conjunction 
with other fields of knowledge and experience, have become de facto policy decisions.  The 
ambiguity in NECAHR’s role, combined with difficulties in predicting the future consequences of 
certain practices, political expediency, limited finances, timeframes, and information, as well as 
the flexibility offered, have all contributed to a case-by-case decision-making approach, which 
lacks legislative support.  The lack of consumer representation on NECAHR also raises concern 
over the marginalisation of the experiences of those with fertility problems in the formulation 
and implementation of policy and ethical decisions.  NECAHR has no legislative power to 
support and enforce their decisions and this has raised concerns with the committee, as well as 
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other commentators.  However, some providers believe accreditation requirements for RTAC 
are sufficient to ensure compliance.  RTAC is an Australian based organisation that is not 
answerable to any Aotearoa/New Zealand agency or authority and has no statutory ability to 
enforce its accreditation requirements or sanctions.  Although recommended by MCART and 
supported by many other commentators in the field, a Aotearoa/New Zealand supplement to 
RTAC’s ‘Code of Practice’ has not eventuated and New Zealander’s involved in ART practices 
have little assurance that these practices will be monitored and regulated in line with local 
cultural and political values and principles.   
 
Providers do not appear to be resistant to compulsory accreditation or the creation of some 
form of policy development body that would oversee and coordinate policy initiatives and 
developments in ART.  However, despite repeated calls for such an organisation, it has not 
eventuated.  If the Graham Bill remains the preferred option for legislating ART practices, it is 
unlikely that such a body will be established in the near future.  It is highly likely that NECAHR 
will be reconstituted to officially recognise the policy-focused role it has undertaken in the last 
few years.  Consequently, the status quo will be maintained and ethical and policy decisions will 
be combined and implemented using a case-by-case approach.  Alternatively, the establishment 
of an ART focused policy body would offer oversight to the ART arena and provide a sense of 
accountability and responsibility in relation to policy decisions.  Such an organisation could also 
co-ordinate the interrelated roles and functions of NECAHR and RTAC in relation to ART and 
could oversee the implementation of policy and ethical decisions in the clinics.  It would enable 
the voice of consumers and providers, as well as other interested publics, organisations, and 
individuals, to be heard.   
 
While this chapter has focused primarily on the initiatives and implementation of ART policy 
from a ‘top-down’ perspective, I do not disregard the consequences and significance of ‘bottom-
up’ policy processes.  The interpretation and observance of ART policy protocols and guidelines 
by providers, consumers, and involved groups and individuals has an influential effect on policy 
formulation and implementation.  The following chapter will investigate how the ad hoc 
development of public funding for ART services has entrenched regional inconsistencies and 
inequities in funding and access. 
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4 
Allocating Resources 
 
At the moment, what is provided where is really historical accident. 
(John Peek, Interview: 12 July 2000)
 73
 
4.1 Introduction 
As the majority of assisted reproductive technology (ART) services in Aotearoa/New Zealand are 
provided through the private sector, access is primarily dependent on the ability to pay.
74
  Most 
health insurance companies do not cover infertility treatment.  The medical insurance scheme 
available to members of the New Zealand Police Force is the only one that provides coverage 
for infertility in Aotearoa/New Zealand (New Zealand Infertility Society, 2000).  Some services 
are provided by the public health sector and the total public funding for ART treatments in 
Aotearoa/New Zealand is approximately $5.8 million (The Dominion, 9 August 2000, p.7).  
However, this figure was arrived at through ad hoc policy development based on historical 
levels of funding, rather than a planned policy to provide publicly funded infertility services.  
This chapter will explore how access to public resources for ART services evolved out of 
contingent responses by particular doctors and researchers to the growing demand for services.  
                                            
73
  John Peek is the Scientific Director for the Fertility Associates group of clinics.  He supervised the 
infertility laboratory at National Women's Hospital from 1984 until he joined Fertility Associates in 1987.  
He is instrumental in overseeing the Fertility Associate group’s contracts with the Health Funding 
Authority (Fertility Associates N.Z., 2001b: http://www.fertilityassociates.co.nz/staff/index.html).  As John 
Peek has worked in the ART field for many years, he has had extensive involvement and historical 
knowledge of the ART policy debates and developments.   
74
  See Chapter Five, Regulating Access, for an analysis of access restrictions to both public and private 
infertility services. 
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Initially funded on an ad hoc basis through research programs and obstetric and gynaecological 
services, ART services expanded into the public health system by default.  Services were 
centralised in Auckland and attracted consumers from throughout Aotearoa/New Zealand.  
Eventually increasing demand led to the opening of private clinics and the establishment of 
regional ART services.  However, regional funding was based on the utilisation of services in 
Auckland and did not consider regional population requirements. 
 
The decision-making processes and values underlying the public provision of ART services have 
never been addressed or publicly debated and I argue that the continued ‘muddling through’ 
approach to ART funding policies has embedded regional inequities and inconsistencies in 
funding public ART services.  Similarly, the contingent and incremental approach to 
implementing access restrictions for publicly funded ART services to limit the demand for public 
resources has further embedded inequities in access.  Recent attempts by government funding 
agencies to address these inequities and inconsistencies have failed to investigate issues 
relating to the prevalence of infertility in Aotearoa/New Zealand or the regional utilisation of 
services.  Consequently, increased funding continues to be based on historical perceptions of 
need rather than considered empirical evidence.  The ad hoc development of funding policies 
has been exacerbated by recent health sector reforms.  This chapter will explore how the 
disbanding of the Regional Health Authorities and the Health Funding Authority (HFA), and the 
establishment of 21 District Health Boards could affect the goal of national consistency in the 
provision of and access to public ART services.   
 
This chapter also provides the background for the following chapter, which will explore how 
limiting access to ART services has further embedded inequities by using restrictions based on 
social judgements and the normative concept of family.  Firstly, I examine how ART services 
were incorporated into the public health sector and discuss how historically determined levels of 
need have contributed to limited and inequitable public access to ART services.  I then consider 
how health sector reforms and the introduction of explicit rationing strategies have influenced 
the development of access criteria to ration publicly funded ART treatments.  This is followed by 
a discussion of how recent changes to funding levels, the prioritisation of infertility within the 
public health system, and further health sector reforms may influence the public provision of 
ART services. 
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4.2 Funding Issues 
John Peek (1999:18) argues that the public funding of infertility treatment in Aotearoa/New 
Zealand has developed in an informal and unplanned way.  Professor Bonham began storing 
frozen sperm at National Women’s Hospital in the late 1970s and by the early 1980s university 
based donor insemination clinics had been established in Auckland, Wellington, Christchurch, 
and Dunedin.  These clinics used university funds and resources and, consequently, the 
universities unwittingly provided ‘free’ treatments.   
In Wellington, infertility service was done by John Hutton through the university.  
He hived off university employees to provide technical services and the technical 
input was from people on university salaries.  The same thing really happened in 
Christchurch.              (John Peek, Interview: 12 July 2000) 
 
In 1983, the first IVF programme was set up at National Women’s Hospital using “borrowed 
staff, borrowed equipment, and borrowed space” (Peek, 1999:18). 
Our hospital board did not even know that they had an IVF program until there 
was a picture of an ultra sound scan of the first baby on the front page of the 
Herald.  That is when the Auckland Hospital Board discovered that there was an 
IVF program in one of its hospitals.  …  So it has had a history of never being 
funded but sought of a wedge has been stuck in the system somewhere and you 
slowly try to lever [more money out of it.] 
        (John Peek, Interview: 12 July 2000) 
The Auckland Hospital Board eventually provided funding for staff and diverted additional funds 
from elsewhere in the hospital system.  Eventually the programme incorporated the existing 
donor insemination and ovulation induction programmes.  The IVF programme treated people 
from throughout Aotearoa/New Zealand and “the inability of this sole public clinic to cope with 
demand led to the opening of private clinics” (Peek, 1999:18).  Blank (1995:14) argues that the 
public does not create the initial demand for biomedical technology and that scientists initiate 
medical research and development, based on their own perception of the need.  Consequently, 
scientists create potential needs that require the availability of new resources.  Demand for 
access by medical professionals and patients increases once the innovation invokes media 
attention.  Increased publicity and availability eventually leads to expectations by the consumer 
public that these innovations will be readily accessible and available for their benefit and, as 
such, the demand for access increases (Blank, 1995:14).   
 
In 1987, Freddie Graham and Richard Fisher established a private clinic in Auckland called 
‘Fertility Associates’ (2001b: http://www.fertilityassociates.co.nz/about/index.html).
75
  By 1993, 
                                            
75
  Graham and Fisher had previously overseen the infertility programme at National Women's Hospital. 
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there were two private clinics in Auckland and IVF programmes in Christchurch and Wellington.  
According to John Peek, public funding was subsequently distributed throughout the regions 
based on how many people from these regions had previously been accessing treatment in 
Auckland. 
Public funding for infertility really started in Auckland and, for a few years, 
Auckland was the only place with an IVF program so that people would come from 
all over the country.  Then when they divided up into regions they just said, “Well 
how many people have been coming from Wellington to Auckland for treatment?”  
Of course, that was relatively low and so there was relatively less funding in those 
areas.               (John Peek, Interview: 12 July 2000) 
 
Infertility programmes outside the Auckland region received less funding because they had 
previously been a minority source of patients for the National Women’s infertility programme.  
As Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) 
indicates, this minority status resulted from the geographical location of the initial IVF 
programme and a lack of resources by potential clients to finance travel and accommodation 
rather than from any indication of actual demand. 
…back in 1984 National Women’s Hospital looked at the socio-economic grouping 
of the people who were seeking IVF.  People at that stage had access from all 
around the country.  What that study showed was that disproportionately more 
people sought treatment form the Auckland region than would be representative 
on a population basis.  Which is a geographical bias and that is because the service 
was accessible and … had a higher profile than [for] somebody living in 
Invercargill.  It was also more accessible because it was geographically close and 
still the socio-economic groupings were above the average for the population.  So 
it was still seen as the domain of those who maybe were well informed. 
   (Rodney Bycroft, Interview: 13 September 2000) 
 
At the same time as IVF programmes were being established nation-wide, health sector reforms 
were being initiated in an attempt to establish a quasi-market that would ensure better access 
and use of resources by separating the roles of purchaser and provider of health services.
76
   
When the old hospital boards broke up or were replaced by the Regional Health 
Authorities they just inherited the budgets for those areas. 
        (John Peek, Interview: 12 July 2000) 
In 1992, the National Advisory Committee on Core Health and Disability Services was set up to 
establish the “boundary between health services that should reasonably be paid for (in whole or 
in part) by the state, and services that should be the responsibility of the individual” (Cheyne, 
et al., 1997:239).  While attempting to retain the “principles of universal access to health care”, 
the government decided to restrict the range of publicly funded health services to an explicitly 
                                            
76
  Area health boards were reconfigured into Crown Health Enterprises (CHEs) and four Regional Health 
Authorities (RHAs) (Cheyne, et al., 1997:239).  It was the role of the RHAs to purchase health services 
according to what they perceived to be the health service requirements of their populations. 
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defined list of ‘core’ health services that would be revised annually (Hunter, 1997:103; Ashton, 
1999: 138).
77
  Coney (1999a:23-24) maintains that infertility services were often used in 
discussion documents as an example of what services might not be part of the ‘core’.  However, 
within seven months of its appointment the Advisory Committee abandoned the concept of a 
specifically defined ‘core’.  They took the view that all existing publicly funded services should 
be regarded as the ‘core’ and began modifying access to these services.  Attention turned 
towards evidence-based medicine, clinical effectiveness criteria, and the development of 
guidelines (Hunter, 1997:104; Ashton, 1999:138).  
 
In line with this change of focus, Wayne Gillett, John Peek, and Richard Lilford (1995)
78
 were 
commissioned to provide a report to the National Health Committee
79
 on the costs and 
effectiveness of infertility services in Aotearoa/New Zealand.  According to the National Health 
Committee (1996), thirteen of the seventeen submissions they received in response to the 
report supported public funding.
80
  In response to increasing surgical waiting lists and waiting 
times between 1993 and 1996, the National-New Zealand First Coalition Government initiated a 
points-based priority criteria system to determine who was eligible for publicly funded health 
care (Ashton, 1999:145).
81
  The points system has been widely interpreted as another way of 
cutting health spending and in 1997 “approximately 30000 people were removed from waiting 
lists because they were not deemed sick enough to be eligible for publicly funded surgery” 
(New Zealand Herald, 21 October 1997 in Ashton, 1999:145).  It was within this context that 
the National Health Committee commissioned the development of access criteria to ascertain 
who would have “the greatest potential to benefit from receiving publicly funded infertility 
services” (1996). 
                                            
77
  These ‘core’ services were to be defined by examining the costs, effectiveness, and benefits of each 
service, as well as through public consultation (Cheyne, et al., 1997:228). 
78
  Wayne Gillett is an academic from Dunedin who had expertise in tubal surgery and IVF; John Peek is 
the Scientific Director of Fertility Associates, based in Auckland; and Richard Lilford is an English 
academic with an interest in the epidemiology of infertility (Peek, 1999:18). 
79
  In 1995, the Advisory Committee was renamed the National Advisory Committee on Health and 
Disability Services (the National Health Committee) to reflect its change of focus and its extended control 
over public health services (Ashton, 1999:138). 
80
  Five were from individuals, four from health care providers, five from advocacy groups, and one each 
from the Ministry of Women s Affairs, the General Practitioners Association, and the Royal New Zealand 
College of General Practitioners (National Health Committee, 1996). 
81
  The criteria combine clinical factors, such as the severity of the illness and effectiveness of treatment, 
with social factors, such as the ability to work and to care for dependants.  Higher priority patients 
acquire a higher point score, which helps clinicians to decide who should be treated and when.  The level 
of funding determines the number of points (the threshold) at which a patient can expect treatment 
(Hunter, 1997:106-107). 
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By 1996, the National Health Committee (1996) and its predecessors had received forty 
submissions on infertility services, “the majority of which were from affected consumers who 
support public funding of infertility services”.  The National Health Committee considered these 
submissions in conjunction with the submissions received by the Ministerial Committee on 
Assisted Reproductive Technologies (MCART, 1994)
82
 and concluded that  
After considering all the submissions, reports and analyses, the National Health 
Committee is of the view that infertility services should receive public funding.  
However, the extent of those publicly funded infertility services and the terms of 
access have yet to be determined.   (National Health Committee, 1996) 
 
The Committee did not explain how or why it had come to this decision, given that it had 
previously acknowledged that many of the submissions to MCART had rejected public funding.  
Blank (1994:12) suggests that policymakers will retain the support of the public as long as they 
talk in general terms with regard to rationing or discontinuing health care expenditures.  
However, as soon as they are specific about what services they are intending to cut they tend 
to face opposition from actual and potential stakeholders.  As a consequence, policymakers are 
unlikely to accept any technology assessment that recommends that a procedure should not be 
funded (Blank, 1994:12).   
 
Those involved in both the provision and funding of services have raised questions about the 
public funding of ART practices. 
One of the key [questions] is do we purchase infertility services [at all]?  And, you 
would be aware that fertility services have been [funded] in a haphazard, 
inequitable way.  My view is that it has not been a funded service.  So, we could 
never really say that we did provide a publicly funded service because it was so 
infinitesimal that you could not actually provide a system.  …  So, I think that is 
one thing about it, is deciding whether we are going to provide it full stop, and if 
we are going to provide it, if fertility as a service is a publicly funded service, then 
there has to be some policy stuff around that.  The policy, I suppose the additional 
funding has come about in that the HFA decided that it would in fact purchase 
infertility services as a part of the core services and that has just happened with 
this new money.  For the first time in New Zealand has fertility services been 
considered to be part of the core. 
(Helen Williams, Interview: 29 August 2000 
Helen Williams (Policy Analyst, Elective Services Project, HFA)
83
 implies that the question of 
                                            
82
  In 1994, the MCART had received almost one hundred submissions in relation to its consideration of 
ART practices in New Zealand.  The National Health Committee (1996) noted that “MCART supported 
public funding, even though many submissions to that committee did not”. 
83
  A change in government in 1996 led to further changes in the health system and on 1 July 1997, the 
RHAs were officially combined into the Health Funding Authority (HFA).  The HFA’s responsibilities 
included determining health care needs and developing, implementing, and managing contracts with 
providers.   
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funding infertility services in Aotearoa/New Zealand has been answered by the provision of 
more money and the incorporation of the services within the ‘core’ public health services.  
However, as with the National Health Committee, she fails to explain what decision-making 
processes and values were used to reach this decision.  The failure of policy-makers to provide 
reasons for their decisions in relation to ART practices is typical of a ‘muddling through’ policy 
process.
84
  The time, information, and reasoning constraints associated with biomedical 
developments contribute to an incremental approach to policy-making, which often involves 
limited analysis and ignores many values and alternatives (Mendeloff, 1985:82-85).  
Consequently, this process simplifies the search for political solutions by avoiding having to 
justify decisions by reference to general ethical principles that may be used to appeal later 
decisions.  Therefore, unjustified decisions allow policymakers greater flexibility in their 
responses to individual cases.  John Peek (Clinical Manager/Group Operations Manager, Fertility 
Associates Auckland), who operates within the public/private field of infertility treatment, 
echoes Helen Williams funding concerns. 
I think that either you should have a generous amount of public funding or no 
public funding.  At the moment, there is so little that the rationing is so severe and 
so illogical.              (John Peek, Interview: 12 July 2000) 
 
Given that the task of matching supply and demand is the responsibility of the providers, they 
frequently face the difficult undertaking of refusing people treatment because of a lack of 
resources.  It may be that providers would prefer not to have to make decisions on the 
allocation of such scarce resources and would prefer the government to make a unilateral 
decision to cease funding entirely rather than maintain an ineffectual system of rationing a 
severely constrained budget. 
 
The National Health Committee (1996) claimed that it had “established a working group to 
develop the cost effectiveness report into access guidelines”.  The ‘working group’ consisted of 
two of the authors of the original costs and effectiveness report (Gillett, Peek, & Lilford, 1995), 
both of whom worked in the provision of ART services.
85
  They were directed to develop criteria 
to that could be used to determine who has the greatest probability of benefiting from publicly 
funded infertility services and to provide advice “on the type of infertility services that should be 
purchased to ensure the most effective use of public funds” (National Health Committee, 1996).  
                                            
84
  Lindbolm (in Green & Thorogood, 1998:12) describes the policy process as an incremental process of 
‘muddling through’ rather than one of rational planning. 
85
  At the time of publication Wayne Gillett was an Associate Professor with the Department of Obstetrics 
and Gynaecology at the University of Otago.  John Peek was the Scientific Director of a private fertility 
clinic (Fertility Associates) in Auckland. 
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Wayne Gillett and John Peek produced Access to Infertility Services: development of priority 
criteria (1997),
86
 which was intended to help frame the Committee’s “formal recommendation to 
the Minister of Health” (National Health Committee, 1996).  The proposed priority criteria were 
intended to introduce a nationalised system for establishing treatment eligibility and were based 
on the “possibility of a successful outcome” (a resulting pregnancy), as well as certain social 
criteria (Coney, 1999a:24).  However, the planned recommendations to the Minister on the 
level of funding never eventuated (Peek, 1999:19). 
Basically, the National Health Committee and its predecessors recognised that 
infertility was something that they could chip off around the edges.  …  The Core 
Health Services Committee really looked around the periphery at health to see 
what little things [they could] chip off and they looked at human reproductive 
technology and fertility and commissioned Wayne [Gillett] and I to do those 
studies.  But, there really was no mechanism once those studies were done, to 
actually make it happen in the Health system.  They presented it to the corporate 
services committee and then it was supposed to be up to the Minister to decide 
how they were going to implement it.  I do not think that was ever done. 
          (John Peek, Interview: 12 July 2000) 
The National Health Committee’s reticence in making recommendations to the Minister of 
Health and inaction with regard to the access criteria, combined with contract negotiations 
based on historically inequitable funding practices, contributed to nation-wide inconsistencies in 
funding, service provision, and access criteria across the different health funding regions 
throughout Aotearoa/New Zealand.  By maintaining the status quo in relation to ART funding, 
there is no consciously made decision to deliver less and health professionals and consumers in 
some regions are conditioned over long periods of time to expect and demand less service than 
is offered in other regions (Klein, et al., 1996:68).  This supports Klein, Day, and Redmayne’s 
(1996:67) claim “that non-decisions are as important as decisions.”  So, services are rationed 
by allowing the “the lottery of history” to determine who gets what and, as a consequence, the 
lack of supply creates its own lack of demand (Klein, et al., 1996:68).   
 
In 1999, John Peek identified continuing funding inequities between the four health regions in 
Aotearoa/New Zealand. 
Public spending on infertility treatments ranges from $0.71-$0.75 per head in the 
Northern and Southern regions, to only $0.27 in the Midland region.  IVF patients 
in Midland and Central still have to pay for drugs (typically between $1500 to 
$2000 per cycle) unless they have a Community Services Card.  The eligibility for 
IVF treatment varied between regions.         (Peek, 1999:19) 
 
                                            
86
  This document forms the basis of the rationing strategies and access restrictions to publicly funded 
infertility treatments.  It is discussed in Chapter 5, Regulating Access, Section 5.4, The Priority Criteria. 
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Gillett and Peek (1997:35) argued that the $4.5 million that was being spent on infertility 
investigations and treatments at the time could not be fairly distributed using any priority 
criteria.  Moreover, certain aspects of the criteria met with disapproval from infertility societies 
and the Human Rights Commission (HRC) (Coney, 1999a:24).  Nevertheless, some providers 
adopted the criteria or modified versions of these guidelines in order to access money from the 
Government’s waiting list fund.  Although there were some variations in the way the criteria 
were administered, all four Regional Health Authority contracts used them in some form to limit 
access to publicly funded treatment.  The Northern, Midland, and Central funding regions used 
‘all or nothing’ thresholds for each variable, so that people needed to be eligible at every point 
in the access criteria to gain access to treatment.  The thresholds were similar but not equal in 
these three regions.  The Southern funding region had adopted the draft priority scoring system 
as developed by Gillett and Peek (1997), applying a threshold of 40 points to the total score 
(Mark Leggett, Business Manager, The Fertility Centre, Christchurch; Interview: 22 September 
1999).  Consequently, those seeking to access publicly funded ART treatment were subject to 
varying restrictions, which were dependent on geographical location.
87
   
 
Disparities also existed in the waiting times for treatment between the four funding regions. 
In the Northern region the wait for IVF treatment is 9-12 months with only one IVF 
cycle offered, while elsewhere up to two cycles are offered but the wait is much 
longer.  Only the Northern region offers an appreciable amounts (sic) of non-IVF 
treatment, such as DI, AIH or ovulation induction.       (Peek, 1999:19) 
 
As Helen Williams (Policy Analyst, Elective Services Project, HFA) points out, there have never 
been planned policy objectives relating to the provision and funding of infertility services in 
Aotearoa/New Zealand. 
Well, it was purchased by the Regional Health Authorities before the HFA.  So, that 
was why it was regionally variable.  My understanding is … some of it was being 
purchased through gynaecology and some of it obstetrics and eventually it got 
filtered out to being infertility.  So, it has been an ad hoc historical thing as 
opposed to a planned policy moving forward to providing a service.  …  Now we 
have moved for the first time to looking [at whether] we should be providing the 
service at all.  I am not aware of any major consumer consultation occurring other 
than what occurred around the National Health Committee document. 
         (Helen Williams, Interview: 29 August 2000) 
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  If those seeking public funding in the Northern, Midland, or Central funding regions failed to reach the 
threshold for any one of the criteria they were refused access.  In the Southern region, the scores for 
each of the criteria were combined and a formula was used to calculate the final score.  Consequently, 
those seeking funding in this region did not have to pass every one of the criteria to gain access to 
publicly funded ART treatment. 
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Correspondingly, John Peek acknowledges the dependence of clinics and consumers on 
individual interest within the HFA rather than coherent policy guidelines in relation to funding 
infertility services. 
…it has really [involved] people pressing the HFA to say we should be doing 
something and interested people within the HFA.  And, there are one or two 
people within the HFA that are interested and are trying to tidy up infertility.  …  It 
is usually [people] in the HFA who get responsibility for a certain area and say, 
“This does not look right.  There are huge geographical inequalities and the rules 
do not make sense” and I guess it is up to people like that to say, “I think I will do 
something about that.”  Whereas some other manager might think that it is just 
too much small funding and anomaly, [and] they will let [it] sit.   
        (John Peek, Interview: 12 July 2000) 
As with ART policy formulation in general, ART funding policies have developed and been 
implemented in an ad hoc and reactive fashion.  Levels of public funding for ART have been 
based on historically determined need, as defined by the numbers accessing the original IVF 
services in Auckland rather than national population requirements.  Until recently, access 
criteria were negotiated as part of the Health Funding Authority (HFA) contracts.  However, 
additional funding and changes to access restrictions were introduced in 2000 in an effort to 
reduce existing inequalities. 
4.3 Changes in 2000 
In August 2000, the HFA implemented changes to the funding and provision of public infertility 
services in an attempt to resolve existing inconsistencies in funding and access.  In addition to 
allocating an additional $3.7 million in funding to tertiary infertility treatments, the organisation 
amended the services specifications for infertility treatment contract holders and introduced the 
national referral guidelines and the Clinical Assessment Criteria (CPAC) for treatment of 
infertility (Health Funding Authority, 2000a).  However, existing disparities in funding and 
access criteria had been created through a lack of attention to national population requirements 
and the changes have been based on these existing inequities.  Policy decisions regarding the 
allocation of resources for the management and treatment of infertility should be based on 
accurate prevalence data (Brander, 1991:9).  However, there has been little investigation into 
the prevalence of infertility or into the utilisation of ART services in Aotearoa/New Zealand.
88
.  
Information on the prevalence of infertility used to guide policy formulation has been obtained 
from international studies (Gillett, et al., 1995:13), literature reviews (Brander, 1991:9-13), and 
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  I address the consequences of this for Mäori in Chapter Six, Addressing Difference: Mäori Infertility & 
ART. 
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a local survey into the contraceptive practice of 1000 women aged between 25-44 years of age 
(Paul, et al., 1988:812).
89
  According to Gillett, Peek, and Lilford (1995:37), the only 
comprehensive information on the treatment and outcomes of infertility in Aotearoa/New 
Zealand is from the Dunedin Database.
90
  However, Helen Williams (Policy Analyst, Elective 
Services Project, HFA) suggests that the collection of information on the use of infertility 
services may improve with the changes initiated by the HFA to the services specifications for 
public infertility treatment. 
We have had even less information on infertility … we do not collect it on the 
National Data System because it is an outpatient service.  We have a quarterly 
report where we collect data for elective services …on who is waiting for the 
quarter and for the year and all that stuff.  We have not been collecting infertility 
data in that but we are just going to start.  …  So, we are changing the service 
specifications and getting them to national consistency.  We are actually putting in 
a whole lot of reporting requirements, which will be national.  But [the clinics] 
report and are accredited by RTAC so it would be [foolish] for us to duplicate that 
so we may very well use some of RTAC’s information. 
         (Helen Williams, Interview: 29 August 2000) 
Nevertheless, it is too soon to tell whether these changes will provide accurate information on 
the use of infertility services in Aotearoa/New Zealand.  As Helen Williams suggests, information 
collected by the Reproductive Technologies Accreditation Committee (RTAC) may be used and it 
                                            
89
  The results of the Aotearoa/New Zealand study suggest that 3% of married women between the ages 
of 25-24 years could be classified as infertile.  However, the authors noted that the definition they used 
for infertility might have resulted in an underestimation of prevalence (Paul, et al., 1988).  However, 
Brander (1991:1) claims that the “most recent reliable estimates of prevalence suggest an infertility rate 
of at least 14% for industrially developed nations.”  MCART (1994:5) claims that most estimates of 
prevalence of infertility for Aotearoa/New Zealand and other western societies have ranged between 
10%-20%.  Increases in the supply and demand for services are assumed to relate to delayed 
childbearing, aging populations, increasing treatment options, and increasing service consultations, rather 
than increases in the overall incidence of infertility (Brander, 1991:1).  Nevertheless, it is estimated that 
only 50% of women with primary infertility consult services for advice and/or treatment (Brander, 
1991:3).  The definition of infertility and methods of measurement have a significant effect on estimates 
of prevalence.  Although the World Health Organisation (in MCART, 1994:4) referred to infertility as the 
failure to conceive after 2 years of “exposure to pregnancy”, Gillett, Peek and Lilford (1995:13) define 
infertility as “the inability to conceive after 1 year of trying for a pregnancy.”  However, they note that 
this definition is arbitrary and that using a 2-year definition would “reduce the resources required for the 
assessment and treatment” (Gillett, et al., 1995:13).  Moreover, the motivation for determining the 
incidence of infertility has an effect on the method of measurement.  In countries were infertility is 
perceived to be a health problem and publicly funded, a focus on the numbers presenting and requiring 
treatment will be relevant as estimates based on service utilisation undoubtedly result in an 
underestimation of prevalence (Brander, 1991:12-13).  However, if the aim of the measurement is to 
“assist population projections or interpret patterns of fertility, a focus on the numbers who have been 
unable to conceive after a year or more of unprotected intercourse” will provide a more accurate 
measurement of infertility (Brander, 1991:12). 
90
  This database was established in 1986 as a joint clinical and research tool to assess diagnosis and 
outcome of infertility treatment.  It is based on referrals for infertility to the Dunedin Hospital clinic from 
the Otago region and does not include IVF referrals until 1994 when IVF Otago and the Dunedin Hospital 
clinic were merged to form the Otago Fertility Service (Gillett, et al., 1995:37). 
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is unclear whether this data will be presented as country-specific or amalgamated with 
Australian data, as with the success rate information collected by RTAC.  Although statistical 
information cannot illustrate how social inequities are produced or how policy can address these 
inequities, they are a useful device for documenting and monitoring of policy outcomes (Green 
& Thorogood, 1998:79-81; Reid, 1999b:84).
91
 
 
Perhaps the most influential move so far, in relation to reducing geographical inequalities in 
access, has been the re-classification by the HFA of public infertility treatment as a ‘core’ health 
service.
92
   
Fertility is now seen as part of the core services … [that] means that DHBs will be 
obliged to provide services. 
      (Helen Williams, Interview: 29 August 2000) 
According to Helen Williams, this re-classification means that regional health and disability 
service providers can no longer choose not to purchase tertiary infertility services.  The changes 
are aimed at extending the coverage of ART services, reducing waiting list periods to a 
maximum of six months, and eliminating inequalities in the services provided throughout 
Aotearoa/New Zealand.  However, what will happen in practice is still uncertain as the District 
Health Boards (DHBs)
93
 take up their responsibilities and the Ministry of Health absorbs some 
aspects of HFA policy work. 
…all I can see with the DHBs is that it is going to fragment this process.  That we 
will not have national consistency and it should not depend on where you live.  
You should be able to access the public health system. 
      (Helen Williams, Interview: 29 August 2000) 
Sue Bagshaw (Medical Training Co-ordinator, Family Planning Association, Christchurch) 
expressed similar concerns in relation to national consistency in access criteria. 
…with DHBs there is a possibility of that getting even worse.  …  You can just see 
21 different funding criteria, different access criteria evolving.  …  But, the worry is 
that because there are so many of them we will not get any national consistency. 
(Sue Bagshaw, Interview: 21 August 2000) 
 
Devlin, Maynard, and Mays (2001) question the effectiveness of establishing 21 health districts, 
some of which have small scattered populations.  They suggest that smaller districts may find it 
                                            
91
  See Chapter Six, Addressing Difference: Mäori Infertility & ART, Section 6.4, Being Counted, for a 
discussion of the consequences, for Mäori, of not collecting information on service utilisation and the 
prevalence of infertility in Aotearoa/New Zealand.  
92
  Although the establishment of specifically defined core services was ‘officially’ dropped, it is apparent 
that the HFA still works within certain parameters of this concept. 
93
  District Health Boards have a majority elected membership, as well as Government appointed 
members to complement those elected.  From the enactment of legislation in 2000 until elections in 
2001, the Government appointed Transitional District Health Boards (Ministry of Health, 2000).   
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difficult to manage their population-based financial resources in an equitable and justifiable 
manner.  The kind and amount of secondary and/or tertiary infertility services provided by the 
individual districts may be prioritised according to how the DHBs interpret their populations’ 
past use of such services rather than on evidence-based needs.
94
  Such prioritising will further 
undermine the goal of national consistency in access to infertility and ART services.  Publicly 
funded ART services are currently provided by a small number of specialised provider clinics 
and, while the DHBs may provide ART services by contracting to existing providers, concern has 
been raised that preference may be given to public providers rather than private clinics (Ken 
Daniels, Interview: 31 August 2000).  In addition, private providers may have to apply for 
public funds and negotiate contracts with potential competitors.
95
  Services may also be 
centralised within the districts, effectively maintaining the status quo and limiting access by 
geographical location.  Consequently, patients will still have to travel to access treatment that 
can sometimes involve staying for several days, adding accommodation costs to travel costs.  
Although the travel and accommodation allowances previously available on application to the 
HFA will no doubt still be available, the added burden of applying for such benefits may deter 
consumers from accessing such benefits.  Therefore, the inequalities in the provision of services 
may be replicated and/or exacerbated under the new system. 
What we do not know is … how far the money is going to go … so we have set the 
threshold at 65 provisionally.  We have said we will review it in 3 months time.  I 
suspect that 3 months is probably going to be a bit soon.  We may well end up 
reviewing it at 6 months.            (Helen Williams, Interview: 29 August 2000) 
 
It is too early to predict how effective the additional money and changes in access criteria will 
be in improving inequities in funding and access, or in reducing waiting lists. 
 
By raising the point threshold (in some regions) some people who had previously been 
‘approved’ for public funding will no longer qualify.  With the introduction of the national CPAC, 
those who were admitted to the Christchurch waiting list prior to the 30 June 1998 were 
assured treatment.  However, those admitted after 1 July 1998 have to undergo reassessment 
using the new threshold (Personal Communication, December 2000).
96
  In Christchurch, where 
the threshold was 40 points, this may eventually mean a reduction in those who make it onto 
                                            
94
  As discussed earlier in relation to the initial funding decisions for regionally based IVF programmes. 
95
  Since the existing infrastructure of hospital management is being used as the initial basis of the DHBs 
and the population that each board will be responsible for approximates the local catchment of its 
hospital, the funders (DHBs) will also be involved in the provision of some competitive services (Devlin, et 
al., 2001). 
96
  Telephone conversation with the waiting list manager of The Fertility Centre, Christchurch, December 
2000. 
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the waiting list.  However, in December 2000, there was a 2?-year waiting list in Christchurch 
for publicly funded access and a recent newspaper report stated that the waiting time in 
Christchurch has actually increased and people now face a three to five year wait for publicly 
funded treatments (Watson, 2001:3).  In Auckland and other regions that previously 
administered ‘all or nothing’ access criteria (100 points), the introduction of the national CPAC 
will possibly lead to increased waiting lists as more people will be eligible under the new 
threshold of 65 points.  Nevertheless, recent reports suggest that there has been a reduction in 
the waiting time for IVF treatment.
97
  Even if people do access the waiting list they are likely to 
become discouraged by the delay and either pay for the treatment themselves, if possible, or 
withdraw completely.  John Peek supports Ashton’s (1999:145) argument that the waiting lists 
work as an implicit form of rationing, in that the presence of the waiting list deters people from 
applying for treatment.  
We used to have a 3 to 4 year waiting list of which 30-40% of people used to drop 
out on the waiting list because they would seek private treatment.  They got sick 
of waiting, looked at other options, or just got lost.  You can get away with any 
amount of rationing if your waiting list is long enough because people drop off or 
get too old or whatever in the process. 
        (John Peek, Interview: 12 July 2000) 
Mechanic (1995) maintains that restricting the resources available in any health area and 
imposing access controls through waiting lists is easier and less controversial than imposing 
explicit exclusions.  Even with the increased funding, it is evident that the waiting lists continue 
to affect access to publicly funded ART treatments. 
 
Although the amended service specifications (Health Funding Authority, 2000b: see Appendix L) 
standardise the types of services that can be publicly accessed and remove co-payments for 
drugs, they also specify a limit of one IVF cycle,
98
 or other clinically appropriate treatments to 
the same value, for those who meet certain points within the CPAC (Health Funding Authority, 
2000a).  Robyn Scott (Executive Officer, New Zealand Infertility Society (NZIS), Interview: 26 
July 2000) suggests that one IVF cycle would be ineffective for most women as the only way of 
perfecting individual responses to drug levels and treatments is through repeated cycles.  
                                            
97
  In June 2001, Fertility Associates’ Newsletter reported reduced waiting time for IVF treatment in all 
regions of the North Island and claimed that the “level of funding should allow treatment within 6 months 
of enrolment, once the initial backlog has been cleared” (Fertility Associates N.Z., 2001a). 
98
  IVF is a ‘cycle’ of treatment involving several discrete stages, all or some of which may be repeated at 
varying intervals.  These treatments include drug-induced ovulation, egg retrieval, insemination, 
fertilisation, embryo culture, and embryo transfer (Farquhar, 1996:134). 
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However, she acknowledges that “one fully funded cycle is still a diagnostic tool.”
99
  Similarly, 
Mark Leggett (Business Manager, The Fertility Centre, Christchurch, Interview: 22 September 
1999) argues that “your best results [are] over 3 [IVF] cycles.”  Scott believes that reducing the 
number of IVF cycles per funded treatment is a way of redistributing the available money and 
reducing the waiting lists.   
I think national criteria will give more people a chance to access treatment, which 
is why it has to be funded differently.  But, then we are going to reduce the 
amount of treatment that is available to people who qualify so we “rob Peter and 
pay Paul”, the usual story.         (Robyn Scott, Interview: 26 July 2000) 
 
Klein, Day, and Redmayne (1996:12) describe this as rationing by dilution, whereby offering a 
reduced scale or ‘depth’ of service decreases demand.  Although there will be an increase in 
overall availability, the amount of treatment for those who qualify for public funding will be 
reduced.  As a consequence of restricting the publicly funded IVF treatments to one cycle, it is 
likely that clinics will be more willing to support and enforce access restrictions that ensure only 
those with the highest chances of success are treated within the public system.  Clinics’ 
reputations attract private consumers and these reputations are primarily based on the number 
of successful conceptions and pregnancies.  As most of the clinics also operate within the 
private sector, they are dependent on reputation and success for their survival in a competitive 
market, as well as when competing for public contracts. 
Reputation is everything in the industry.  Well, success and reputation, particularly 
in a competitive environment like in Auckland where you have three or four 
centres.  Reputation and results are key.  Branding is important. 
    (Mark Leggett, Interview: 22 June 2000) 
The results from publicly funded treatments are incorporated into the clinics’ overall results and 
the restriction on repeated cycles imposed by the changes to funding will mean that the clinics 
will want to ensure that their chances of success are as high as possible for each publicly 
funded treatment. 
In New Zealand, we report our results, along with all the Australian clinics, to the 
National peri-natal statistics unit in Sydney but they are all anonymous so they are 
just abc’s.  You can usually work out a few of them. 
                    (John Peek, Interview: 12 July 2000) 
                                            
99
  Cussins (1998:76) argues that all fertility clinics base their predictions of success on statistics, and that 
such predictions legitimate doing the same thing again in the face of failure because the statistical 
probability of never succeeding reduces as the number of attempts increases.  To support this rationale 
for continuing treatment, each attempt must be exactly the same as the one preceding it.  However, 
each cycle is often “fine-tuned” to allow for individual hormone responses to drugs or poor oocyte 
maturation.  Consequently, practitioners have no way of knowing if the failure to conceive is a statistical 
“dry run” or an indication that the procedure has been changed in a relevant and detrimental way.  
Therefore, cycles can be disregarded as “crucially not the same and so not counted” (Cussins, 1998:76).  
Therefore, slight alterations in drug levels, procedures, and timing provide a reason for proclaiming every 
failed attempt as a diagnostic tool. 
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Although the results from Aotearoa/New Zealand clinics are amalgamated and supposedly 
anonymous when published, the size of the ART community, combined with word of mouth or 
clinic self-promotion, will ensure that the clinics’ success rates are easily attainable or 
deducible.
100
   
 
The NZIS Executive Officer sees the restriction to one fully funded IVF treatment as effectively 
setting the providers and the consumers against each other and breaking down a traditional 
coalition of support. 
One cycle is much easier for the clinic to administer.  The clinics are not totally 
opposed; I mean they are not opposed to it at all. 
      (Robyn Scott, Interview: 26 July 2000) 
She also expressed concern over how increasing private business, through the efforts by 
providers to attract international clients, may affect this alliance.  Although supportive of the 
necessity for providers to sustain and build their businesses, she expressed some apprehension 
over the possibility that such moves may also affect the levels of support they have previously 
shown public consumers.  
…it has never been an issue in the past.  The people who laid the foundation 
stones for the infertility industry have always been such huge supporters of the 
consumers that I really do not know!  Certainly there are some indicators now that 
perhaps the business ethic, where the private work is worth a lot more than the 
public work, that maybe that will become more of an influence.  And, I think that is 
a shame.           (Robyn Scott, Interview: 26 July 2000) 
 
Past funding decisions or ‘non-decisions’ are also seen as placing people with infertility 
problems in opposition to people who have unlimited access to publicly funded maternity and 
reproductive health services.
101
 
I can understand the HFA.  The Health dollar does not stretch to infinity.  
However, I really take umbrage with the fact that reproductive health in terms of 
infertility is completely singled out.  We do not ration antenatal services, we do not 
say you can have 1.9 children [and] after that, you start paying for your own 
maternity care.  We do not ration family planning services and we certainly do not 
ration terminations!  Now when you have unlimited access to those services you 
                                            
100
  For example, see Information on Assisted Reproductive Technology: Treatment procedures, risks and 
outcomes (Otago Fertility Service, 1997), Assisted Reproductive Technologies (Serono Colloquia 
Australasia, 1997a), and In-vitro Fertilisation & Associated Procedures: Success Rates with IVF (New 
Zealand Centre for Reproductive Medicine Ltd, 2001). 
101
  According to Peek (1999:20), the total public funding spent on elective reproductive services is 
approximately $300 million annually.  At the time of the interviews for this thesis, approximately $4.5 
million was spent directly on ART services.  Much of that money was spent on investigations and only 
$1.5 million was spent on ART treatments.  Elective reproductive services include antenatal care, 
obstetrics, postnatal care, family planning, and abortion services.  Therefore, it should be noted that 
individuals with fertility problems also have access to reproductive health services, such as the Family 
Planning Association and maternity service funding, if pregnancy is achieved.  In addition, not all those 
diagnosed as ‘infertile’ will seek ART treatment in order to overcome the problem. 
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do have a lot of choices.  When you are infertile you have [severely constrained] 
choices!           (Robyn Scott, Interview: 26 July 2000) 
 
Consequently, consumer representative groups may face an undermining of their ability to 
influence policy decisions.  Consumers are not represented on NECAHR and have limited 
representation on RTAC.  If their coalition with the providers is strained or fractured, they may 
find it more difficult to be heard and influence policy decisions, particularly funding decisions.   
 
At the time of writing, it is too early to tell whether additional funding to tertiary infertility 
treatments, changes to access restrictions, the reduction of services, and the reclassification of 
infertility treatment as a ‘core’ service’, combined with the effects of the health service reforms, 
will help to reduce or simply exacerbate the existing inequalities. 
4.4 Conclusion 
As discussed in the previous chapter, ART policy in Aotearoa/New Zealand has developed in an 
ad hoc and reactive manner.  Likewise, the introduction and maintenance of public funding for 
ART treatments has been informal and unplanned.  The provision of ART services within the 
public health system began as part of a research strategy at National Women’s Hospital in the 
early 1980s and, as interest and demand grew, services were extended to other regions.  
Although funding for the Auckland service was initially provided by default through the provision 
of staff and facilities, the Auckland Hospital Board eventually incorporated an IVF programme 
into its funded services and treated people from throughout Aotearoa/New Zealand.  With the 
development of IVF programmes in other regions, funding was re-distributed based on the 
number of people from these regions who had been accessing treatment in Auckland.  
Consequently, there has been little detailed consideration given to the population requirements 
for such services and no coherent discussion of what funds would be required to provide an 
equitable service throughout Aotearoa/New Zealand.  The geographic and financial constraints 
that affected the level of access by people from outside Auckland were not taken into account 
and, by the early 1990s, inequitable provision of services and public funding had evolved 
throughout Aotearoa/New Zealand. 
 
In response to health sector reforms and the introduction of explicit rationing strategies, the 
National Health Committee commissioned an investigation into the costs and effectiveness of 
infertility treatment in Aotearoa/New Zealand.  Based on this report (Gillett, et al., 1995) and in 
response to supportive submissions between 1993 and 1996, the National Health Committee 
decided to continue funding ART services.  The introduction of points-based priority criteria to 
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reduce waiting times and waiting lists in 1996 prompted the National Health Committee to 
commission the consultation document, Access to Infertility Services: development of priority 
criteria (Gillett & Peek, 1997).  This document was intended to provide a framework for funding 
recommendations to the Minister of Health, as well as provide a structure for the introduction of 
access criteria on a national basis.  Nevertheless, the National Health Committee failed to make 
funding recommendations to the Minister of Health or to introduce the national access criteria 
for publicly funded ART treatment.  Consequently, nation-wide inconsistencies in funding, 
service provision, and access restrictions prevailed and these inequities were exacerbated by 
disparities in the waiting times for treatment between the four health funding regions.  By 
failing to make decisions regarding the inequalities in the level of funding, the National Health 
Committee maintained the status quo and did not have to justify any increase or reduction of 
funding in relation to ART treatments.  Individual clinics and consumer groups were left to 
canvass these issues with the Health Funding Authority, relying on the personal interest of 
administrators rather than consistent policy guidelines to overcome the deep-seated inequalities 
in access to and funding of public ART services.  Funding authorities and service providers face 
considerable difficulties in allocating severely constrained resources and both providers and 
administrators have raised questions about the continued funding of such services.  Invariably, 
a decision by government to cease funding completely would reduce the strain of trying to 
match supply and demand, as well as the face-to-face burden clinicians encounter when having 
to refuse people treatment for financial reasons. 
 
In August 2000, the HFA increased funding, incorporated ART treatment into the ‘core’ services 
provided in each region, amended service specifications, and introduced national referral 
guidelines for ART treatment and Clinical Assessment Criteria (CPAC) (see Appendix K).  These 
changes were aimed at extending the coverage of ART services, reducing waiting list times, and 
eliminating the regional inequalities.  However, these changes were not based on information 
regarding the prevalence of infertility or utilisation of ART services in Aotearoa/New Zealand.  
Therefore, additional funding appears to have resulted as a contingent response to lobbying by 
consumers and providers and has built on existing inequitable funding decisions.  The changes 
to the public provision of ART services occurred in an environment of further health sector 
reforms, which included the disbanding of the four Regional Health Authorities and the HFA and 
the establishment of 21 District Health Boards (DHBs).  As part of the funding reforms, the 
points threshold for the priority criteria was standardised across regions and funding was 
limited to one IVF cycle or equivalent-value treatment.  Consequently, the HFA has increased 
the overall availability of services but diluted the amount of treatment available to those who 
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qualify for public funding.  Provider support for these changes and consumer resistance to the 
dilution of services may affect the long-standing alliance between providers and consumer 
support groups, thus undermining consumers’ ability to influence the policy debate.  Funding 
decisions have been based on historical perceptions of need, as indicated by the initial demand 
for services and recent attempts at addressing regional inconsistencies in funding have not 
taken into account actual levels of infertility in Aotearoa/New Zealand nor considered regional 
population requirements.  Uncertainty remains about the effectiveness of the changes, as the 
newly introduced DHBs may maintain the centralised location of services and funding and 
access may continue to be prioritised according to historical use of services by their 
populations.  At the time of writing, the increased funding, national CPAC, and health sector 
reforms have not been operational long enough to evaluate the effect of the changes.   
 
The rationing of publicly funded ART treatment combines both implicit and explicit approaches, 
including restricted funding, waiting lists, a reduction of services offered, and the introduction 
of the CPAC.  Funding decisions based on historical interpretations of need have combined with 
the normative definitions of family that underlie the Status of Children Amendment Act 1987 
(SCAA) to influence the restriction of access to ART practices.  In the next chapter, I will discuss 
how access to ART treatment is regulated by social judgements about the ‘worthiness’ to parent 
and the implications of this situation for individuals and couples who wish to use ART services. 
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5 
Regulating Access 
 
Reproductive technologies serve as a litmus test for concerns about contemporary 
relations to nature and children, about who can and should parent, about what 
families can and should look like.             (Farquhar, 1996:10) 
5.1 Introduction 
Access to assisted reproductive technology (ART) services in Aotearoa/New Zealand has always 
been restricted in some way.  Initially, these restrictions were not solely related to resource 
constraints, and marital status and sexuality were used to limit access to ART treatments.  
Although providers have relaxed these access restrictions in relation to private treatment, 
access to publicly funded treatment is dependent on meeting tightly constrained criteria, which 
have been influenced by the values that motivated the original access restrictions.  As described 
in the previous chapter, health sector reforms and resource constraints influenced the 
development of explicit rationing strategies in the form of the Clinical Assessment Criteria 
(CPAC) to limit demands for ART services in Aotearoa/New Zealand.  Although explicit in the 
sense that they provide guidelines for decision-making, I argue that little or no attention was 
paid to the values that underlie the inclusion of several social factors in the development of the 
criteria.  As a consequence, the CPAC rely heavily on social judgements of ‘worthiness’ to 
parent.   
 
Although the problem of allocating scarce health care resources has always existed (Hunter, 
1997:17), demographic changes, advances in medical science and technology, and rising public 
expectations of availability and standards of service means that these resources will continue to 
be constrained (Klein, et al., 1996:vii-viii).  Consequently, it will not be possible to meet all 
health care needs and demands now or in the future.  As Klein, Day, and Redmayne (1996:139) 
argue, there will never be a perfect solution for deciding who should receive treatment when 
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resources are severely constrained.  Therefore, setting priorities and deciding how to distribute 
limited resources will continue to be a political and managerial necessity (Hunter, 1997:17).  
However, relying on explicit guidelines may only mask the fact that clinical decisions are based 
on value judgements (Hunter, 1997:28).  Therefore, I argue that attention should be paid to 
who sets these priorities and establishes the guidelines and, if social judgements are used to 
assist in the prioritisation of access, then the judgements that are included should be clearly 
identified and openly debated. 
 
In this chapter, I investigate how attempts to limit demands for ART services and ration existing 
resources have privileged certain individuals and groups over others.  I examine how access 
restrictions for both public and private ART treatments have been shaped by the normative 
definition of family, discriminating against and marginalising individuals who do not conform to 
certain norms of parenthood.  To begin with, I analyse the concept of ‘biological infertility’ and 
explore how this concept has been used to justify the exclusion of single women and lesbian 
couples from access to public funds.  I also consider the use of women’s age as a limiting factor 
for access to ART treatment.  Following this, I explore how the prioritisation of rights is used to 
justify limitations on access, while the human rights legislation has been used to expand access 
limitations.  Finally, I analyse the national Clinical Assessment Criteria (CPAC) (Health Funding 
Authority, 2000a; see Appendix K).  I maintain that the CPAC obscures the use of moral and 
social judgements and relies heavily on social rather than clinical considerations of the ability to 
benefit from treatment.  Although ostensibly used to ration scarce financial resources, I argue 
that the CPAC effectively regulate who is considered ‘worthy’ to parent. 
5.2 Restricting Access 
As discussed in Chapter One, the definition of family as comprising of two heterosexual parents 
and their children is implicit within the Status of Children Amendment Act 1987 (SCAA) and 
contributes to the marginalisation of more diverse concepts of family, particularly those 
recognised by Mäori.
102
  The dominance of this definition of family has influenced who has 
access to ART treatments and has been implicit in the formulation of access criteria for publicly 
funded ART treatment.  In the past, only married couples were considered eligible for treatment 
and de facto couples, single women, and lesbians were excluded.  Eventually de facto 
                                            
102
  See Chapter 1, Introduction, Section 1.4, Families & ART, for a discussion of how the SCAA reinforces 
the heterosexual, two-parent family as the norm in relation to ART practices. 
  
116
 
heterosexual couples in stable relationships were admitted to some programmes (Department 
of Justice, 1985:13).  The Human Rights Commission Act 1977 made it illegal to discriminate on 
the grounds of sex, marital status, religious belief, ethical belief, colour, race, and ethnic or 
national origins.  The subsequent Human Rights Act 1993 added the new grounds of disability, 
age, political opinion, employment status, family status, and/or sexual orientation when 
providing goods and services (Human Rights Commission, 2001).  Consequently, moves by 
certain clinics to prevent a lesbian woman and a couple with disabilities from accessing 
treatment have been challenged under these Acts and ART providers have gradually relaxed 
their access criteria (Hamed, 1997).
103
  Although post-menopausal women, single women, and 
lesbian couples do seek assistance from ART providers to conceive, the majority of people who 
use ART services are heterosexual couples (Daniels & Burn, 1997:79) and debate has continued 
over the issue of access by those who do not fit the normative categorisation of ‘worthy’ 
parents. 
 
As mentioned earlier, in August 2000 the HFA implemented updated service specifications 
(Health Funding Authority, 2000b; see Appendix L) and the national CPAC (Health Funding 
Authority, 2000a; see Appendix K) for the provision of publicly funded ART services.  Previous 
versions of the service specifications assumed heterosexual coupledom throughout.  The 
modified service specifications and referral guidelines endeavour to reduce exclusive language 
by substituting “individual/couple” where the term “couple” had appeared in earlier versions.  
While lesbian and gay couples and single men and women are not obviously excluded, the 
eligibility requirements assume heterosexuality and the availability and/or willingness of a 
sexual partner of the opposite sex. 
…the services should be available to all people with biological infertility, 
including those whose fertility is or will be impaired by cancer treatment or injury  
         (Health Funding Authority, 2000b:1, emphasis added) 
The HFA also defines ‘eligible’ service users as those who are heterosexual and have a 
physiological impediment that prevents them having children. 
…those who are unable to achieve pregnancy after at least one year of 
unprotected intercourse of attempting (sic), or have biological circumstances 
which prevent them from attempting, or are unable to carry pregnancy to term. 
         (Health Funding Authority, 2000b:2, emphasis added) 
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  See footnote no.48 in Chapter 3, Regulating Practices, Section 3.2, Policy Background. 
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Similarly, existing contracts are titled “Medical Treatment for Biological Infertility” (see Appendix 
M) and are interpreted by John Peek (Clinical Manager/Group Operations Manager, Fertility 
Associates Auckland) as referring to heterosexual couples.
104
 
…the public contract only really covers people with biological infertility so that 
means only couples, heterosexual couples get treated.  Single women, people in 
lesbian relationships can have private treatment but they are not eligible for public 
funding. 
 (John Peek, Interview: 12 July 2000) 
By positioning infertility as a biological condition of those in heterosexual relationships, those 
who do not fit the normative concept of the heterosexual nuclear family are rendered “invisible 
within the terms of consideration” (Shildrick, 1997:185).   
...the current service specifications do not delineate them out.  They just say that 
you have to have a biological infertility so the partner who is receiving the 
treatment has to have a biological infertility.  Social infertility does not count. 
   (Mark Leggett, Interview: 22 June 2000) 
Consequently, it is unlikely that those outside the definition of eligibility, as assessed by the 
service providers, will gain access to public funds. 
 
The Ministerial Committee on Assisted Reproductive Technologies (MCART, 1994) also 
differentiates between ‘social’ and ‘biological’ infertility, claiming that single women and lesbian 
couples “while not physiologically infertile are socially infertile” (MCART, 1994:14). 
The stated aim of many providers has been to treat the physiologically infertile, 
and in particular, DI is said to be used for the treatment of male infertility.  
Because of these aims, most providers to date have only treated couples in stable 
heterosexual relationships of at least two years duration. 
 (MCART, 1994:14) 
MCART failed to recognise the involvement of fertile women in treatment of male infertility, 
assuming that infertility is a condition of heterosexual relationships rather than a physiological 
condition of one individual.  This is also evident in the HFA’s new service specifications where it 
is stated that 
…each couple will be treated as a unit. 
              (Health Funding Authority, 2000b:1) 
By treating the couple as a unit, different subject positions are collapsed into one category, ‘the 
                                            
104
  Given organisational changes in the health sector it is uncertain whether contracts will be 
renegotiated with existing providers or whether the biological emphasis will remain.  However, it is 
assumed existing contracts will continue until their expiry date.  A personal communication with the 
Christchurch Fertility Centre (December 2000) suggests that clinics have had no guidelines on how to 
interpret the new access criteria and therefore will continue to use their existing interpretations until they 
are instructed otherwise.  The use of such discretionary methods could undermine the purpose of the 
nationally implemented CPAC to create national consistency in referral and access to publicly funded ART 
treatments. 
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infertile’, making invisible or marginalising those who cannot or do not want to conceive without 
the assistance of ART because of genetically inheritable conditions, physical disabilities, sexual 
orientation, or their single status.  It also obscures the fact that many of the heterosexual 
women and men who use ART are fertile.  For example, a woman may be able to conceive and 
carry a pregnancy to term and yet be involuntarily childless because of her relationship with an 
infertile man.  Shildrick (1997:200) claims that male infertility is often ‘treated’ by undertaking 
ART interventions and techniques on women’s bodies while barely acknowledging that the 
women have any subject identity.  Consequently, the treatment and pregnancy becomes an 
attribute of the heterosexual couple rather than the individual (Kirejczck in Shildrick, 1997:200).  
Although infertility and involuntary childlessness can be related issues, the latter is a social 
condition which can be attributed to a fertile individual’s relationship with an infertile partner, 
sexuality, and/or an individual’s single status.  Recognising that publicly funded ART is often 
used to resolve involuntary childlessness rather than infertility for many individuals in 
heterosexual relationships highlights the discriminatory practices sustained by ART funding 
policies and the access criteria.
105
 
 
In their submission to the Ministerial Committee on Assisted Reproductive Technologies the 
Women’s Health Action Trust (1994) acknowledges the parallel between single women and 
lesbians and fertile ‘involuntarily childless’ married women.  However, they question whether 
ART treatment can be justified for any form of social infertility. 
Single women, lesbians and fertile married women do have the option of getting 
pregnant the regular way with a fertile man.  While this might be considered 
distasteful by the individuals concerned, it is possible for them to have a child 
without medical intervention.  It is arguable whether medical resources should be 
provided in such circumstances.          (Women's Health Action Trust, 1994) 
 
Arguments that claim single women, lesbians, and post-menopausal women (at some point in 
their lives) are fertile individuals if they “undertake sexual intercourse with a fertile man” 
(Daniels & Burn, 1997:79) reinforce the distinction between ‘social’ and ‘biological’ infertility.  
However, they disregard the social and moral constraints that prevent people from engaging in 
casual or temporary sexual encounters, as well as the possible health risks involved.  They also 
seem to place the desire to parent in competition with bodily and sexual integrity and freedom 
of choice.  Conversely, MCART (1994:14) argues that the provision of ART services to lesbian 
couples and single women may reduce the risk of infection because ART services are "especially 
designed to minimise the spread of infectious diseases like HIV/AIDS and hepatitis".  They also 
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  The access criteria are discussed in Section 5.4, The Priority Criteria, in this chapter. 
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argue that by allowing these groups access to ART and "the policies which regulate it, the 
offspring may well have the best chance for obtaining information about his or her genetic 
origins in future years" (MCART, 1994:14).  Nevertheless, the Women’s Health Action Trust 
offers a counter argument. 
…people who do not want to conceive by normal sexual intercourse might come to 
private arrangements in the case of access to sperm.  The argument has been put 
forward that these people run risks of catching infectious diseases where the 
arrangements are informal.  We are not aware that sperm from men informally 
donating it is any more likely to be infectious than sperm deposited during normal 
sexual intercourse.  Screening for HIV/AIDS and hepatitis is available, so this is a 
matter of public education for all people.  We believe that informal donation of 
sperm will in any case continue even if the services are provided through clinics, as 
they are now.  Some people do not want to or cannot pay for what is essentially a 
simple service.            (Women's Health Action Trust, 1994) 
 
While opposed to gamete donation in general, the Women’s Health Action Trust appears to 
support what they call “informal arrangements”, arguing that these will continue irrespective of 
medical intervention.  They defend their opposition to donated gametes by arguing that  
…the more human the relationships between people, the better the outcome will 
be.       (Women's Health Action Trust, 1994: emphasis removed) 
 
This argument rests on the assumption that heterosexual intercourse and reproduction are 
essential to humanness and does not acknowledge that relationships based on this ‘essential’ 
ingredient are not always positive or in the best interests of those involved. 
 
Coney (1999a:23-24) argues that restrictions to access apply only to publicly funded services 
and that those who can pay can access a full range of services in the private sector.  However, 
those making the decisions about who is worthy of treatment in the public sector are generally 
the same practitioners who treat patients in the private sector and occasionally patients are 
being treated within both systems.
106
  As those who make the decisions about who can access 
ART are also the people who design and implement the procedures and decide the criteria for 
eligibility, their personal values and beliefs will be inherent in their decisions (Ministry of 
Women’s Affairs in Henaghan, 1992:198, no.59).  Mark Leggett (Business Manager, The Fertility 
Centre, Christchurch) acknowledged that the clinic enforces its own age restrictions in relation 
to private treatment. 
We will not treat people over 50.  They have to be clinically appropriate to treat.  
We will not replace more embryos than two or three if they are over 40.  So, we 
have our own limits in that sense.     (Mark Leggett, Interview: 22 June 2000) 
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  “Often the patients who go on the public waiting list, they’ve got two to two and a half years to wait, 
will pay for a treatment while they’re waiting” (Mark Leggett, Interview: 22 September 1999). 
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Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) maintains 
that there are no limitations on privately funded ART treatments. 
No, none at all.  Other than those restrictions that are biological and that are partly 
related to maternal age.  In other words, if somebody comes to us at the age of 50 
and they are almost menopausal and the chances of tertiary treatment are so low 
that it would be ridiculous to keep going then we would discourage them from 
spending their money on it.  However, they still have the right to do silly things. 
   (Rodney Bycroft, Interview: 13 September 2000) 
However, both Leggett and Bycroft indicate that there are some restrictions on private access 
irrespective of the ability to pay, and that these restrictions are partly based on the social 
judgements of the ART provider about what age is appropriate for a woman to parent.  Another 
provider representative acknowledged that, while there are no restrictions on private access 
other than biological considerations that affect the likelihood of a successful outcome, this did 
not mean that the clinics willingly treated all those who could afford treatment. 
There are lots of people the doctors would prefer not to treat.  And, there are lots 
of people our doctors tell to “go away” … because the doctor thinks the chances 
are low and tells people the chances are low.  We have had one or two cases 
where we have thought it was crazy treating people. 
            (John Peek, Interview: 12 July 2000) 
John Peek argues that there should be limits imposed on both publicly funded and private ART 
provision and maintains these limits should follow the biological limits of death for men
107
 and 
menopause for women. 
I think there are some limits we should impose and they would be biological limits.  
I think there are some exceptional circumstances but I prefer that people did not 
father children after they are dead because I think that is a good biological limit to 
fertility (laughs).  …  I personally think that having children beyond menopause, 
goes beyond what the human species biological inheritance [is] if you like.  But, on 
the other hand, the Human Rights Commission has told us that donor egg is very 
liberating for women because it gives them the same chance of having a 
pregnancy when they are older as men do.  Men do not suffer the menopause so 
they have interpreted in the sort of feminist way that donor egg is liberating 
women from the constraints of their biology. 
        (John Peek, Interview: 12 July 2000) 
While John Peek sees the Human Rights Commission (HRC) argument as a feminist strategy to 
override ‘nature’, he fails to recognise that many medical interventions into the human body 
override the constraints of the patients’ biology.  Heart, kidney, lung, and cornea transplants 
are all used to liberate both men and women from the limitations imposed by a physiological 
condition and to overcome biological boundaries, such as death and illness.  Nor does he 
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  Recent media debate has highlighted controversy surrounding the use of frozen sperm after the 
donor has died (Sunday Star Times, 28 March 1999; The Press, 14 June 2000, p.3; McLeod, The Press, 
17 June 1999, p.4; Dekker, The Press, 24 June 2000, p.3; Coney, Sunday Star Times, 29 June 1999).  
This controversy motivated NECAHR (2000b) to issue Guidelines for the Storage, Use, and Disposal of 
Sperm from a Deceased Man.  
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acknowledge that menopause is not solely related to older age in women.  Just as some older 
women may conceive without medical intervention (Stein & Susser, 2000:1682), some younger 
women may be infertile because they have experienced early menopause and, for this reason, 
may require ART treatment.  Farquhar (1996:87) contends that by continually emphasising 
infertility as an affliction of “delayed childbearers” and equating women’s biological lifespan with 
their reproductive lifespan, the discourse surrounding ART re-establishes the connection 
between maternity and biology that ART practices, such as embryo donation, surrogacy, and 
egg donation, have destabilised.   
 
The HRC (1994:8) maintains that there are no grounds for discriminating against older women 
in the provision of ART services, particularly as the “medical technology exists to make post-
menopausal pregnancy relatively safe for mother and child” and they note that men do not 
experience discrimination by private providers based on age.  The age of an intending father is 
not questioned within the policy discourse,
108
 however, recent research suggests that the age of 
the male gamete provider can have an effect on the ability to conceive (Ford, et al., 2000),
109
 
and it has been known for some time that certain inherited genetic disorders are more common 
in the children of older fathers (Stein & Susser, 2000).  Using hormones to assist uterine 
responsiveness and the donation of oocytes greatly increases the chances of older women, 
including post-menopausal women, to successfully gestate and give birth to a child.
110
  The 
Canadian Royal Commission on New Reproductive Technologies (1993a:260-261) examined 
pregnancy and birth outcomes in their evaluation of the effects of aging on female fertility and 
found that, although studies over the last forty years suggest that older women have increased 
risk of experiencing adverse pregnancy related outcomes, the absolute level of risk remained 
low when combined with good obstetrical care and monitoring.  Similarly, Stein and Susse’s 
(2000:1681-1682) review of research into the risks of having children later in life suggests that 
although “the higher relative risk for older women persists, their absolute risk has been greatly 
                                            
108
  See Chapter One, Introduction: Framing the Issues, Section 1.2, Setting the Context, for a discussion 
of the marginalisation and invisibility of men in relation to ART practices and policy. 
109
  Other studies acknowledge that male fecundity declines with age.  However, they place less 
emphasis on its importance and suggest that effects are “less dramatic and only become significant in the 
late forties and early fifties” (Fox, 2000). 
110
  Gosden and Rutherford (1995) claim that “remarkably high pregnancy rates can be achieved when 
eggs are transferred from younger to older women, and successful pregnancy long after the normal age 
of menopause shows that the egg rather than the uterus is the Achilles' heel of human reproduction.”  
Similarly, Stein and Susser (2000:1682) maintain that there is no difference in embryo implantation 
between women older than 40 and younger women when using IVF with donor oocytes and “in which 
the uterus is hormonally prepared”.   
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reduced” with advances in obstetrics and prenatal screening.  They argue that the biological 
disadvantages that older mothers may face can be balanced against the social advantages of 
more knowledge and experience, and better economic circumstances (2000:1682).  Similarly, 
Millns (1995:92-93) suggests that 
…an older woman, with a wealth of experience and time to devote to bringing up a 
child, is not necessarily incapable of doing so simply because of her age. 
 
Consequently, limiting access to ART treatment based on age can no longer be solely justified 
by equating older age with menopause and using it as a ‘natural’ benchmark for fertility.  ART 
developments that enable women to extend their reproductive lifespan highlight the normative 
judgements and expectations surrounding the suitability of older mothers.
111
  In the following 
section, I investigate how the expression of rights is used in arguments for both limiting and 
expanding access to ART services. 
5.3 Access & Rights 
Although clinics do treat lesbian couples and single women in the private sector, it is clearly 
more difficult for them to access publicly funded treatment given the emphasis placed on 
biological infertility.  By granting itself a partial exemption from complying with the Human 
Rights Act 1993,
112
 the Aotearoa/New Zealand Government has been able to limit public funding 
to ‘biological’ infertility and implement criteria that disadvantage lesbian couples and single 
women.  Consequently, the government appears to be implying that some groups have more 
legitimate rights than others to publicly provided financial and biological resources in relation to 
ART practices.  According to MCART (1994:58), the exemption also appears to create an 
inconsistency between the public and private health sectors in the application of anti-
discrimination laws.  MCART’s report, Assisted Human Reproduction: Navigating Our Future, 
dealt with access issues under the chapter entitled “Discrimination”, addressing topics raised by 
the Human Rights Act 1993 (1994:50-61).  The chapter addressed changes in social values and 
challenges to the restriction of access on the grounds of age, sexual orientation, disability, 
marital status, and ethnicity.  While the committee recommended the establishment of an 
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  See Parks (1999) for a feminist analysis of the exclusion of post-menopausal women from access to 
ART treatments.   
112
  The New Zealand Government exempted itself from complying with the Human Rights Act 1993 in 
relation to its own legislative policies and practices until 1 January 2000 (Human Rights Commission, 
1998).  The subsequent passing of the Human Rights Amendment Act 1999 extended the compliance 
deadline until 31 December 2001.  From 1 January 2002 the Government became liable for discrimination 
in the public sector and will only be able to discriminate if the enactment or practice in question can be 
"demonstrably justified in a free and democratic society" (Human Rights Commission, 2002). 
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advisory and overseeing body consisting of a diverse range of representatives from various 
interest groups, it was unclear whether they intended this body to oversee or facilitate access 
decisions.   
 
MCART outlined the functions of the proposed ‘Council on Assisted Human Reproduction’ and 
stated that it 
…could act as an advisory body to Ministers, and it could prepare or assist in the 
preparation of codes of practice and guidelines. … It would liase with the variety of 
different agencies which play a role in the work of ART.  It could have a powerful 
influence on future policy formation, in safeguarding competing interests and in 
overseeing assisted reproduction generally.    (MCART, 1994:44) 
 
The committee’s principal recommendation in relation to access issues was that ART providers 
“review their practices and policies and make alterations to comply with the law” (MCART, 
1994:61).  The subsequent officials’ committee report, Assisted Human Reproduction: A 
Commentary on the Report of the Ministerial Committee on Assisted Reproductive Technologies 
(Department of Justice, 1995), endorsed this recommendation.  However, the committee did 
not support the development of general guidelines by the Human Rights Commission or a 
‘Council on Assisted Reproduction’, suggesting that “providers would need to have sufficient 
discretion to decide each case on an individual basis taking into account all relevant 
circumstances” (Department of Justice, 1995:12).  The officials’ committee also suggested that 
it would “not be unlawful discrimination for a provider to refuse treatment to persons where it is 
in the interests of the potential offspring to do so” (Department of Justice, 1995:12).  While it is 
unclear what measures or standards would be used to decide what was in the best interests of 
the child and who would make the decision on whose interests to prioritise, the implication is 
that the medical profession would continue to decide who is eligible to receive ART treatment 
and that any complaints could be addressed through procedures set up by the Human Rights 
Commission under the Human Rights Act 1993 (MCART, 1994:61).   
 
The Fertility Centre also prioritises the rights of the child in its ‘Conditions of Service’. 
The aim of the Fertility Centre is to help couples achieve a wanted pregnancy and 
child.  At times there is conflict between those involved.  In these circumstances 
the Fertility Centre staff act primarily in the interest of any potential child 
conceived. 
     (New Zealand Centre for Reproductive Medicine (The Fertility Centre), 1997) 
While it is again unclear what values and methods would be used to define the best interests of 
the child, the HRC claims that the ‘rights’ and the ‘welfare’ of the child are often used when 
arguing for the restriction of ART services to those who fit the ideal nuclear family (Hamed, 
1997).  The subjective nature of decisions based on the interests of the child is acknowledged 
by Robyn Scott (Executive Officer, NZIS). 
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We feel that the rights of the children over-ride all rights but I would have to say 
that is a very loose bandied around term and can be used by any group with an 
interest, a vested interest, in this area.  What exactly does that mean?  What 
exactly (is meant) by the rights of the children. 
       (Robyn Scott, Interview: 26 July 2000) 
The Women’s Health Action Trust (1994) states that they agree in general that there should be 
no discrimination on the grounds of disability, age, family status, sex, religious belief, sexual 
orientation, ethical belief, ethnic origins, national origins, or race in access to infertility services.  
However, their submission to MCART states, 
We have some difficulty with the prospect of people with some (particularly 
mental) disabilities having access to ART procedures.  We believe that the rights of 
the child need to be balanced here against the rights of adults to access services. 
        (Women's Health Action Trust, 1994) 
This statement places a condition the earlier declaration of support for non-discriminatory 
access by singling out people with mental disabilities as in need of special consideration.  There 
is an inference that people with mental disabilities are less likely to be good parents and, 
consequentially, will be detrimental to the interests of any children they intend to parent.  This 
statement brings into focus the Human Rights Commission’s (Hamed, 1997) claim that 
arguments concerning rights and interests of children are often used to mask certain 
assumptions and expectations about what “the best type” of parent or families should be like. 
The concept of the interests of the child is subjective and often carries a myriad of 
unexamined assumptions with it.  Such ideas are usually defined according to the 
speaker's own interests and beliefs.          (Hamed, 1997) 
 
Similarly, Zipper and Sevenhuijsen (1987:132) suggest that the dominant political actors in 
relation to ART often define the ‘interests of the child’ in terms of growing up in a two parent 
heterosexual family. 
 
Few rights are unconditional, however, and the HRC recognises that it may be necessary to 
balance the rights of “nondiscrimatory treatment and other competing human rights” (1994:12).  
While discrimination in order to protect a child may be necessary in particular circumstances, 
assessing individual cases is very different from excluding a whole group in society from access 
to services (MCART, 1994:12).  MCART was opposed to ART providers formulating blanket rules 
denying single women, lesbian couples, and post-menopausal women access to ART services 
and suggested that “some wider consultation and the production of guidelines is called for, to 
ensure that there is proper balancing of interests within the structure provided for by the 
Human Rights Act” in relation to deciding access issues (1994:59).  This position is supported 
by the HRC. 
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Blanket rules in this area are not helpful.  They not only fail to give due regard to 
the individual circumstances and merits of each person or couple wishing to use 
the service but are denying them their right to be treated fairly and with human 
dignity.             (Hamed, 1997) 
 
It is the ART providers’ responsibility to show lawful grounds for discrimination or to seek an 
exemption under section 97 of the Human Rights Act 1993 to support a decision not to treat 
somebody.  However, in order for people to challenge any such decisions they must be 
knowledgeable about their entitlements and rights, as well as being aware that they are being 
discriminated against.  If the clinicians’ decision-making processes are not transparent, it is 
unlikely many potential users of these technologies will be able to challenge decisions not to 
treat.   
 
In the Access to Infertility Services: development of priority criteria consultation document, 
Gillett and Peek (1997:24) suggest that “because of the Human Rights Act, access to treatment 
by single and lesbian women will need to be covered by this criterion.”  This quote implies that 
if this law was not in place these groups would not be considered for publicly funded assisted 
reproduction and individual commentators have reinforced this assumption. 
…well the point is that it is illegal to … the whole point is not really whether we 
would support it or not but the fact that it is illegal to discriminate against people 
like that so there is not much point in us not supporting that because it would be 
illegal.         (Robyn Scott, Executive Officer, NZIS, Interview: 26 July 2000) 
 
Similarly, Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) 
acknowledges the influence of the Human Rights legislation. 
Yes, we are obliged to do that.  Human Rights’ legislation was amended to make it 
unlawful to discriminate on the basis of gender and sexual orientation. 
(Rodney Bycroft, Interview: 13 September 2000) 
John Peek (Clinical Manager/Group Operations Manager, Fertility Associates Auckland) discusses 
how the legislation has affected medical practice in relation to making non-medical decisions on 
whom to treat.  However, he suggests that the Human Rights Act does not sufficiently protect 
the interests of the children because of its focus on preventing discrimination in the provision of 
services. 
There have been a few people that we wanted to refuse treatment but we went to 
the Human Rights Commission and we were told we had to treat them.  …they 
acknowledged our concerns for the child but there is no law in New Zealand that 
says that you have to take the child’s interests into account.  There is the Human 
Rights Act and that takes precedence.  We also did not want to treat single women 
and lesbians, initially, on the grounds that we were an infertility clinic and we 
thought that was outside our scope.  The Human Rights Commission said that we 
provide goods and services and therefore we cannot distinguish.  So, for 
something like donor insemination if someone just says, “I want it” then we have 
to provide it even if they are not infertile.       (John Peek, Interview: 12 July 2000) 
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While the implication is that the Human Rights’ legislation conflicts with the welfare of the child 
by allowing lesbian couples and single women to access ART, the distinction between biological 
and social infertility is used to justify the clinic’s unwillingness to treat such groups.   
 
Some commentators oppose public funding of ART for lesbian couples on the grounds that 
there are limited resources available to treat heterosexual couples. 
I think also, there are some practical problems for the clinics in treating those 
groups, in that there are insufficient donors for couples with biological infertility 
and I think it poses a lot of logistical problem for clinics in that they do not have 
sufficient donors in the first place. 
       (Robyn Scott, Executive Officer, NZIS, Interview: 26 July 2000) 
There is an implicit assumption that heterosexual couples have an overriding right to both 
financial and biological resources, reinforcing the notion that the nuclear family is the norm for 
reproduction and parenthood.  Cook (1995) argues that it is usually the marginalised and 
vulnerable in society who have to invoke the principles of human rights to protect and promote 
their interests.  In contrast, those who have benefited from occupying a dominant social 
position and its inherent protection of their rights, often resist challenges to their position.  
While those in positions of power will often be supportive of rights that advance their own 
privileged position, they may “resist service to rights that requires them to yield or share their 
privilege, observe duties related to rights, or support action that would reduce their privilege to 
no more than the rights that are shared by all others” (Cook, 1995).   
 
The two bills before the Health Select Committee do not directly address the regulation or 
control of access to ART, nor do they address the issue of resource allocation.  As discussed in 
Chapter Three, the focus of both bills is on the control of certain practices and the regulation of 
access to information by donors, recipients, and people conceived using donor gametes.  At 
present, access to ART services is mediated by the ability to pay, clinic location, and/or being 
able to fit the narrow access criteria for public funding, 
 
thus there is no automatic entitlement 
to the use of reproductive technologies.  The New Zealand Infertility Society (NZIS) (1995) 
defines infertility as a disability and argues for access to ART services on the grounds that those 
with infertility or sub-fertility have a right to adequate health care, which may enable them to 
found a family. 
The greatest benefit of treatment is to enable people to fulfil a basic human right – 
to found a family.   (New Zealand Infertility Society, 1995; emphasis removed) 
 
They argue for this right under the International Declaration of Human Rights and such 
conventions that recognise “the right to found a family”, “the right to adequate health care”, 
and “the right to share in scientific advancement and its benefits” (New Zealand Infertility 
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Society, 1995).  Likewise, the Family Planning Association’s (FPA) policy on the use of ART 
advocates for 
…the right of women and men to have access to the fertility treatment services of 
their choice, including assisted human reproductive technology.  FPA believe that 
the human rights of those seeking fertility treatment should be upheld.  In 
particular, fertility treatment AHRT [Assisted Human Reproductive Technologies] 
should not be denied on the grounds of disability except where the disability is 
such to significantly reduce the chances of the treatments effectiveness.  Nor 
should it be denied on the grounds of relationship status or sexual orientation. 
          (Family Planning Association, 1999a) 
However, others argue that ‘the right to found a family’ does not apply to the use of medical 
treatment to create a child as such rights were “formulated to address the situation of people in 
extreme situations” (Coney, 1999c:42).  Coney (1999c:42) interprets ‘the right to a family’ as a 
negative right, and does not believe people have a positive right to assistance or resources to 
fulfil the desire to found a family.
113
  
We do not believe that any person or couple has a 'right to a child'.  In our society, 
rights are always conditional, and the rights of society and of others affected by 
the actions of individuals have to be balanced against the rights of individuals to 
do as they please.     (Women's Health Action Trust, 1994: emphasis removed) 
 
Conversely, the Family Planning Association (FPA) interprets the use of ART to reproduce as a 
positive right.  However, they recognise that this right must be mediated by the medical 
likelihood of success, as well as limited resources.  
FPA acknowledges that fertility treatment services are unlikely to be offered in 
cases where there is expected to be a poor outcome from the treatment, or where 
there are limited resources.  In this regard, FPA believes that women and men 
have the right to be informed of the imposed criteria in being considered for 
fertility treatment.             (Family Planning Association, 1999b) 
 
Limitations on the right to reproduce require the consideration of other rights and 
responsibilities.  It is the specific responsibility of the government to ensure that the clinical 
criteria used to ration funds and limit access are based on sound scientific and medical 
research, and that the acceptance of social criteria and practitioner discretion to assist in the 
prioritisation of access is clearly identified and openly debated. 
 
There are limited resources available for the public provision of healthcare and rapid advances 
in technology, growing professional and public expectations, and changing demographics (aging 
and rising populations) continually increase demand (Ministry of Health, 1998b).  Consequently, 
                                            
113
  See Bonnie Steinbock’s Rethinking the Right to Reproduce (1998) for a comprehensive discussion of 
the distinction between moral and legal rights, as well as positive and negative rights, in relation to 
reproduction and ART.  
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some strategy for rationing the available resources is undoubtedly necessary.
114
  As discussed in 
the previous chapter, inequitable and limited funding for public access to ART treatment has 
resulted from funding decisions based on historical need.  Moreover, health sector reforms and 
rationing strategies have led to the introduction of the national CPAC to restrict access to the 
available public funding.  Although Adair (1998:265) claims that the imposition of access 
restrictions on publicly funded ART treatment is solely due to the lack of resources, I argue in 
the next section that the criteria used to restrict access to public funding have been influenced 
by a normative definition of family and social judgements surrounding what the appropriate age 
is for women to experience pregnancy and parenting.  Consequently, normative assumptions 
about who is ‘worthy’ to conceive, gestate, and parent work to exclude those who do not fit the 
perceived ideal for parental or family arrangements.   
5.4 The Priority Criteria 
As a result of the Aotearoa/New Zealand Government’s history of non-intervention in ART, 
certain medical professionals have almost total unregulated power to make social, moral, and 
legal judgements with regard to who can use ART (Henaghan, 1992:172).  Although there is no 
explicit legislation or prohibition restricting access to treatment in Aotearoa/New Zealand, 
access to ART practices are most obviously controlled through the rationing of publicly funded 
treatment.  As mentioned earlier, providers holding contracts to provide public treatment are 
required to restrict access through the application of the Clinical Assessment Criteria (CPAC) 
and the imposition of a point threshold.  Consequently, the Health Funding Authority’s (HFA) 
service specifications and the CPAC are the most influential documents in relation to the control 
and regulation of clinics that compete for public funding.  Nevertheless, the interpretation and 
implementation of the policies outlined in these documents remain the responsibility of the 
individual clinicians.  Health professionals also control and regulate the recruitment and 
selection of gamete donors, as well as deciding who will have access to the donated gametes 
and what information will be collected (Daniels & Lewis, 1996a:1525).  As the ART provider is 
customarily the only link between all of the parties involved, and the only person with access to 
relevant information about the use of gametes and the identity of donors, they hold a powerful 
position in deciding what happens to that information (Else, 1999b:57).  As a consequence, 
they regulate the relationships that can exist between these parties (Daniels & Lewis, 
                                            
114
  The terms ‘priority-setting’ and ‘rationing’ are often used interchangeably when considering the 
allocation of resources. 
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1996a:1525).  Although there are certain biomedical considerations regarding the ultimate 
success of any ART procedure that must be taken into account, the issue of restricted access 
based on social rather than clinical factors places non-medical decisions about who are 
appropriate parents in the hands of the clinicians.  According to Henaghan (1992:177), the 
power to decide who can use ART “is really the power to decide who has the right to have 
children.”  However, as discussed in Chapter Three,
115
 this is not a power that some health 
professionals necessarily want. 
There are social issues that have to be discussed, where you have got values 
issues, like the single women and the lesbians, those things I do not really mind 
either way, because I would prefer not to have to make that decision, I will 
manage the policy.  You make the policy; I will manage it. 
    (Mark Leggett, Interview: 22 June 2000) 
 
The newly implemented CPAC is based on the National Health Committee’s consultation 
document, Access to Infertility Services: development of priority criteria (Gillett & Peek, 1997).  
This document was commissioned in response to the health sector reforms and the 
rationalisation of public services and funds mentioned earlier.  It proposed a set of guidelines 
that were “intended to standardise diagnosis of infertility for any couple presenting to a 
primary, secondary or tertiary infertility service” (Gillett & Peek, 1997:6, emphasis added).  
However, its main aim was to present criteria for access to publicly funded infertility services 
and to provide a model for more explicit rationing.  The CPAC require service providers to 
identify exclusion factors and modifying factors, and to allocate points to objective and social 
factors.  Exclusion factors for access to treatment are based on situations that the providers 
consider would compromise the safety of the couple or a child (Health Funding Authority, 
2000a:28).  The referral guidelines do not specify how such risks will be assessed and who will 
be considered able to make such judgements.  Although it is acknowledged that “no factor may 
be used that is unlawful and that might breach the Human Rights Act or the Bill of Rights Act”, 
it is also stated that “ultimately it will be the doctor, practising at a primary, secondary or 
tertiary level, who will decide – and that doctor would need to defend this decision” (Health 
Funding Authority, 2000a:28).  However, Hunter (1997:28) argues that the debate surrounding 
whether health service rationing should be explicit or remain implicit arises from a “growing 
perception” that doctors are always the most adept at making rationing decisions.  As stated 
earlier, this is not necessarily a function that ART providers wish to have control over. 
 
                                            
115
  See Chapter 3, Regulating Practices, Section 3.6, Professional Self-Regulation, for further discussion 
of this issue. 
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Modifying factors for access to treatment are identified as body weight and medical factors that 
can be alleviated by surgery or treatment.  Although it is stated in the consultation document 
that extremes in body weight can affect ovulation and ovarian stimulation, body weight is not 
used as a deciding factor (Gillett & Peek, 1997:21).  It would appear that this factor has been 
included in the document to encourage self-surveillance and monitoring by those who wish to 
access ART and to provide the clinicians with more discretionary power.  Shildrick (1997:49) 
suggests that the capillary processes of power multiply the norms of function/dysfunction and 
the subject is “made responsible, and thus all the more cautious and manageable, for her own 
success in obtaining state benefit”.  According to Mark Leggett (Business Manager, The Fertility 
Centre, Christchurch, Interview: 22 June 2000), weight can be used to delay treatment and 
ensure conformity to the standardised weight range.  Women seeking publicly funded ART 
treatment who are outside the body mass index (BMI) range of 18-32 will be placed on the 
waiting list but have to demonstrate they are committed to treatment by losing weight.  
Although body weight is not ‘officially’ a deciding factor, it would appear that it does influence 
how providers interpret a client’s commitment to treatment and their eventual ‘worthiness’ for 
accessing treatment.  This discretionary power is reinforced by the referral guidelines. 
There are factors that limit the success of weight improvement, and in this 
circumstance it is reasonable to proceed with treatment providing the ovarian 
response is closely monitored.  Treatment should only continue if the response is 
satisfactory.             (Health Funding Authority, 2000a:28) 
 
Although not inevitable, extremes in body weight can have adverse effects on reproduction.  
However, recent research suggests that some of these problems can be overcome by ART 
treatment.  Wang, Davies, and Norman (2000) maintain that “there is no conclusive evidence 
that extremes of weight are associated with a low rate of pregnancy in women receiving 
assisted reproduction treatment.”  Although some weight loss or gain may increase the chances 
of ‘natural’ conception in women with weight related infertility, their ability to lose or gain 
weight may have been the reason they sought ART treatment in the first place.  Although it is 
claimed that body weight is an influencing factor and not a determining factor in granting 
access, it would appear that it has been included in the CPAC to further limit the numbers that 
would qualify for higher points under the “prognosis of conceiving without treatment” criteria. 
 
Coney (1999a:24) claims that restrictive criteria on weight effectively excludes women from 
certain ethnic groups from accessing publicly funded ART procedures because of the tendency 
for such women to exceed the recommended body mass index (BMI).  Similarly, the Human 
Rights Commission (HRC) argues that 
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…the factor of body weight could have some implications in relation to indirect 
discrimination on the basis of race and ethnic origins.  Certain ethnic groups in 
New Zealand have a propensity for either higher or lower than average body 
weight to height ratios (BMI, body mass index). 
          (Human Rights Commission, 1997:3) 
However, as the CPAC do not use the BMI as a deciding factor for access, it is unlikely that 
claims of indirect discrimination on the basis of race would be able to be made (Human Rights 
Commission, 1997:3).  John Peek (Clinical Manager/Group Operations Manager, Fertility 
Associates Auckland) suggests that the weight range is necessary because it eliminates those 
who have a reduced likelihood of responding ‘efficiently’ to ART treatments.  Nevertheless, he 
recognises that the weight range effectively excludes many Mäori and Pacific Island people. 
…Mäori tend to be a lot heavier and therefore they need more drugs to respond 
and [they are] more likely not to respond to stimulation IVF and at the moment 
the emphasis is on making the service efficient so we only treat the people who 
are going to get the highest chance of pregnancy which are the people who are 
going to respond the most to the drugs.  So, you have got a weight range - a BMI 
of 18-32 which excludes a lot of Mäori and then a lot of Mäori and Pacific Islanders 
who fall into that are at the top end and they do not respond so well to the drugs. 
                    (John Peek, Interview: 12 July 2000) 
Peek claims that it is not “about equity of access but about biological differences that somehow 
you have to work out” and argued that the resolution would be to provide more funding so that 
“Mäori people having an IVF cycle should be allowed to spend more on drugs for instance or 
not have such strict … weight related restrictions” (John Peek, Interview: 12 July 2000).  
However, Teresa Wall (Senior Analyst, Mäori Health Branch, Ministry of Health, Interview: 24 
July 2000) suggests that asking for more money to treat Mäori or Pacific Island people obscures 
the fact that the criteria are discriminatory.  Similarly, Grant Allen (Senior Policy Analyst, Te 
Puni Kökiri) suggests the use of the BMI scale, even as a modifying factor, implicitly 
discriminates against Mäori and Pacific Island peoples. 
Unfortunately, the BMI is based upon a western profile.  …  There have been 
studies that have shown that the density of a Pacific Island person’s body is 
heavier in general than Europeans.  So you may have those problems, I mean the 
criteria itself is probably a profile for the type of people going through, middle-
class, white middle class?          (Grant Allen, Interview: 25 July 2000) 
 
Universally formulated policies are blind to differences of race, culture, gender, age, or disability 
and often maintain rather than challenge social inequality.  Such policies often accept the 
capabilities, values, behaviours, and physiology of the dominant group as the standard or norm 
and assess all those applying for social assistance against these norms (Young, 1990:173-174).  
Accordingly, Young (1990:174) maintains that social equality can only be accomplished through 
the development of certain “group-conscious” policies, which acknowledge the group’s 
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distinctiveness.
116
  She argues that the “oppressions of cultural imperialism that stereotype a 
group and simultaneously render its own experience invisible can be remedied only by explicit 
attention to and expression of the group’s specificity” (Young, 1990:174).  Consequently, it may 
be necessary to acknowledge this difference in relation to body weight and establish distinct 
access criteria for some ethnic groups.
117
   
 
The ‘objective’ factors are scored on a points system and they include age of the female 
partner, prognosis of conceiving without treatment, hormone levels, and a history of current 
smoking in the female partner.  In their submission on the consultation document, the HRC 
claim that the inclusion of age and the “heavy weighting through a relatively narrow range of 
age bands” appeared to be subjective (1997:4).  Gillett and Peek (1997:21) admit that “the rate 
at which fertility falls with age seems to vary between studies performed in different countries, 
and on different population groups within large countries such as the United States of America”.  
While they acknowledge that older women may have a greater need than younger women 
because of age related infertility (Gillett & Peek, 1997:22), they disregard this argument and go 
on to state twice in the document that “women who wish to embark on parenthood need to 
consider their priorities well before 35 years of age” (Gillett & Peek, 1997:6 & 38).  This 
statement appears to be based on a moral judgement by the authors rather than ‘objective’ 
fact.  Similarly, John Peek discusses the emphasis on age in the education kits that Fertility 
Associates provide to schools. 
…the big message we are trying to get across is “Try to plan your family as much 
as you plan your career …and be aware of the fact that once you are in your late 
thirties your chance of pregnancy really reduces.” 
        (John Peek, Interview: 12 July 2000) 
The emphasis on women prioritising and planning their reproductive ‘careers’ fails to allow for 
demographic changes in Aotearoa/New Zealand and life events that may preclude having a 
family any sooner.  Such arguments do not acknowledge that pressure to conform to male 
orientated career paths and inadequate childcare facilities may impact on decisions about when 
to have children (Woliver, 1991:486).  Similarly, a partner may have some influence on the 
decision when to have a child or some women may not have access to a willing male sexual 
partner.   
                                            
116
  Young defines ‘social equality’ as the “full participation and inclusion of everyone in a society’s major 
institutions, and the socially supported substantive opportunity for all to develop and exercise their 
capacities and to realize their choices” (1990:173). 
117
  See Chapter 6, Addressing Difference: Mäori Infertility and ART, for a discussion of the constraints 
facing Mäori in relation to accessing ART. 
  
133
 
 
Sandra Coney (Executive Director, Women's Health Action Trust) suggests that focusing on 
personal choice and ‘career planning’ in relation to having a family disregards the influence of 
social and economic conditions on women’s reproductive choices. 
…the other thing we could do is actually provide better social and economic 
conditions so that women can have children when they are younger.  …  I think 
that is discrimination because the way the work force has changed quite rapidly in 
recent years means that it is very difficult for women to take time out to have 
children.  …to think that somehow women should be thinking at the age of 25 “Oh, 
if I leave it too much longer I might you know not have enough points when I...” is 
just bizarre.  So, I think there are a lot of things that could be done in social and 
economic policy to support women in having children when they may prefer to 
have them at a younger age.       (Sandra Coney, Interview: 13 July 2000) 
 
Fertility in women does reduce with age and by the age 45 is almost half that of a 20 year old 
(Serono Colloquia Australasia, 1997b:6-7).  However, these statistics are based on averages 
and do not take into account the individuality of women’s fertility.  Klein, Day, and Redmayne 
(1996:87) argue that applying information about groups to individuals and using it as criteria 
for allocating resources can lead to discriminatory and inequitable decisions.  They contend that 
using age as a rationing strategy could lead to an older person with a good prognosis being 
denied treatment while a younger person with a poor prognosis is offered treatment.  The HRC 
(1997:4) argue that the ‘age of the female partner’ and ‘prognosis of conceiving without 
treatment’ criteria and the scores associated with them are contradictory, given that age could 
be a contributing factor to the inability to conceive without treatment.  The objective factors 
give higher points to women who have a poor chance of pregnancy without treatment.  
Although the consultation document allows that the “chance of pregnancy per month falls as 
the woman’s age increases” (Gillett & Peek, 1997:21), the CPAC scores reduce as the woman’s 
age increases and effectively eliminate anyone over the age of 39 from achieving access to 
publicly funded ART treatment.
118
  As mentioned earlier, the use of donor oocytes can improve 
the likelihood of older women benefiting from ART treatments. 
 
The inclusion of ‘a history of current smoking in the female partner’ in the objective criteria 
implies that its effect on the ability to conceive is supported by clinical evidence.  However, the 
consultation document states that smoking “seems” to reduce the likelihood of conception and 
offers no conclusive evidence (Gillett & Peek, 1997:22-23).  As the HRC point out, the desire to 
                                            
118
  The current point threshold to access publicly funded ART is 65 points.  Using this threshold no 
woman over the age of 39 would qualify for public funding, even if she scored the maximum points on 
the remaining criteria. 
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eliminate smoking and its harmful effects is commendable but it should be made explicit that 
this is a social factor based on a moral judgement of a social behaviour rather than evidence-
based. 
It is recognised that the elimination of smoking is an admirable public health goal.  
However, factors such as this should be justified on clinical grounds.  The language 
of the report is somewhat hesitant as to the actual known effect of smoking on 
fertility.  Without sound reasoning being provided for the exclusion of smokers it 
could seem that this is a moral judgment of individuals' social behaviour rather 
than a logical medical reason such as protecting a child in utero from risks to its 
health and safety.  Perhaps this factor could be better grouped among the social 
criteria.      (Human Rights Commission, 1997) 
 
Although the inclusion of smoking as a restrictive criteria appears to be based on the ‘capacity 
to benefit’ principle (Klein, et al., 1996:88), it has also been interpreted by one provider as an 
indication of how deserving of treatment the individual is.  Mark Leggett (Business Manager, 
The Fertility Centre, Christchurch) sees smokers as less deserving of public funds because their 
habit may be contributing to the condition for which they are seeking treatment. 
You could not say if you are a smoker, you cannot get service.  That would be 
stupid.  But, if you are a smoker, it reduces the amount of service you can get.  
Because we can only afford so much and why would we give it to someone who is 
going to minimise their chances deliberately?  So, that makes sense.   
   (Mark Leggett, Interview: 22 June 2000) 
Gillett and Peek (1997:23) argue that smoking does not “significantly impair sperm quality or 
reduce fertility” in men.  However, the American Society for Reproductive Medicine (2001) 
claims that heavy smoking can increase abnormalities in sperm mobility and shape and may 
combine with other factors to reduce fertility.  The consultation document does not include any 
acknowledgment of the effect of passive smoke inhalation by female partners of male smokers, 
which may also contribute to “abnormalities of reproductive function” (American Society for 
Reproductive Medicine, 2001).  This omission highlights the CPAC’s focus on the women’s 
bodies and behaviour, and emphasises the invisibility of men in both the reproductive process 
and the disciplinary techniques used to control and normalise procreative behaviour.
119
   
 
The purpose of the consultation document was to “develop criteria based on a couple’s 
measurable need and their opportunity to benefit” (Gillett & Peek, 1997:36).  According to 
                                            
119
  Disciplinary power operates to control and regulate certain populations through the use of disciplining 
techniques.  Modern medicine provides an important system of knowledge and related practices, which 
enable the body to be understood and experienced.  Knowledge gained through the ‘clinical gaze’ of 
medical practitioners and the ‘confessions’ of their patients is used to inform discourses and practices that 
construct the body and its various parts.  Disciplinary power operates within the medical encounter by 
providing guidelines for how patients should understand, regulate, and experience their bodies.  By 
subjecting patients to examination, observation, and measurement, bodily norms are established and 
individuals can be compared and categorised (Lupton, 1997:101). 
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Klein, Day, and Redmayne (1996:25) an idea of equity underlies most rationing strategies and 
is often defined as allocation according to need.  However, problems arise when trying to 
establish operational definitions of the concepts of ‘equity’ and ‘need’ as a way of comparing the 
relative needs of one individual or group against those of another (Klein, et al., 1996:29).  
Gillett and Peek acknowledge the difficulties in judging need with respect to older women as 
opposed to younger women in relation to the age criterion. 
It may be argued that older women, who may have a greater need, should have a 
higher priority than younger women.  The difficulty here is that although the need 
might be greater (and how do we judge that?) there is no doubt that the 
effectiveness is lower.         (Gillett & Peek, 1997:22) 
 
From the final weighting of points given to older women it must be assumed that desire for 
efficiency and cost-effectiveness finally outweighed any perceived need by older women (Health 
Funding Authority, 2000a:30).  Along with need, a variety of other principles are often used, 
either implicitly or explicitly, when making resource allocation decisions.  Some of these 
principles focus on the characteristics of the individuals concerned and include concepts of 
desert and merit (Klein, et al., 1996:30).  Others, however, are concerned with considerations 
about the use of resources for the good of society and include the argument that “resources 
should go … to whoever is likely to benefit most as a result of treatment” (Klein, et al., 
1996:31).  The social priority criteria are presented as reflecting “opinion as to the worthiness 
of access to treatment” (Gillett & Peek, 1997:7), a concept that is obviously based on the 
principles of need, merit, and desert.  As they stand, the social priority criteria establish the 
level of ‘worthiness’ in relation to the duration of infertility, number of children in the current 
relationship, and previous sterilisation.  All three criteria are based on a perceived ‘need’ for 
treatment and contain elements that require a degree of discretionary input by the service 
provider.  Klein et al (1996:29) argue that “discretion … is a function of ambiguity” and its use 
by service providers is a reasonable response to decision-making criteria that are not sufficiently 
specific or able to be applied to all possible circumstances.  Although the CPAC appear to limit 
the discretionary element in the decision-making process and provide consistency in access 
throughout the country, John Peek acknowledges that the points system provides areas of 
ambiguity in deciding ‘worthiness’ of treatment. 
Well there are some advantages [in the ‘all or nothing’ access criteria] because it is 
easy to say yes or no.  …  With the points system some of the criteria [or] 
components to the points are a little bit more subjective and you grade for severity 
of infertility … and that I guess could be challenged.  You are also asking your 
patients to self-report on the length of infertility and I am sure that would be 
generously interpreted in the future.  …  But, we try to keep the grey areas to a 
minimum because there is no boundary to a grey area.   
        (John Peek, Interview: 12 July 2000) 
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The ‘all or nothing’ system for deciding access is interpreted as being easier to administer, as 
there are no ‘grey areas’ in the decision-making process that need to be negotiated by the 
provider.  The subjectivity inherent in making non-medical decisions is also acknowledged as 
presenting grounds for the providers’ decisions to be challenged.  Discretion in the 
interpretation of guidelines, codes of practice, and rules is characteristic of all systems of 
service delivery (Klein, et al., 1996:138) and is a necessary aspect of some clinically based 
decisions (Mechanic, 1995).  However, Mechanic (1995) suggests that problems arise when 
doctors make assumptions about benefit of treatment based on social judgements “about 
intelligence, family circumstances, personality traits, and the like” rather than “subjective 
judgements of medical necessity.”  
 
Although Gillett and Peek (1997:24 & 27) approached health professionals and consumers to 
indicate what factors they thought should be regarded in priority setting, only forty-eight 
responded.
120
   
The respondents were asked to list up to 10 factors that they deemed important 
and were asked to rank them from 10 (the most important) to 1 (the least 
important).          (Gillett & Peek, 1997:17) 
 
From these responses, the authors selected the four top ranking factors for inclusion in the 
priority criteria: length of infertility, prognosis without treatment, female age, and number of 
living children (Gillett & Peek, 1997:18).  However, they disregarded other high-ranking factors 
and, although they give some reasons for excluding these, they are not explicit about why all 
these factors were excluded (Gillett & Peek, 1997:18).  It is unclear from the consultation 
document how many people included the top four criteria in their selection as the final ranking 
was based on cumulative points.  Therefore, some respondents may have selected the criteria 
but given them relatively low ranking in importance compared to other respondents.  Neither is 
it specified in the document, which groups of people selected each of the criteria or the 
rankings each respondent gave the criteria that they did select.  A further three criteria (follicle 
stimulating hormone [FSH] levels, smoking, and previous sterilisation) were selected by the 
authors but they do not specify why they selected these factors over others, especially as all 
three factors had low response rates and/or low rankings.
121
  Furthermore, only twenty-eight 
people responded to the exercise to determine what ‘values’ would be allocated to categories 
                                            
120
  These included 19 consumers, 26 health professionals (mainly from IVF units) and 3 health 
administrators (Gillett & Peek, 1997:17). 
121
  FSH levels were selected by nine respondents with a mean ranking of seven, smoking was selected 
by four respondents with a mean ranking of 3.5, and sterilisation reversal was selected by eight 
respondents with a mean ranking of 2.3.   
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within the individual criteria.  The authors acknowledge that there are limitations to the ‘values’ 
chosen to represent the various levels of worthiness within the social criteria because of the 
limited number of responses.  Despite this, they rationalise the inclusion of these values 
because “there are no other data available” (Gillett & Peek, 1997:24).  They maintained that 
“refinement of these scores can be made by seeking the views of a wider group of people” once 
the priority criteria had been established in clinical practice (Gillett & Peek, 1997:24).  Although 
the draft criteria were “tested in a least 2 NZ (sic) tertiary centres”, they were introduced as the 
national CPAC with only minor changes in August 2000 (Health Funding Authority, 2000a:24).  
There is no clear indication that any further public consultation has been carried out in relation 
to defining the criteria for need assessment and the opinions of an undefined number of people 
(a maximum of forty-eight) have been institutionalised as definitive of what social categories of 
people are ‘worthy’ of ART treatment. 
 
Gillett and Peek (1997) suggest that the implementation of the CPAC would empower infertile 
couples seeking public access. 
The present model puts some power into the hands of the infertile couple – all 
doctors should be able to calculate the same score in the same circumstances.  
The opinion of the individual doctor about whether treatment is worthwhile will be 
replaced by objective scoring.        (Gillett & Peek, 1997:38) 
 
An analysis of the criteria listed indicates that the only ‘power’ conferred on those hoping to 
access ART procedures is self-surveillance and modification of their own bodies.  The only 
factors that the potential women patients have any direct control over are body weight and 
smoking habits.  By taking the authors’ advice and considering their priorities “well before 35 
years of age” (Gillett & Peek, 1997:6 & 38), women may have some control over the age factor.  
However, there is no guarantee that their efforts will be rewarded, as it is ultimately the medial 
profession’s definition of the norms that these characteristics will be measured against.  Gillett 
and Peek (1997:7) suggest that the model based on these criteria will improve “the standards 
of care in Aotearoa/New Zealand, allowing greater and fairer access to treatment programmes 
and giving the opportunity to couples, who are most in need and most likely to benefit, to 
attain their life goal of having a family” (emphasis added).  It is clear from this statement who 
is considered to be the most deserving of treatment.  At present, the public provision of ART 
services benefits and reinforces the ‘normal’ heterosexual nuclear family (Shildrick, 1997:186).  
Nevertheless, the consultation document takes a contradictory stance from its earlier couple 
focused treatment criteria when it claims, “to achieve a fertile status will require individuals to 
be aware of the issues that prevent them from being parents” (Gillett & Peek, 1997:39).  
Farquhar (1996:42) and Sawicki (1991:84) claim that focusing attention on the individuals’ 
responsibility depoliticises the causes of infertility by deflecting attention and energy away from 
  
138
 
addressing the environmental,
122
 iatrogenic,
123
 or idiopathic
124
 causes, as well as the social and 
economic issues that restrict access to adequate health care and nutrition. 
 
The referral guidelines and CPAC provide doctors and ART providers with criteria for good 
practice in the distribution of public funds and, undoubtedly make the decision-making 
processes for allocating resources more visible and explicit (Klein, et al., 1996:137).  
Nevertheless, the preceding analysis of the CPAC highlights how the decision-making processes 
surrounding access to publicly funded ART include judgments about complex issues that cannot 
be resolved solely by appealing to medical knowledge and science (Klein, et al., 1996:62).  The 
technical nature of medicine means that successful health policy will always be reliant on the 
specialised knowledge of the medical and associated professions to some degree (Blank, 
2001:149).
125
  However, the emphasis on explicit clinical decision-making as promoted by the 
CPAC (Clinical Assessment Criteria) obscures what are in effect decisions made on social and 
moral grounds about the degree of ‘worthiness’ or ‘need’ exhibited by those applying for public 
funding of ART treatment (Hunter, 1997:28).  Limited resources and increasing demand 
necessitates constraints on access to publicly funded ART treatment and clinical grounds may 
not always be adequate for deciding who should receive treatment when resources are severely 
                                            
122
  Recent studies have demonstrated links between environmental pollution, including toxic work 
environments, and human reproductive system dysfunction (Gupta, 2000:340-343).  Higher rates of 
infertility have been observed in women whose employment has exposed them to nitrous oxide, glycol 
ethers, and organic solvents.  Similarly, pesticides have been connected with the low sperm counts of 
men, male infertility, and other unfavourable reproductive outcomes (Fidler & Bernstein, 1999).   
123
  Symptoms or illness unintentionally caused by medical intervention. 
124
  Used to describe a disease or disorder that has no known or identifiable cause. 
125
  Traditionally, the medical profession has had a high level of autonomy that has protected it from 
control by the state or other professional groups (Davis & Ashton, 2001a:12).  This autonomy has been 
challenged and eroded over recent years, both internationally and locally.  Throughout the 1980s and 
1990s, health sector reforms in New Zealand shifted health care decisions to managers and 
administrators (Blank, 2001:148 & 150).  However, the medical profession still plays a major role in 
health policy agenda (Hunter in Davis & Ashton, 2001a:12) and are ultimately responsible for 
implementing any health policy decisions, such as determining the allocation of resources to individual 
patients (Klein, et al., 1996:136).  While limited resources mean that judgements must be made about 
what treatments are funded and who has access to them, debate continues over the suitability of using 
implicit or explicit strategies in allocating and rationing resources.  See for example, Blank, R.H., 1994.  
New Zealand Health Policy: A Comparative Study.  Auckland: Oxford University Press; Feek, C.M., et al., 
1999.  'Experience with rationing health care in New Zealand', British Medical Journal [Online], Vol.318, 
No.7194, pp.1346-1348, Available: http://www.bmj.com [29 November 2001]; Hunter, D.J., 1997.  
Desperately Seeking Solutions: Rationing Health Care.  London & New York: Longman; Klein, R., P. Day 
& S. Redmayne, 1996.  Managing Scarcity: Priority Setting and Rationing in the National Health Service.  
Buckingham: Open University Press; Mechanic, D., 1995.  'Dilemmas in rationing health care services: the 
case for implicit rationing', British Medical Journal [Online], Vol.310, No.6995, pp.1655-1659, Available: 
http://www.bmj.com [2 December 2001]. 
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constrained (Hunter, 1997:24).  Additionally, any form of rationing will disadvantage some 
people and be interpreted by some as unfair no matter how explicit it is (Hunter, 1997:32).   
The notion that there is some ‘ultimate solution’, waiting to be discovered, is 
illusory.  Decisions about managing scarce resources … involve trying to reconcile 
competing values, interests and concepts of the good.  The balance struck at any 
one point in time will inevitably shift in the light of experience and changing social 
expectations.  Neither science nor economics will resolve the pain of choice.  The 
best we can hope for is to strive to improve the process by which we reach the 
decisions.           (Klein, et al., 1996:139) 
 
Blank (1995:183) also argues that the most appropriate question is not whether rationing 
should be done but who should be responsible for establishing procedures and guidelines that 
are non-discriminatory and reasonable.  To ensure that health policy is fair and publicly 
acceptable, any decision-making about the content and implementation of such policy should 
only occur after considerable public consultation and input has taken place (Blank, 2001:157; 
Davis & Ashton, 2001b:275).  Similarly, health researchers and health professionals should be 
frequently consulted about current and potential developments in medical technology, as well 
as the implications of these for health policy (Davis & Ashton, 2001b:276).  It may inevitably be 
necessary to limit access to publicly funded ART treatments on more than clinical grounds.  
However, if it is necessary to restrict access by using criteria such as the age of the women, 
social behaviours, weight, number of children, and previous sterilisation, it should be clear how 
and why these social criteria are arrived at.  Moreover, the clinicians and health care 
professionals who have been given the authority to make rationing decisions should be publicly 
accountable for the way in which they make these decisions, and those applying for public 
funding should be fully informed of the nature of the criteria on which they are being judged. 
5.5 Conclusion 
ART treatment was initially restricted to married couples, but access restrictions were eventually 
eased to allow de facto heterosexual couples in stable relationships into some programmes.  In 
1987, the Status of Children Amendment Act (SCAA) institutionalised the definition of family in 
relation to ART practices as comprising of two co-habitating heterosexual parents with (ideally) 
genetically related children.  The legislation reinforced the idea that only heterosexual couples 
were appropriate candidates for ART treatment and effectively marginalised the more diverse 
concept of family acknowledged by Mäori.  Nevertheless, attempts by clinics to restrict access 
by lesbians and people with disabilities were challenged under the Human Rights Commission 
Act 1977 and the Human Rights Act 1993.  Consequently, providers have gradually relaxed their 
access restrictions in relation to private ART treatment and currently treat single women and 
lesbian couples.  Regardless, debate has continued over the issue of access to ART treatment 
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by those who do not fit the traditional concept of ‘parent’.  Some commentators have implied 
that the welfare of the child and the rights of heterosexual couples should take precedence over 
the rights of single women, lesbian couples, and post-menopausal women who wish to access 
ART practices.  Such arguments are often based on assumptions about who should parent and 
how families should be constructed.  While acknowledging that individual rights need to be 
considered in relation to each other, others have debated that blanket rules denying access to 
ART by certain groups fail to allow for individual circumstances.  Although not overtly excluded 
from publicly funded access to ART, lesbian couples and single women are marginalised within 
the terms of eligibility.  The Health Funding Authority’s (HFA) recently modified service 
specifications no longer include exclusive references to ‘couples’, but eligibility requirements 
continue to assume heterosexuality.  By confining eligibility to biological infertility and defining 
this as a physiological problem experienced by one member of a heterosexual couple, lesbians 
and single women are outside the interpretation of eligibility.  The distinction between biological 
and social infertility is founded on treating the heterosexual couple as a unit and regarding the 
individual’s infertility as a condition of the relationship.  This distinction obscures the fact that 
many of the heterosexual women and men who access publicly funded ART services as 
members of a couple are socially infertile. 
 
Age is also used to restrict access to ART services in both the private and public sector.  
However, it is only used to restrict the access of older women.  There are no limits on the age 
of men applying to use ART services and death is considered the only limit to male fertility.  The 
national Clinical Assessment Criteria (CPAC) use age to restrict access on the grounds that 
women’s fertility declines with age.  There is no concession allowed for age being a contributing 
factor in the need to access ART services.  Age-related declining fertility, menopause as 
women’s ‘natural’ fertility limit, and the risks of pregnancy associated with older women are all 
used to justify limiting older women’s access to both public and private ART services.  However, 
the possibility of using donated oocytes has removed the barrier of menopause.  Likewise, 
pregnancy complications are not inevitable and medical advances in obstetrics have eliminated 
or reduced many of the risks encountered by later pregnancy.  Older women, single women, 
and lesbian couples are not incapable of raising children nor are the children necessarily 
disadvantaged by the structure of their family.  Therefore, I argue that social judgements on 
the value and ability of such mothers should not be used to exclude them from accessing ART. 
 
As well as making the decision-making processes for the allocation of scarce resources more 
visible, the CPAC also highlight the incorporation of non-medical judgements about the social 
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issues of ‘worthiness’ and ‘need’.  Although the name of the national Clinical Assessment 
Criteria (CPAC) implies that priority decisions will be made on explicit clinical grounds, the CPAC 
include moral and social judgements, as well as some medical ones.  The CPAC is explicit about 
the inclusion and use of some social factors to limit access to publicly funded ART services.  
Nevertheless, other factors that are based on ‘worthiness’ or ‘deservedness’ of treatment are 
less obvious and the non-medical basis of their inclusion is concealed by references to 
inconclusive evidence of their detrimental effects on reproduction.  Both the weight and 
smoking related criteria are partly based on whether the applicant ‘deserves’ treatment, given 
that their weight or behaviour may be causing their condition.  The emphasis on explicit clinical 
decision-making also obscures the discretionary judgements that service providers are required 
to undertake in relation to the criteria.  The limited public consultation and the subsequent lack 
of responses in relation to selecting the access criteria and the allocation of ‘values’, 
undermines the validity of the CPAC and calls into question how reflective of the wider 
community’s social values the criteria are. 
 
Limited resources and increasing demand will continue to place pressure on the provision of 
publicly funded ART services.  Similarly, medical professionals will necessarily continue to play 
an important role in the formulation and implementation of any access restrictions, particularly 
in relation to the clinical applications of ART.  While it may be necessary to include social, 
moral, and value judgements in the limitation of access to severely constrained ART services, it 
should be made clear why these judgements have been included and what groups or individuals 
have contributed to their inclusion.  Given that any form of rationing will disadvantage some 
members of society and be interpreted by some as unfair, it should be anticipated that any 
criteria for limiting access to ART services will be subject to challenges by those who feel 
themselves to be disaffected.  Therefore, every effort should be made to ensure that any 
access criteria are as fair and non-discriminatory as possible and that procedures are in place to 
facilitate the public accountability of those who implement them. 
 
Both implicit and explicit access restrictions for ART services have been influenced by the 
normative definition of family underlying the Status of Children Amendment Act 1987 (SCAA).  
The document that underlies the CPAC, Access to Infertility Services: development of priority 
criteria (Gillett & Peek, 1997), reinforces the ‘normal’ heterosexual nuclear family and 
marginalises alternative family formations by making assumptions about ideal child-rearing 
arrangements and family structures.  Consequently, limited funding and restrictive access 
criteria combine to disadvantage single women, lesbian couples, and older women, as well as 
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ethnic groups that recognise a broader concept of family than the two parent nuclear model.  
The following chapter will explore how Mäori are marginalised within the wider health sector 
and how the ad hoc development of ART policy may affect their ability to access ART services. 
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6 
Addressing Difference: 
Mäori Infertility & ART 
 
The politics of difference … aims for an understanding of group difference as 
indeed ambiguous, relational, shifting, without clear boundaries that keep people 
straight – as entailing neither amorphous unity nor pure individuality.  …  
Difference now comes to mean not otherness, exclusive opposition, but specificity, 
variation, heterogeneity.  …  Difference no longer implies that groups lie outside 
one another.  To say that there are differences among groups does not imply that 
there are not overlapping experiences, or that two groups have nothing in 
common.                  (Young, 1990:171) 
6.1 Introduction 
Social policy affects the lives of all New Zealanders but not necessarily equally.  For most of 
Aotearoa/New Zealand’s colonised history, social policy has developed from a Päkehä 
perspective, which has often marginalised and sometimes discriminated against Mäori.  Early 
state policies enabled the acquisition and confiscation of Mäori land in the face of Mäori 
opposition, as well as encouraging assimilation through education (Consedine & Consedine, 
2001:89-95).
126
  Likewise, state policies aimed at assisting Mäori were often assimilatory and 
paternalistic in nature and have contributed to the marginalisation of Mäori values and 
perspectives and a loss of traditional knowledge (Cunningham, 1998:396; Consedine & 
Consedine, 2001:20).  However, public sector agencies are “now required to be responsive to 
the needs of Mäori in carrying out their business” (Cunningham, 1998:397).  Nevertheless, ART 
policy continues to assume homogeneity among those accessing ART services, failing to 
                                            
126
  See Consedine and Consedine (2001: 76-118) for an overview of some of these policies and their 
effect on Mäori culture and society.  
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acknowledge or accommodate social diversity in relation to family structure,
127
 let alone cultural 
diversity.  The lack of adequate data on the prevalence of infertility within groups and the 
ethnic and socio-economic backgrounds of those accessing ART services contributes to the 
formulation of policy on access that may be discriminatory in effect, if not in intention.  It is not 
within the scope of this chapter to address all the policy issues surrounding infertility and ART 
in relation to Mäori.  Nevertheless, I will attempt to highlight some issues that may contribute 
to and/or exacerbate inequalities in access to ART by Mäori, as well as highlight areas that 
require more research and public policy consideration.   
 
Although the focus of this chapter is on issues surrounding the use of ART by Mäori, I recognise 
that other ethnic and cultural groups may have similar or divergent issues relating to ART.  
However, I have focussed on Mäori because of their unique status as tangata whenua and as 
partners to te Tiriti o Waitangi (the Treaty of Waitangi).  Te Tiriti o Waitangi is Aotearoa/New 
Zealand’s founding document and, as such, recognises the partnership between the “two 
sovereign peoples”, Mäori and Päkehä (Manatu Mäori in MCART, 1994: Appendix E, p.2).  This 
relationship necessitates that the drafting, implementation, and monitoring of policy 
incorporates and acknowledges the “values and norms inherent within Mäori society”, such as 
the importance of whakapapa in Mäori culture (Manatu Mäori in MCART, 1994: Appendix E, 
p.2).
128
  Accordingly, Dyall (1999:35) maintains that the Treaty embodies a number of 
fundamental principles that provide a framework for determining the rights and responsibilities 
of the different actors involved in determining and implementing ART and surrogacy policy in 
relation to ensuring cultural safety. 
 
The decision to include a Mäori focussed chapter was fraught with personal and political 
difficulties.
129
  However, I considered that such a chapter was necessary if I was to avoid 
contributing to the marginalisation and invisibility already experienced by Mäori in this area.  
                                            
127
  See Chapter One, Introduction, Section 1.4, Families & ART, for a discussion of this issue. 
128
  There is ongoing debate about the relevance and necessity of including the Treaty in social 
legislation.  See Te Kawenata o Waitangi: The Application of the Treaty of Waitangi to Health (Durie, 
1998:81-97), Te pupuri I te ao ote tangata whenua (Reid, 1999a:56-59), and Why treaty has no place in 
social law (Graham, 2000) for discussions relating to this debate.  Both the Te Puni Kökiri and Ministry of 
Health representatives, who were interviewed in relation to issues Mäori may have regarding ART policy, 
claimed that changes in government (administration) had significantly influenced the nature of the 
debate.  They maintained that the change in 1999 from a National-led Coalition Government to a Labour-
led Coalition Government had resulted in the debate focusing on how to incorporate the Treaty in social 
legislation, rather than whether to incorporate it at all. 
129
  For a discussion of these difficulties see Chapter Two, The Research Process, Section 2.9, Cross-
Cultural Research. 
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While the overall focus of this project was to discover how ART policy constrained or enabled 
reproductive choice in Aotearoa/New Zealand, I discovered little Mäori-specific information or 
policy in relation to ART practices.  The most comprehensive discussion I could find on ART 
policy issues for Mäori was produced by Manatu Mäori (Ministry of Mäori Affairs), which 
provided a seven-page submission to the Ministerial Committee on Assisted Reproductive 
Technologies (MCART, 1994: Appendix E) in the mid-1990s.  The submission raised some 
specific areas of concern for Manatu Mäori in relation to the provision and use of ART.  These 
included 
…the protection of whakapapa and informed choice and consent, as well as 
ensuring that across all technologies the processes involved are culturally 
supportive and safe.  In addition, it is the view of this working group that there is a 
need to promote the prevention of infertility within the context of today’s health 
risks.             (MCART, 1994, Appendix E: 3) 
 
In spite of these concerns, there has been no discussion or research into whether these issues 
are relevant or have been dealt with appropriately.  Although many commentators and 
researchers mention Mäori in relation to ART practices, it is often with regard to access to 
information, the relationship between whängai and surrogacy, or the shortage of Mäori gamete 
donors.  Similarly, those interviewed as representatives of Mäori focused organisations, could 
offer little or no insight into Mäori policy responses to ART practices.  Although there are 
generic strategies in place that are designed to minimise the inequalities of access and 
treatment that Mäori experience within the health sector, these are not specific to ART practices 
and do not appear to be enforced in this area.  Consequently, I discovered silences in ART 
policy in relation to Mäori and turned my attention to addressing the questions and issues 
raised during the interviews that are believed to contribute to these silences.   
 
As issues such as the definition of whänau and family formation have been discussed in an 
earlier chapter,
130
 this chapter will start by looking at whether there is a current or future need 
for ART services among Mäori.  In this section, I examine the various health issues and lifestyle 
changes that may influence future fertility rates for Mäori.  Next, I discuss the issue of Mäori 
access to health services and how this may impact on Mäori using ART.  Recognising that the 
wider issues of disparity in health care and socio-economic status will impact on Mäori 
accessing and using ART services, the following section examines how the collection of data on 
ethnicity impacts on policy formulation.  I have included in this section a discussion of the 
                                            
130
  See Chapter One, Introduction, Section 1.4, Families & ART, for a discussion surrounding the 
influence of the Status of Children Amendment Act 1987 (SCAA) on the definition family and whänau in 
relation to ART. 
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difficulties in defining Mäori and the use of ethnicity as a variable in social research.  This is 
followed by consideration of the use of the traditional practice of whängai as an alternative to 
ART for those experiencing infertility.  I then explore the issue of protecting whakapapa in 
relation to the use of ART and donated gametes.  Finally, I look at issues surrounding diversity 
and difference within the Mäori population and the need to acknowledge heterogeneity within 
groups as a policy strategy. 
6.2 Is there a need? 
The question really is what degree do problems with fertility exist in the Mäori 
population? 
(Teresa Wall, Senior Analyst, Mäori Health Branch, 
Ministry of Health, Interview: 24 July 2000) 
 
The desire and ability to have children is no less important for Mäori than it is for any other 
group of people (Dyall, 1999:35).  Both Lorna Dyall (Hui Whai Maramatanga Whai Oranga & 
Ministry of Mäori Development, 1995:29; Dyall, 1999:37) and Chris Cunningham (Hui Whai 
Maramatanga Whai Oranga & Ministry of Mäori Development, 1995:33) have suggested that the 
prevalence of infertility in the Mäori population of Aotearoa/New Zealand may be increasing.  
While there is a small amount of data available on the prevalence of infertility in the general 
population of Aotearoa/New Zealand, there is no ethnic-specific data on the incidence of 
infertility.
131
  Information on access and utilisation of ART services by Mäori is also non-existent 
and the information collected during this research was mainly anecdotal.  However, in 1993 Te 
Puni Kökiri (cited in Durie, 1998:129) found that Mäori women were 1.4 times more likely to be 
at risk of reproductive system disorders than non-Mäori women.  Similarly, recent research into 
the prevalence of sexually transmitted infections (STI) (McNicholas, et al., 2001) found that 
chlamydia was the second most commonly diagnosed STI in Aotearoa/New Zealand in 1998 and 
approximately two-thirds of the diagnoses were in people aged less than 25 years.  Rates of 
chlamydia and gonorrhoea infection were found to be disproportionately high among Mäori and 
Pacific Island people.  Chlamydia and gonorrhoea are recognised as significant causes of tubal 
infertility, and research by Peek (1990:64) found that there was “a high incidence of chlamydia 
in Aotearoa/New Zealand women being treated with IVF for tubal disease.”  Consequently, 
there may be a growing demand for ART services among Mäori women in the near future.   
                                            
131
  See Chapter Four, Allocating Resources, Section 4.2, Funding Issues, for comments on the prevalence 
of infertility in Aotearoa/New Zealand. 
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…recent research showed that chlamydia and gonorrhoea were very high in the 
Mäori population … [so] this is going to become more important in the future. 
       (Grant Allan, Interview: 25 July 2000) 
Although ART issues may not be designated a high priority within Te Puni Kökiri’s (Ministry of 
Mäori Development) mandate at present, Grant Allan (Senior Policy Analyst, Te Puni Kökiri) 
acknowledges that these issues may become more important in the future. 
 
Penny Ehrhardt (Policy Analyst, Te Puni Kökiri) suggests that changing childbearing trends by 
Mäori women may affect future demands for ART services. 
There is also the issue of the changing demographics in society, so for Päkehä 
population the age of giving birth has increased dramatically and it has 
subsequently done that among the Mäori population.  …  So, although there is a 
group of Mäori women who have children very young…, there are a lot more Mäori 
women waiting until they finish their education, careers, etc., etc, just the same as 
non-Mäori women.  I know that people working in the fertility areas would say that 
is an issue because when women do look to start their families they may find that 
they are less fertile than they had been or they assumed that it was just something 
to avoid for all those years. 
  (Penny Ehrhardt, Interview: 25 July 2000) 
Although the Mäori population has a slightly higher rate of natural increase than the non-Mäori 
population, there has been a substantial decline in Mäori fertility over the last 40 years.  
According to Pomare, Keefe-Ormsby, Ormsby, Pearce, Reid, Robson, and Watene-Haydon 
(1995) this decline has been “one of the most rapid ever documented in the world and it is the 
result of a number of factors including reducing Mäori mortality over the previous decades; 
rapid urbanisation; the availability of contraception, and fuller participation in education and 
employment, especially for women.”  Conversely, there remains a widespread belief that Mäori 
have large families even though the 1996 census shows that empirically this is not the case.  
This census showed that there was little difference in the fertility rates of Mäori and non-Mäori 
women; an average 2.1 children were born to Mäori women aged 15 years and over, while non-
Mäori women in the same age group gave birth to an average of 1.9 children (Ministry of 
Health, 1998a:27).  However, Mäori women tend to have their children at a younger age than 
non-Mäori.  Mäori women in the 15 to 24 age group are three times more likely to have at least 
one child than non-Mäori women in the same age group (Ministry of Health, 1997:22; Ministry 
of Health, 1998a:27).  While Mäori women tend to start and finish having their children at a 
younger age than non-Mäori, there is “evidence that Mäori women’s childbearing patterns are 
becoming similar to that of non-Mäori women” (Ministry of Health, 1997:22).  If this is the case, 
then it is probable that an increasing number of Mäori women will experience fecundity 
problems associated with declining fertility in relation to age.  However, Mäori women and men 
may encounter more barriers to accessing ART services than non-Mäori women and men. 
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6.3 Access Issues 
Te Puni Kökiri’s second report in the Closing the Gaps (2000) series
132
 shows that Mäori 
“experience poorer health status, lower income levels, higher unemployment, higher rates of 
prosecution and conviction, lower educational status, and lower rates of living in owned homes 
than non-Mäori” (Te Puni Kökiri, 2000a:10).  There can be little doubt that these structural 
conditions influence Mäori health status and access to health care services.   
Accessibility is one of the biggest [problems] in terms of rural and local [Mäori] but 
that is not to say that just because you live outside the doors of the hospital you 
have accessibility.  That is another issue. 
(Naida Glavish, Chief Advisor-Tikanga, Mäori Health Development Service, 
Auckland Healthcare Services Limited, Interview: 9 August 2000) 
 
There has been a great deal of work done on the influence of socio-economic status and 
ethnicity in relation to health care access and outcomes.  This work has highlighted the barriers 
that exist for Mäori in relation to costs (services, childcare, transport, and lost wages), location, 
and lack of cultural comfort and safety within many mainstream health services (Pomare, et al., 
1995; Ministry of Health, 1998a; Baxter, 2000; Tobias & Howden-Chapman, 2000; Tobias, 
2001).  Teresa Wall (Senior Analyst, Mäori Health Branch, Ministry of Health) argued that these 
barriers are also likely to impact on Mäori accessing ART services.   
…there are lots of barriers to Mäori getting into services.  A lot of it is to do with 
the costs, the transport, where the service is, all those sorts of things. 
        (Teresa Wall, Interview: 24 July 2000) 
 
As all the specialist fertility clinics are located in the main urban centres, geographic access 
remains limited for people living outside these centres.  However, some clinics provide blood 
tests and diagnostic services in outlying areas in order to reduce travel and financial costs for 
their out-of-town clients. 
We send one of the doctors up to Nelson on a six weekly basis to run clinics so 
that patients do not have to come here for a first visit….  We try to make sure that 
they get all their blood tests done and their scans and things done up there….  So, 
they get out of the need to pay for the trip down and … the number of times they 
have to visit here is minimised.  They have to come here for the actual end point 
treatment anyway but we get done what we can. 
(Mark Leggett, Business Manager, The Fertility 
Centre, Christchurch, Interview: 22 June 2000) 
 
                                            
132
  Te Puni Kökiri published the first Progress Towards Closing the Social and Economic Gaps Between 
Mäori and non-Mäori: A report to the minister of Mäori Affairs in 1998.  The purpose of this report was to 
provide a benchmark against which progress towards closing gaps between Mäori and non-Mäori 
achievements in education, labour force participation, housing, and health could be measured (Te Puni 
Kökiri, 2000a).   
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John Peek (Clinical Manager/Group Operations Manager, Fertility Associates Auckland) also 
discussed strategies his clinic had initiated to overcome the problems experienced by those 
without a fertility clinic in their city or town. 
…that is why we set up clinics in Hamilton and Wellington.  So that people will not 
have to travel and we do consultations in most small cities in the North Island.  So, 
it is easier to access.  We tried to address them indirectly I guess.  …  We have 
clinics in Whangarei and we have gone a long way to try to make blood tests easy 
by people sending it by courier or by doing it locally.  So, I guess we have tried to 
address some of the access issues that Mäori face… 
        (John Peek, Interview: 12 July 2000) 
However, patients still have to travel to the clinics for treatment that may involve staying for 
several days, adding accommodation costs to travel costs.
133
  Although travel and 
accommodation allowances are available on application from the Health Funding Authority 
(HFA), Ken Daniels (Associate Professor, Department of Social Work, University of Canterbury) 
suggests that those experiencing fertility problems may find applying for such benefits an added 
burden. 
If you live in Timaru and you can get assistance to get to Christchurch for 
treatment in the public health system…, if in fact you are using it, a whole lot more 
people become aware.  Say you are in a [small town] and you have to apply [for a 
benefit] to somebody [you know] … or somebody is dealing with your file that you 
do not particularly want to know [about it]. 
  (Ken Daniels, Interview: 31 August 2000) 
Boston and St John (1999:102) outline the various factors that can contribute to low take-up 
rates for such benefits.  These include a lack of awareness of entitlement, a desire to avoid 
being stigmatised, a need to maintain privacy, abatement rates that reduce entitlements to 
negligible amounts, time-consuming procedures, and complex forms to fill in.   
 
Although geographic and financial access remain important barriers for many Mäori, Teresa 
Wall argues that these obstacles are only part of the problem and suggests that institutional 
racism plays some part in limiting access by Mäori to health services. 
Then conversely, there are professional assumptions made about whether Mäori 
will be good patients, whether they will comply with treatments and, if they think 
that they do not comply, then there is no point in really referring them on.  So, 
there are all those sort of issues about primary care.  Whether [GPs] have these 
assumptions and whether they actually refer them on to secondary care.  If they 
do have these assumptions, [how do they] affect the way in which they treat 
[people]?  [Do] they give them the best treatment or the best available treatment?  
I think that there are some that are fine [however,] … I think there is still a huge 
                                            
133
  IVF, in particular, involves ‘cycles’ of treatment that can entail several stages, repeated at varying 
intervals.  These treatments include drug induced ovulation, egg retrieval, insemination, fertilisation, 
embryo culture, and embryo transfer. 
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amount of organisational or institutional racism.  There are a lot of presumptions 
about Mäori and Pacific people and that affects the treatment that they get. 
      (Teresa Wall, Interview: 24 July 2000) 
This claim is supported by Baxter (2000:XII) who maintains, “institutional racism likely 
contributes to … poor outcome from health services.”  Services are developed without 
considering the full extent of Mäori needs, and discrimination is likely to manifest itself in 
individual and institutional attitudes to Mäori “through lower levels of expectation of outcomes, 
negative stereotypes of Mäori and potentially through lack of access by Mäori to services” 
(Baxter, 2000:XII).  Howden-Chapman, Wilson, and Blakely (2000:162) also suggest that the 
“institutional arrangements and disrespectful attitudes” within the medical profession contribute 
to differentials in access to health care.  Citing American research, Bhopal (1998) has also 
claimed that socio-economic status (SES) is not the only explanation for ethnic disparities in 
health outcomes.  Escarce et al (in Bhopal, 1998) found that health care services received by 
‘black’ patients were influenced by differences in disease patterns, levels of doctor-patient 
contact (particularly specialist contact), patients’ preferences, and doctors’ management of their 
patients on the basis of ethnicity, as well as economic and organisational barriers.  Similar 
factors may influence the referral of Mäori women and men with fertility problems by primary 
health care providers to specialists or fertility clinics for secondary or tertiary care.  
Furthermore, information about treatment options and funding entitlements may be less 
accessible by Mäori for similar reasons.  However, these issues require further research in 
Aotearoa/New Zealand. 
 
ART services are expensive and, at present, appear to be mainly utilised by those who can 
afford to pay for them.  When asked about the demographic composition of his clinic’s clients, 
Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland)
134
 claimed 
that they were generally well off. 
In general, private IVF is the domain of the well to do and that disadvantages a 
significant section of society.  …  Definitely white middle to upper class.  I mean to 
say, if you are realistically thinking of having somewhere between 10 and 20 
thousand dollars of disposable income that you could allocate to having a child you 
are not talking about three-quarters of the Auckland population which is 
unfortunately the case.     (Rodney Bycroft, Interview: 13 September 2000) 
 
The majority (approximately 60%) of the Christchurch Fertility Centre’s clients are private 
patients.  However, some of those who enter as public patients can access money to pay for 
private treatment. 
                                            
134
  As a private clinic, Artemis does not hold a public contract for the provision of fertility services.  
Consequently, all those accessing treatment at the clinic are fee-paying patients/clients. 
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Often the patients who go on the public waiting list, they’ve got two to two and a 
half years to wait, will pay for a treatment while they are waiting. 
  (Mark Leggett, Interview: 22 September 1999) 
 
Rodney Bycroft acknowledges that socio-economic status influences those seeking treatment, 
specifically through lack of knowledge of treatment options and the cost involved. 
So if you were … [to] take someone who has not got a really good education, who 
does not have access to information with respect to Internet, newspapers, or TV, 
and doesn’t really know much about IVF, then it is unlikely that even if they have a 
problem that they would end up seeking treatment.  So they are disadvantaged 
geographically, they are disadvantaged quite often because of race and ethnicity, 
and certainly disadvantaged from income. 
   (Rodney Bycroft, Interview: 13 September 2000) 
The inability to pay for treatment may also be viewed as affecting the patients’ commitment to 
the treatment.  In their proposal to the HFA on how to achieve national consistency in publicly 
funded treatment, two clinics suggested that co-payments for drugs in relation to fertility 
treatment “would tally with some providers’ comments that patients tend to show more 
commitment to treatment if they have to pay for some of it themselves” (Leggett & Peek, 
1999).  Cussins’ (1998:73 & 96 n.15) ethnographic research into the practices of infertility 
clinics in the United States of America revealed that some physicians equated their levels of job 
satisfaction with the kinds of patients they were able to work with; white middle-class or higher.  
Similarly, Ken Daniels (Associate Professor, Department of Social Work, University of 
Canterbury) suggests that paying clients may be accorded a higher status in the eyes of the 
providers. 
If you are going for private treatment, you get it much faster and maybe there are 
some other subtle influences too.  If you are seen to have important status in the 
eyes of the people who are providing the service…. 
  (Ken Daniels, Interview: 31 August 2000) 
Consequently, it would be unrealistic to assume that inequalities in relation to overall health 
status and differentials in access and utilisation of services between Mäori and non-Mäori based 
on the ability to pay would not be replicated within this narrower field of inquiry.  Furthermore, 
the factors that affect the take-up rate of targeted benefits may also deter those experiencing 
fertility problems from seeking medical help.
135
   
 
Mark Leggett (Business Manager, The Fertility Centre, Christchurch) suggested that a lack of 
information and knowledge about entitlement contributes to the paucity of people in lower 
socio-economic groups accessing treatment. 
                                            
135
  MCART (1994:7) cites a study in the United Kingdom that estimates that less than 50% of all 
‘couples’ experiencing infertility present to health services. 
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Some people do not know that it can be free. 
    (Mark Leggett, Interview: 22 June 2000) 
However, the limited resources and extended waiting lists mean that the clinic is hesitant to 
advertise the fact that treatment is publicly funded. 
We really do not want to advertise it as being free because we just cannot cope 
with the demand and the waiting list would just expand out.  I’ve got no problem 
with having more people on the waiting list but it doesn’t do our patients any 
favours, they wait longer so … if there was funding, complete funding I would be 
advertising left right and centre that you could get it free. 
   (Mark Leggett, Interview: 22 June 2000) 
This service provider engages in a form of implicit rationing in an attempt to balance supply and 
demand.  Methods of rationing that deflect or deter people from making demands on services 
cause rationing to be less visible, lessen political costs, and assist those who are involved in 
avoiding having to make difficult decisions as to how resources should be allocated (Klein, et 
al., 1996:16 & 25).  By not actively advertising the fact that infertility treatment is publicly 
funded, the clinic contributes to the rationing process by limiting the number of people who will 
approach the clinic directly.  The clinic manager sees this as a way of helping to limit the 
number of people on the waiting list.  While this approach may help those already in the system 
by reducing the potential demand on public funding and keeping waiting list times down, it is 
more likely to impact negatively on those who do not have access to the information from other 
sources.  As Mäori are less likely to utilise primary healthcare services (Pomare, et al., 1995), 
they are less likely to be informed of their options with regard to publicly funded infertility 
treatment.  Policy in relation to ART continues to be based on the perceived needs of the 
historically dominant Päkehä culture and applied without investigation into the actual 
prevalence of infertility or the demand for ART services by Mäori. 
That is kind of across the board.  That is a major issue that Te Puni Kökiri has with 
the social services across the board - the lack of accurate data to make these kinds 
of decisions. 
  (Grant Allan, Senior Policy Analyst, Te Puni Kökiri, Interview: 25 July 2000) 
6.4 Being Counted 
…I suspect that even the number of people who front up to [fertility clinics], their 
ethnicity would not be collected.  Ethnicity collection across the whole of the health 
sector is very poor. 
(Teresa Wall, Senior Analyst, Mäori Health Branch, 
Ministry of Health, Interview: 24 July 2000) 
 
According to Reid (1999b:84), the collection of quantitative data is “an acknowledgement of 
being valued” and is vital to the effective monitoring of state policy outcomes and evaluating 
the fulfilment of guarantees made in te Tiriti o Waitangi.  Subsequently, the lack of adequate 
data means that it is impossible to answer the questions raised by Teresa Wall. 
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You have to come back further and ask if fertility or problems with fertility are 
problems that Mäori exhibit at the moment?  …  Is there a need in the Mäori 
community for fertility services?  Is there behaviour at the moment, which may 
lead to fertility problems in the future and, if there is, what should we be doing 
about it?            (Teresa Wall, Interview: 24 July 2000) 
 
Although contracts for the provision of publicly funded ART require clinics to implement certain 
policies with regard to the collection of data on ethnicity (Health Funding Authority, 2000a: 10, 
see Appendix K; Health Funding Authority, 2000b:18, see Appendix L), John Peek (Clinical 
Manager/Group Operations Manager, Fertility Associates Auckland) argues that in the past the 
HFA has not collected this information.
136
 
The trouble with the HFA and Mäori things is that they do not implement it.  They 
put all these requirements for Mäori, have Mäori policies, in the contract that say 
what you should do, but they never bother implementing it.  We have to report 
every month on things but, although our contract has reporting requirements, they 
do not ask us to report on those.  …  I mean it doesn’t mean to say we don’t think 
they are important and try to do something about it, but what the HFA requires in 
its contracts and what it actually expects the provider to do on a day-to-day 
practical basis, I think are a bit different at the moment.  
          (John Peek, Interview: 12 July 2000) 
Helen Williams (Policy Analyst, Elective Services Project, Health Funding Authority) confirms this 
claim. 
I know we have not even collected [data on] ethnicity.  So, we do not even know 
who’s been fronting up.  [Some people] have been collecting that data on their 
own accord but the HFA has never asked for it.  And, all contracts now have the 
generic overview section on Mäori.  …  Sometimes this is more relevant than 
others and often there is no data to put into that section anyway because we do 
not collect it.              (Helen Williams, Interview: 29 August 2000) 
 
Te Puni Kökiri’s (2000b:29) review of the Health Funding Authority found “the collection of 
ethnicity data is not well enforced, particularly in the case of hospitals.”  Consequently, health 
service priorities may be generated by historic demands without taking the issues for Mäori into 
consideration (Te Puni Kökiri, 2000b:30).  Heitman and Schlachtenhaufen (1996:191) warn that 
the assumptions underlying the collection of demographic data on infertility may be based on 
the needs and interests of the population already seeking treatment, a population that appears 
to be disproportionately white and middle-class.   
 
Helen Williams argues that there is a lot of work taking place to address these inadequacies and 
that reclassifying infertility services as part of the core services will help in the collection of 
data.   
                                            
136
  All new HFA contracts with both Mäori and mainstream providers include standard clauses that 
establish contractual requirements for providers to be attentive to the needs of Mäori (Te Puni Kökiri, 
2000b:31). 
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…we have not been collecting infertility data but we are just going to start.  …  So, 
we are changing the service specifications and getting them to National 
consistency.  We are actually putting in a whole lot of reporting requirements, 
which will be national.             (Helen Williams, Interview: 29 August 2000) 
 
Current changes to the health sector structure have not had time to take effect and it is 
uncertain whether the reclassification of infertility services will improve the situation in relation 
to data collection or the implementation of other Mäori-specific requirements.  Nevertheless, the 
lack of adequate data in relation to ART is not specific to Mäori and would appear to be the 
situation for ART services in general. 
…as far as planning, we are not even asked at the moment to plan for European.  
At the moment, we do not even know what the infertility needs in epidemiology
137
 
are, let alone planning for them.  I think that is what we need to do. 
 (John Peek, Interview: 12 July 2000) 
 
However, while there is a need for research into the prevalence of infertility and the demand for 
ART services in general, a Päkehä perspective remains dominant within the policy discourse 
surrounding ART and influences how policy is formulated and whose needs are attended to.  
Unless challenged by alternative perspectives on social relations and interaction, as well as 
different values and language, this perspective will continue to be asserted as universal and the 
interests of Mäori will be assumed to correspond with those of the dominant group (Young, 
1990:185-186).  Young (1990:185) suggests that those in a privileged social position are less 
inclined to protect or advance the interests of marginalised groups “partly because their social 
position prevents them from understanding those interests, and partly because to some degree 
their privilege depends on the continued oppression of others.”  This is particularly relevant to 
publicly funded ART services as they are constrained by limited funding and biological 
resources, creating increased competition for these resources among potential consumers.  
While this competition adds to the necessity for restrictive access criteria, it also has an effect 
on the continued marginalisation or exclusion of groups who do not have the material or social 
resources to campaign for or even be aware of their entitlements.  Likewise, while data on 
ethnicity may be collected, its analysis and use may not be relevant or adequate for informing 
policy with regard to the access to and utilisation of services by Mäori.  Consequently, the lack 
of information collected in relation to Mäori infertility and access to ART services will affect the 
ability of Mäori to access these services in the future, as policies will continue to be made 
                                            
137
  Epidemiology is the study of the distribution and determinants of disease.  According to Bhopal and 
Senior (1994), the main method of epidemiological study, when investigating the causes of disease, is to 
compare populations with different risks of disease and, increasingly, ethnicity is used as a variable to 
define these populations.  
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without adequate consideration of the issues for Mäori.  Of particular relevance to data 
collection is the way in which ethnicity is defined and recorded. 
 
Central to being able to generate statistics on Mäori infertility and use of ART are issues relating 
to how to define Mäori.  As Pomare et al (1995) point out, the Mäori population is dynamic and 
constantly changing, and problems with defining Mäori have contributed to difficulties in 
monitoring this population.  Although statutory definitions of Mäori have changed over time,
138
 
from 1860 to 1986 Government definitions of Mäori were based on biological concepts of race 
(Reid, 1999b:84).
139
  Since the mid-1970s the concepts of ‘ethnicity’ or ‘culture’ have replaced 
the biologically based concept of race, and in 1986, the Aotearoa/New Zealand census form 
dropped the term ‘race’ in favour of ‘ethnicity’ and self-identification became the method used 
to determine ethnic identity (Durie, 1998:124).  Accordingly, the preferred definition of Mäori 
became “a person who has Mäori ancestry and who chooses to identify as Mäori” (Pomare, et 
al., 1995:30).  The most recent official definition of an ethnic group used by Statistics New 
Zealand is a social group whose members share a common origin, claim a common and 
distinctive history and destiny, possess one or more dimensions of collective cultural 
individuality,
140
 and feel a sense of unique collective solidarity.  Using this definition, ethnicity 
can be differentiated from the related concepts of ancestry,
141
 natality,
142
 and nationality.
143
  
However, ethnicity is not purely a matter of personal choice or preference.  It is a fluid and 
dynamic concept that allows individuals to identify with more than one ethnic group and to 
move between ethnic groups over time (Tobias, 2001:2).   
 
Many analysts have addressed the difficulties surrounding the use of ethnicity as a variable in 
social research, especially in relation to health (Senior & Bhopal, 1994; Pomare, et al., 1995; 
Heitman & Schlachtenhaufen, 1996; Bhopal, 1997; Bhopal, 1998; Durie, 1998; Green & 
Thorogood, 1998; Reid, 1999b; Mckenzie & Crowcroft, 2001; Tobias, 2001).  These difficulties 
                                            
138
  See Durie (1998:123-126) and Reid (1999b) for explanations of these changes. 
139
  During the 19
th
 century, differences between races were assumed to be biological and were used to 
support the perceived superiority of ‘white’ races and to justify the continued subordination of ‘coloured’ 
groups (Bhopal, 1998).  However, modern genetics have weakened the biological concept of race, 
proving there is more genetic variation within racial groups than between them.  Moreover, the genes 
responsible for physical features that are often used as the basis of racial differentiation are “few, 
atypical, and not associated with genes responsible for disease” (Senior & Bhopal, 1994). 
140
  Tobias (2001:2) defines this concept as “a unique language, religion, customs, mythology, or 
folklore.” 
141
  Origin or descent. 
142
  Birthplace or country of origin. 
143
  Country of permanent residence or citizenship. 
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include inconsistent definitions of ethnicity used in data sets such as the national census, 
hospital admissions, live births records, and mortality and morbidity rates.  Although there has 
been widespread progress in relation to defining ethnicity through cultural affiliation and self-
identification, there remains some variation between government departments (Durie, 
1998:125-126).  These inconsistencies mean that accurate comparisons cannot be made across 
government data sets or between the same data set over time.  Pomare et al (1995:31) define 
the three current options for estimates of the Mäori population as ‘Mäori Ancestry’,
144
 ‘Mäori 
Ethnic Group’,
145
 and ‘Sole Mäori’.
146
  Questions regarding ethnicity have changed over four 
consecutive censuses and the change in 1996 led to a large decrease in the size of the ‘Sole 
Mäori’ population and an increase in the size of the ‘Mäori Ethnic Group’ population (Te Puni 
Kökiri, 2000a:51).
147
  Each data set has its own meaning and policy advice will differ depending 
on the data set used to inform particular studies or policy issues.  Therefore, consideration 
should be given to “which population should be used for which occasion” (Pomare, et al., 
1995:31) as the outcomes may determine how Mäori roles and needs are defined for many 
years.
148
  According to Tobias (2001:21), difficulties in measuring ethnicity are also 
compounded by a lack of understanding or acceptance by the general population who continue 
to interpret ethnicity as biological race, natality, or nationality.  Senior and Bhopal (1994) 
suggest that the terms ethnicity and race are often used interchangeably in health research and 
that this infers that differences in the incidence of certain diseases between ethnic groups is 
partly due to genetic variations.  Consequently, they argue that it is important for researchers 
to be clear about the differences between the two terms.   
                                            
144
  Those who identified Mäori ancestry. 
145
  Those who identified Mäori as one of their ethnic groups. 
146
  Those who identified Mäori as their only ethnic group  
147
  Between the 1991 and 1996 censuses, the ‘Sole Mäori’ population “unexpectedly decreased by 16% 
… while the Mäori ethnic group increased by 20%” (Te Puni Kökiri, 2000a:51).  These changes cannot be 
explained by the demographic processes of births, deaths, and migration (Statistics NZ in Te Puni Kökiri, 
2000a:51).  Instead they reflect changes in the wording of the ethnicity question between the 1991 and 
1996 censuses.  ACNeilsen (in Te Puni Kökiri, 2000a:51) argues that wording that encouraged people to 
tick more than one ethnic group category precipitated the accidental capture of information on ancestry, 
rather than ethnicity.  Consequently, Statistics New Zealand (in Tobias, 2001:9) reverted to the 1991 
wording of the ethnicity question for the 2001 census in the hope that the results will enable better 
comparative analysis with the 1991 census.  According to Tobias (2001:10), Statistics New Zealand is 
undertaking a major review of ethnicity measurement, which may result in changes to the ethnicity 
questions for future censuses. 
148
  Reid (1999b:86) highlights the difference in outcomes that can be achieved by using the ‘Sole Mäori’ 
population in contrast to the ‘Mäori Ethnic Group’ population when comparing the first admission rates for 
Mäori and non-Mäori women with psychiatric disorders between the years 1991-93.  Using the ‘Sole 
Mäori’ population as the denominator reveals considerable disparity between Mäori and non-Mäori.  
However, when the ‘Mäori Ethnic Group’ population is used as the denominator this disparity is 
considerably reduced. 
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Although the HFA does not enforce the collection of ethnicity data by ART providers, some 
clinics do attempt to collect this information. 
We actually give them ethnicity of treatments and stuff but that is the only 
demographic stuff we are required to provide… and within the clinic, the 
information gathering on treatment is really good…  But, as far as IVF, we have 
got databases and we know lots of stuff about every single treatment cycle that 
we do.              (John Peek, Interview: 12 July 2000) 
 
A lack of incentive and guidance may mean that the information collected is not consistent 
between clinics or in a form that can inform policy with regard to the prevalence, access, or 
utilisation issues for Mäori.  While the new service specifications (Health Funding Authority, 
2000b:10, see Appendix L) for publicly funded ART treatments provide a chart for recording 
patients’ ethnicity, they do not set out guidelines for the collection of the data.  Neither do they 
appear to provide a definition for any of the ethnic groupings shown on the form.  The accuracy 
of the data is also dependent on the method used to complete this section of the form. 
We are supposed to be identifying the ethnic groups of all our patients but that is 
not an easy task.  And I would say you could probably count on two hands the 
number of patients that would call themselves Mäori or are recognisable as Mäori 
off the names on the list, you know looking for a Mäori surname and things like 
that.         (Mark Leggett, Interview: 22 June 2000) 
 
While some researchers (in Senior & Bhopal, 1994) have maintained that names analysis is 
“sensitive and specific” in identifying ethnic group status, such methods do not take into 
account ethnic intermarriage and the adoption of a spouse’s name.  Embarrassment by clinic 
staff may prevent direct questioning and speculation about ethnicity based on physical 
appearances is highly inaccurate (Kilgour & Keefe in Durie, 1998:125).  According to Heitman 
and Schlachtenhaufen (1996:192), direct questioning or filling out forms may result in 
respondents refusing to provide the information or providing inaccurate information.  Such 
responses may be motivated by suspicions about how the information will be used and mistrust 
in a health system that they perceive to have excluded them or worked against their interests in 
the past. 
 
Traditionally, Mäori health and illness statistics have been presented in comparison to non-Mäori 
statistics (Durie, 1998:127).  Such comparative approaches inevitably use the dominant 
population as the norm (Bhopal, 1997) and are based on the assumption that health outcomes 
should be the same, imposing a “common concept of health on all ethnic groups” (Tobias, 
2001:22).  Consequently, they are in danger of supporting assimilative aims and goals (Durie in 
Reid, 1999b:89).  However, highlighting the disparity in health needs and outcomes between 
Mäori and non-Mäori can also portray Mäori health as being less than or inferior to non-Mäori.  
Green and Thorogood (1998:78) point out that there has been substantial criticism of 
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explanatory methods that use cultural practices to explain differences in health outcomes.  Such 
methods look to explain differences in health outcomes in the behaviour of the disadvantaged 
groups and emphasise a ‘victim blaming’ approach.  Bhopal (2001) acknowledges this dilemma 
when using ethnicity as a variable in health research.  While conceding that ethnocentrism can 
only be challenged by an analysis based on the examination of differences and accepting that 
such an analysis requires data on ethnicity, he argues that such analyses also perpetuate the 
use of ethnicity to accentuate differences and provide the potential for abuse.  It is this 
potential for abuse that concerns Grant Allan (Senior Policy Analyst, Te Puni Kökiri) in relation 
to the use of Mäori specific statistics.  He argues that such statistics may be used to negatively 
portray Mäori
149
 and he uses Mäori teenage pregnancy rates
150
 as an example. 
…they actually use our pregnancy as an indicator for something, which is negative, 
when it could be interpreted as a positive.  It is difficult to take.   
         (Grant Allan, Interview: 25 July 2000) 
Likewise, Penny Ehrhardt (Policy Analyst, Te Puni Kökiri) questions the use of comparative 
statistics and ethnocentric analysis in relation to teenage pregnancy.
151
 
It is a very interesting issue for Mäori because, of course, there is a lot of 
government policy and a lot of public comment concerned about teenage 
pregnancy rates and young people having children.  So, there is a lot of emphasis 
on that and traditionally, say 30 or 40 years ago, Mäori have had children younger 
than non-Mäori and that has been publicly perceived as a bad thing.  [Contributing 
to] poor health outcomes and linked to the mother being young when she has her 
first child.  There is some debate as to whether that is a culturally biased way of 
looking at our family formation.   (Penny Ehrhardt, Interview: 25 July 2000) 
 
                                            
149
  Bishop (1996:14-15) highlights reasons why Mäori are growing increasingly resistant to research into 
their lives by non-Mäori researchers.  He argues that traditional research has misrepresented Mäori 
knowledge for the “consumption” and benefit of “the colonisers”.  Consequently, the voice and authority 
of the “expert” researcher has subjugated Mäori experiences and knowledges.  Furthermore, he argues 
that Mäori cultural practices and meanings have been misinterpreted and misrepresented by non-Mäori 
researchers, and have been used to further subordinate Mäori culture (Bishop, 1996:14-15). 
150
  There is some debate over the consequences of Mäori teenage pregnancy.  The Ministry of Health 
(1997:21 & 24) maintains that unplanned pregnancy is an important issue for Mäori, and that teenage 
pregnancy is associated with and perpetuates disadvantage.  While Chris Cunningham (Hui Whai 
Maramatanga Whai Oranga & Ministry of Mäori Development, 1995) acknowledges that teenage 
childbearing may disadvantage both mother and child, he argues that the measure of “unplanned 
pregnancy” (the number of births to both teenage mothers and unpartnered women) disadvantages 
Mäori because of their ‘natural’ pattern of fertility.  Te Puni Kökiri’s stated position (in Ministry of Health, 
1997:21) is “that for Mäori no pregnancy or baby, whether intended or not, is unwanted or a problem if 
adequate support exists.”  Accordingly, they claim many Mäori support a pro-Mäori childbearing position 
as a means of continuing to increase the Mäori population.   
151
  Ginsburg and Rapp claim that Western industrial societies have an obsession with classifying teenage 
sexuality and pregnancy as a “social problem.”  Cross-cultural comparison suggests that such societies 
construct the problem in relation to their own understanding of adolescence, “reduced value placed on 
fertility, and lack of cultural and social supports, all of which are differentially mediated by considerations 
of age, class, race, ethnicity, sexual preference, and marital status” (Ginsburg & Rapp, 1991:320). 
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Although the collection of routine statistics alone does little to identify the means by which 
“social inequalities are reproduced as health inequalities, or how policy could usefully address 
them” (Green & Thorogood, 1998:81) and may negatively impact on some groups, they are 
fundamental for documenting and monitoring inequities in health policy and service outcomes, 
as well as for evaluating the achievement of guarantees made in te Tiriti o Waitangi. 
6.5 Whängai & ART 
Several of those interviewed suggested that the use of ART might not be an issue for Mäori as 
they could possibly use more culturally acceptable ways of dealing with infertility, such as the 
practice of whängai.   
Mäori may have ways of dealing with it that do not require IVF, as with respect to 
whängai children of families.          (Teresa Wall, Interview: 24 July 2000) 
 
This suggestion was has been echoed in the available documentation and literature.  The New 
Zealand Law Commission (2000:75 n.246) maintains that “infertility was often used as a reason 
why a child was offered as a whängai to a relative.”  Similarly, Dyall (1999:36-37) argues that 
the traditional practice of whängai has enabled Mäori to address infertility (social and 
biological), as it facilitates the sharing of children within kin groups.  Whängai has also been 
used as a means to heal conflict and create or strengthen relationships between whänau, hapü, 
and iwi.
152
  Mäori use the concept of whängai (feed/nurture) to describe situations where adults 
other than the birth parents and grandparents assume primary care of a child for any significant 
period (Durie-Hall & Metge, 1992:71).  Integral to this concept is the belief that children are not 
the exclusive possession of their parents, but that they belong to the whänau, hapü, and iwi.  
“They are ‘ä tätou tamariki’ (the children of us many) as well as ‘ä täua tamariki’ (the children 
of us two)” (Durie-Hall & Metge, 1992:63-64).  The concept of whängai is supported by 
principles of openness, placement within the whänau, whakapapa (genealogy), and “the 
centrality of relationships to the Mäori way of life” (whanaungatanga) (New Zealand Law 
Commission, 2000).  Therefore, unlike traditional Päkehä adoption practices, whängai does not 
involve secrecy and the children grow up with knowledge of their whakapapa and why their 
care has been shared (Dyall, 1999:37).  Consequently, the concept of whängai encourages the 
continuation of relationships between the child and both birth and social parents.  Whängai has 
had varying levels of legal endorsement and, although it is no longer legally recognised, Mäori 
                                            
152
  Whängai placements were generally arranged between members of the same hapü or iwi, although 
relatives by marriage would occasionally be considered as caregivers.  Consequently, land rights did not 
become diffused and remained concentrated within the tribe (New Zealand Law Commission, 2000:75). 
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continue to practise whängai placement as a means of caring for children (New Zealand Law 
Commission, 2000:73 & 85).
153
   
 
Some commentators (Daniels & Taylor, 1991; Adair & Rogan, 1998) have equated the concept 
of whängai to surrogacy.  Similarly, some submissions by public bodies to MCART (1994:107) 
endorsed certain forms of surrogacy on the grounds that it could be compared to both Mäori 
and Päkehä traditional practices.  However, the various arrangements known as surrogacy 
centre on the involvement of a woman who provides gestation and the birth of a child with the 
intention that others will raise the child.
154
  While there is no empirical evidence that whänau 
members have conceived children for the sole purpose of whängai, there is some anecdotal 
evidence that this has occurred.  One of those interviewed had been told of a child that had 
been deliberately conceived in order to be raised by another family member. 
…her daughter was infertile so somebody else in their whänau had a baby for her. 
     (Robyn Scott, Interview: 26 July 2000) 
Correspondingly, the only submissions to MCART (1994, Appendix C, p.27) that “actively 
supported surrogacy came from Mäori who discussed the whängai concept….”  Father Henare 
Tate (in New Zealand Law Commission, 2000:75) maintains that the tikanga associated with the 
concept of whängai can vary between iwi.
155
  Accordingly, there were differing opinions among 
those interviewed on the appropriateness of equating whängai to surrogacy.  Naida Glavish 
(Chief Advisor - Tikanga, Mäori Health Development Service, Auckland Healthcare Services 
Limited) argues that it is not appropriate to compare the concept of whängai with surrogacy. 
                                            
153
  See Adoption and Its Alternatives: A Different Approach and a New Framework (New Zealand Law 
Commission, 2000:73-92) for a discussion of the varying degrees of legal recognition placed on Mäori 
customary adoption practices, as well as a discussion of the succession and inheritance issues 
surrounding whängai.  See A Question of Adoption (Else, 1991:172-196) for a brief account of the impact 
of the Päkehä system of adoption on the Mäori practice of whängai. 
154
  The various arrangements known as surrogacy involve a woman who provides the gestation and birth 
of a child for others.  However, this woman may also provide the ova and conception so that she is the 
genetic mother, as well as the birth mother (Blyth, 1993:248).  There are three main types of surrogacy 
arrangement: 1. Insemination by intercourse with the intending father or a donor.  This is usually a 
private arrangement with no medical involvement; 2.  Artificial insemination, using sperm from the 
intending father or from a donor.  This does not technically require the services of an assisted 
reproductive technology provider but may involve health professionals; 3.  Gestational surrogacy, also 
known as ‘full surrogacy’ or ‘IVF surrogacy’.  One or more embryos, created (usually by IVF) from the 
gametes of the intending parents, one of the intending parents plus a donor, or two donors, are 
transferred to the womb of a woman who has no genetic connection to the embryos (Else, 1999a:50).  
See Appendix A for a more detailed description of the various surrogacy arrangements that can occur by 
using of ART. 
155
  Tikanga can include law, customs, values, traditional behaviour, and philosophy (New Zealand Law 
Commission, 2000:75 n.247).  According to Naida Glavish (Chief Advisor - Tikanga, Mäori Health 
Development Service, Auckland Healthcare Services Limited, Interview: 9 August 2000), “tikanga are the 
customs and protocols of spirituality that Mäori require to be included in the delivery of services.” 
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…in some instances the whängai are in actual fact “gifted” children.  …  They are 
given out, whängai out, for specific purposes and they are special, very special.  
But, there are instances when the whängai is one who the whänau, the mother or 
the father, just cannot cope and the baby is given away.  So, there are positive 
and negative in the terminology of whängai.  But, surrogacy, whängai does not 
enter into the surrogacy world.    (Naida Glavish, Interview: 9 August 2000) 
 
While not opposed to non-commercial surrogacy, Naida Glavish argues that it is the deliberate 
conception of a baby to be raised by someone else that differentiates surrogacy from whängai. 
Usually with whängai, it is not decided before the baby is even conceived that 
there is going to be a baby conceived to whängai out.  And so, surrogacy in one 
sense, whereby the womb has got a “for sale” sign on it … violates the tapü of the 
womb, the tapü of the wharetangata.  But surrogacy, agreeing to have the baby 
out of the goodness of your heart because you feel for your best mate who cannot 
have children, well that is a different issue all together. 
 (Naida Glavish, Interview: 9 August 2000) 
 
As discussed earlier, both whakapapa and whänau presuppose relationships, responsibilities, 
and obligations that allow a range of adult kin to take parenting roles in the lives of Mäori 
children (Pihama, 1998:182).  Parents are expected and expect to share care and control of 
their children with other whänau members (Durie-Hall & Metge, 1992:64).  Mäori children are 
regarded as an integral part of the whänau, rather than individuals divisible from the whänau 
(New Zealand Law Commission, 2000:82).  It is in relation to this concept of shared care that 
one commentator sees the parallel between surrogacy and whängai, as well as the possible 
acceptance of surrogacy by Mäori as an alternative to other ART practices.  
Non-Mäori [attitudes to the] ownership of children is an issue that is at odds with 
how Mäori might see or view children.  So, surrogacy may well be a reproductive 
solution that Mäori might find more acceptable than [other ART practices].  …  I do 
not know whether people would have had babies for somebody else so much, but 
certainly, it is not uncommon for people to have a baby and someone ask them for 
it.              (Teresa Wall, Interview: 24 July 2000) 
 
As whängai facilitates the sharing of children within kin groups, ensuring that the children grow 
up with knowledge of their whakapapa and why their care has been shared, it would be more 
appropriate to compare whängai to the Päkehä concept of fostering or guardianship where the 
biological parents remain the legal parents and the child is fully aware of its genetic and familial 
origins.  The concept of whängai is consistent with an increasing commitment to ‘open 
adoption’ in which the birth parents retain social connections with both the adoptive parents 
and the child.  These practices challenge traditionally dominant definitions of family and resist 
the prevailing legal principle of severing relationships between birth and social parents that has 
existed within traditional Päkehä adoption practices.
156
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  An emphasis upon secrecy has pervaded adoption law since 1955 (New Zealand Law Commission, 
2000:3).  Although New Zealand adoption policy has encouraged ‘open’ adoptions since the 1980’s, there 
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While acknowledging that whängai and fostering may be used as an option for addressing 
infertility, Penny Ehrhardt (Policy Analyst, Te Puni Kökiri) recognises that it was difficult to 
predict whether the use of traditional practices would mean there is less demand for ART 
services among Mäori.  
It may be worth looking at the concepts of fostering and whängai in terms of 
family formation.  [They may be] options that Mäori are more likely to pursue if 
they do not have biological children of their own.  [It is not clear] whether those 
[options] are supported by policy and government strategies and whether that 
does mean there is less demand.   (Penny Ehrhardt, Interview: 25 July 2000) 
 
Indeed, in their submission to MCART (1994, Appendix E, p.3), Manatu Mäori (Ministry of Mäori 
Affairs) argued that the “need for fertility clinics to devise and implement culturally supportive 
and safe processes in respect of ART arises from the recognition that this technology is being 
sought by Mäori recipients and donors.”  The inclusive concept of whänau combined with the 
concept of whängai may have enabled some Mäori to address infertility without using ART.  
Nevertheless, Mäori do seek out and use ART services to overcome infertility problems. 
…the number of people coming for consultations, Mäori and Pacific Islanders, in 
the Northland health area is about the same as the population so I think we are 
reaching people relatively well.            (John Peek, Interview: 12 July 2000) 
 
Therefore, while whängai may be an appropriate alternative to ART treatment for some Mäori, 
there may be many reasons why it is not considered appropriate or feasible by others.  For 
those who choose to use ART to address their fertility problems it is necessary to ensure that 
issues surrounding the protection of whakapapa are attended to. 
6.6 Protecting Whakapapa 
…there are the things about whakapapa, and children of Mäori parentage being 
able to track their whakapapa.  So there is the matter of donors giving over that 
information, it being stored, and some way in which the child is given that 
information. 
(Teresa Wall, Senior Analyst, Mäori Health Branch, 
Ministry of Health, Interview: 24 July 2000) 
 
It is the knowledge of whakapapa (genealogy) rather than the extent of an individual’s Mäori 
‘blood descent’ that determines membership to a whänau, hapü, or iwi and, as such, this 
knowledge is an integral part of being Mäori (Dyall, 1999:35).  Knowledge of ancestry is also 
                                                                                                                       
is no legislative control to ensure that such arrangements continue.  See Adoption and Its Alternatives: A 
Different Approach and a New Framework (New Zealand Law Commission, 2000) for a comprehensive 
review of the law of adoption, and the Law Commission’s recommendations on how the legal framework 
should be changed to better address contemporary social needs. 
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important in relation to exercising certain constitutional rights, particularly the right to take 
claims to the Waitangi Tribunal, to register on the Mäori electoral role, to access scholarships, 
and to own and sell Mäori land (Dyall, 1999:35; Reid, 1999b:86; New Zealand Law Commission, 
2000:83).  Consequently, as the use of ART sometimes involves the use of donated gametes, 
the collection of and access to information regarding gamete donors and genetic background is 
particularly relevant to Mäori.  The traditional culture of secrecy surrounding donor insemination 
practices,
157
 as well as restrictions on access to information about donors and birth parents, can 
create difficulties for Mäori conceived using donated gametes who wish to trace whakapapa and 
access entitlements (New Zealand Law Commission, 2000:83).  The movement in 
Aotearoa/New Zealand towards information openness in adoption and gamete donation has 
been strongly influenced by Mäori culture and its emphasis on knowing one’s whakapapa 
(Daniels, 1998b:94).
158
  Consequently, secrecy in relation to adoption and donor insemination is 
no longer the accepted practice.  Nevertheless, openness is not a legal requirement and access 
to any information is limited by whether or not the parents tell their children of the 
circumstances of their conception and whether the child was conceived after the clinic or 
general practitioner involved had overturned its policy of secrecy and anonymity or kept records 
of those involved.  Although accredited clinics no longer provide the option of anonymity to 
donors, the legislation still upholds this practice by legitimating the provision of a ‘false’ birth 
certificate and, consequently, the suppression of the genetic origins of individuals’ conceived 
through the use of donor gametes. 
 
The Status of Children Amendment Act 1987 (SCAA)
159
 changes the legal status of the child in a 
similar way to the Adoption Act 1955.  However, unlike adoption, there is only one birth 
certificate and it reads as if the legal parents are the biological parents (New Zealand Law 
                                            
157
  Daniels (1999:6) maintains that donor insemination has been practised in New Zealand for at least 55 
years and until the early 1990s it was the policy within clinics to guarantee anonymity to gamete donors.  
The culture of secrecy and anonymity that has surrounded the practise of donor insemination has led to 
an unknown number of children being born in New Zealand who will have no access to either identifying 
or non-identifying information about the donor. 
158
  It should be noted that this was not the only influence on the move to open adoption.  Other factors 
influential in initiating the practice of ‘open adoption’ include changes in social values in relation to single 
motherhood, the feminist movement, active campaigning by adopted adults, birth parents, and adoptive 
parents for an individual’s ‘right to know’ about their genetic connections, and changes in nursing home 
policies (Else, 1991:169; Else, 1999b:57). 
159
  See Chapter One, Introduction, Section 1.4, Families & ART, for a discussion of the Status of Children 
Amendment Act 1987 and how it affects the legal status of parents and children who have been 
conceived through the use of donor gametes. 
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Commission, 2000:210).
160
  So, as Else (1995:217) points out, the SCAA “ensures that, unlike 
adoption, sperm and egg donation leave no legal traces, because no legal process is required to 
establish parenthood.”  This has significant consequences for Mäori and raises issues about an 
individual’s rights to access information about donors and their genetic background.
161
  The use 
of donated gametes together with the SCAA can inhibit an individual’s access to knowledge of 
their whakapapa and, consequently, their access to their cultural heritage and entitlements.  
According to Else (1995:218), “the key to making openness effective, whether in adoption or in 
birth through ART, is the free availability to the offspring of full and honest birth certificates.”  
Although official records can only hold a limited amount of information and cannot provide “the 
fullest possible knowledge of the genetic and/or birth connection” afforded by personal contact, 
they can provide a starting point for contact (Else, 1999b:60).  Even though openness can be 
encouraged, it would be impossible to legislate for compulsory disclosure or to enforce such a 
law without infringing on individuals’ right to privacy.  Therefore, the issue of secrecy or 
disclosure will no doubt be left to the parents to resolve.  However, without legislation or 
specific guidelines that ensure the collection of culturally relevant identifying information, as 
                                            
160
  Upon adoption, a child’s birth record is sealed and a new birth certificate, showing only the names of 
the adoptive parents and their ages at the birth of the child, is issued. By concealing the child’s genetic 
and (in some cases) cultural background, the ‘culture of secrecy’ was further embedded into Päkehä 
adoption practices. However, this ‘culture of secrecy’ has been partly undermined by the Adult Adoption 
Information Act 1985 (New Zealand Law Commission, 2000:19).  This act makes it possible for adopted 
people aged 20 years or over to obtain their original birth certificate and the birth parents may obtain the 
adopted persons name, subject to the adopted person’s consent.  However, either party may place a veto 
on the release of identifying information concerning them (Griffith, 1991:154).  As birth fathers are not 
often named on the birth certificate, adopted people are currently dependent on the birth mother for 
information about the birth father.  Similarly, the Adult Adoption Information Act 1985 does not provide 
access to information about siblings, half-siblings, grandparents, and other extended family members 
(Iwanek, 1998). 
161
  Although New Zealand culture places a strong emphasis on individual’s right to know their genetic 
origins, there is no statutory requirement for the collection and storage of information about gamete and 
embryo donors, surrogates, and any people born from the use of donated genetic material.  Nor is there 
any provision for these people to access identifying or genetic information about donors or surrogates 
(Henaghan, 1992:184).  Until the early 1990s, it was the policy within clinics to guarantee anonymity to 
gamete donors.  However, New Zealand’s position on access to identifying information has been 
influenced by the Adult Adoption Act 1985, which recognised the need for information by adopted people, 
and accredited clinics no longer provide the option of anonymity to donors.  Although this is not a legal 
requirement, New Zealand fertility clinics encourage donors to agree to contact should the person 
conceived using their gametes wish it (Adair & Rogan, 1998:268-270).  RTAC’s ‘Code of Practice for 
Centres using Assisted Reproductive Technologies’ (RTAC, 1999) ensures that accredited clinics keep 
permanent records of “ART procedures, identifying patients, gamete or embryo donors and recipients, 
and outcomes of attempted fertilisation and conceptions.”  Clinics are advised that they “should allow all 
donors and patients access to their records” (RTAC, 1999).  The ‘Guidelines for Screening for Gamete 
Donation’ (RTAC, 1999: Attachment J) sets out what information about the donor’s social history is 
“considered to be appropriate” and “which may be of assistance to parents of children at a later date”.  
However, the guidelines do not specify who may have access to what information, and it appears that 
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well as the permanent availability of such information, the individuals involved in donor ART 
practices remain vulnerable to the inconsistencies of location, clinical discretion, and clinic 
closure in relation to information being available when they need it. 
 
According to MCART (1994:70), secrecy about genetic origins “is antithetical to Mäori values 
and could be said to conflict with the principles of the Treaty of Waitangi.”  Although the 
Assisted Human Reproduction Bill (Graham Bill; see Appendix J) stresses a policy of openness, 
proposing the establishment of a centralised system of information gathering and giving those 
involved in ART extensive information rights, it fails to include any mention of te Tiriti o 
Waitangi or its provisions for the protection of Mäori as tangata whenua (Coney, 1999a:25; 
Dyall, 1999:35).
162
  In contrast, the Human Assisted Reproductive Technology Bill (Yates Bill; 
see Appendix I, p.2) establishes the Treaty as one of the guiding principles of the bill.  
However, neither bill fully addresses what genetic information should be recorded or how it will 
be collected and stored.  Alternatively, the New Zealand Law Commission’s (2000:73) review of 
the legal framework surrounding adoption in Aotearoa/New Zealand acknowledges the “unique 
status that Mäori occupy as tangata whenua and as partners to the Treaty of Waitangi” when 
considering Mäori views on adoption and recommends that there should be 
…unrestricted access to information by those in the adoption triangle.  This should 
alleviate the concerns of Mäori and other cultural groups regarding access to 
whakapapa/genealogical information.      (New Zealand Law Commission, 2000:91) 
 
This review also recommends unrestricted access to information about donors and individuals 
conceived using donor gametes for “persons born as a result of assisted human reproductive 
technology/donor insemination, their parents and the donor” and that “access to such 
information by other persons would be limited in the same way as for adoption information” 
(New Zealand Law Commission, 2000:228).  However, while outlining two options for recording 
and storing donor information, it falls short of recommending which option should be 
implemented.  Until either bill is enacted (in its original form or as an amended/combined 
version) or the adoption laws are amended to include ART practices involving donor gametes, 
the recording and maintaining of information is limited, voluntary, and dependent on the 
requirements of the Australian Reproductive Technology Accreditation Committee (RTAC). 
                                                                                                                       
these issues will be decided by the clinics in question.  Moreover, access to this information is limited by 
whether or not the parents tell their children of the circumstances of their conception. 
162
  Sir Douglas Graham (2000), who introduced this bill, has since argued that the Treat of Waitangi has 
no place in legislation relating to health, education, housing, and the social services in general.  He 
maintains, “there are many areas where the treaty is simply irrelevant.  The provision of health services 
is one of them.” 
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The ‘Code of Practice for Centres using Assisted Reproductive Technologies’ (RTAC, 1999) 
ensures that some records are kept by accredited clinics.  However, there is no legal 
requirement for Aotearoa/New Zealand clinics to be accredited and much of the information is 
retained according to the clinics’ discretion.  Other concerns include the lack of accountability by 
RTAC to the Aotearoa/New Zealand Government and the absence of an Aotearoa/New Zealand 
supplement in the ‘Code of Practice’ that would recognise and protect Mäori involvement in ART 
practices.
163
  Although there have been repeated calls for the development of a Aotearoa/New 
Zealand-specific supplement to the RTAC guidelines, this supplement has not eventuated and 
now appears to be dependent on the outcome of the Health Select Committee’s consideration 
of the two bills on ART.  These two bills have been under consideration since 1996 and 1998, 
and at the time of writing, a combined report was due in May 2002.  However, this deadline 
had been revised several times since the beginning of this thesis and there is no guarantee that 
this is a definite date for the publication of the report.  Some protection may be afforded those 
who access publicly funded ART treatment as the Health Funding Authority (2000b:5) now 
requires clinics that hold public contracts to “be cognisant of Mäori requirements around 
guardianship of personal information and practise these rigorously.”  However, there is no 
guarantee that this requirement will be enforced or monitored and it is too early to tell whether 
recent changes to the service specifications for infertility services will improve the situation in 
relation to the implementation of Mäori specific requirements.  In the meantime, Mäori gamete 
donors, surrogates, commissioning parents, and individuals conceived with donor gametes are 
offered little protection that the information they may seek will be permanently available, 
accurate, or culturally relevant.
164
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  See Chapter Three, Regulating Practices, Section 3.6, Professional Self-Regulation, for a discussion of 
RTAC’s role in the regulation of New Zealand fertility clinics. 
164
  As highlighted in Section 5.2: Is there a need?, there is a possibility that the use of ART by Mäori will 
increase as a result of female reproductive disorders caused by STD’s.  However, it should be 
acknowledged that there are differences in the practices surrounding sperm donation and ovum 
donation.  While it is traditionally acceptable for recipients experiencing male-factor infertility to use 
sperm from unknown donors, recipients experiencing female-factor infertility are encouraged to use ova 
donated by a family member and to engage in face-to-face contact with the donor.  For these reasons, 
ova donation may lead to fewer problems in relation to future access to genetic information by any 
children conceived from these gametes.  Therefore, the practices surrounding ova donation may be more 
culturally acceptable to Mäori than the traditional practices surrounding sperm donation.   
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6.7 Policy Issues 
Chris Cunningham (Hui Whai Maramatanga Whai Oranga & Ministry of Mäori Development, 
1995:28) argues that the sharp drop-off in fertility rates for Mäori women should be of concern 
and may lead to increased demand for ART services by Mäori.  However, Teresa Wall (Senior 
Analyst, Mäori Health Branch, Ministry of Health) questions the need for public investment in 
high cost technologies at the expense of preventative measures. 
Preventing the problem at the outset or putting in place high cost technologies?  
For Mäori it should be identifying whether there is going to be a problem in the 
future and I suspect that there will be, because of the reports that we are getting 
now about the higher chlamydia rates.  We need to be combating that as opposed 
to putting in place high cost technologies, which may not be [effective].  Mäori will 
have problems getting [access to] them irrespective, because of targeting and 
because its perception that it is not an issue.   
        (Teresa Wall, Interview: 24 July 2000) 
Similarly, Penny Ehrhardt, (Policy Analyst, Te Puni Kökiri) stressed the need to focus on 
preventative approaches to reduce the need for ART in the future. 
The need to protect fertility … seems more of a priority because of [sexually 
transmitted infections] etcetera, are high and the recent research that has come 
out that they seem particularly high among young Mäori women, and therefore 
issues of infertility may become greater issues in the future.  The hope is to take a 
preventative approach at this stage rather than focus on down the track helping a 
lesser number if possible.    (Penny Ehrhardt, Interview: 25 July 2000) 
 
Most of those interviewed argued for improved educational programs that would inform young 
people on how they could best avoid exposure to fertility risks.  Similarly, Blank and Merrick 
(1995:221-222) suggest that more resources spent on preventative measures for the known 
causes of infertility and research into the causes of unknown infertility would better assist 
marginal groups than increased spending on ART innovations.  However, those young Mäori 
women who have already been exposed to fertility threatening STI’s are likely to face the 
barriers mentioned to accessing ART services in the near future and prevention focused policies 
will not assist them.  Regardless of resources devoted to preventing infertility, there is a need 
to examine how ART services can better assist Mäori people who are already experiencing 
fertility problems.   
 
The exclusion or marginalisation of Mäori within the policy discourse surrounding ART practices 
is not necessarily a deliberate strategy implemented by policy-makers, providers, and 
consumers.  According to Iris Marion Young (1990:185), “policy issues are often defined by the 
assumptions and priorities of the privileged.”  Groups with social and economic privilege have 
the “material, personal, and organisational resources” that facilitate their ability to express their 
needs and priorities so that they are seriously considered (Young, 1990:185).  As such, and 
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without specific information on the use of ART by Mäori, ART policy continues to be based on 
the perceived needs of the culturally dominant Päkehä group.  This is not to say that providers 
are unaware of the barriers to services that Mäori face.  Some are already trying to 
accommodate cultural diversity and improve their services for Mäori. 
It is very hard because there is not a Mäori voice to go to you know.  We have 
used Mäori people and we have used particular feedback from patients to try to be 
more sensitive and to try to think and deliver a better way…. 
      (John Peek, Interview: 12 July 2000) 
Similarly, Rodney Bycroft (Scientific Director/Manager, Artemis North Shore Fertility, Auckland) 
acknowledges the need for cultural sensitivity in relation to ART practices. 
…the relationship we have with other cultural groups needs to be recognised.  I 
would say that would include, in Auckland because it is such a cosmopolitan city 
now, Chinese, Asian, Korean, Indian, Pacific Island, you name it.  That means that 
we have to have access to interpreters, we have to be culturally sensitive to their 
requirements, and the specific issues of whänau and iwi and consultation with 
hapü and their elders.  …  And, I believe that that consultation process is vital to 
some of the specific issues of [certain] ethnic groups. 
   (Rodney Bycroft, Interview: 13 September 2000) 
While these clinics have indicated a willingness to consult with Mäori about how they can better 
improve their services and make them culturally safe, as stipulated in the service specifications 
(Health Funding Authority, 2000b:2, see Appendix L), it appears that there are no sanctions 
implemented regarding non-compliance.  The conditions imposed by the service specifications 
for publicly funded ART require clinics to implement a Mäori health policy that recognises “that 
Mäori health is a specifically identified health gain priority area” and to “identify how these 
services will be measured to ascertain what benefit is evident and any other additional 
opportunities that may exist for furthering Mäori health gain” (Health Funding Authority, 
2000b:2, see Appendix L).  However, there are no specific procedures outlined to assist clinics 
in developing and implementing this policy and, although providers are required to submit their 
plan within three months of the implementation of the service specifications, there is no 
guarantee that the Ministry of Health will follow up or enforce these plans anymore than the 
HFA implemented the data collection requirements of the previous contracts.
165
 
 
Young’s (1990:158) politics of difference promotes “equality as the participation and inclusion of 
all groups” and argues that, as such, “it sometimes requires different treatment for oppressed 
or disadvantaged groups.”  Accordingly, social policy should recognise that certain groups have 
particular needs and should target these groups for specific treatment.  While the Ministry of 
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  In January 2001, the HFA’s functions were integrated into the Ministry of Health and District Health 
Boards. 
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Health recognises that Mäori are particularly disadvantaged in the health arena and address this 
issue through the inclusion of Mäori focused policies, the inequalities in access appear to have 
low priority in relation to ART.  This is perhaps influenced by the perception of ART and 
infertility treatment as a “niche” area, mainly utilised by the white middle classes.  However, 
some Mäori do use ART and, although the policy discourse that does exist in relation to the use 
of ART by Mäori articulates a need for ART practices to be culturally safe, what these 
requirements might be are not explicitly laid out.  The formulation of adequate policy in relation 
to Mäori and the use of ART must start with the collection of information, addressing issues 
such as whether technological solutions to infertility are appropriate or acceptable for Mäori and 
what issues need to be addressed to make ART practices culturally safe.  As John Peek (Clinical 
Manager/Group Operations Manager, Fertility Associates Auckland) acknowledges, 
…we still do not know what proportion of Mäori feel comfortable using ART as an 
approach to infertility and what proportion [are uncomfortable with it]. 
      (John Peek, Interview: 12 July 2000) 
This raises a point made by Penny Ehrhardt (Policy Analyst, Te Puni Kökiri) in relation to finding 
out what Mäori see as the main issues regarding the use of ART. 
The other point to make in terms of Mäori input, if [the Ministry of] Health or 
anyone was going to do a look at ART [or the] guidelines, we feel it is important 
that they actually go and ask Mäori what they see as their priority. … Not 
necessarily door knocking, maybe going to Mäori organisations.  Te Puni Kökiri 
does not speak for Mäori.    (Penny Ehrhardt, Interview: 25 July 2000) 
 
 
Reid (1999b: 89) argues that it is important to recognise that “Mäori are a diverse population, 
expressing ethnicity across a spectrum of realities, from conservative to modern and tribal and 
urban.”  There is no one Mäori voice to articulate the needs of Mäori; nor is there one Mäori 
reality.  As Durie (1998:215) and others (Cunningham & Kiro, 2001:68) have pointed out, Mäori 
inhabit varied cultural worlds.  Tobias (2001:21) argues that the “ethnic experience is different 
for males and females, for people living in different parts of the country…, for people of 
different birth cohorts ageing through different periods…, and for people belonging to different 
social classes.”  Similarly, Dame Joan Metge (in New Zealand Law Commission, 2000:84) 
contends that “many urban Mäori are alienated from their cultural heritage and may be more 
comfortable with Päkehä views and practices.”  Accordingly, those interviewed in relation to 
Mäori infertility and the use of ART (Glavish, Wall, Peek, Ehrhardt, and Allan) emphasised or 
reiterated the point made by Grant Allan (Senior Policy Analyst, Te Puni Kökiri). 
You cannot just generalise the opinion of one Mäori to another. 
       (Grant Allan, Interview: 25 July 2000) 
Although Crown objectives concentrate on reducing inequalities between ethnic groups, 
Cunningham and Kiro (2001:68) argue that the increasing disparity within the Mäori population 
  
170
 
is of equal importance and that health policy must allow for heterogeneity in relation to cultural 
experience, health status, and expectations with regard to outcomes.  However, Naida Glavish 
(Chief Advisor - Tikanga, Mäori Health Development Service, Auckland Healthcare Services 
Limited) argues that at present all health services 
…are basically homogenous and are ill equipped, bordering on incompetent, to 
deal with the heterogeneous and accepting difference.  All the structures are 
designed for that homogenous psyche basically. 
 (Naida Glavish, Interview: 9 August 2000) 
Recognising that Mäori are a diverse group of people whose needs and values are varied and 
complex highlights the difficulties surrounding policy formation.  Teresa Wall (Senior Analyst, 
Mäori Health Branch, Ministry of Health, Interview: 24 July 2000) argues that investment in the 
notion, if not the belief, of a homogeneous population was a way of simplifying policy 
formulation.  She maintains that catering for the diversity of human relationships within the 
policy framework is too difficult and that a uniform a notion of family is easier to manage at a 
policy level.
166
  Young (1990:174) argues that affirming ‘difference’ may produce stigma and 
exclusion and highlights past strategies where “group-conscious policies were used to separate 
those defined as different and exclude them from access to the rights and privileges enjoyed by 
dominant groups.”  However, the assumption of homogeneity within groups as a policy strategy 
will also continue to disadvantage those who do not fit the accepted norms and standards 
associated with that group.  The marginalisation of Mäori in the existing ART policy discourse 
appears to be based on the belief that “…Mäori don’t access it” (Helen Williams, Policy Analyst, 
Elective Services Project, Health Funding Authority, Interview: 29 August 2000) and that Mäori 
may have other ways of dealing with infertility.  These assumptions are direct results of the lack 
of information available about the prevalence of infertility and the ethnic composition of those 
already accessing ART treatments.   
6.8 Conclusion 
While exploring ART policy and its impact on reproductive choice in Aotearoa/New Zealand, I 
was unable to locate any significant documentation or policy initiatives relating to Mäori use of 
ART.  Specific concerns had been raised by Manatu Mäori (Ministry of Mäori Affairs) (MCART, 
1994: Appendix E) about the protection of whakapapa and the use of culturally supportive and 
safe ART practices.  However, there appeared to be no research into whether these concerns 
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  See Chapter One, Introduction, Section 1.4, Families & ART, for a detailed discussion about this in 
relation to the definition of family. 
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continue to be of relevance.  In general, interviewees offered little insight into Mäori specific 
policy responses to ART practices.  Consequently, the focus of this chapter became the silences 
in the ART policy discourse in relation to Mäori, as well as the issues raised by the interviewees 
about the prevalence of infertility in the Mäori population, the barriers Mäori encounter to 
accessing health services, and the collection of information on ethnicity within the health 
system. 
 
There is no data available with regard to the prevalence of infertility in the Mäori population of 
Aotearoa/New Zealand.  Neither is there any quantitative information about the utilisation and 
access of ART services by Mäori.  However, high rates of reproductive system disorders and 
exposure to sexually transmitted infections by young Mäori women, as well as changing 
characteristics in relation to Mäori women’s childbearing patterns indicate that there may be an 
increasing demand for ART services by Mäori women in the near future.  As Mäori women and 
men generally hold lower socio-economic status than non-Mäori women and men, they are 
more likely to encounter barriers to accessing ART services.  These access barriers include 
financial costs and geographic location, as well as experiencing cultural insensitivity and 
discomfort in mainstream health services.  Similarly, obstacles experienced in relation to the 
take-up rates of other social assistance schemes may also influence the take-up rate of publicly 
funded ART treatment.  Lack of entitlement awareness, stigmatisation, privacy issues, 
abatement rates, and the time costs may all contribute to the inability or unwillingness to 
access publicly funded treatment. 
 
Until accurate quantitative data is available in relation to who actually accesses ART services, it 
will be impossible to accurately identify the needs of Mäori in relation to infertility treatment or 
to effectively evaluate and monitor the State’s health policy outcomes.  Although HFA contracts 
require fertility clinics providing publicly funded fertility treatment to retain information on the 
ethnic composition of ART consumers, this requirement is not enforced and, as yet, there is no 
evidence that the newly instigated health sector restructuring will alter this situation.  
Difficulties in defining Mäori and the use of ethnicity as a variable in social research further 
complicate the collection and generation of statistics in relation to Mäori infertility and access to 
ART services.  Inconsistencies in defining ethnicity and the inability to make comparisons across 
data sets, as well as the use of statistics to engage in negative comparisons of Mäori and non-
Mäori, have all contributed to a distrust of data collection in relation to Mäori by some 
commentators.  Nevertheless, until accurate statistical data are available, ART related policy will 
continue to be based on historic demands and influenced by the perceived needs and welfare of 
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the culturally dominant Päkehä population.  As such, those who do not have the social or 
material resources to compete for scarce resources in this area will continue to be marginalised.   
 
Several commentators have suggested that the use of whängai is a culturally acceptable 
alternative to ART treatment for infertility and others have equated whängai to surrogacy.  
Although it is possible that surrogacy is more acceptable to Mäori than other ART practices 
because it shares some characteristics with whängai, there is no empirical evidence to support 
either of these suppositions.  While there is undoubtedly a diverse range of definitions 
associated with the practice of whängai within Mäoridom, it is perhaps more suitable to 
associate whängai with the Päkehä concept of fostering or guardianship or the increasingly 
acceptable concept of ‘open adoption’.  Although whängai may be an appropriate alternative to 
ART for some Mäori, it cannot be presumed that it is an acceptable or even feasible solution to 
infertility for all Mäori.  Mäori men and women do currently use ART services and this raises 
important issues in relation to the protection of whakapapa.  Even though there has been a 
move towards a culture of openness in relation to donor insemination and adoption in 
Aotearoa/New Zealand, this is not a legal requirement.  Access to information is dependent on 
parental openness about the circumstances of their children’s birth and the availability of 
accurate information.  Legislation continues to promote secrecy through the provision of a 
‘false’ birth certificate and, although RTAC requires that some records be kept by accredited 
clinics, they are an Australian based committee that, as yet, does not include an Aotearoa/New 
Zealand-specific supplement to their ‘Code of Practice’.  Therefore, the lack of legislation to 
promote and guide the collection of ethnically relevant information means that Mäori involved in 
donor ART practices must continue to rely on clinical discretion to ensure that knowledge of 
whakapapa will be permanently available.   
 
Rather than speak for members of another ethnic and/or cultural group, my intention was to 
highlight what I perceive to be the silences surrounding the use of ART by Mäori in relation to 
policy issues.  ART innovations and applications will continue to advance and, as highlighted 
earlier, there may be an increasing demand for ART practices by Mäori people.  However, the 
ability of Mäori to access ART will continue to be severely constrained by the lack of information 
about the prevalence of infertility experienced by Mäori and the continued policy emphasis on 
the needs of the dominant cultural group in Aotearoa/New Zealand.  By positioning infertility as 
a white middle class problem and contending that ART is not an option considered by Mäori 
people with fertility problems, policy-makers and commentators ignore barriers to access that 
may effect take-up rates by Mäori and low-income groups.  Consequently, the take-up rate is 
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presumed to be a reflection of the need rather than a symptom of inequality in access and 
policy.  However, increasing recognition of Mäori as a diverse group of people with varied needs 
and values will continue to undermine the homogeneous focus of most policy initiatives and 
may accentuate the need for Mäori-specific access policies to overcome the inequalities and 
barriers they experience in relation to the health system.  This chapter does not presume to 
recommend how Mäori might wish to address policy issues surrounding access to and the 
provision of ART services for Mäori.  Nonetheless, it does highlight a need for more research 
into the barriers Mäori experience in relation to accessing ART treatment for infertility.  It also 
emphasises the need for more information gathering in relation to the use of ART practices by 
Mäori so that future policy can accurately provide for the needs and interests of Mäori 
individuals without assuming that they correspond with the needs and interests of the equally 
diverse dominant Päkehä group. 
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7 
Policy in Practice 
7.1 The ‘Messy Reality’ 
This thesis has explored how access to assisted reproductive technologies (ART) has been 
shaped by the current policy context in Aotearoa/New Zealand.  At first glance, it would appear 
that the absence of specific legislation to control and regulate ART practices has left the 
regulation of ART practices in a policy vacuum.  However, although the Status of Children 
Amendment Act 1987 (SCAA) is currently the only piece of legislation that explicitly deals with 
ART, there are many existing regulations and statutes that could be used in relation to legal 
issues arising from ART practices.  These include professional codes of practice and legislation 
specific to the health and medical sector, as well as legislation relating to adoption and human 
rights.  However, policy is not only developed and instigated through Acts of Parliament, 
ministerial edicts, and government initiated guidelines and strategy documents.  Although these 
procedures play a major part in policy development, they are not the only approaches available 
for formulating policy.  By examining how ART is regulated and controlled in Aotearoa/New 
Zealand, I have demonstrated that policy formulation and implementation does not always 
occur through the ordered, linear, and progressive models prescribed by some policy theorists.  
The ‘messy reality’ of the ad hoc approach to ART policy formulation provides an excellent case 
study of how the complex interactions, relationships, and policy initiatives of a variety of social 
actors work together to shape policy and, as a consequence, the reproductive choices of some 
individuals and groups in Aotearoa/New Zealand.  As seen in Chapter Three, ART policy has 
been influenced and shaped by the interactions and relationships between state controlled 
policy and funding agencies, the National Ethics Committee on Assisted Human Reproduction 
(NECAHR), managers, healthcare professionals, patients, interest groups, and the wider 
community, as well as contingent responses to ART developments and health sector changes. 
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I acknowledge that this process of ‘muddling through’ may have provided a practical solution to 
developing policy in an area where there are difficulties in predicting the future consequences 
of certain biomedical developments and practices, as well as limited financial resources, 
timeframes, and information.  However, ad hoc policy responses to ART developments and 
practices have often involved limited analysis and resulted in the marginalisation of alternative 
values and options.  This is particularly evident in the lack of attention or action taken to 
incorporate an Aotearoa/New Zealand supplement to the Reproductive Technologies 
Accreditation Committee’s (RTAC) ‘Code of Practice’.  Subsequently, the cultural and political 
values and principles of Aotearoa/New Zealand are marginalised in the monitoring and 
regulation of clinic practices.  The deflective capacity of such policy-making strategies has also 
allowed various governments to avoid direct responsibility for decision-making in relation to 
ART.  Consequently, the potentially controversial and contentious issues have been dealt with 
by the National Ethics Committee on Assisted Human Reproduction (NECAHR).  Successive 
governments have avoided making politically unfavourable decisions and instigating overt state 
involvement in matters that are generally considered private.  Undoubtedly, the flexibility and 
political expediency offered by a case-by-case decision-making approach have influenced the 
State’s continued reliance on contingent and incremental policy-making.  Nevertheless, delays 
in taking a more proactive approach to ART policy through legislative action and the complete 
avoidance of establishing a policy focused body to oversee ART developments and practices has 
placed the rights of those involved at risk and marginalised concerns about information access 
and retention, cultural safety, and the protection of whakapapa. 
 
The lack of a considered and consistent approach to ART policy formulation means that the 
resolution of any social and ethical concerns remains dependent on the interest and attention of 
providers, NECAHR, and RTAC.  At present, NECAHR’s dual role as an ethics committee and de 
facto policy body places it in an ambiguous position, which compromises its ability to maintain 
an independent position in ethical decision-making.  Although professional self-regulation is 
provided by RTAC, accreditation only ensures the control and regulation of the practical aspects 
of ART procedures.  Accreditation remains voluntary, although providers do not appear to be 
resistant to compulsory certification.  Neither NECAHR nor RTAC has any statutory power to 
ensure that providers comply with decisions made by NECAHR and, as an offshore accrediting 
body, RTAC is not accountable to the Aotearoa/New Zealand Government.  While non-
compliance with either NECAHR’s decisions or RTAC’s regulations would undoubtedly result in a 
loss of accreditation, the effectiveness of this as a sanction is questionable.  The limited 
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consumer input into NECAHR and RTAC raises concerns about the marginalisation of those who 
experience infertility problems in relation to the formulation of policy and/or ethical decision-
making.  As a consequence of this marginalisation, any policy decisions (or non-decisions) may 
not consider the interests of those most affected and alternative solutions may be ignored.  
While ethical and practical considerations should form the basis of ART policy, input from other 
fields of interest, knowledge, and experience is necessary to ensure a balanced and considered 
approach is taken to such policy formulation. 
 
Advances in ART and ART practices continue to be rapidly included into acceptable practice and 
any ART policy decisions are threatened with being out of date and invalid within a very short 
timeframe.  While this necessitates careful consideration before enacting prescriptive legislation 
that cannot be easily changed or adapted, it also requires considered attention to the negative 
consequences of relying on ad hoc policy responses to ART innovations and applications.  
Predicting the possible effects of biotechnology may be difficult and the rapid nature of such 
advances may create time and information constraints that limit the ability of policy-makers to 
take a proactive stance.  Nevertheless, ad hoc policy responses may allow incremental 
advances or changes in ART practices to become cemented into common practice before the 
negative consequences are apparent.  Fast moving ART developments impose time constraints 
for the formulation and implementation of policy and this means that policy is likely to be made 
without the collection of necessary empirical evidence.  Similarly, the pressure to develop and 
implement rapid policy responses could mean that the values underlying any decisions are not 
questioned and alternative solutions are in danger of being disregarded or overlooked.  
Consequently, the rights and interests of certain individuals and groups may be marginalised 
while attention is given to those groups that can better articulate their needs and interests. 
7.2 ‘Muddling Through’ 
In Chapter Four, I examined the contingent responses by ART providers and state funding 
agencies to the increasing demands for ART services.  My investigation illustrates that the 
maintenance of an ad hoc policy approach has established and maintained inequities and 
discriminatory practices in relation to the public provision of ART services.  The initial use of 
research facilities and resources to fund and develop IVF programs resulted in providers 
expanding into the public health arena and infertility treatments being publicly funded by 
default.  Growing demands, generated through increased availability and publicity, led to public 
funds for ART services being distributed throughout Aotearoa/New Zealand on a regional basis.  
However, the regional allocation of resources was based on the numbers of individuals from the 
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various regions that had accessed ART in Auckland rather than detailed consideration of the 
incidence of infertility in Aotearoa/New Zealand or population based requirements.  
Consequently, government funding agencies have entrenched regional inequalities and 
disparities in funding and access policies.  Given the highly constrained health budget, 
questions have occasionally been raised about the rationale for continuing to publicly fund ART 
services.  Nevertheless, there has not been a thorough examination of the underlying principles 
for providing such services and funding has continued at historically established levels.  Political 
expediency makes it unlikely that funding for these services will be completely withdrawn.  
Nevertheless, rationing strategies have depleted availability and entitlement to such services.   
 
The introduction of explicit rationing strategies and an investigation into the costs and 
effectiveness of infertility treatment did not lead to equitably funded ART services or nationally 
consistent access restrictions.  These health sector strategies have resulted in incremental 
policy changes rather than consistent guidelines to help overcome the deep-seated inequalities 
in the access to and funding of publicly resourced ART services.  By avoiding in-depth analysis 
of principles underlying ART funding decisions (or non-decisions), policy-makers do not have to 
justify any politically contentious decisions and inequities do not have to be publicly addressed.  
Campaigning by individual clinics and consumer organisations and the forbearance of some 
administrators in the Health Funding Authority (HFA) has resulted in some policy changes.  
However, the introduction of increased funding, national referral guidelines, and the Clinical 
Assessment Criteria (CPAC) appear to be a contingent response to increasing demand, rising 
costs, and growing waiting lists.  Additional funding has been based on historically established 
funding levels and the reduction of publicly funded IVF cycles available to individuals under the 
new funding package dilutes the available services and reduces visible demand rather than 
actual demand.  Moreover, health sector reforms have created uncertainty over the 
effectiveness of these changes.  The creation of 21 health districts and administrative boards to 
allocate resources may exacerbate and further embed regional inequities and inconsistencies in 
ART funding.  The fragmentation of funding decisions may also undermine the goal of national 
consistency in access to ART services.  However, it is too early to evaluate what the combined 
effect of the increased funding, national use of the CPAC, and health sector reforms on funding 
and access will be.  The formulation and implementation of the CPAC may further entrench 
inequalities in access based on ‘worthiness’ to parent and conformity to the normative definition 
of family. 
  
178
 
7.3 Limiting Entitlement 
Rapid advances in technology, mounting professional and public expectations, and changing 
demographics have all contributed to increased demands for the limited resources available for 
publicly funded healthcare.  Consequently, the allocation of the available resources has become 
more dependent on explicit rationing strategies.  Nevertheless, access to publicly funded ART 
services is rationed through a combination of both implicit and explicit approaches, including 
restricted funding, waiting lists, a reduction of services offered, and the use of the Clinical 
Assessment Criteria (CPAC).  Although it has become increasingly necessary to limit access to 
publicly resourced ART services, access has not always been restricted on the basis of 
constrained public funds.  In the past, access has been limited by marital status and sexuality, 
as well as geographical location.  Originally restricted to married couples, access was eventually 
extended to de facto heterosexual couples in stable relationships.  Thus, the definition of family 
that underlies the Status of Children Amendment Act 1987 (SCAA) has also influenced the 
restriction of access to ART services.  Access restrictions were relaxed to include single women 
and lesbian couples only after clinics were challenged under the human rights legislation.  While 
it would appear that there are no longer any obvious value-based limitations on access to 
private ART treatment, menopause as a ‘natural’ constraint on women’s reproductive lifespan is 
used to justify age limits on private ART treatment.  This remains a contentious issue given that 
the use of donated oocytes overcomes the ‘natural’ constraint of menopause and medical 
supervision reduces the physical risks often associated with older childbearing women.   
 
The debate has continued over the issue of access to ART services by those who do not fit the 
normative definition of ‘worthy’ parents.  In recent changes to the service specifications and 
referral guidelines for publicly funded ART treatment, the HFA has attempted to eliminate 
exclusionary language that emphasised heterosexual coupledom as the norm for access.  
However, changing the language has not addressed the underlying principles that originally 
governed the use of this language and the distinction between biological and social infertility 
remains a deciding factor for granting access to public ART treatment.  As I have argued in 
Chapter Five, this distinction rests on a definition of infertility that conflates heterosexual 
relationships and involuntary childlessness.  I claim that access to publicly funded ART services 
is still considerably more difficult for single women and lesbian couples than for those 
individuals who conform to the normative concept of an ideal family arrangement.  This is 
because the underlying principles that were originally used to exclude single women and lesbian 
couples remain uncontested and unresolved. 
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As the most obvious method of rationing ART treatments and restricting access, the 
government initiated CPAC have been influenced by normative assumptions about who is 
‘worthy’ to conceive, gestate, and parent and have added to the invisibility of men in the policy 
debate surrounding these issues.  The Aotearoa/New Zealand Government granted itself partial 
immunity from complying with the Human Rights Act 1993 until December 2001 and, 
debatably, this has had an impact on its ability to introduce access criteria that disadvantage 
lesbian couples and single women.  In contrast, the human rights legislation has influenced the 
practices of ART providers in relation to making non-medical decisions about access.  
Consequently, single women and lesbian couples are no longer excluded from gaining access to 
private ART treatment.  Nevertheless, there is an ongoing policy debate relating to the 
prioritisation of children’s rights over the rights of would-be parents whose personal 
circumstances do not conform to the normative definition of family.  Irrespective of whether 
there is an ultimate ‘right’ to use ART to assist in the creation of a family, I maintain that the 
individual rights of all those involved in ART practices should be considered in relation to each 
other.  As I have argued previously, the rights and interests of the donors, recipients, 
surrogates, and intending parents, as well as the rights of adults conceived using ART practices, 
are in danger of being overlooked or marginalised if the rights and interests of children are the 
sole focus of the policy debate.   
 
Although the CPAC outwardly make the decision-making process for the allocation of scarce 
resources more visible, they effectively obscure the use of non-medical and discretionary 
judgements by providers to establish entitlement to publicly funded ART services.  I maintain 
that the CPAC have been influenced by a normative definition of family and social judgements 
surrounding what the appropriate age is for women to experience pregnancy and parenting and 
that the emphasis on clinical assessment obscures the use of these judgements to restrict 
access to ART.  While the use of social judgements to establish ‘worthiness’ or ‘need’ may be 
necessary to limit access to tightly constrained public resources, I contend that the limited 
consultation and ill-defined methods used to decide what criteria would be used to limit access 
to publicly funded ART services undermine the validity of the CPAC.  There has been little or no 
analysis of the values and principles that underlie the selected criteria.  Therefore, the CPAC 
further embed inequities in the distribution of limited resources by marginalising or excluding 
those who do not fit the perceived ideal for parental or family arrangements.  Any form of 
rationing will disadvantage some individuals or groups and changing social values and 
expectations may call into question any criteria used to determine entitlement.  Nevertheless, 
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adequate public consultation, a system of accountability, and transparency in the decision-
making processes would reduce the possible discriminatory effects of limiting access. 
7.4 Considering Difference 
Although te Tiriti o Waitangi (the Treaty of Waitangi) creates a relationship between Mäori and 
Päkehä that necessitates that policy formulation, implementation, and monitoring recognises 
and encompasses the values and principles of Mäori society, there is considerable silence 
surrounding the use of ART by Mäori in the ART policy discourse.  Concerns have been raised 
by Manatu Mäori (Ministry of Mäori Affairs) in relation to the protection of whakapapa, informed 
choice and consent, and cultural safety.  Nevertheless, specific attention to these concerns has 
not been forthcoming and ART policy continues to be influenced by the perceived needs and 
interests of the culturally dominant Päkehä population.  This is highlighted in Chapter One by 
my analysis of the SCAA, which has institutionalised a definition of family that fails to recognise 
or accommodate social diversity in relation to family structure, especially the more diverse 
concept of whänau acknowledged by Mäori.  Similarly, the CPAC contain standards of 
acceptable weight that are based on a western profile.  The homogenous focus of ART policy is 
exacerbated by the contingent and incremental approach used to develop and implement any 
policy initiatives or changes.  As mentioned earlier, this approach does not allow for in-depth 
analysis of the values and principles that underlie ART policy formulation.  As I argue in Chapter 
Six, if Mäori perspectives on social relations and interaction, as well as their values and 
language, are not considered and acknowledged during the policy-making process, the 
dominant values and perspective will continue to be upheld as universal.  As a result, the 
interests and needs of Mäori in relation to ART treatment will be assumed to correspond with 
those of the dominant Päkehä group. 
 
The marginalisation of Mäori in the ART policy debate is aggravated by the lack of quantitative 
data on the prevalence of infertility in the Mäori population and information on the utilisation of 
ART services.  The availability of such information would assist in the formulation of policy that 
accurately identified the needs of Mäori in relation to infertility treatment and would enable 
interested publics to effectively evaluate and monitor future ART policy initiatives.  I 
acknowledge that there are difficulties in collecting and analysing accurate or useful quantitative 
data, especially in relation to ethnicity.  The collection of data on ethnicity may be limited by 
inconsistencies in defining Mäori, the ability to make comparisons across data sets, and the use 
of statistics to undertake negative comparisons between Mäori and non-Mäori.  Inadequate or 
irrelevant analysis of such information may further hinder its usefulness for informing policy.  
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Nevertheless, without accurate information relating to Mäori infertility and access to ART 
services, policy decisions will continue to be made without sufficient attention to the issues for 
Mäori and the ability of Mäori to access these services in the future will be affected.  This is 
particularly relevant as available information on reproductive health issues for Mäori women, as 
well as changing demographics in relation to Mäori women’s childbearing patterns, indicate that 
there may be an increasing demand for ART services by Mäori women in the near future.   
 
The prediction of increased demand is not definite and other commentators have suggested 
that Mäori may use whängai as an alternative to ART practices in dealing with infertility.  
However, there is no empirical evidence to support this assumption.  Although there is a diverse 
range of definitions associated with the practice of whängai in Mäoridom and it may be used by 
some Mäori as an alternative to ART, I would suggest that this concept is more accurately 
equated to the Päkehä concepts of fostering, guardianship, or ‘open’ adoption.  Consequently, 
whängai should not be used to justify lack of policy attention to the use of ART by Mäori.  Mäori 
men and women do currently use ART services and this raises important issues in relation to 
the protection of whakapapa and the retention of culturally appropriate information.  Although 
access to information is ultimately dependent on parental openness about the circumstances of 
their children’s birth, existing legislation continues to promote secrecy through the provision of 
a ‘false’ birth certificate.  Furthermore, the lack of legislation to ensure the collection of 
ethnically relevant information means that Mäori involved in donor ART practices must currently 
rely on clinical discretion to ensure that knowledge of whakapapa will be permanently available.   
 
The diversity of the Mäori population, as of any population, makes it difficult to establish 
policies that equitably address all the issues.  Nonetheless, attention to the diverse nature of 
the Mäori population will destabilise the universal focus of ART policy initiatives and highlight 
the availability of alternative values and options.  Although there has been some attention to 
Mäori specific policies to overcome existing inequalities and inconsistencies in access to the 
wider health system, there is a need for more research into the barriers Mäori experience in 
relation to accessing ART treatment for infertility.  Similarly, the collection of accurate 
information in relation to the use of ART practices by Mäori and the consideration of Mäori 
values and principles are necessary if future ART policy is to be accurate in its attention to the 
needs and interests of Mäori individuals without marginalising them in relation to the needs and 
interests of the dominant Päkehä group. 
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7.5 Future Considerations 
The complexity of the technologies involved in assisted reproduction and the relationships these 
technologies make possible require a more complex set of policy responses than has previously 
been instigated.  Given the speed of biomedical innovation and implementation, incremental 
and contingent policy approaches will continue to play a necessary role in regulating and 
controlling ART development and practices.  However, developing ART policy solely as a 
contingent and/or incremental response to the financial, ethical, and medical dimensions of 
service provision will potentially marginalise or exclude the consideration of other issues.  The 
fragmented organisational responsibility and time constraints inherent in such ad hoc policy 
responses has already resulted in a lack of consideration of the principles influencing funding 
and access decisions, as well as the marginalisation of alternative values and interests in 
relation to family formation.  As I argued earlier, the establishment of an ART focused policy 
body would offer regulatory oversight of ART practices and provide a system of accountability 
and responsibility in relation to ethical and policy decision-making.  Such an organisation could 
also co-ordinate the interconnected functions of NECAHR and RTAC and could oversee the 
implementation of policy and ethical decisions by providers.  Moreover, it could facilitate the 
development of proactive and carefully considered ART policy that incorporates the values and 
concerns of consumers and providers, as well as other interested publics, organisations, and 
individuals, while enhancing the decision-making process through the inclusion of a more 
diverse range of knowledges and experiences.  Consequently, those currently marginalised and 
silenced within the ART policy discourse would gain greater voice and visibility.  
 
It is necessary to consider what areas of concern require legislative control, as well as the 
consequences of implementing proscriptive laws.  Although some areas of concern are currently 
being addressed by the Health Select Committee considering the two proposed bills on ART, 
issues such as the use of sex-selection techniques and embryo donation have not been 
addressed and may be introduced into practice before adequate consideration is given to the 
consequences of their use.  Similarly, protracted delays in legislative action have left the rights 
of those conceived using donated gametes unprotected in relation to information retention, 
storage, and access.  The proposed banning of some unethical practices, such as the cloning of 
humans, raises questions about how the use of technologies developed overseas through such 
processes will be dealt with in Aotearoa/New Zealand.  Similarly, banning the sale of human 
gametes and embryos highlights concerns surrounding the ownership of biological material and 
the rights of embryos.  ART policy decisions relating to funding and access need to be informed 
by accurate quantitative data on the incidence of infertility in Aotearoa/New Zealand.  Attention 
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to who is using ART services and what access barriers individuals experience is crucial to policy 
formulation.  Consequently, more research into these issues is required, as well as research into 
how policies that distribute resources and limit access are interpreted, implemented, and 
managed by providers.   
 
By exploring the ad hoc policy process and fragmented organisational responsibilities in relation 
to the regulation and control of ART practices in Aotearoa/New Zealand, as well as the resulting 
inequities in funding and access to publicly funded ART services and the marginalisation of 
Mäori in the policy debate, I have shown that some individuals and groups have their 
reproductive choices constrained by the present ART policy situation in Aotearoa/New Zealand.  
Although government initiatives and decisions are central to the instigation and formulation of 
formal policy in relation to ART, there are many individuals and non-governmental organisations 
involved in the development and formulation of policy.  By contributing to the ART policy 
debate, different actors influence the language used and the issues that are considered, as well 
as having an impact on how and when the issues will be addressed and resolved.  Accordingly, 
this thesis is part of the policy debate and discourse relating to ART developments and 
practices.  I hope that it will contribute to and have a positive effect on the policy-making 
process and the necessary public discussion of the principles and values underlying ART 
practices, as well as highlight issues of concern relating to the inequitable public provision of 
these technologies. 
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Appendix A: 
Abbreviations & Definitions  
 
 
Abbreviations: 
CPAC: Clinical Assessment Criteria 
HFA: Health Funding Authority 
HRC: Human Rights Commission 
MCART: Ministerial Committee on Assisted Reproductive Technologies 
NECAHR: National Ethics Committee on Assisted Human Reproduction 
NZIS: New Zealand Infertility Society 
RTAC: Reproductive Technology Accreditation Committee 
SCAA: Status of Children Amendment Act 1987 
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Definitions: 
ART: assisted reproductive technologies 
Assisted reproductive technologies refer to those reproductive technologies that aid or 
achieve conception.  These include, but are not limited to, ovulation induction, IVF, DI, 
AIH, IUI, GIFT, ICSI, ZIFT, frozen embryo transfer, cryopreservation of gametes, and 
assisted hatching.  See below for definitions of these terms, as well as definitions of 
amniocentesis, ultrasound imaging, PGD, and FISH, which are associated with ART 
procedures. 
 
AIH: assisted insemination homologous 
Term for assisted insemination when the sperm from the woman’s husband or partner is 
used.  Also known as ‘assisted insemination by husband.  AIH is used for unexplained 
infertility, mild or moderate male factor infertility, or endometriosis.  
 
Amniocentesis:  
A procedure in which a needle is used to withdraw a small amount of amniotic fluid that 
surrounds the foetus in the uterus.  The fluid can be tested for chromosomal 
abnormalities and genetic disorders. 
 
Assisted Hatching:  
This is an option in IVF or ICSI.  A small hole is made in the soft shell of the embryo 
before it is replaced in the uterus.  There is some evidence that assisted hatching can 
improve pregnancy rates in some groups of IVF patients, mainly those who are older or 
who have had several IVF cycles without success. 
 
Cryopreservation: preservation through freezing with liquid nitrogen. 
Embryos can be frozen through cryopreservation.  Frozen embryos can be 'thawed' and 
used at a later time.  Once embryos are frozen and stored, most will remain unchanged 
for long periods of time.  About two thirds of embryos will survive the process of 
freezing and thawing. 
 
DI: donor insemination 
Sperm from a donor is inseminated close to the time of ovulation.  The time of ovulation 
can be identified from blood tests, or urinary tests done at home.  Traditionally DI has 
been used when men have no sperm or poor quality sperm, but it is also an option for 
single women and women in a lesbian relationship.  
 
Donor Egg:  
A donor (sometimes a friend or family member) starts an IVF cycle but donates the eggs 
to the recipient.  The recipient receives hormonal treatment so that her uterus is 
synchronised with the embryo's development.  Donor eggs can be used for women who 
do not produce oocytes of their own. 
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Embryo:  
In humans, this term usually refers to the early stages of growth after fertilisation, from 
two weeks through the eighth week after fertilisation. 
 
Foetus: 
The developing entity from eight weeks after fertilisation until birth.  The two earlier 
stages of development are zygote (fertilisation to two weeks) and embryo (two weeks 
until eight weeks). 
 
FISH: Fluorescence in-situ hybridisation 
FISH utilises fluorescent probes, which are specific for a given chromosome.  A mix of 
several probes of different colours is added to the cell nucleus.  The probes attach to 
their target chromosomes showing up as coloured spots, which can be counted to 
ensure the embryo has the correct number.  (Fertility Associates Auckland has 
permission from NECAHR to develop the technique but do not have approval to use the 
technique.)  
 
Frozen Embryo Transfer:  
In the majority of Assisted Conception cycles, stimulation with hormonal medications 
results in the production of several follicles and the retrieval of multiple oocytes.  While 
an attempt is usually made to fertilize all available oocytes, not all resulting embryos are 
immediately transferred.  When the 'optimal' number (as defined by your clinic) of 
embryos for transfer is exceeded, the 'extras' can be cryopreserved for use at a later 
time.  When embryos are to be thawed, the woman’s menstrual cycle is monitored with 
blood tests to make sure the embryos are replaced at the right time of the menstrual 
cycle. 
 
FSH: Follicle stimulating hormone 
FSH is the hormone secreted by the pituitary gland, which stimulates follicles to develop 
in the ovary.  As the follicles grow, they make the hormone oestrogen, which in turn 
reduces the amount of FSH secreted.  If the ovary does not make any or much 
oestrogen, then the pituitary makes more FSH to compensate.  A high FSH level means 
the pituitary is working harder to stimulate the ovaries.  It is believed that this is often 
associated with the ovary having fewer or poor quality eggs left to stimulate.  There is 
evidence that high FSH levels are associated with a much lower chance of pregnancy.  
As women get close to the menopause, the number of eggs in their ovaries falls, and 
their FSH levels rise.  For this reason, some people look at FSH levels as a marker of 
ovarian age, as distinct from biological age.   
 
Gamete:  
The mature male or female reproductive cell, which contains half the normal number of 
chromosomes (23) that unites with another cell of the opposite sex in the process of 
sexual reproduction.  Ova and spermatozoa are gametes that unite to produce a cell 
(zygote) that may develop into an embryo. 
 
GIFT: gamete intra-fallopian transfer 
GIFT is used when the woman has undamaged fallopian tubes, and when a good rate of 
fertilisation is expected.  After the eggs are removed from the ovaries, two or three eggs 
and some sperm are put directly into the Fallopian tubes. 
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ICSI: intracytoplasmic sperm injection 
ICSI is a variation of IVF, where instead of the sperm and eggs being mixed in a test 
tube, a single sperm is injected into each mature egg.  ICSI is used when sperm quality 
is too poor for conventional IVF to work.  The female partner will undergo ovarian 
stimulation and egg recovery in preparation for micromanipulation and embryo transfer.   
 
IUI: intrauterine insemination 
A form of donor insemination in which sperm are placed directly into the uterine cavity.  
It may be used to overcome barriers to natural insemination, such as incompatibility 
between sperm and cervical mucus, impotence, or vaginismus. 
 
IVF: in vitro fertilisation. 
IVF usually has several steps.  Firstly, hormonal drugs are used to increase the number 
of eggs developing in the cycle from one to around 5-15.  Progress is monitored by 
blood tests and ultrasound scans.  Maturation of the eggs is stimulated by another drug, 
and the eggs are sucked out of the ovary using a needle guided by ultrasound.  Sperm 
and eggs are placed in a test tube together to allow fertilisation.  Fertilisation is checked 
the day after adding the sperm, usually two embryos are replaced in the uterus 1-4 days 
later. 
 
Laparoscopy:  
A procedure, requiring general anaesthetic, in which the reproductive organs are viewed 
through a narrow, light-transmitting instrument (laparoscope) inserted near the naval 
after the abdomen has been inflated with carbon dioxide.  It is used to investigate for 
adhesions, endometriosis, and pelvic inflammatory disease. 
 
Micromanipulation:  
Performance of surgery, injections, dissection with attachments to a microscope, which 
allows magnified visualisation. 
 
Oocyte: a cell that develops into a female reproductive cell 
 
Ova: a female egg or oocyte, formed in an ovary 
 
Ovulation induction:  
Drug treatment to induce ovulation in women with irregular or absent cycles.  Ovulation 
induction can involve taking pills, or subcutaneous injections of drugs (the way diabetics 
give insulin).  It nearly always involves blood tests and ultrasound scans to monitor 
progress, both to time intercourse and to reduce the chance of multiple pregnancy.  
Usually the couple has intercourse when ovulation is predicted or triggered, but artificial 
insemination using partner's sperm can be used, especially if the drugs affect the ability 
of sperm to make their way through the woman's cervix. 
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PGD: preimplantation genetic diagnosis 
One or two cells are removed from an 8-cell zygote on day 3 after fertilisation and the 
genetic material analysed using a technique called FISH (fluorescence in-situ 
hybridisation).  The cells are typically screened for the five or six chromosomes most 
commonly associated with pregnancy loss using and only embryos showing a normal 
number of chromosomes are transferred.  The rapid advance in genetics is starting to 
allow testing for a particular genetic make-up rather than counting chromosomes.  At 
the moment detecting an abnormal gene, such as for cystic fibrosis, is a lot harder than 
counting the number of chromosomes, but already more than 100 children around the 
world have been born from IVF embryos screened for major gene defects before they 
were transferred.   
 
Spermatozoa (sperm): male reproductive cells 
 
Ultrasound:  
Scanning procedure using high frequency sound waves, which are focussed on the body 
and reflected to provide a video image of internal organs, tissues, and structures.  Often 
used for in utero examinations of a developing foetus, for guidance of the needle in 
amniocentesis, for the evaluation of the development of ovarian follicles (fluid filled 
structure in the ovary that contains the developing egg), and for guided retrieval of eggs 
for IVF and its alternatives. 
 
ZIFT: zygote intrafallopian transfer 
A form of assisted reproduction in which a zygote obtained by IVF is transferred to the 
fallopian tube, usually by a catheter (small tube) through the uterus under ultrasound 
guidance.  This technique is also known as PROST (pronuclear oocyte salpingo transfer) 
and TEST (tubal embryo stage transfer). 
 
Zygote:  
The fertilised egg until approximately 14 days of development; from 2 weeks to eight 
weeks of development the developing entity is termed and embryo; from eight weeks to 
birth it is termed a foetus. 
 
 
 
The above definitions have been adapted from: 
The New Zealand Centre for Reproductive Medicine Ltd website (http://www.nzcrm.co.nz/); 
Fertility Associates N.Z. website (http://www.fertilityassociates.co.nz/); 
Xtra Health, Ask an Expert website (http://www.xtra.co.nz/health/0,,212-615828,00.html); 
Encarta World English Dictionary, North American Edition website (http://dictionary.msn.com); 
Royal Commission on New Reproductive Technologies Canada, 1993.  Proceed with Care: Final 
Report of the Royal Commission on New Reproductive Technologies.  Vol. 2 of 2.  Ottawa: 
Canada Communications Group, pages 1147-1174; 
Coney, S. & A. Else (eds.), 1999.  Protecting Our Future.  Auckland: Women's Health Action 
Trust, page 13. 
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Surrogacy: 
The various arrangements known as surrogacy centre on the involvement of a woman who 
gives birth to a child for others by providing gestation and birth.  She may also provide the 
ovum and conception, so that she is the genetic and birth mother.  It is this woman who is 
referred to as the ‘surrogate mother’.  There are three main types of surrogacy arrangement: 
 
1. Traditional surrogacy - insemination by intercourse with the intending 
father or a sperm donor.  This is usually a private arrangement 
with no provider involvement.  The surrogate is the genetic and 
birth mother. 
 
2. Assisted surrogacy - assisted insemination, using sperm from the 
intending father or from a donor.  This does not technically require 
the services of an assisted reproductive technology provider.  The 
surrogate is the genetic and birth mother.  
 
3. Gestational surrogacy – one or more embryos, created (usually by 
IVF) from the gametes of the intending parents, or two donors, are 
transferred to the womb of a woman.  The woman is the birth 
mother but has no genetic connection to the embryos unless she is 
related to the intending parents.   
 
Adapted from Else, A., 1999.  'Surrogacy' in Protecting Our Future.  S. Coney & A. Else (eds.).  
Auckland: Women's Health Action Trust, page 50. 
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Appendix C: 
Interview Participants 
 
State: 
Helen Lockyer, Senior Policy Analyst, Ministry of Health, Wellington. 
Matthew Soeberg, Policy Analyst, Ministry of Health, Wellington. 
Interview: 24 July 2000 
 
The Ministry of Health develops policy advice for the Government on health and disability 
issues, administers health regulations and legislation, funds health and disability support 
services, plans and maintains nationwide frameworks and specifications of services, monitors 
sector performance, and provides information to the wider health and disability sector and the 
public.  Recently, the enactment of the New Zealand Public Health and Disability Act 2000 has 
allowed for the functions of the Ministry of Health and Health Funding Authority to be combined 
and for District Health Boards to be established.   
 
Adapted from: 
http://www.moh.govt.nz/moh.nsf/e00eda991ab5e3704c256670004079ba/58579029ccf1fb73cc2
56abd0003449a?OpenDocument  
 
Teresa Wall, Senior Analyst, Mäori Health Branch, Ministry of Health, 
Wellington. 
Interview: 24 July 2000 
 
The Mäori Health Directorate is headed by the Deputy Director-General Mäori Health, and 
currently includes a Mäori health policy advice section, Te Kete Hauora, a Chief Advisor Mäori 
Health, Special Projects Manager, Manager Mäori Health Policy and Strategy, Manager Service 
Development, Senior Locality Manager Mäori Development, and Manager, Treaty and Iwi 
Relationships.  The role of the Mäori Health Directorate is to provide policy advice on the overall 
strategy for achieving the government's objective for Mäori health which is to reduce disparities 
in health status for Mäori; to work with other branches, sections and teams within the Ministry 
to enable them to incorporate Mäori issues into their policy advice and increase their 
understanding and responsiveness to the needs and aspirations of Mäori; to develop 
relationships with the key organisations and agencies which contribute to a health and disability 
sector which works for Mäori. 
 
Adapted from: http://www.moh.govt.nz/moh.nsf/ 
 
 
 
  
213
Grant Allan, Senior Policy Analyst, Te Puni Kökiri, Wellington. 
Penny Ehrhardt, Policy Analyst, Te Puni Kökiri, Wellington. 
Interview: 25 July 2000 
 
The Ministry of Mäori Development Act 1991 established Te Puni Kökiri, the Ministry of Mäori 
Development in 1992.  Currently, Te Puni Kökiri’s work focuses on providing high quality policy 
advice to Government and other agencies on the Crown’s relationship with iwi, hapu, and 
Mäori, and the Government’s objectives, interests and obligations relating to Mäori.  Te Puni 
Kökiri’s key functions (under the Ministry of Mäori Development Act 1991) include promoting 
higher achievement by Mäori in the areas of education, training and employment, health, and 
economic resource development.  Te Puni Kökiri also has a role in monitoring and liasing with 
each department and agency that provides, or has a responsibility to provide, services to or for 
Mäori to ensure the adequacy of those services.  In 2000, Government broadened the policy 
focus of Te Puni Kökiri to include some direct provision of services to Mäori. 
 
Adapted from: http://www.tpk.govt.nz/about/role/default.htm 
 
Diane Yates, Member of Parliament (Hamilton East), Wellington. 
Interview: 25 July 2000 
 
Dianne Yates was the Labour MP for Hamilton East and is currently a Labour Party List Member 
of Parliament.  Dianne Yates introduced the Human Assisted Reproductive Technology Bill as a 
Private Member’s Bill in 1996 (Yates Bill; see Appendix I). 
 
Adapted from: http://www.labour.org.nz/yates/index.html 
 
Helen Williams, Policy Analyst, Elective Services Project, Health Funding 
Authority, Dunedin. 
Interview: 29 August 2000 
 
The Health Funding Authority (HFA) was established on 1 July 1997.  The HFA’s responsibilities 
included buying or funding health and disability services on behalf of the National Advisory 
Committee on Health and Disability.  It assessed healthcare needs, consulted with communities 
over priorities, and decided where to spend the money made available through Vote Health.  
One of its roles was to provide detailed information on the level of service it could buy with 
available funding and to identify where there were shortfalls and what it would cost to fill the 
gaps.  The HFA paid providers for contracted services and it was responsible for developing, 
implementing, and managing the contracts with providers.  In November 2000, the HFA was 
disbanded and its functions were integrated into the Ministry of Health and District Health 
Boards. 
 
Adapted from: 
National Advisory Committee on Health and Disability, 1997.  The Best of Health 3: Are we 
doing the right things and are we doing those things right? (Online).  Wellington: National 
Advisory Committee on Health and Disability.  Available: 
 http://www.nhc.govt.nz/pub/bestofhealth3/index.htm [21 February 2002]. 
 
  
214
Providers: 
Mark Leggett, Business Manager, The Fertility Centre, Christchurch. 
Interviews: 22 September 1999 & 22 June 2000 
 
The Fertility Centre is the trading name of the New Zealand Centre for Reproductive Medicine 
Ltd, a joint venture set up between Healthlink South and the University of Otago.  The Fertility 
Centre is located at Hiatt Chambers, St George’s Medical Centre Christchurch and provides both 
private and public infertility services.  At the time of the interview, the Fertility Centre held the 
contract for the Southern Funding Region, as well as a portion of the Central contract that 
covered the Nelson/Marlborough region.   
 
Adapted from: http://www.nzcrm.co.nz/ 
 
John Peek, Clinical Manager/Group Operations Manager, Fertility Associates, 
Auckland. 
Interview: 12 July 2000 
 
Fertility Associates was founded in 1987 by Freddie Graham and Richard Fisher, who had 
previously introduced in vitro fertilisation (IVF) to New Zealand while they ran the infertility 
programme at National Women’s Hospital.  Fertility Associates is the provider of publicly-funded 
tertiary infertility services in the North Island and is the largest fertility clinic in New Zealand, 
with clinics in Auckland, Wellington, and Hamilton.  Fertility Associates is also a partner of 
Fertility Associates North Shore, which offers fertility services on Auckland’s North Shore. 
 
John Peek is the Scientific Director for the Fertility Associates group of clinics.  He supervised 
the infertility laboratory at National Women's Hospital from 1984 until he joined Fertility 
Associates in 1987.  He is instrumental in overseeing the Fertility Associate group’s contracts 
with the Health Funding Authority.  As John Peek has worked in the ART field for many years, 
he has had extensive involvement and historical knowledge of the ART policy debates and 
developments.  He is co-author of Costs and effectiveness of infertility services in New Zealand: 
a decision analysis.  A Report to the National Advisory Committee on Core Health and Disability 
Support Services (Gillett, Peek, & Lilford, 1995) and Access to Infertility Services: development 
of priority criteria (Gillett, & Peek, 1997). 
 
Adapted from: http://www.fertilityassociates.co.nz/staff/index.html 
 
Naida Glavish, Chief Advisor - Tikanga, Mäori Health Development Service, 
Auckland Healthcare Services Limited, Auckland. 
Telephone Interview: 9 August 2000 
 
In 1994, Auckland Healthcare was one of the first Hospital and Health Services in New Zealand 
to establish a Mäori Health team to focus on Mäori health issues within the organisation’s 
environment.  Auckland Healthcare’s partnership with Mäori continues to promote values and 
qualities unique to Mäori.  He Kamaka Oranga (Mäori Health Development) is involved in key 
projects within Auckland Healthcare. 
 
Adapted from: http://www.adhb.govt.nz/akhealth/Intro-Human.html 
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Rodney Bycroft, Scientific Director/Manager, Artemis North Shore Fertility, 
Auckland. 
Telephone Interview: 13 September 2000 
 
At the time of the interview, Artemis North Shore Fertility was a private fertility clinic.  The clinic 
did not provide public ART services.  However, in February 2001 the doctors of North Shore 
Fertility, Fertility Associates, and Shore Women merged to form a new company called Fertility 
Associates North Shore.  Rodney Bycroft left the company in December 2000. 
 
Adapted from: http://www.fertilityassociates.co.nz/news/index.html and email communication 
with Fertility Associates North Shore, 20 February 2002. 
 
 
Consumers/Commentators: 
Cindy Carmichael, Health Worker, The Health Alternatives for Women 
(THAW), Christchurch. 
Aline Medland, Health Worker, The Health Alternatives for Women (THAW), 
Christchurch. 
Interview: 14 June 2000 
 
THAW is a health information and resource centre.  The centre offers free pregnancy testing 
and information, free condoms, abortion information and referral, safe sex information, health 
information, and referrals to other groups, individuals, or practitioners.  THAW works in a 
political way to change the health practices that damage women’s health.   
 
Adapted from: http://www.cmrf.org.nz/chr/thaw.htm and THAW information pamphlet. 
 
Sandra Coney, Executive Director, Women's Health Action Trust, Auckland. 
Interview: 13 July 2000 
 
Women's Health Action is a charitable trust with the aims of providing women with high quality 
information and education services to enable them to maintain their health and make informed 
choices about their health care.  The Trust has a health promotion and disease prevention 
focus, with a special interest in screening and approach health within a holistic framework of 
the whole of women's lives, rather than from a narrowly medical perspective.  Since 1984 
Women's Health Action has been at the forefront of women's health in New Zealand.  Founded 
by health activists Phillida Bunkle and Sandra Coney, the group came to national prominence 
when it broke the story of 'the unfortunate experiment' at National Women's Hospital in 
Auckland.  As advocates the Trust lobbies health officials and politicians, makes submissions 
and contributes to the policy development processes, makes media statements Act as consumer 
representatives on government and other health sector committees, publishes reports, books, 
and discussion papers, and networks with other community groups and health professionals. 
 
Sandra Coney is the Executive Director of Women’s Health Action.  She is the co-editor of 
Protecting Our Future (Coney & Else, 1999).  Protecting Our Future is a discussion document, 
which was produced by the Women's Health Action Trust “to assist the debate around ART” 
(Coney & Else, 1999:iii). 
 
Adapted from: http://www.womens-health.org.nz/  
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Robyn Scott, Executive Officer, New Zealand Infertility Society, Wellington. 
Interview: 26 July 2000 
 
The New Zealand Infertility Society (NZIS) is New Zealand’s National Infertility Network.  It was 
formed in 1989 and actively encourages links between all those involved in the treatment and 
support of infertility.  The NZIS is a non-profit consumer-based organisation committed to 
promoting the well being and welfare of all people with fertility problems through national 
representation in the general community, medical arena, and scientific arena.  Its main three 
objectives are Support and Networking, Information, and Advocacy.  The NZIS sees its role as 
advocate for people with fertility problems as involving the promotion of public awareness 
through national representation in the political arena; ensuring that the views and wishes of 
those in the infertility area are represented to decision makers; consumer representation on 
RTAC; accreditation of all clinics working in infertility; and promoting the views of the Society’s 
members with respect to Public funding of infertility services, medical insurance coverage of 
infertility, and legislation affecting the area of infertility. 
 
Adapted from: http://www.nzinfertility.org.nz/about.htm 
 
Sue Bagshaw, Medical Training Co-ordinator, Family Planning Association, 
Christchurch. 
Interview: 21 August 2000 
 
The Family Planning Association (FPA) provides sexual and reproductive health information, 
clinical services, education, training, and research.  Services include- contraception, STD/STI 
checks, menopause, talking to your children about sexuality, vasectomy, PMS, adolescent 
sexuality, pregnancy and many other topics.  The Association is a not for profit charitable 
organisation working to promote a positive view of sexuality.  They aim to help people make 
informed choices about their sexual and reproductive health. 
 
Sue Bagshaw is now the Manager, Medical Services, Southern Region, Family Planning 
Association.  She has been involved in a number of research projects on chlamydia. 
 
Adapted from:  
http://www.theword.org.nz/ and http://www.fpanz.org.nz/default.asp 
 
 
Ken Daniels, Associate Professor, Department of Social Work, University of 
Canterbury, Christchurch. 
Interview: 31 August 2000 
 
Ken Daniels is an Associate Professor in Social Work at the University of Canterbury.  He 
teaches values and ethics and has taken advanced studies in bioethics.  He has been 
researching and writing in the field of assisted human reproduction for twenty four years and 
has published over 100 papers, chapters, and books on this issue.  He is currently involved in 
research in Sweden, Germany, the United Kingdom, Singapore, Argentina, and New Zealand.  
 
Adapted from: http://www.sowk.canterbury.ac.nz/ and  
http://www.newhealth.govt.nz/necahr/membership.htm 
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1 June 2000 
«Title» 
«Branch» 
«Building_Name» 
«Organisation» 
«PO_Box» 
«Street_Address» 
«Suburb» 
«City» 
Attention: «Attention» 
Dear «Attention» 
SUBJECT: SOCIAL POLICY AND ASSISTED REPRODUCTIVE TECHNOLOGY. 
I am a post-graduate student in the Department of Sociology at the University of Canterbury.  
In order to complete my Master’s degree, I am carrying out a research project on policy issues 
surrounding the use of assisted reproductive technology.  In this research project I intend to 
focus on what those involved in the policy discussion (politicians, providers, and consumer 
representatives) consider to be the constraining and/or empowering aspects of the present 
policy situation in New Zealand. 
I would appreciate the «Organisation»’s participation in this study.  Involvement would require 
a one hour semi-structured interview with yourself or a nominated representative of your 
«OrgMin».  During the interview we would discuss current policy issues regarding control, 
regulation, funding, research, and access to assisted reproductive technologies, as well as the 
influence of the proposed legislation should it be enacted.  I will follow this letter with a 
telephone call within the next two weeks to ascertain your«OrgMin»’s willingness to participate 
and to arrange the interview time and location.  At this stage I am anticipating being in «City» 
during early July.   
The project is being carried out under the supervision of Dr Jane Higgins and Ms Rosemary Du 
Plessis.  Both can be contacted at the Department of Sociology, University of Canterbury, phone 
(03) 3667001.  They are willing to discuss any concerns you may have about participation in 
the project.  Should you be interested in the results of this project a ten-page summary will be 
available to your «OrgMin» upon request at the completion of the thesis.  The completed 
document will also be available for reading in the University of Canterbury library. 
Yours sincerely, 
Lynne Batty 
Ph: (03) ******* 
Email: l.batty@soci.canterbury.ac.nz 
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University of Canterbury 
Department of Sociology 
 
 
 
Information Sheet 
 
 
 
 
Social Policy and Assisted Reproductive Technology. 
 
 
I am Lynne Batty, a post-graduate student in the Department of Sociology at the University of 
Canterbury.  My Master’s thesis involves research on policy issues surrounding the use of 
assisted reproductive technology.  I intend to focus what those involved in policy discussion 
about assisted reproduction (politicians, providers, and consumer representatives) consider to 
be the constraining and/or empowering aspects of present policy in New Zealand. 
 
 
During this interview we will discuss current policy issues regarding control, regulation, funding, 
research, and access to assisted reproductive technologies, as well as the influence of the 
proposed legislation should it be enacted.  You will be asked to reflect on your organisation’s 
role in policy discussion and any changes or inclusions to the current policy situation it would 
support. 
 
 
The project is being carried out under the supervision of Dr Jane Higgins and Ms Rosemary Du 
Plessis.  Both can be contacted at the Department of Sociology, University of Canterbury, phone 
(03) 3667001.  They are willing to discuss any concerns you may have about participation in 
the project.  Should you be interested in the results of this project a ten-page summary will be 
available to your organisation upon request at the completion of the thesis.  The completed 
document will also be available for reading in the University of Canterbury library. 
 
 
 
 
 
Lynne Batty 
Ph: (03) ******* 
Email: l.batty@soci.canterbury.ac.nz 
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Consent Form 
 
Social Policy and Assisted Reproductive Technology. 
 
 
 
I have read and understood the description of the above-named project.  On this basis I agree 
to participate in the project in my professional capacity, and I consent to the results of the 
interview being used in Lynne Patricia Batty’s Master’s thesis.   
 
 
Please tick the appropriate boxes: 
 I agree to the use of my name in the above project. 
 I agree to the use of my position in the above project. 
 I agree to the use of my organisation’s name in the above project. 
 
 
 
_______________________________  ______________________________ 
Name       Position     
 
 
 
_________________________________ 
Organisation 
 
 
 
 
 
Signed:_______________________________           Date:________________ 
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Topics Covered in Interviews 
Services & Access Restrictions 
• Services provided by clinics 
• Percentage of publicly funded services versus private services 
• Access restrictions on private services 
• Connecting with consumers 
• Access mediated by geographic location 
• Advertising overseas and “off-shore” clients 
• The proposed national priority access criteria 
• Surrogacy 
Information Collection & Storage 
• Record keeping and storage of information on donors, recipients, and children 
• Access to information on donors, recipients, and children 
• Organisations position on the proposed centralised data collection agency 
Funding 
• Public funding issues 
• Allocation of funding 
• Contract negotiation 
• Changes to funding 
Consumers 
• Ethnic diversity of consumers 
• Availability and/or demand for different ethnicity in donors, recipients, etc 
• Treatment of single people and lesbian or de facto couples 
• Barriers to people using your services – other than funding 
• Who are most affected by these barriers? 
• Information on the demographics of your consumers 
• Public awareness of infertility and its causes 
Policy Issues 
• Organisations role in the ART policy discussion and/or formulation of policy 
• Constraining/empowering aspects of the current policy situation 
• Reaction to the two bills before the Health Select Committee 
• Changes or inclusions the organisation would like to see in the current policy situation 
• The affect of the proposed legislation on current practices 
• Consultation and/or information sharing between clinics, the NZIS, and government 
agencies involved in formulating policy in New Zealand 
• Research – causes of infertility, ART techniques, cloning, genetics, sex-selection, embryo 
research 
• Embryo donation and sex-selection 
• Documentary evidence - submissions, etc. 
Regulation & Control 
• Professional self-regulation or external regulation 
• The Australian Reproductive Technology Accreditation Committee (RTAC) 
• Sanctions for not belonging to or complying with RTAC 
• A New Zealand based overseeing organisation 
• The National Ethics Committee on Assisted Human Reproduction (NECAHR) as a “de 
facto policy maker” 
• Representation and membership of NECAHR 
• Changes to NECAHR’s responsibilities proposed under the Graham bill 
• Tighter regulation and control over ART practices 
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Appendix H: NUDIST Codes 
 
 
 
NVivo revision 1.2.142 Licensee: Sociology Department 
Project: ART & Policy User: Lynne Batty Date: 31/10/01 - 15:27:27 
NODE LISTING 
 
 
Nodes in Set: All Tree Nodes 
Created: 04/09/00 - 17:33:23 
Modified: 04/09/00 - 17:33:23 
Number of Nodes: 54 
 
 
 
1 (1)  /Access 
2 (1 1)  /Access/Priority Criteria 
3 (1 2)  /Access/Points Threshold 
4 (1 3)  /Access/Location 
5 (1 4)  /Access/International 
6 (2)  /Awareness 
7 (2 1)  /Awareness/Education 
8 (2 2)  /Awareness/Entitlement 
9 (3)  /Bills  
10 (3 1)  /Bills /Yates 
11 (3 2)  /Bills /Graham 
12 (4)  /Commercialisation 
13 (5) /Contracts_Service Specs 
14 (6)  /Control_Regulation 
15 (7)  /Family 
16 (8)  /Funding 
17 (8 1)  /Funding/History 
18 (10)  /Gender 
19 (10 1)  /Gender/Differences 
20 (11)  /Information 
21 (12)  /Language 
22 (13)  /Maori 
23 (14)  /Marginal Groups 
24 (14 1)  /Marginal Groups/Single  
25 (14 2) /Marginal Groups/Lesbian 
26 (14 3) /Marginal Groups/Older 
27 (15)  /NECAHR 
28 (16)  /Policy 
29 (17 1)  /Policy/History 
30 (18 2)  /Policy/TPK 
31 (19)  /Research 
32 (19 1)  /Research/Sex-Selection 
33 (19 2)  /Research/Cloning 
34 (19 3)  /Research/Embryos 
35 (19 4)  /Research/Genetics 
36 (20)  /Rights  
37 (20 1)  /Rights/Choice 
38 (20 2)  /Rights/Human Rights Act 
39 (20 3)  /Rights/Children 
40 (20 4)  /Rights/Others 
41 (21)  /Self-Regulation 
42 (21 1)  /Self-Regulation/Sanctions 
43 (22)  /Surrogacy 
44 (22 1)  /Surrogacy/Whangai 
45 (23)  /Statistics_Demographics 
46 (24)  /Social Aspects 
47 (25)  /General 
48 (25 1)  /General/State 
49 (25 2)  /General/Providers 
50 (25 3)  /General/Consumers 
51 (26)  /Ethics 
52 (27)  /Treaty of Waitangi 
53 (28)  /Prevention 
54 (29)  /Accountability 
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Access to this document is available from: http://www.knowledge-basket.co.nz/gpprint/acts 
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Appendix J: Graham Bill 
 
Access to this document is available from: http://www.knowledge-basket.co.nz/gpprint/acts 
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Appendix K: 
Clinical Assessment Criteria 
(CPAC) 
 
G Y N A E C O L O G Y
National Referral Guidelines
PAGE 1
SPECIFIC GYNAECOLOGY REFERRAL LETTER GUIDELINES
• Referrals can be accepted from registered Medical Practitioners, smear takers and midwives.
• Referrals should include GP diagnosis and categorisation with reference to National Gynaecology ACA.
NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options
Gynaecology problems are
addressed under the following
headings:
Page No.
• Amenorrhoea 2
• Cervical Dysplasia (CIN) 2
• Dysmenorrhoea 6
• Ectopic Pregnancy 6
• Infertility 8
• Miscarriage 9
• Menorrhagia 9
• Ovarian cysts 15
• Pelvic pain 15
• Pelvic inflammatory disease 16
• Postcoital bleeding 16
• Postmenopausal bleeding 16
• Postpartum bleeding 17
• Prolapse 17
• Urinary symptoms 17
• Vaginal discharge 18
• Vulval disease 18
A thorough history and
examination is required
to determine a specific
diagnosis and its degree
of urgency.  Some
appropriate investigation
by the referrer will
facilitate the referral
process.
Specific treatments –
see relevant sections.
These guidelines are
provided (below) to
give greater clarity in
situations of the
primary/secondary
interface of care.
Local communication
requirements may be
annotated here:-
Referral Guidelines
Note: These national referral recommendations have been prepared to provide guidelines for referral to specialist gynaecology
services.  They should be regarded as examples or guidelines for referring health professionals and are not an exhaustive
list.  The referring health professional should ensure that in using these national referral recommendations generally accepted
clinical practice should be properly taken into account.  If there is a conflict between the national referral recommendations
and generally accepted clinical practice, then generally accepted practice should prevail.
Version 1 Gynaecology Referral Guidelines and Priorisation Criteria  •  Date: 7/12/2000  •  Authorised: Elective Services, HFA
NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options
HISTORY:
• Age > 15 years
• Weight/height BMI
• Diet
• Exercise
• Family
• Sexual
• Galactorrhoea
• Hirsutism
• Contraception and Drugs
• Environmental factors
• Stress and anxiety
• Past gynaecological and
surgical history
EXAMINATION:
• Secondary sexual
characteristics
• Evidence of any
congenital gynaecological
abnormality/abdominal
mass
• Masculinisation/hirsutism
INVESTIGATIONS:
• FSH/LH/HCG
• Prolactin x 3*
• Thyroid function test
• Ultrasound
• Testosterone
• Chromosomal studies
may be requested in
consultation with the
specialist service
(if unsure).
Counselling and support Refer:
• Where there are
abnormal results
• Failure of secondary
sexual development
• If associated with
infertility
• Significant patient stress
and anxiety.
All category 4
[Note:  Endocrinology
referral recommendations]
Referral Guidelines
AMENORRHOEA
Primary and Secondary
*  Note: only one is necessary
if initial test is normal.
HISTORY:
• Intermenstrual bleeding
• Post coital bleeding
• Smoking
• Sexually transmitted
diseases
EVALUATION:
• Visualise cervix
INVESTIGATION:
• Consider endocervical
swabs
• See attached flow chart
• Treat infections
• Advise re:
Smoking
Safer sex
See attached Flow charts.
Refer to: ‘Guidelines for the
management of women
with Abnormal Cervical
Smears” Sept 1998:
Published by the HFA for
the National Cervical
Screening Programme
Glossary attached as
appendix 1 (page 3)
CERVICAL DYSPLASIA
(CIN)
PAGE 2
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PAGE 3
Summary of the revised Bethesda System (1991) (TBS)15
G Y N A E C O L O G Y
Adequacy of the Specimen
• Satisfactory for evaluation
• Satisfactory for evaluation but limited by….
(specify reason)
• Unsatisfactory for evaluation…. (specify reason)
General Categorisation
• Within normal limits
• Benign cellular changes : See descriptive diagnosis
• Epithelial cell abnormality : See descriptive diagnosis
Descriptive Diagnosis
Benign cellular changes
Infection
• Trichomonas vaginalis
• Fungal organisms morphologically consistent with Candida
• Predominance of coccobacilli consistent with shift in
vaginal flora
• Bacteria morphologically consistent with Actinomyces
• Cellular changes associated with Herpes simplex virus
• Other
Reactive epithelial changes
• Inflammation (includes typical repair)
• Atrophy with inflammation (“atrophic vaginitis”)
• Radiation
• Intrauterine contraceptive device
• Other
Epithelial cell abnormalities
Squamous cell
• Atypical squamous of undetermined significance (ASCUS)
Qualify: favour reactive or favour premalignant/malignant
process
• Low grade squamous intraepithelial lesion (LSIL):
encompassing CIN 1 and/or human papillomavirus (HPV)
• High grade squamous intraepithelial lesion (HSIL):
encompassing moderate and severe dysplasia, CIN 2 and
CIN 3/Carcinoma in situ (CIS)
• Squamous cell carcinoma
Glandular cell
• Endometrial cells in a post menopausal woman who is
not on hormone replacement therapy
• Atypical glandular cells of undetermined significance
(AGUS)
Qualify: favour reactive or favour premalignant/malignant
process
• Endocervical adenocarcinoma in situ (AIS*)
• Endocervical adenocarcinoma
• Endometrial adenocarcinoma
• Extrauterine adenocarcinoma
• Adenocarcinoma, not otherwise specified
Other malignant neoplasms: Specify
* NZ addition to TBS
APPENDIX 1
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Satisfactory
Satisfactory but limited *
Unsatisfactory Smear
Previous normal smears
First smear, or more than 5 years since
last smear
Previous abnormal smears
Previous normal smears
First smear, or more than five years
since last smear
Abnormal smear in last five years
Smear in 3 years
Smear in 1 year
Refer to flow chart
Smear in 1 year
Smear in 1 year
Smear in 6 months
Smear in 1-3 months
Smear Result Smear History Action
PAGE 4
Action Plan for Cervical Smear Results
G Y N A E C O L O G Y
1.  NORMAL OR BENIGN/REACTIVE CHANGES
* Except absent endocervical/metaplastic cells – in which case; If the cervix has been visualised and adequately
sampled and there is no other indication to repeat the smear earlier, repeat the smear in three years.
Smear Result Smear History Action
2.  ABNORMAL
Ascus: unqualified or favour
reactive or LSIL
AGUS: unqualified or favour
reactive
LSIL: CIN 1 and/or HPV
Previous normal Smears
Previous abnormal smear
Smear in 6 months
* AGUS:  favour dysplasia
* AIS
HSIL: CIN 2-3
* HSIL in pregnancy
ASCUS:  possible HSIL
* Suspicious or diagnostic of
invasive carcinoma
Refer to flow chart
* Refer to an experienced colposcopist
* See Appendix 1 for glossary (page 3)
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PAGE 5
Management of the Abnormal Smear
G Y N A E C O L O G Y
ASCUS: unqualified of favour reactive
or LSIL
AGUS: unqualified or favour reactive
LSIL: CIN 1 and/or HPV
* ASCUS: favour dysplasia
* AIS
HSIL: CIN 2-3
* HSIL in pregnancy
ASCUS: possible HSIL
* Cytological or clinical suspicion of
invasive cancer
Index Smears
Smear at 6 months
Normal Abnormal
COLPOSCOPY
(includes evaluation,
treatment and post
treatment smear)
If histological diagnosis
LSIL or less
If histological diagnosis
HSIL or AIS
* refer to an experienced colposcopist
Category 4
Smear at 1 year Smear at 1 yearSmear at 1 year
Smear at 1 year Smear at 1 yearSmear at 1 year
Smear at 6 monthsSmear at 6 months
Three yearly smear until age 70 years Annual smear until
age 70 years
Category 3
Any
abnormal
smears
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NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options
• Pain ( suspect
Endometriosis),
• Fever
• Vomiting 
• Associated discharge
• Deep dyspareunia
• Pain with bowel movement
• Fainting
• Time off activities
EXAMINATION:
• Pelvic mass
• Cervical excitation
INVESTIGATIONS:
• If PID suspected
(see below).
• Ultrasound if pelvic mass
suspected.
1. The key to adequate pain
control is to treat at first
hint of pain/period.
Symptomatic analgesia.
NSAIDs – Any short acting
NSAID O.K.
Response to NSAID can
be idiosyncratic.  The
addition of paracetamol
 may be helpful.
Ponstan for refractory
cases may be tried.
2. COCPs with appropriate
warnings re VTE
3.    Depo Provera
• Unresponsive to
treatment ( no
improvement in 90 days)
– category 4.
• If symptoms severe –
category 3.
• Evidence of mass or
endometriomas -
category 3.
Referral Guidelines
DYSMENORRHOEA
• Diagnosis relies heavily on
suspicion radiological and
biochemical evidence
• Non-acute - Quantitative
serum HCG
• Ultrasound
• An intrauterine pregnancy
should be visible on trans-
vaginal scan if the HCG
>1000 mIU/ml
• If not, and the patient is
>6 weeks pregnant, there
is a 95% chance of ectopic
– D/W  O & G specialist.
• If <6 weeks, and no
intrauterine or ectopic
pregnancy is seen, the
HCG should be repeated
in 2 days (provided the
patients condition is
stable)
• HCG should increase by at
least 80% every 2 days in
established pregnancy
• If the repeat HCG has
increased >80%: re-scan in
10 days
• If the repeat HCG has
fallen, or increased by
<80%: D/W O& G specialist
Acute – refer category 1
Refer
Refer
ECTOPIC PREGNANCY
PAGE 6
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PAGE 7
Investigation of a patient with suspected
Ectopic Pregnancy
G Y N A E C O L O G Y
Suspected ectopic
pregnancy
Qualitative urinary
pregnancy test
Signs of
Haemoperitoneum
Carefully consider
alternative diagnosis
Patient entirely stable
LaparoscopyLaparotomy
Suspected ectopic
pregnancy
Laparoscopy
Definite or presumed
ectopic pregnancy
Approprite medical or
surgical management
Quantitative serum
B-HCG + ultrasound
pelvisa
Intra-uterine pregnancy
Negative
Positive
a  An intra-uterine gestational sac should be seen with abdominal ultrasound when the
B-HCG level is above 2000 mlU/ml.  If a transvaginal probe is used, a gestational sac should
be seen if the level is above 1000 mlU/ml.
Abbreviation: HCG - Human chorionic gonadotrophin
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NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options
INVESTIGATIONS:
• History and examination of
both partners includes
assessment of fertility
awareness1
• Health screening tests for the
female partner – rubella
immunology, VDRL, hepatitis
B antigen, blood group
antibodies2
• Routine semen analysis,
repeated in 4-6 weeks if
abnormal3
• Assessment of menstrual
cycle including3
- a plasma progesterone
timed for 5-9 days before
the next expected period.
 If cycle is long to be
repeated at weekly
intervals until next period
- plasma FSH, LH, prolactin,
thyroid function if the
cycle is prolonged and/or
irregular.  FSH (day 2-5
cycle) for older women
(is measure of biological
age of ovary).
-    Ultrasound of pelvis in
some cases4
* Early Management
- Fertility awareness
- Both partners should be
advised to give up
smoking and limit alcohol
intake
- A supervised weight
improving programme is
advised outside of the BMI
range 18-32
- GPs should advise women
presenting with infertility
to take 0.4 mg folic acid
as a supplement and
during the first 12 weeks
of a pregnancy.
- Counseling and grief
support
- Plan for ongoing support
in primary care after
referral
The fertile phase is a 5 day
period preceding ovulation and
ending on last day of ovulation.
 There is no evidence that the
use of temperature charts and
LH detection kits to time
intercourse improves outcome
and their use should be
discouraged.  Couples should
be advised to have regular
intercourse throughout the
cycle.
• Refer if any abnormality in
history, examination or
investigation
- Refer if unexplained
infertility > 18 months
duration BUT
• Early referral if:
- female age ≥ 35
- a female history of any
pelvic surgery, STDs, PID,
severe cyclical pain
- male history of genital
pathology, urogenital
surgery, STD
Category 4
Referral Guidelines
INFERTILITY
Notes:
1. These will establish predictive factors for various disease processes.  Awareness of the fertile time may not only facilitate
rapid resolution of their infertility, but improve the response to treatment programmes.
2. Tests that should be performed early.  Treatments should be withheld until pregnancy risk factors and their prevention
are addressed.  (Note HIV and Hep C tests for both partners are also recommended if the couple go onto assisted reproductive
procedures).
3. To be completed early in the evaluation.
4. To be completed early in the evaluation if there is a menstrual or ovulation disorder or for assessment of pain.  Its predictive
values for menstrual disorders are outstandingly high.  It is also useful for the definition of ovarian disorders, including
the PCOS and endometriomas.
PAGE 8
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NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options
• Most pregnancies failing in
the first 8 weeks are likely to
completely abort
• After 8 weeks an incomplete
abortion is more likely.
• Assess for cardiovascular
shock, degree of pain,
amount of bleeding, and
social circumstances
• Vaginal examination is
mandatory:
if the cervical os is open there
is no need for ultrasound
scanning;
if closed, a scan is indicated
to distinguish
– threatened abortion
- ongoing pregnancy
- missed abortion
- incomplete abortion
- ectopic pregnancy
• When clinical assessment
suggests a simple,
uncomplicated miscarriage,
and when social
circumstances permit, events
can be allowed to run their
course without admission to
hospital
• Reassessment for any
worsening of symptoms or
signs, or persistence of
bleeding beyond 36 hrs
• Note: Remember anti-D
(within 72 hrs) for any
bleeding or trauma in
pregnancy if patient is Rh-ve
• Refer acute category 1
• Non acute category 2 -  the
next available operating list
Referral Guidelines
MISCARRIAGE
• Menstruation associated with
flooding and/or hourly pad
changes.
• Consider pictorial bleeding
chart (see appendix 2)
• Pelvic examination
• Investigations:
- FBC
- Ultrasound scan
- Pipelle if experienced in
technique (If endometrial
thickness >12mm
or if patients weight > 90 kg
or if patients age > 45 years
Medical Treatment:
• NSAIDs
• Tranexamic Acid (with
Consultant approval)
• OCP
• Levonorgestrel Intrauterine
System (Mirena)
See NHC Guidelines
• Abnormal ultrasound scan
• Failed medical treatment
• To access pipelle sampling
• Category 3-4
See NHC Guidelines
MENORRHAGIA
PAGE 9
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PAGE 10
National Guidelines for Management of Heavy Menstrual
Bleeding Alogorithm
G Y N A E C O L O G Y
NOTE : NHC Guidelines Website:  http://www.nzgg.org.nz/library/gl_complete/gynae_hmb/index.htm
Woman with Heavy Menstrual Bleeding (HMB)
Prolonged irregular cycles?
Abnormal exam uterine
size > 12 weeks
Yes
Yes
Anaemic? Hb <80g/l ?
No
Full menstrual history, Examination, Full blood count (refer page 11)
Refer to Specialist
(refer page 11)
Yes Severe
Access risk of endometrial hyperplasia (refer page 11)
High Risk
No
Yes Mild
Low Risk
Treat Anemia
Hb 80-115g/l
No
Assess endometrium
(refer page 12)
Hyperlastic endometrium
or carcinoma
Refer to specialist
Surgery consideration
(refer page 12)
Treatment success?
Medical Therapy
(refer page 12)
Unexplained HMB Normal endometrium
NoYes
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PAGE 11
G Y N A E C O L O G Y
Explanation of Grading Evidence: The working party accepted a grading of evidence recommended by the Department of Health, UK and
endorsed by the National Health Service Executive, UK (Mann 1996).
Grade A - based on randomised controlled trials*
Grade B - based on robust experimental or observational studies
Grade C - based on more limited evidence but the advice relies on expert opinion and has the 
endorsement of respected authorities
* in diagnostic testing comparative cross sectional studies with a gold standard are Grade ‘A’. A gold standard test is defined as best
available test.
Assess risk of endometrial hyperplasia
Risk of endometrial hyperplasia or carcinoma in women with heavy menstrual bleeding:
All women 4.1%
<45 years old & <90 kg 2.3%
90 kg 10.0%
45 years old 6.0%
Other risk factors for endometrial hyperplasia  (Evidence Grade B):
• Infertility + nulliparity
• Exposure to unopposed endogenous or exogenous estrogen / tamoxifen
• Family history of endometrial and colonic cancer (Evidence Grade C).
Endometrial hyperplasia with atypia may progress (if untreated) to endometrial carcinoma in 20%-75% of cases over
a 13 year period  (Evidence Grade B).
It is estimated that 20% of women with regular HMB will require endometrial assessment because of increased risk
factors.
Refer to Specialist
The following women are recommended to see a specialist at the initial consultation because of increased likelihood
of pathology: (it is beyond the scope of this guideline to provide recommendations for management in these
instances).
• Women with erratic menstrual cycles (regardless of loss) (Evidence Grade B).
• Women with an abnormal pelvic examination (confirmed by transvaginal ultrasound if possible) (Evidence
Grade C).
• Perimenopausal women with less frequent cycles but normal blood loss do not require referral (Evidence
Grade C).
• Women with severe anemia (Evidence Grade C).
It is estimated that approximately 15% of all women with HMB will require specialist referral at the initial consultation.
Full menstrual history, Examination, Full blood count
• Of women who present with HMB, only 50% have menstrual blood loss >80 mls/cycle (Evidence Grade B).
• In women <20 years old pelvic examination is unlikely to contribute to management of heavy bledding and
the likelihood of pathology is small (Evidence Grade C).
• Increased likelihood (70%) of heavy menstrual blood loss .80 mls/cycle if Hb ,120 g/l (Evidence Grade A).
• Consider pictorial blood loss assessment charts (appendix 6.5) for women with normal Hb (Evidence Grade A).
Version 1 Gynaecology Referral Guidelines and Priorisation Criteria  •  Date: 7/12/2000  •  Authorised: Elective Services, HFA
PAGE 12
G Y N A E C O L O G Y
Medical Therapy
• Comparative Table of Medical Therapy
• The Choice of Medical Therapy
• Decision Analysis of Medical Therapy
Levonorgestrel IUS 94 % 100 % Contraception Menstrual cramps
No requirement Expulsion of system (5%)
to take tablets Intermenstrual bleeding (27%)
Oral Progesterone 87 % 86 % Cycle regularity Bloating, Mood swings, PMS
(days 5-25)**
Tranexamic Acid 47 % 56 % None Nausea, Diarrhoea
NSAIDs 29 % 51 % Relief of Nausea, Diarrhoea, Headaches
dysmenorrhoea,
Headaches 
OC pill 43 % 50 % Contraception Nausea, Breast tenderness,
Relief of Headache
dysmenorrhoea, PMS
Danazol 50 % 76 % None Weight gain, Acne
Oral Progesterone -4 % 18 % Cycle regularity Hot flushes, Bloating, Mood
(luteal phase) swings, PMS
Comparative Table of Medical Therapy for the Treatment of Heavy Menstrual Bleeding
Drug Mean Reduction Women Specific Benefits Adverse Effects
in Blood Loss Benefiting*
Assess endometrium
• Transvaginal ultrasound is recommended as first option for endometrial assessment but if not possible then
an endometrial sample should be taken (Evidence Grade A).
• If endometrial thickness on transvaginal ultrasound > 12 mm then an endometrial sample should be taken
(Evidence Grade A).
• Consider specialist referral if abnormal transvaginal ultrasound suggestive of submucous fibroids  (Evidence
Grade B).
• Fifty percent of women >90 kg, who have an endometrial thickness >12 mm on TVS, have endometrial
hyperplasia (Evidence Grade A).
• Less than 1% of women >90 kg, who have an endometrial thickness <12 mm have endometrial hyperplasia
(Evidence Grade A).
• The number of endometrial samples needed to detect 1 case of endometrial hyperplasia overall is 23. In women
> 90 kg the number needed to detect 1 case is 8 (Evidence Grade B).
* Proportion with MBL <80 ml/cycle
** Based on only one randomised controlled trial.
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The Choice of Medical Therapy
The Choice of Medical Therapy will be dependent on individual patient requirements. For example:
Does the patient require contraception ?
Consider:
• LNG-IUS
• OC pill
Does the patient have painful menstruation ?
Consider:
• LNG-IUS
• NSAIDs
• OC pill
Is the patient unable to tolerate hormone treatments ?
Consider:
• NSAIDs
• Tranexamic Acid
• LNG-IUS
See decision analysis at the following table
Some women who have completed their family may decline medical therapy and choose surgery as a first option.
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Decision Analysis of Medical Therapy
Medical Therapy* Ranking According
to Decision Analysis**
(Evidence Grade A)
Levonorgestrel IUS 1
Tranexamic acid 2
NSAIDs 2
OC pill 3
Norethisterone (D5-25 15 mg daily) 3
Danazol 4
* More than one therapy can be considered
** Based on efficacy, side effect profile and acceptability to women over 12 months (Lethaby et al, 1998) (see
appendix 6.5 for full description)
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Pictorial Bleeding Assessment Chart
Name: Date:
        TOWEL 1 2 3 4 5 6 7 8
1
5
20
      TAMPON 1 2 3 4 5 6 7 8
1
5
10
   DAILY SCORE
   TOTAL SCORE =
Name:
        TOWEL 1 2 3 4 5 6 7 8
1
5
20
      TAMPON 1 2 3 4 5 6 7 8
1
5
10
If score of > 185 then likelihood of menstrual blood loss ≥80 mls/cycle is increased.
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E
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Diagnosis Evaluation Management Options Referral Guidelines
OVARIAN CYST
PELVIC PAIN
HISTORY
• Cyclical symptoms
• Pain
• Dyspareunia
• Irregular cycle
• Gastrointestinal
Note: ovarian pathology (e.g.
torsion or carcinoma) may
present with gastrointestinal
symptoms.
• Risk of malignancy greater
pre-pubertally and with
increasing age to 70+.
EXAMINATION:
• Abdominal
• Pelvic
INVESTIGATIONS:
• Ultrasound scan
• CA 1251 in post menopausal
women and all cysts >5cm
• If 5 cms and larger refer.
• If less than 5 cms repeat scan
after a menstrual period
when applicable (can exclude
corpus luteal cysts).
• Refer torsion – category 1.
• Refer others– category 2.
1 CA 125 is associated
with epithelial
irritation of the
ovary so may also be
raised in benign
conditions such as
endometrosis etc
HISTORY
• Severity and duration – pain
on at least 14 days each
month x3 months
• Pain calendar (relative to
menstruation)
• GI function
• GU function
• Dyspareunia
• Dysmenorrhoea
• Sexual history/PID/Surgery
• ?  Sexual abuse in the past
• Time off activities
EXAMINATION
• Swabs/smear – current
• Bimanual examination
• Rectal examination
INVESTIGATIONS
• HVS/Endo Cx swabs
• MSU
• Ultrasound
• Symptomatic analgesia
• COCPs
• Psychological support
• Unresponsive to treatment
refer Category 4
• If symptoms severe
category 3
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NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options Referral Guidelines
PELVIC
INFLAMMATORY
DISEASE
Acute
(c.f. Sexual Health
Referral
Recommendations)
• Pain, discharge, pyrexia
• Recent sexual history
EXAMINATION:
• Pelvic tenderness
• Adnexal masses
• Discharge
INVESTIGATIONS:
• FBC/ESR
• Endocx/urethral
swabs(consider rectal &
throat swabs) for culture &
sensitivity
• Pregnancy test
• Smear if due
1. Link and liaise with STD clinic
as appropriate for contact
tracing etc.  All cases of
resistant gonorrhoea should
be referred to STD
2. Antibiotics:
Augmentin 500mg 8 hrly p.o.
for 14 days
Plus Doxycycline 100mg p.o.
12 hourly for 14 days,
Antibiotics used should be
determined by local
sensitivities.
Note: In pregnancy:
Augmentin as above
Plus Erythromycin ethyl
succinate (EES) 400mg 6 hrly
p.o. for 14 days.
Ceftriaxone 1 gram can be used
as stat doses in the treatment
of gonorrhoea Ciprafloxacin
500 mg (needs specialist
recommendation)
1. May require prolonged
course of antibiotics:
Augumentin; or
Amoxil and metronidazole
instead of augmentin
Acutely unwell, pelvic mass,
unresponsive to treatment
(24 hours).  Refer category 1.
If septic abortion is suspected
refer to category 1
Unresponsive to treatment -
refer category 1.
POSTCOITAL
BLEEDING
• Examine
• Smear
• HVS/endocervical swab
• Small endocervical polyps (less
2cm) in premenopausal
woman with normal smear can
be avulsed and sent for histology
• Ectropion with normal smear
– Rx silver nitrate
1. Refer if recurrent –
category 2
2. If polyps are large, broad
based or the base is not
visible refer – category 3
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POSTMENOPAUSAL
BLEEDING
• Drug history. (Contraception,
HRT)
• Evidence of any genital tract
abnormalities e.g. cervical
polyps1/atrophic change or
abdominal mass
• Sexual/PID history
INVESTIGATIONS:
• Smear
• HVS/endocervical swab
• Pipelle (if experienced in
technique2
• Pelvic  transvaginal
ultrasound3
• Pregnancy Test (unnecessary
> 55 years)
Treatment options for atrophic
vaginitis include short term local
oestriol, or longer term
combination HRT therapy4
(only if ultrasound exam is
normal)
If PMB is a single event, the
ultrasound is normal and no
other cause is suspected then
repeat ultrasound in 3 months
to exclude proliferative
endometrium.  If bleeding
recurs then refer for specialist
assessment
1. Refer to specialist service -
category 2
2. Irregular bleeding on HRT4
– category 2
3. If patient on tamoxifen and
has post menopausal
bleeding refer for specialist
opinion- category 3
(6 months from last
menstrual period)
Notes:
1 Cervical polyps are almost always a benign condition, but referral indicated if associated with post menopausal bleeding, to exclude
other serious causes.
2 If pipelle fails to sample sufficient tissue ultrasound or referral is necessary
3 Endometrial thickness (ET) double thickness measurements are highly predictive of endometrial carcinoma.
If ≤ 5 mm then carcinoma is unlikely
4 It is felt that HRT, its risk assessment and management is the domain of the General Practitioner but referral of women with abnormal
bleeding on HRT after 6 months of therapy is recommended.
Chronic Chronic pain, discharge, erratic
bleeding, recurrent episodes of
acute PID, dyspareunia
INVESTIGATIONS:
• See acute
• Ultrasound scan for pelvic mass
Unresponsive to treatment -
refer category 1.
NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options Referral Guidelines
POSTPARTUM
BLEEDING
• Drug history incl.
contraception
• Delivery history
• Pain, fever.
EXAMINATION:
• Uterine size, tenderness,
temperature
INVESTIGATIONS:
• Endocervical swab
• Chlamydia test
• Hb
• Treat with Augmentin 500mg
TDS  5 to 7 days (dependent
on local sensitivities)
1. Heavy bleeding or pain.
Refer – category 1
2. No response to treatment –
refer – category 2
(within 6 weeks)
Notes:  Ultrasound
scan can be
confusing in
postpartum
bleeding and has
little value in
aiding diagnosis.
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PROLAPSE
(Pelvic anatomical
relaxation)
HISTORY:
• Swelling/Lump
• Interference with
micturition/defaecation
• Dyspareunia
• Oestrogen deficiency
(includes post partum, depo
provera)
EXAMINATION:
• Grade prolapse
INVESTIGATIONS:
• MSU
• FBC
1. If post menopausal,
symptoms of prolapse
without signs may resolve
on treatment with local
oestriol which is worth
a try before referral (i.e.,
3 months)
2. Consider ring pessary.
Symptomatic prolapse -
category 4.
URINARY
SYMPTOMS
UROLOGICAL HISTORY:
- stress, urge incontinence
- frequency, nocturia, enuresis
- Voiding difficulty (hesitancy)
- Haematuria dysuria
GYNAECOLOGICAL HISTORY
(Prolapse Symptoms)
• Medical/Drug History
• Previous Gynaecological/
Obstetric History
• Abdominal/Pelvic/
Neurological Exam
INVESTIGATIONS:
• MSU/Urinalysis (if infected
treat and reassess)
• Urinary diary
• Assess post void residual
• (physical exam/
catheterization/ ultrasound
1. Lifestyle Interventions
(decrease caffeine, weight and
smoking; treat constipation;
appropriate fluid intake)
2. Pelvic Floor Muscle Training
(PFMT) and Bladder retaining
by trained continence
therapist for 3/12
3. Topical vaginal oestriol /HRT
if postmenopausal unless
contraindictated.
4.   Trial of Bladder Relaxants if
presumed overactive bladder
(and no significant post void
residual)
Referral to Gynaecological or
Urological Service in the
following circumstances:
• Failed conservative treatment
(PFMT and Bladder
retraining)
• Complex History e.g.
- Recurrent incontinence
- Incontinence associated
with:
• Pain
• Haematuria
• Recurrent Infection
• Voiding symptoms
• Pelvic irradiation
• Radical pelvic surgery
• Suspected fistula
• Significant Post Void Residual
• Significant Pelvic Organ
Prolapse
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NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Diagnosis Evaluation Management Options Referral Guidelines
VAGINAL
DISCHARGE
(C.F. Sexual Health
referral
recommendations)
VULVAL DISEASE
1. Sexual and PID history
2. Characteristics - odour,
quantity, irritation, blood
staining.
INVESTIGATIONS:
• Smear
• Swab, HVS, Chlamydia, Viral
(if indicated by vesicles)
• Blood Glucose (if recurrent
candida)
1. STD’s - treat patient and
partner.  If GP unable to
arrange contact tracing  and
couselling referral to STD
clinic.
2. Candida: Topical Azole e.g.
Clotrimazole.
Recurrent candida: Topical
Azole course premenstrually
for 3 months or oral
medications e.g. Fluconazole
or Itraconazole
3. Vaginal antiseptic Aci-Jel
4. Physiological – counselling
and education.
1. Refer those women with
copious physiological
discharge and a wide
ectropion for cryotherapy.
2. Unexplained post
menopausal discharge –
category 2
3. Recurrent or failure to
respond to therapy –
category 4
HISTORY:
• pain, swelling, pruritus,
dyspareunia, localised lesions
(pigmented or non-
pigmented lesions)
• Current treatment to date
• Systemic dermatological
problems.
INVESTIGATIONS:
• Consider swabs/scrapings
• Consider biopsy for a
generalised skin condition
1. Antibiotic treatment of
Bartholins abscess is of little
value.  Acute referral for
drainage recommended.
2. The older the patient and/or
the more localised the lesion
of the vulva, the more urgent
the assessment.
3. Topical treatment
appropriate to diagnosis.
• Bartholins abscess/
category 1.
• Bartholins cyst refer
category 4.
• Persisting symptoms despite
treatment – category 2.
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National Access Criteria for First Assessment [ACA]
• highly abnormal cervical smear with
cervical lesion
• post menopausal bleeding
• gestational trophoblastic disease
• genital lesions or pelvic masses highly
suspicious of cancer
• large masses causing symptoms
• heavy vaginal bleeding with severe
anaemia
• Ovarian cysts > 5cms
• Pruritus vulvae
• Procidentia
• Dysmenorrhoea
• Premenstrual symptoms
• Genital prolapse
• Abnormal uterine bleeding
• Infertility
• Amenorrhoea
• Hirsutism
• P.C.O.
• Endometriosis
• Congenital abnormalities
Category Criteria Examples (not an exhaustive list)
• Diagnosed or suspected malignancy
• Major functional disturbance
• Pain requiring narcotic or high levels of
analgesia
• Pelvic masses with low risk of malignancy
• HGSIL of cervix
• Vulval abnormalities
• Anaemia
• Moderate functional impairment
• Chronic PID
• Menorrhagia
• Gynaecological disorders with limited
functional impairment
• Fertility
• Endocrine dysfunction
• Other non urgent problems
• LGSIL of  cervix
2. Urgent
3. Semi - Urgent
4. Routine
NATIONAL REFERRAL GUIDELINES : GYNAECOLOGY
Category Definitions : These are recommended guidelines for hospital specialists prioritizing referrals from primary care.
1. Immediate - acute admission to be arranged
2. Urgent - to be seen at next available clinic or within 2 weeks
3. Semi-urgent - within 4 weeks
4. Routine - within 16 weeks
Immediate and Urgent cases must be discussed with the Specialist or Registrar in order to get appropriate prioritisation and then a referral
letter sent with the patient, faxed or e-mailed (there may be local variety to this). The times to assessment may vary depending on size and
staffing of the hospital department.
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National Access Criteria for Specialist  Clinical Priority
Assessment
General comments and directions
• These criteria do not apply to acute admissions, nor to surgery directly purchased by ACC.
• All sections of the form should be completed including particulars of diagnosis, procedure intended and the outcome of the assessment.
• Select one score only from each category from the options provided.
• The score should be calculated during the consultation, and the patient informed of their eligibility or otherwise for publicly funded
treatment.  This may occur during the first consultation or it may be in a follow-up consultation after investigations have assisted with
establishing a diagnosis (eg CT scans).
• If there is a conflict between generally accepted clinical practice and the decision made by comparing a patient’s criteria score to the
threshold, then generally accepted clinical practice should prevail.  Do not adjust the total score but make comment in the box provided
as to the reasons why the clinician considers that this patient is an exception.  This must be clear so that hospital administrative staff
are aware that the clinician has over-ridden the threshold score and will book the patient in for surgery.  It is expected that the number
of exceptions will be very small and these exceptions may be audited from time to time.
More than one procedure
Where two or more related procedures are contemplated at the same session (for example,
under the same anaesthetic) then the score should relate to the most significant procedure.  If the procedures are unrelated then a separate
score should be determined for each procedure.
Staged procedures
A treatment procedure may be staged over several months or years.  For the purposes of the priority access scoring a related series of
treatments should be considered as one event.  Repeat scoring is not required.
Diagnostic investigations or procedures
Unless there is a specific scoring category that is relevant (for example ‘suspicious of malignancy but unproven’), diagnostic investigations
or diagnostic procedures should be scored as if the investigation will lead to the most likely unfavourable diagnosis.  The patient will be
scored again following diagnosis and before being booked for the definitive procedure.
SPECIFIC COMMENTS
Exclusions:
• These criteria only apply to elective and arranged admissions but not to acute admissions nor ACC purchased surgery.
• These criteria exclude standard operative investigations or treatment for infertility unless the surgery is required to enhance physical
health ( e.g. ovarian cysts, endometrosis – see separate criteria) undertaken at the secondary care level but excludes tertiary infertility
services (including tertiary-level infertility investigations) (separate criteria).
• Sterilisations are excluded (separate criteria).
• Planned terminations of pregnancy are excluded, as various requirements and processes are prescribed by the Contraception, Sterilisation
and Abortion Act 1977.
Clinician judgement for scoring, not patient self-scoring
Scoring should be based on the considered view of the clinician taking into account the patient’s history, examination, results of investigations
and the clinician’s experience in treating like patients.  This is particularly with respect to the scoring categories of ‘degree of pain’,
‘functional impairment’ and ‘social participation’.  It is not appropriate for patients to be asked to complete these scores, as the differentiation
between patients can only occur from the clinician’s experience of this patient compared to other patients in general, and so that the
clinician can ensure that patient-reported pain levels, etc are consistent with the history and examination findings.
“Current Pathology” section
‘No pathology’ means conditions where surgery might be indicated although no pathological process is present.  ‘Benign’ pathology and
the other scoring options within this section mean abnormal function or structure.  ‘Premalignancy’ includes CIN I - CIN III.
“Natural history” section
‘Window of opportunity’:  For some conditions there is an optimum time of treatment.  If treatment is delayed the benefits of the procedure
will substantially diminish or be lost altogether, or the potential for malignancy or another major complication is greatly increased.  It is
felt that such clinical situations should be afforded a higher priority.
“Degree of pain” section
(Refer ‘clinician judgement’ above.)
“Functional impairment” section
(Refer ‘clinician judgement’ above.)
Where relevant, this may include the impact on parents, guardians or caregivers of children and dependent patients.
“Social participation” section
This should be taken from the perspective of both the individual patient’s situation and ability as well as what is relevant to the patient’s
age, gender, etc.  Wide consideration may be given to the patient’s situation, including, for example, the ability to work or carry out usual
activities, live independently, undertake recreational activities, give care to dependents.  For children, it is important that this should include
the ability to participate in appropriate educational activities. (Refer ‘clinician judgement’ above.)
“Effectiveness of procedure/investigation” section
Diagnostic procedures/investigations are assumed to be fully effective.  The effectiveness of therapeutic procedures should be based on
the usual effectiveness of that procedure taking into account anything of direct relevance to the particular patient that would increase
or reduce that effectiveness.
G Y N A E C O L O G Y
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National Clinical Priority Assessment Criteria (CPAC) for
Treatment
Patient ID: Complete patient details or place patient sticker here
Nat. Hospital No.:      Consultant:
Name:                                                                    D.O.B.
Address:
Name of Assessor:
Date of Assessment:
Diagnosis: Procedure:
Current pathology
Malignancy proven 40
Suspicious of malignancy, but unproven 35
Premalignancy 30
Benign 10
No pathology 0
Natural history of the potential/actual problem
Likely to progress to major complication/
window of opportunity 15
Likely to continue to deteriorate 10
Likely to remain stable 5
Likely to improve in the short term 0
Degree of Pain
Severe (dominates life and regularly interferes with sleep) 10
Moderate (persistent pain causing modification to
aspects of daily living) 6
Intermittent 4
Minimal or no pain 0
Functional impairment - disturbance in patient’s
life including sexual function
Major disturbance 15
Moderate disturbance 10
Minor disturbance 5
No disturbance 0
Social participation
Immediately threatened 10
Threatened but not immediately 6
Not threatened but more difficult 4
Not threatened or difficult 0
Effectiveness of therapeutic procedure/
diagnostic investigation
Diagnostic investigation or very effective therapeutic procedure 10
Moderately effective therapeutic procedure 5
Therapeutic procedure of low effectiveness 0
TOTAL
COMMENTS
GENERAL GYNAECOLOGY
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National Clinical Priority Assessment Criteria (CPAC)
Sterilisation Procedures
Patient ID: Complete patient details or place patient sticker here
Nat. Hospital No.:      Consultant:
Name:                                                                    D.O.B.
Address:
Name of Assessor:
Date of Assessment:
Age of female
30 years or younger 5
31 -35 years 10
36 years or older 15
Number of live children
0 0
1 - 3 5
More than 3 10
Unplanned pregnancies
Nil 0
1 10
2 15
3 or more 20
User contraception
No contraception difficulty 0
User contraception difficult (irrespective of cause) 25
Medical History: Health risk impact due to potential pregnancy
No identified health risk 0
Health problems that increase health risk during pregancy
(mild) 10
(moderate) 20
(severe) 30
TOTAL
COMMENTS
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National Guidelines for using the National Sterilisation
Clinical Priority Assessment Criteria (CPAC)
General comments and directions
• These sterilisation criteria apply to both female and male sterilization. In the case of male
sterilisation the female partners age, user contraception and medical history are to be
considered.
• All sections of the form should be completed including particulars of diagnosis, procedure
intended and the outcome of the assessment.
• Select one score only from each category from the options provided.
• The score should be calculated during the consultation, and the patient informed of their
eligibility or otherwise for publicly funded treatment.
• If there is a conflict between generally accepted clinical practice and the decision made
by comparing a patient’s criteria score to the threshold, then generally accepted clinical
practice should prevail.  Do not adjust the total score but make comment in the box
provided as to the reasons why the clinician considers that this patient is an exception.
This must be clear so that CHE administrative staff are aware that the clinician has over-
ridden the threshold score and will book the patient in for surgery.  It is expected that the
number of exceptions will be very small and these exceptions may be audited from time
to time.
More than one procedure
Where two or more related procedures are contemplated at the same session (for example,
under the same anaesthetic) then the score should relate to the most significant procedure.
If the procedures are unrelated then a separate score should be determined for each procedure.
“User contraception” section
User contraception difficulty is irrespective of cause and may, for example, relate to:
• either the woman or her partner
• inability to use other forms of contraception
• unsuitability of other forms of contraception
• adverse reactions or allergies
Version 1 Gynaecology Referral Guidelines and Priorisation Criteria  •  Date: 7/12/2000  •  Authorised: Elective Services, HFA
G Y N A E C O L O G Y  /  I N F E R T I L I T Y
PAGE 24
National Specialist Guidelines for Investigation of Infertility.
Priority Criteria for Access to
Public Funding of Infertility Treatment
In 1997/98 the publication of the National Health Committee’s consultation document
“Access to infertility services: development of priority criteria” received numerous
public and professional submissions, almost all being in favour of the general principles
that fair and equitable access to publicly funded could be achieved by these criteria.
These criteria have been tested in at least 2 NZ tertiary centres and with minor
modifications the original proposal is being presented to the HFA to introduce to the
NZ Health system.
This document is not about directing therapy.  It is about guiding the evaluation of
the infertile couple to achieve a standardised diagnosis and then providing a rationing
basis for public access for treatment, especially using the assisted reproductive
techniques.  It is intended to benefit those who are most in need for therapy, but
balanced by a system that will ensure maximum benefit.  The actual level of access
will be dictated by the proportion of public funds available for treating infertility.
Evaluation of the pilot application of these criteria for IVF funding have, however,
confirmed the view that infertility services are severely underfunded. We see these
criteria as an essential step in establishing the level of funding needed for infertility
treatment and request that Health Practitioners, working with them, use the criteria
with diligence and honesty.  Already the HFA have declared its support by providing
significant funding to assist in clearing the waiting lists for Assisted Reproduction.
We emphasize that the application of the criteria and their weighting is just the
beginning.  These criteria need to be validated by ongoing research and public
discussion.
Wayne R Gillett, John Peek, July 1999
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Section I
Investigation and Diagnosis – a Standardised Approach
Investigation in Primary Care
Refer to National Referral Recommendations: Gynaecology; Infertility
Investigation in Secondary Care
As for primary care.  In addition:
• A post–coital test may be used in the early investigation of a referred couple,
but the results should be interpreted with caution.  Performance of this test is
not essential to complete the diagnostic categorisation of the couple (see
diagnostic categories).
• Screening for antisperm antibodies is not a routine test, but is suggested when
there is a history of testicular trauma or vasectomy reversal.  Performance of
this test is not essential to complete the diagnostic categorisation of the couple.
• Sperm function tests and sperm assessment procedures (e.g. swim-up tests)
should not be used in secondary care practice.  They may be of value in helping
a couple choose an appropriate ART in a tertiary level service.
• A hysterosalpingogram may be used to test tubal patency.  Laparoscopy is the
gold standard test for tubo-peritoneal disease and is the preferred method,
especially when evaluation of the pelvis is required.  If there is a severe semen
defect (score of 6, see next page) then there is no need for laparoscopy unless
indicated for other gynaecological reasons (or following failed DI treatment).
Furthermore for ovarian defects, a trial of therapy is indicated before laparoscopy
is considered.   Otherwise laparoscopy should be booked within 6 months in the
following circumstances:
1. severe cyclical pain or suspected pelvic pathology
2. infertility of 18 months duration and where there is a female history of any
pelvic surgery, STDs or PID
3. infertility of 18 months duration and a female age ≥ 30 years of age
4. otherwise unexplained infertility ≥ 3 years duration
5. failed DI or ovulation induction (3-6 cycles of treatment)
Diagnostic categories – to be completed at the secondary
(specialist) level
The diagnostic model given here recognises the importance of the severity of a
diagnosis and a combination of infertility factors on the probability of a successful
outcome without treatment.  To define the prognosis calculate the points for each
diagnostic category 1,2,3,4,5 and 6.
SECTION 1
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Patient ID: Complete patient details or place patient sticker here
Nat. Hospital No.:      Consultant:
Name:                                                                    D.O.B.
Address:
Name of Assessor:
Date of Assessment:
(2)  Semen Defects Categories
Semen sample collected after 2-3 days abstinence.
To be repeated in 4-6 weeks if abnormal.
The measurement of antisperm antibodies, post
coital test or other sperm function tests are not
essential for this category, but may be included as
indicated
<1 million motile sperm/ml / severe ejaculatory
dysfunction / severe sperm antibodies
1 < 5 million motile sperm /ml / moderate antibodies
/ repeat negative PCT or sperm function abnormality
5-10 million motile sperm/ml
Any other semen defect
No semen defect
SCORE 2
6
3
2
1
0
(3)  Endometriosis Categories
The American Fertility Society Classification
(American Society for Reproductive Medicine 1997).
This requires direct visualization by laparoscopy.
Surgical treatment at the time of diagnosis will be
at the discretion of the gynaecologist conducting
the procedure, depending on the common practice
of the clinic.
stage IV AFS classification
stage III AFS classification
stage II AFS classification
stage I AFS classification
No endometriosis
SCORE 3
To be completed following laparoscopy
6
3
2
1
0
(1)  Ovulation Defects Categories
From history, including
• a plasma progesterone timed for 5-9 days before
the next expected period.  If cycle is long to be
repeated at weekly intervals until next period
• plasma FSH, LH, prolactin, thyroid function if the
cycle is prolonged and/or irregular.  FSH (day 2-
5 cycle) for older women (is measure of biological
age of ovary).
amenorrhoea - any cause
oligomenorrhoea from any cause / luteal defect
anovulation with normal menstrual cycle
intermittent anovular cycles
no ovulation defect
SCORE 1
6
3
2
1
0
Initial Assessment
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(4)  Other Tubo-peritoneal Disease Categories
6
3
2
1
0
(5)  Other Factors Categories
6
3
2
1
0
Although classification can be based on experience
of examining specialist, we encourage the use of the
American Fertility Society classification of adnexal
adhesions (1988).  In many cases the pathology may
be different on each side.  The adnexa with the least
pathology should be used (best side).
Surgical treatment at the time of diagnosis will be
at the discretion of the gynaecologist conducting the
procedure, depending on the common practice of
the clinic.
Proximal or distal (complete or partial) occlusion
on best-side / severe encapsulating tubal or ovarian
adhesions on best-side, / missing tubes / or
unsuccessful proximal or distal surgery after 12
months
Moderate encapsulating  tubal or ovarian adhesions
on best-side adnexa / unsuccessful surgery after 6
months
tubal polyps / mild encapsulating adhesions on
best-side or / normal tube on best-side with tubal
occlusion on the other-side or uterine adhesions
minimal tubal or ovarian adhesions on best-side
adnexa
No tubo-peritoneal pathology
SCORE 4
These should be classified at discretion of specialist,
e.g. psycho-sexual disorders
fibroids
intrauterine pathology
severe
moderate
mild
minimal
absent
SCORE 5
(6)  Unexplained Infertility Categories
If no diagnostic abnormality then define the duration
of the unexplained infertility
Unexplained infertility ≥ 5 years
Unexplained infertility ≥ 4 < 5 years
Unexplained infertility ≥ 3 years < 4 years
Unexplained infertility < 3 years
SCORE 6
No diagnosis abnormality identified, i.e. unexpained infertility
6
3
2
1
Final Score for Diagnosis
Add scores 1,2,3,4,5,6 =  Score D
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Access to Publicly Funded Treatment
General Principles:
1. Provision of basic support and guidance at the primary level should be subject to normal primary care
charging
2. Simple ovulation induction may be managed by the GP in consultation with a specialist service.
3. Simple conditions requiring medical or psychological therapy should be provided within the primary
or secondary services without need for access criteria
3. Conditions with organic disease requiring surgery to enhance physical health (e.g. ovarian cysts,
endometriosis) should be subject to the same criteria as for Gynaecology access criteria
4. Conditions that can be managed equally as well with ART or surgery (e.g. tubal occlusion) should be
subject to access criteria for infertility.  These treatments include AIH, IVF, IVF and ICSI, DI, ovulation
induction using gonadotrophins (± AIH).  The treatment available per individual couple should be
directed by the specialist in charge of the individual / couples infertility and in consultation with that
individual / couple.  The cumulative amount of treatment available to people will depend on public
funding available.
A
SECTION 2
Steps in defining access criteria
1. Exclusion factors for access to treatment
The first is absolute - with access refused if there are situations that compromise the safety of the couple
or a child.  However no factor may be used that is unlawful and that might breach the Human Rights Act
or the Bill of Rights Act.   Ultimately it will be the doctor, practicing at a primary, secondary or tertiary
level, who will decide - and that doctor would need to defend this decision.
B
2. Modifying factors for access to treatment
These are conditions that can be modified to improve the chance of conception:
• Hydrosalpinges
Complete distal tubal occlusion, or the hydrosalpinx, accumulates tubal fluid that may drain into the
uterine cavity giving a detrimental effect on pregnancy rates with IVF.  Depending on the severity of the
tubal disease, either salpingostomy or salpingectomy should be performed in women planning entry into
an IVF programme.  The surgery should be performed by specialists trained in microsurgery or laparoscopic
surgery.  Each main centre in New Zealand has such specialists.
• Body weight
Weight improvement programmes should be instituted before beginning treatment in women who are
outside the BMI range of 18-32.  There are factors that limit the success of weight improvement, and in
this circumstance it is reasonable to proceed with treatment providing the ovarian response is closely
monitored.  Treatment should only continue if the response is satisfactory.
Version 1 Gynaecology Referral Guidelines and Priorisation Criteria  •  Date: 7/12/2000  •  Authorised: Elective Services, HFA
PAGE 29
G Y N A E C O L O G Y  /  I N F E R T I L I T Y
3. Calculation of the Priority Score
Each of the following criteria should be recorded following diagnosis and request for therapy, and modified
on an annual basis.  For example, June 1 of each year may be regarded as the ‘annual’ date of revision,
since new HFA funding rounds follow on July 1.  Simple spreadsheet programmes are available that can
recalculate a priority score, simply by adding a new date. Copy of programme available from Wayne Gillett,
Dept. O&G PO Box 913.
The final score is the product of a group of objective factors (O1 – O4) and a group of social (subjective)
factors (S1 – S3).  Points for each of the objective factors are directly proportional to the pregnancy rate.
 Points for the subjective factors were derived from the results of questionnaires returned by health
professionals and consumers.
• The age of the female partner
The weighting of the points reflects the probability of conceiving with therapy..
• The prognosis of conceiving without treatment
See section I for calculation of diagnostic scores.
If Score D = 6 then prognosis < 5% probability of conception in 1 year
If score D = 3 < 6 then prognosis 6 - 20 % probability of conception in 1 year
If Score D = 2 < 3 then prognosis 21-50% probability of conception in 1 year
If Score D < 2 then prognosis >50% probability of conception in 1 year
The weighting of these points reflect the inverse relationship of the likelihood of conceiving
• The basal plasma FSH
Ovarian reserve is commonly measured by basal FSH levels between days 2-5 of the menstrual cycle.
The normal range will depend on the local assay.  The weighting of points reflect the chance of conceiving.
 If donor oocytes are used in an IVF programme, the donor’s FSH level should be measured.  FSH should
be measured within 6 months before the first planned ART cycle, and repeated at least every 6 months.
The normal value be ≤ 12 IU; borderline be >12≤15; and abnormal be >15.
• A history of current smoking in female partner
The point system reflects the relative risk on pregnancy outcome of smoking.
Although this will become a priority factor we envisage most women, by stopping smoking, will increase
their priority points after 6 months and improve their eligibility depending on the threshold for access
to treatment.  We believe every effort should be made by women seeking any form of fertility treatment
to give up smoking. Duration of smoke free to be three months and no cigarettes at all.
• Duration of infertility
The points given here relate to how people feel about the burden of the duration of infertility, rather
than how it affects the chance of pregnancy.  The duration of infertility to cumulative of previous and
current relationships. For single women or lesbians it will be on the basis of either biological infertility
or in the case or unexplained infertility to be confirmed by 12 cycles of DI of which 6 should be within
an accredited RTAC unit.
• Number of children
A child may include an adopted child.  These are children currently living with the couple or person.
• Previous sterilisation
The points given here recognise the burden of some people never having had children, or the burden of
having lost a child (children) by death.
Version 1 Gynaecology Referral Guidelines and Priorisation Criteria  •  Date: 7/12/2000  •  Authorised: Elective Services, HFA
G Y N A E C O L O G Y  /  I N F E R T I L I T Y
PAGE 30
Calculation of priority criteria points for publicly-funded infertility treatment
Criteria
symbol Points awarded Criteria and their categories
Points
available
Chance of pregnancy
without treatment
≤ 5% 10
6-20% 7
21-50% 4
>50% 2
Woman’s age
≤ 39 years 10
40-41 5
42+ 1
Basal FSH, day 2-5 cycle, with
respect to reference range
always within 10
sometimes above 8
mostly/always above 2
Woman’s smoking
non smoker 10
smoker 6
O1
O2
O3
O4
Multiply O1 x O2 x O3 x O4 = OC (points from objective criteria)
= Now divide OC by 10000 = Revised OC (ROC)
OC ROC
National Clinical Assessment Criteria (CPAC) for Treatment
of Infertility
Duration of infertility
< 1 year 5
1<3 year 20
3<5 years 40
≥ 5 years 50
S1
Number of children
None 30
1 by current relationship 10
> 1 by current relationship 5
≥ 1 child by prev relationship 8
S2
Sterilisation reference
rangeS3
neither partner sterilised 20
death of child 20
one partner sterilised 10
Sum S1 + S2 + S3 = SC (points from social criteria) =
SC
Multiply ROC x SC = Priority Score (PS) =
PS
Patient ID: Complete patient details or place patient sticker here
Nat. Hospital No.:      Consultant:
Name:                                                                    D.O.B.
Address:
Name of Assessor:
Date of Assessment:
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SERVICE SPECIFICATION 
SERVICE CODE : ASSISTED OR ARTIFICIAL REPRODUCTIVE 
TECHNOLOGY SERVICE 
1. DEFINITION 
 
The Service will provide a range of tertiary treatment services for people experiencing 
infertility.  You will also provide advice and information services and best practice guidelines 
on fertility issues for primary and secondary services. 
 
The service you provide covers Assisted Reproductive Technologies (ART) including: 
 
• In Vitro Fertilisation (IVF) 
• Intrauterine Insemination (IUI) including hyperstimulation 
• Intracytoplasmic Sperm Injection (ICSI) including the sperm retrieval techniques of 
? Percutaneous Epididymal Sperm Aspiration (PESA) 
? Testicular Sperm Extraction (TESE) 
? Microsurgical Epididymal Sperm Aspiration (MESA) 
• Donor Insemination (DI) 
• Ovulation Induction with gonadotrophins 
• First and follow-up consultations tertiary consultation 
• Tertiary level investigations for diagnosis e.g. tests of sperm function to decide between 
IVF and ICSI. 
• Social work & counselling 
• Long term storage of gametes for oncology 
 
Indication for Assisted Reproductive Technologies (ART) will be guided by the clinical priority 
assessment criteria (CPAC) access threshold 
 
This service is closely related to but distinct from: 
 
Gynaecology services including secondary fertility services 
Sexual health services 
Urology services 
Surgical services 
Endocrinology services 
Genetic services 
 
which are covered by separate service specifications. 
2. SERVICE OBJECTIVES 
2.1 General 
 
You will adhere to the guidelines for infertility services: 
 
a) the ART services you provide are the most appropriate treatment for the person. 
b) each couple will be treated as a unit 
c) the services should be available to all people with biological infertility, including those 
whose fertility is or will be impaired by cancer treatment or injury 
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2.2 Maori Health 
 
The Treaty of Waitangi establishes the unique and special relationship between Iwi, Maori 
and the Crown.  As a Crown agency, the health Funding authority considers the Treaty of 
Waitangi's principles of partnership, proactive protection of Maori health interests, co-
operation and utmost good faith, to be implicit conditions of the nature in which the internal 
organisation of the Health Funding Authority responds to Maori health issues. 
 
You agree that Maori health is a specifically identified health gain priority area.  You must 
therefore establish and implement a Maori health policy that reflects that fact.  In developing 
this policy, and without limitation, you must take into account our strategic direction for Maori 
health in terms of minimum requirements for Maori health based on the Treaty of Waitangi, 
Crown objectives for Maori health and specific requirements negotiated from time to time with 
us. 
 
You must specify how you intend to implement this policy.  In particular, you will identify how 
these services will be measured to ascertain what benefit is evident and any other additional 
opportunities that may exist for furthering Maori health gain. 
 
The plan will be available within 3 months of the implementation of the service specifications 
3. SERVICE USERS 
 
Eligible people are those who are unable to achieve pregnancy after at least one year of 
unprotected intercourse of attempting, or have biological circumstances which prevent them 
from attempting, or are unable to carry a pregnancy to term.. 
4. ACCESS 
4.1 Entry and Exit Criteria 
 
You will provide this service in accordance to the referral guidelines (RG’s), access criteria for 
first specialist assessment (ACA) and clinical priority assessment criteria (CPAC) 
 
4.1.1 Boundaries to treatment 
 
You will apply the following boundaries to the service: 
 
a) treatment should normally be commenced within 6 months of it being offered. 
b) treatment must normally be completed within 18 months of starting first cycle 
c) frozen embryos should normally be used where practical from the first OPU cycle to 
commencing a second OPU cycle.  Couples will be expected to pay for storage after  18 
months of first storage 
d) further IVF funded by the provider can be declined if ovarian response was poor – namely 
if when using 300 IU gonadotrophin per day there were three follicles or fewer or the 
maximum blood estradiol level was less than 3000 pmol/l  -  
e) IVF treatments will be available for a maximum of one cancelled and/or incomplete cycle 
and one completed cycle
1
 per couple 
 
4.1.2 Co-payments 
 
You will not charge a co-payment for any public services provided under this service 
specification except for 4.1.c above or where a couple elect to have services beyond those 
covered by this contract. 
                                                           
1
 A completed cycle is defined as one that goes to embryo transfer and/or freeze transfer 
A cancelled or incomplete cycle is one that does not result in a transfer 
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4.2 DISTANCE 
 
Patients shall be eligible for transport and accommodation expenses as per  the current HFA 
guidelines.   
5. SERVICE COMPONENTS OF TERTIARY INFERTILITY 
 
SERVICE COMPONENT DESCRIPTION 
Initial assessment by an appropriately 
qualified clinician and development of a 
treatment plan 
 
 
 
 
This includes: 
 
1. Initial assessment by the 
specialist 
2. Confirmation that the patients 
meet the access criteria and are 
suitable for ART treatment 
3. Referral of patients who do not 
meet criteria or are unsuitable 
back to the referring clinician and 
explanation of the reasons to the 
patients/whanau 
4. Primary and secondary 
investigations have been 
completed as per national referral 
guidelines. 
5. Discussion of ART treatment and 
management plan with 
patients/family/whanau as 
appropriate, including 
expectation, possible risks, after 
care arrangements, expected 
waiting time to receive treatment 
(essential information to be 
supplied in writing) 
6. Written consent obtained for 
treatment procedures and 
anaesthesia 
7. (If appropriate) pre-operative 
referral to the appropriate 
anaesthetist for anaesthetic 
management during treatment 
and respiratory and pain 
management post treatment 
Peri-treatment care This includes: 
 
1. Preparation and treatment of the 
women for ART procedures, 
including preparation counselling 
2. The service in this phase includes 
all counselling by medical, 
nursing, social work and scientific 
staff, including laboratory tests 
and radiology services 
3. Pharmaceuticals required to be 
administered at the time of each 
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treatment 
4. All necessary ultrasound scans 
and blood tests after instituting 
this service phase 
5. Oocyte pick up 
6. Insemination and Embryo 
replacement 
7. Embryo freezing per cycle (as 
appropriate) 
8. Immediate post treatment 
recovery including medical, 
nursing and other technical 
services as required 
Post-treatment care Managed care including: 
 
1. Immediate response to 
emergencies 
2. Pain control 
3. Prevention and management of 
post-treatment complications 
4. Professional clinical services 
including medical, nursing, 
counselling and other 
professional and technical 
support services as required 
5. Discharge as soon as it is 
appropriate and with a written 
discharge summary and care plan 
to be provided to the patient, 
specialist and general practitioner 
6. Patients are familiar with their 
current medication and can 
address any concerns before 
leaving clinic/hospital or 
arrangements are made with the 
patient’s general practitioner for 
this to occur 
Provision of consumable supplies while 
in clinic/hospital 
This includes, but is not limited to 
anaesthetic agents and other 
pharmaceuticals and disposable 
equipment 
Clinical follow-up This includes: 
 
1. Specialist assessment of 
treatment effects and further 
treatment requirements 
2. One follow-up appointment or 
more if clinically required 
3. Review clinic 3-4 months post 
ART or as indicated. 
4. Early pregnancy assessment 
(ante-natally up to 12 weeks, then 
referred on) 
Consultation and education services 1. Educative services are provided 
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to general practitioners and other 
specialists concerning 
appropriate referral protocols and 
indications for ART 
2. Consultation and advisory 
services are provided to general 
practitioners and other specialists 
concerning the condition and 
ongoing management of the 
referred couples 
 
5.3 Settings 
 
The place where the service is provided will be an inpatient or day case setting. 
5.4 Service Levels 
 
You will provide this service at a tertiary level 
5.5 Equipment 
 
You will have access to equipment appropriate to operate a Reproductive Technology 
Accreditation Committee (RTAC) accredited laboratory 
5.6 Support Services 
 
You will provide the following support services; 
 
5.6.1 Clinical support services – You will provide or have access to the following services 
as clinically required: 
 
- operating theatre and anaesthetic services 
- laboratory 
- pharmacy 
- radiology - ultrasound 
- sterile supply 
 
5.6.2.  Consumer registration service 
 
You will maintain complete and accurate records identifying consumers, donors and 
recipients of all gametes involved in fertilisation and embryo formation and detailing the use or 
disposal of all gametes and embryos. 
 
You will maintain an information system which allows for consumer follow-up and 
confidentiality within accepted guidelines and lawful requirements. You will be cognisant of 
Maori requirements around guardianship of personal information and practise these 
rigorously. 
 
5.6.3.  You will provide a specialised scientific and laboratory services including storage, 
analysis and programme implementation. 
5.7  Facilities 
 
You will provide commercial support services including: 
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- inpatient and outpatient facilities, including furnishings, fittings, equipment, lighting, 
heating and other amenities 
- laundry services 
- catering 
- cleaning 
5.8 Key Inputs 
 
Counselling 
 
You will provide a counselling service to address the social and psychological effects of 
undergoing infertility treatments as well as other options such as adoption or living without 
children to all eligible couples.  You will ensure that, where appropriate, the special needs of 
Maori will be accommodated.  This may include involvement of whanau in counselling 
sessions. 
 
You will ensure that you have access to cultural advice including that received from Maori 
advocates, Maori providers, and Kaumatua support where that is identified by the 
client/whanau. 
6. SERVICE LINKAGES 
 
Associated Services 
 
You should provide the following support services in providing infertility services: 
 
a) pathology services 
b) radiology services 
c) operating services 
d) anaesthetic services 
e) pharmacy services 
 
You will ensure links are established and maintained with: 
 
a) primary health services, including health education 
b) general practitioners 
c) secondary and tertiary medical services 
d) general surgical services 
e) community support groups including NZ Infertility Society 
f) Maori health providers  
 
You are to have effective links and continuity of care with the following services: 
 
• Community groups including the Infertility Society 
• Research units 
• Ethics Committees  
 
And continuity of care with: 
 
• Primary health services including General Practice, Family Planning Association, New 
Zealand Association of Natural Family Planning, Sexual Health Clinics, Maori and Pacific 
Island providers, maternity providers 
• Secondary medical and surgical services, especially gynaecology and urology 
7. EXCLUSIONS 
 
• You will follow the CPAC guidelines and any further changes 
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• ACC claimants 
8. QUALITY REQUIREMENTS 
 
All specialists undertaking the procedures are registered as medical specialists in the relevant 
medical or surgical discipline and have specialised training and experience in ART. 
 
The service has current accreditation by the Reproductive Technology Accreditation 
Committee (RTAC). 
 
All anaesthetists undertaking the procedures are registered as specialist anaesthetists. 
 
All other professional staff providing the service must hold a current practising certificate 
applicable to their profession. 
 
Health professionals holding current practising certificates will supervise all health 
professionals under training programmes, who do not yet hold current practising certificates. 
 
Laboratory services (or as applicable, individual pathology departments) are registered or 
working towards registration with IANZ or an equivalent accreditation programme. 
 
Ethical review and advice is obtained from an accredited Ethics Committee of the Health 
Funding Authority for research and experimental treatments, in accordance with the national 
standards for Ethics Committees. 
8.1 General 
 
You will aim to minimise complications of treatment, including hyperstimulation syndrome, 
infections, multiple pregnancy and babies needing neonatal intensive care.  This means 
careful consideration of the number of embryos transferred in IVF and of the degree of 
ovarian stimulation in all treatments. 
8.2 Access  
You will provide General Practitioners and relevant Specialists with information about the 
services provided in this contract, including eligibility.  You will be available to answer queries 
about the service from doctors and the public. 
 
Once referred for consultation, you will see new patients within a specified time, to be agreed 
on between the provider and the HFA. 
 
You will identify and remedy any barriers to access by Maori, and obtain Maori opinion about 
the service. 
8.3 Acceptability 
 
a) You will undertake customers surveys, and change the delivery of the service according 
to the feedback received. 
 
b) You will ensure Maori views are heard, and that Maori participate in planning, delivery 
and monitoring the service. 
 
c) You will provide a private and confidential service, and have a named privacy officer to 
monitor performance and answer any complaints.  Privacy issues include those of 
gamete and embryo donors, and children conceived using donated gametes and 
embryos. 
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d) You will ensure all patients understand the diagnosis and treatment they are undertaking 
through the provision of written and verbal information in plain language, and the 
availability of interpreters. 
 
e) You will ensure informed consent is obtained before any treatment or investigation is 
started, and that all consent for treatments involving gametes and embryos is written. 
 
f) You will ensure that all services are co-ordinated from the perspective of the patient. You 
will help patients accept their infertility when treatment is not available, not chosen, or 
does not lead to pregnancy.  Patients should feel they have achieved the best outcome in 
the circumstances. 
 
g) You will promote awareness of infertility, its prevention, and the minimisation of its impact 
among the general public. 
8.4 Efficiency 
 
You will ensure that the services in this contract are delivered within the contract price and 
that services are equally distributed over each individual year. 
8.5 Safety 
 
a) You will ensure that the clinic is accredited by the Reproductive Technology Accreditation 
Committee of Australia. 
 
b) You will comply with all relevant legislation, regulations, statutory requirements, and 
guidelines from professional bodies. 
 
c) You will have risk management procedures in place, including for infection control, 
medical emergencies, and failure of key equipment. 
 
d) You will have procedures in place to report incidents, accidents, and error, and 
procedures to remedy these. 
 
e) You will ensure staff have training and experience in ART, and registration, occupation 
licenses or certificates appropriate to their job.  Staff who do not have registration or 
certification will be supervised by staff who do. 
 
f) Laboratory services will be registered, or working towards registration, with IANZ or an 
equivalent accreditation programme. 
 
g) You will ensure ethical review and advice for new treatment and for research is obtained 
from the National Ethics Committee on Assisted Reproductive Technology, or its 
successor. 
 
h) You will have written policies outlining the storage, usage and disposal of all body tissues 
during and after procedures, and policies relating to ethical considerations for the use of 
donor ovum and sperm.  This will include culturally appropriate policies which addresses 
the needs of Maori 
 
i) You will have quality improvement systems for clinical practice. 
 
j) You will ensure that referring doctors provide sufficient information about the patients 
being referred. 
 
You will endeavour to maximise the chance of pregnancy, while controlling the incidence of 
untoward consequences.  
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8.6 Facilities 
 
a) Your facilities are accessible to consumer irrespective of age, physical or mental disability 
or any other factor.  Facilities for clients with a disability are clearly sign posted. 
 
b) A family/whanau room is provided within your facility for the family/whanau of clients. 
 
c) Facilities are maintained in hygienic and orderly condition suited to their purpose. 
 
d) All reasonable steps are taken to ensure that all buildings and equipment are secure, 
waste management programmes are implemented, and the safety of patients/couples, 
staff and visitors is assured. 
9 PURCHASE UNITS 
 
9.1 Tertiary Consultancy and Assessment of new couples 
 
 
Service Category Purchase Unit Pricing Unit 
First Specialist Assessment Capacity Consultation 
 
 
9.2 Purchase Units and Reporting Requirements 
 
The following table indicates the reporting requirements you will forward to us. 
 
Service Category 
Pricing 
Unit $ 
First Specialist Assessment 175 
IVF Programme  4,600 
ISCI addition 954 
IUI 779 
DI 677 
AIH simple 385 
AIH + stimulation 779 
Donor egg addition 1,208 
Frozen embryo replacement 600 
Ovulation induction 1,453 
Surgical retrieval of sperm 500 
Sperm freezing 100 
Annual storage of sperm 115 
Cancelled cycle 1,566 
Incomplete cycle 4,300 
 
Definition:  
Cancelled cycle - terminated prior to gonadotrophins – day 7 
Incomplete cycle – no embyro transfer – usually failed fertilisation
292 
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8 REPORTING REQUIREMENTS 
 
The following information is the be reported quarterly to us: 
 
Service Category 
Age < 37 
years 
Age 38-
39 
years 
Age >40 
years 
Ethnicity 
Other 
Maori Pacific 
Island 
Asian NZ 
Europea
n 
Other 
Europea
n 
First Specialist 
Assessment 
         
IVF Programme           
ISCI addition          
IUI          
DI          
AIH simple          
AIH + stimulation          
Donor egg addition          
Frozen embryo 
replacement 
         
Ovulation induction          
unknown donor 
oocyte 
         
Surgical retrieval of 
sperm 
         
Sperm freezing          
Annual storage of 
sperm 
         
Cancelled cycle          
Incomplete cycle          
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Annually you should report to us  
• as per the RTAC report for services under this contract: 
• Organisational plan for Maori including: 
• Maori consumer satisfaction 
• Services meet the needs of Maori 
• Maori participation 
• Quality plan 
• Support for Maori 
• Strategies to recruit and train Maori. 
• A narrative report outlining any issues potential  service changes 
• Supply data as requested for evaluation of the Fertility Referral & Assessment guidelines 
 
And any other reports as requested. 
10.2 Purchase Units 
 
As per table above 
10.2 Quality Measures 
 
Clinical indicators  
• In 100 consective cycles that no cycle is in a woman greater than 35 years of age, that 
third or more cycles are excluded.  Using these guidelines a 15 % live birth rate per OPU 
is the minimum standard 
• Embryo survival or live birth rate of frozen/thawed embryos 
• Quality measures for IUI, DIUI,DI programmes 
• Minimum targets for the clinic are live birth rates, in women aged 37 years or younger, of 
15% per oocyte collection in IVF, 15% per insemination cycle in DI, 10% per insemination 
cycle in AIH with ovarian stimulation. 
10.3 Service Planning Information 
 
You will provide us, on request, the following information: 
1. Summary of client characteristics 
2. Waiting Times information 
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Appendix M: Contract 
 
244574 / 156209/02
Provider No. / Contract No.
Variation to Agreement
between
229 Moray Place 650 Great South Road
PO Box 5849 Private Bag 92-522, Wellesley St.
Dunedin Auckland
Ph: (03) 477 4222 Ph: (09) 580 9000
Fax: (03) 474 0080 Fax: (09) 580 9001
Contact: TimWood
and
FERTILITY ASSOCIATES LTD
MEDICAL TREATMENT FOR BIOLOGICAL
INFERTILITY
Ascot Integrated Hospital
90 Greenlane Road
Private Bag 28910
Auckland
Ph: 09-520 9520 and Fax: 09-520 9521
Contact:
244574 / 156209/02
Provider No. / Contract No.
CONTENTS OF THIS AGREEMENT
Section A Summary
Section B Provider Specific Terms and Conditions
244574 / 156209/02
Provider No. / Contract No.
A : SUMMARY
A1 Definitions
a) "we", "us", "our" means the Health Funding Authority (HFA)
b) "you", "your" means Fertility Associates Ltd
c) “either of us” means either we or you
d) “both of us” means both we and you
A2 Existing Variation
In 1999 both of us entered into Variation 244574 / 156209/01 “the existing
variation”. This existing variation commenced on 01-Jul-1999 and ended on 30-
Sept-1999. Any associated alternate Contract numbers are also listed 02240/00.
A3 This Variation
This Variation (244574 / 156209/02) extends the term and changes the price
specified in the existing Variation (156209/01). This Variation begins on 01-
Oct-1999 and ends on 30-Sep-2002.
A4 Section B
The attached Section B includes all of the adjustments to this Agreement as a
result of this variation.
A5 Remainder of Agreement
The remaining terms and conditions of the Agreement are confirmed in all
respects except for the variations as set out in this document.
244574 / 156209/02
Provider No. / Contract No.
VARIATION – V1.0 Page 2
A6 Signatures
Please confirm your acceptance of the Agreement by signing where indicated
below.
For Health Funding Authority: For Fertility Associates Ltd:
Name: Name:
Position: Position:
Date: Date:
244574 / 156209/02
Provider No. / Contract No.
VARIATION – V1.0 Page 3
B : PROVIDER SPECIFIC TERMS AND
CONDITIONS
B1 It is agreed that the following details apply to this Variation
Legal Entity Name Fertility Associates Limited
Legal Entity Number 244574
Contract Number F244574/156209-02
Variation Commencement Date 01-Oct-1999
Variation End Date 30-Sept-2002
B2 Details of all purchase units which apply to this Variation
Purchase Unit (PU ID) Total Price excl.
GST
GST
Rate
(%)
Payment
Type
N-Fertil
Fertility Services
$3,160,227.00 12.5 SSSG
Total price for the Service Schedule $3,160,227.00
244574 / 156209/02
Provider No. / Contract No.
VARIATION – V1.0 Page 4
B3 Payment Schedule
Payments will be
made by us on these
dates:
On invoices
received by us on
or before:
For services
supplied in the
period:
Amount
(excl GST)
22 November 1999 31 October 1999 October 1999 $87,784.08
20 December 1999 30 November 1999 November 1999 $87,784.08
20 January 2000 31 December 1999 December 1999 $87,784.08
21 February 2000 31 January 2000 January 2000 $87,784.08
20 March 2000 29 February 2000 February 2000 $87,784.08
20 April 2000 31 March 2000 March 2000 $87,784.08
22 May 2000 30 April 2000 April 2000 $87,784.08
20 June 2000 31 May 2000 May 2000 $87,784.08
20 July 2000 30 June 2000 June 2000 $87,784.08
21 August 2000 31 July 2000 July 2000 $87,784.08
20 September 2000 31 August 2000 August 2000 $87,784.08
20 October 2000 30 September 2000 September 2000 $87,784.08
20 November 2000 31 October 2000 October 2000 $87,784.08
20 December 2000 30 November 2000 November 2000 $87,784.08
22 January 2001 31 December 2000 December 2000 $87,784.08
20 February 2001 31 January 2001 January 2001 $87,784.08
20 march 2001 28 February 2001 February 2001 $87,784.08
20 april 2001 31 March 2001 March 2001 $87,784.08
21 May 2001 30 April 2001 April 2001 $87,784.08
20 June 2001 31 May 2001 May 2001 $87,784.08
20 July 2001 30 June 2001 June 2001 $87,784.08
20 August 2001 31 July 2001 July 2001 $87,784.08
20 September 2001 31 August 2001 August 2001 $87,784.08
22 October 2001 30 September 2001 September 2001 $87,784.08
20 November 2001 31 October 2001 October 2001 $87,784.08
20 December 2001 30 November 2001 November 2001 $87,784.08
21 January 2002 31 December 2001 December 2001 $87,784.08
20 February 2002 31 January 2002 January 2002 $87,784.08
20 march 2002 28 February 2002 February 2002 $87,784.08
22 April 2002 31 March 2002 March 2002 $87,784.08
20 May 2002 30 April 2002 April 2002 $87,784.08
20 June 2002 31 May 2002 May 2002 $87,784.08
22 July 2002 30 June 2002 June 2002 $87,784.08
20 August 2002 31 July 2002 July 2002 $87,784.08
20 September 2002 31 August 2002 August 2002 $87,784.08
21 October 2002 30 September 2002 September 2002 $87,784.20
TOTAL $3,160,227.00
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B4 SERVICE SPECIFICATION
SERVICE SPECIFICATION
SERVICE CODE ARTIFICIAL
REPRODUCTIVE TECHNOLOGY SERVICE
1. The Service
You will provide a range of tertiary treatment services for couples experiencing infertility.
You will also provide advice and information services and best practice guidelines on fertility
issues for primary and secondary services.
The service you provide covers Artificial Reproductive Technologies (ART) including:
• In Vitro Fertilisation (IVF)
• Interuterine Insemination (IUI) including hyperstimulation
• Gamete Intrafallopian Transfer (GIFT)
• Intracytoplasmic Sperm Injection (ICSI) including the sperm retrieval techniques of
• Percutaneous Epididymal Sperm Aspiration (PESA)
• Testicular Sperm Extraction (TESE)
• Microsurgical Epididymal Sperm Aspiration (MESA)
• Donor Insemination (DI)
• Any new techniques which we may approve
• First and follow-up consultations for tertiary infertility
• Tertiary level investigations for diagnosis
• Social work & counselling as part of consultation and treatment
• Distribution of Authorised Pharmaceuticals.
Indications for Artificial Reproductive Technologies (ART) include:
• Tubal damage (not consequent on tubal ligation)
• Male infertility (not consequent on vasectomy)
• Unexplained infertility (more than three years duration)
• Ovulatory disorders
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This service is closely related to but distinct from:
• Gynaecology services
• Sexual health services
• Urology services
• Surgical services
• Endocrinology services
• Genetic services
which are covered by separate service specifications.
2. Service Objectives
2.1 General
You will provide infertility services to the levels specified in section 9.
You will adhere to the guidelines for infertility services:
a) the ART services you provide are the most appropriate treatment for the couple.
b) each couple will be treated as a unit
c) the services should be available to all people with biological infertility, including
those whose fertility is or will be impaired by cancer treatment of injury.
2.2 Maori Health
The Treaty of Waitangi establishes the unique and special relationship between Iwi, Maori
and the Crown. As a Crown agency, the Health Funding Authority considers the Treaty of
Waitangi’s principles of partnership, proactive protection of Maori health interests, co-
operation and utmost good faith, to be implicit conditions of the nature in which the internal
organisation of the Health Funding Authority responds to Maori health issues.
You agree that Maori health is a specifically identified health gain priority area. You must
therefore establish and implement a Maori health policy that reflects that fact. In developing
this policy, and without limitation, you must take into account our strategic direction for
Maori health in terms of minimum requirements for Maori health based on the Treaty of
Waitangi, Crown objectives for Maori health and specific requirements negotiated from time
to time with us.
You must specify how you intend to implement this policy. In particular, you will identify
how these services will be measured to ascertain what benefit is evident and any other
additional opportunities that may exist for furthering Maori health gain.
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3. SERVICE USERS
Eligible people are those who are unable to achieve pregnancy after at least one year of
trying, or have biological circumstances which prevent them from trying, or are unable to
carry a pregnancy to term. Earlier referral is appropriate when the preliminary investigations
show absolute or very severe factors, such as azoospermia or bilateral tubal disease.
4. Access
4.1 Entry and Exit Criteria
You will provide this service in accordance to the referral guidelines (RG’s), access criteria
for first specialist assessment (ACA) and clinical priority assessment criteria (CPAC) for
treatment.
You will provide this service in accordance with any nationally agreed criteria, when such
criteria are supplied to you by the HFA.
You will distribute Authorised Pharmaceuticals in accordance with the eligibility criteria
issued by Pharmac .
4.1.1 Boundaries to treatment:
You will apply the following boundaries to the service:
a) treatment should normally be taken up within 12 months of it being offered, or within
three months if the women are 37 years or older
b) treatment must normally be completed within 18 months of starting first cycle
c) frozen embryos should normally be used within nine months of the last IVF cycle.
Couples may be expected to pay for storage or any further treatment privately outside
these limits or following an ongoing pregnancy
d) further IVF funded by the provider can be declined if ovarian response was poor –
namely if when using 225 IU gonadotrophin per day there were three eggs or fewer or the
maximum blood estradiol level was less than 4000 umol/l
e) IVF treatments will be available for a maximum of one cycle per couple
4.1.2 Co-payments
You will not charge a co-payment for any public services provided under this service
specification except for 4.1.c above or where a couple elect to have services beyond those
covered by this contract.
4.2 Distance
Patients shall be eligible for transport and accommodation expenses using the current HFA
guidelines, with expenses to be paid from this contract.
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5. SERVICE COMPONENTS
5.1
SERVICE COMPONENT DESCRIPTION
5.1.1
Initial assessment by an appropriately
qualified clinician and development of a
treatment plan
This includes:
1. Initial assessment by the specialist
2. Confirmation that the patients
meet the access criteria and are
suitable for ART treatment
3. Referral of patients who do not
meet criteria or are unsuitable
back to the referring clinician and
explanation of the reasons to the
patients/whanau
4. Discussion of ART treatment and
management plan with
patients/family/whanau as
appropriate, including
expectation, possible risks, after
care arrangements, expected
waiting time to receive treatment
(essential information to be
supplied in writing)
5. Written consent obtained for
treatment procedures and
anaesthesia
6. (If appropriate) pre-operative
referral to the appropriate
anaesthetist for anaesthetic
management during treatment and
respiratory and pain management
post treatment
5.1.2
Peri-treatment care
This includes:
1. Preparation and treatment of the
women for ART procedures,
including preparation counselling
2. The service in this phase includes
all counselling by medical,
nursing, social work and scientific
staff, including laboratory tests
and radiology services
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3. Pharmaceuticals required to be
administered at the time of each
treatment
4. All necessary ultrasound scans
and blood tests after instituting
this service phase
5. Oocyte pick up
6. Insemination and Embryo
replacement
7. Embryo freezing per cycle (as
appropriate)
8. Immediate post treatment
recovery including medical,
nursing and other technical
services as required
5.1.3
Post-treatment care
Managed care including:
1. Immediate response to
emergencies
2. Pain control
3. Prevention and management of
post-treatment complications
4. Professional clinical services
including medical, nursing,
counselling and other professional
and technical support services as
required
5. Discharge as soon as it is
appropriate and with a written
discharge summary and care plan
to be provided to the patient,
specialist and general practitioner
6. Patients are familiar with their
current medication and can
address any concerns before
leaving clinic/hospital or
arrangements are made with the
patient’s general practitioner for
this to occur
5.1.4
Provision of consumable supplies while
in clinic/hospital
This includes, but is not limited to
anaesthetic agents and other
pharmaceuticals and disposable
equipment
5.1.6
Clinical follow-up
This includes:
1. Specialist assessment of treatment
effects and further treatment
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requirements
2. One follow-up appointment or
more if clinically required
3. Review clinic within 6 months
post ART
4. Early pregnancy monitoring and
care to 12 weeks, or when referred
for obstetric care.
5.1.6
Specialist support for other providers
[was: Consultation and education
services]
1. Educative services are provided to
general practitioners and other
specialists concerning appropriate
referral protocols and indications
for ART
2. Consultation and advisory
services are provided to general
practitioners and other specialists
concerning the condition and
ongoing management of the
referred couples
5.1.7
Distribution of Authorised
Pharmaceuticals
1. Protocols for the use of human
gonadotrophins for ovulation
induction and eligibility criteria for
their use are provided to potential
prescribing doctors.
2. Pharmaceuticals are distributed in
response to requests from prescribers
3. Information is gathered on the use
and outcome of pharmaceuticals that
have been distributed.
5.2.1 Management of Pharmaceutical Budget
You will hold the budget and control overall expenditure on authorised pharmaceuticals
[specified in Section 9.5] when supplied in connection with ovulation induction, both to
consumers accepted under this contract for Treatment of Biological Infertility (referred to as
"public consumers") and to other eligible consumers resident in the Northern Region
(referred to as "private consumers”).
You will meet with other providers, within the Northern Region, of services for biological
infertility to private consumers and will develop with them an agreed protocol for treatment
and you will endeavour to ensure that expenditure of the budget is programmed evenly over
each whole year.
You are to ensure that consumers receive authorised pharmaceuticals [specified in Section
9.5] only upon presentation of an application from an authorised prescriber. An authorised
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prescriber is a gynaecologist or an endocrinologist who is associated with an Reproductive
Technology Accreditation Committee (RTAC) accredited clinic, or who has agreed to
comply with treatment protocols and guidelines issued by an RTAC accredited clinic.
You will keep a register and notifiy the HFA annually throughout the contract term of the
names of all authorised prescribers
You will collect monthly data recording utilisation, by public and private consumers of
fertility services, of authorised pharmaceuticals specified in Section 9.5, and will forward
such information to the HFA (which will in turn notify Health Benefits Limited).
5.3 Settings
The place where the service is provided will be an inpatient or day case setting.
5.4 Service Levels
You will provide this service at a tertiary level.
5.5 Equipment
You will have access to whatever equipment is needed to deliver the services described in
this contract.
5.6 Support Services
You will provide the following support services:
5.6.1 Clinical support services
You will provide or have access to the following services as clinically required:
- operating theatre and anaesthetic services
- laboratory
- pharmacy
- sterile supply.
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5.6.2 Consumer registration service
You will maintain complete and accurate records identifying consumers, donors and
recipients of all gametes involved in fertilisation and embryo formation and detailing the use
or disposal of all gametes and embryos.
You will maintain an information system which allows for consumer follow-up and
confidentiality within accepted guidelines and lawful requirements.
5.6.3 Specialised services
You will provide a specialised scientific and laboratory services including storage, analysis
and programme implementation.
5.6.4 Register of prescribers
You will provide a register of all prescribers requesting Authorised Pharmaceuticals.
5.7 Facilities
You will provide commercial support services including:
- inpatient and outpatient facilities, including furnishings, fittings, equipment, lighting,
heating and other amenities
- laundry services
- catering
- cleaning.
5.8 Counseling
You will provide a counseling service to address the social and psychological effects of
undergoing infertility treatments as well as other options such as adoption or living without
children to all eligible couples.
6. SERVICE LINKAGES
6.1 Associated Services
The following support services should be provided by you in providing infertility services:
a) pathology services
b) radiology services
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c) operating services
d) anaesthetic services
e) pharmacy services.
You will ensure links are established and maintained with:
a) primary health services, including health education
b) general practitioners
c) secondary and tertiary medical services, including in vitro fertilisation
d) general surgical services
e) community support groups including NZ Infertility Society
f) Maori health groups.
You are to have effective links and continuity of care with the following services:
• Community groups including the Infertility Society
• Research units
• Ethics Committees.
And continuity of care with:
• Primary health services including General Practice, Family Planning Association, New
Zealand Association of Natural Family Planning, Sexual Health Clinics, Maori and
Pacific Island providers, maternity providers
• Secondary medical and surgical services, especially gynaecology and urology.
7. EXCLUSIONS
You will follow the CPAC guidelines and any further changes.
8. QUALITY REQUIREMENTS
8.1 General
You will aim to minimise complications of treatment, including ovarian hyperstimulation
syndrome, infections, multiple pregnancy, and babies needing neonatal intensive care. This
means careful consideration of the number of embryos transferred in IVF, and of the degree
of ovarian stimulation in all treatments.
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8.2 Access
You will provide General Practicioners and relevant Specialists with information about the
services provided in this contract, including eligibility. You will be available to answer
queries about the service from doctors and the public.
Once referred for consultation, you will see new patients within a specified time, to be agreed
on between the provider and the HFA.
You will identify and remedy any barriers to access by Maori, and obtain Maori opinion
about the service.
8.3 Acceptability
You will undertake customer surveys, and change the delivery of the service according to the
feedback received.
You will ensure Maori views are heard, and that Maori participate in planning, delivery and
monitoring the service..
You will provide a private and confidential service, and have a named privacy officer to
monitor performance and answer any complaints. Privacy issues include those of gamete and
embryo donors, and children conceived using donated gametes and embryos.
You will ensure all patients understand the diagnosis and treatment they are undertaking
through the provision of written and verbal information in plain language, and the availability
of interpreters.
You will ensure informed consent is obtained before any treatment or investigation is started,
and that all consent for treatments involving gametes and embryos is written.
You will ensure that all services are coordinated from the perspective of the patient.
8.4 Effectiveness
You will ensure that referring doctors provide sufficient information about the patients being
referred.
You will endeavour to maximise the chance of pregnancy, while controlling the incidence of
untoward consequences. Minimum targets for the clinic are live birth rates, in women aged
37 years or younger, of 15% per oocyte collection in IVF, 15% per insemination cycle in DI,
10% per insemination cycle in AIH with ovarian stimulation.
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You will help patients accept their infertility when treatment is not available, not chosen, or
does not lead to pregnancy. Patients should feel they have achieved the best outcome in the
circumstances.
You will promote awareness of infertility, its prevention, and the minimisation of its impact
among the general public.
8.5 Efficiency
You will ensure that the services in this contract are delivered within the contract price and
that services are equally distributed over each individual year.
8.6 Safety
You will ensure that the clinic is accredited by the Reproductive Technology Accreditation
Committee of Australia.
You will comply with all relevant legislation, regulations, statutory requirements, and
guidelines from professional bodies.
You will have risk management procedures in place, including for infection control, medical
emergencies, and failure of key equipment.
You will have procedures in place to report incidents, accidents, and errors, and procedures to
remedy these.
You will ensure staff have training and experience in ART, and registration, occupation
licenses or certificates appropriate to their job. Staff who do not have registration or
certification will be supervised by staff who do.
Laboratory services will be registered, or working towards registration, with TELARC or an
equivalent accreditation programme.
You will ensure ethical review and advice for new treatment and for research is obtained
from the National Ethics Committee on Assisted Reproductive Technology , or its successor.
You will have written policies outlining the storage, usage and disposal of all body tissues
during and after procedures, and policies relating to ethical considerations for the use of
donor ovum and sperm.
You will have quality improvement systems for clinical practice.
You will have a cultural safety programme which addresses the needs of Maori, and people
of other non-European cultures.
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8.7 Facilities
Your facilities are accessible to consumer irrespective of age, physical or mental disability or
any other factor. Facilities for clients with a disability are clearly sign-posted.
A family/whanau room is provided within your facility for the family/whanau of clients.
Facilities are maintained in hygienic and orderly condition suited to their purpose.
All reasonable steps are taken to ensure that all buildings and equipment are secure, waste
management programmes are implemented, and the safety of patients/couples, staff and
visitors is assured.
9. PURCHASE UNITS
The total contract price is $1,053,409 per annum exclusive of GST.
9.1 Specialist support for other providers
$42,500 per annum exclusive of GST.
Service category Purchase Unit Pricing Unit
Specialist support Capacity
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9.2 Consultancy and assessment of new couples
$81,600 per annum exclusive of GST for 320 first patient attendances.
Service category Purchase Unit Pricing Unit
First specialist
assessment
Capacity Consultation
9.3 Treatments
$840,809 exclusive of GST per annum, as set out below:
Service
Category ID
Service category Price
Per unit ($)
Indicative number
of units per year
DI 621 80
AIH simple 385 10
AIH + stimulation 721 145
IVF 4233 120
ICSI addition 954 55
Donor egg addition 1208 3
Frozen embryo replacement 525 64
Ovulation induction 421 25
Microsurgery 3265 11
Testicular biopsy 410 10
Sperm freezing 81 120
Annual storage of sperm 73 340
The average number of IVF cycles shall average at least 120 per annum over the duration of
the contract. For the other treatments, the numbers are indicative outputs and it is permissible
for the provider to vary these in order to meet demand, providing that in no circumstances is
the total cost of treatment to exceed the total price.
9.4 Support for consultation and treatment
$17,000 exclusive of GST per annum for administration.
$6,500 exclusive of GST per annum for travel and accommodation support, and for
interpreting services.
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9.5 Authorised Pharmaceuticals
$65,000 exclusive of GST per annum.
The provider will purchase only the brands and strengths of pharmaceuticals set out below, at
the lowest price.
Pharmaceutical Brand names Strengths
Human Chorionic Gonadotrophin Pregnyl 1500 iu, 5000 iu
Profasi 2000 iu, 5000 iu
Human Follicle Stimulating Hormone Gonal F 38 iu, 75 iu, 150 iu
Puregon 50 iu, 100 iu, 150 iu,
200 iu
Buserelin acetate Suprafect Injection, 1 mg/ml, 5.5
ml
10. REPORTING REQUIREMENTS
The following information is the be reported quarterly to us:
In the reporting period;
• The number of first patient attendances.
• Ethnicity of patients (clients are allowed to indicate more than one ethnicity) as per the
Ministry of Health standard:
 NZ Maori
 NZ European or Pakeha
 Other European
 Samoan
 Cook Island Maori
 Tongan
 Niuean
 Chinese
 Indian
 Other
• The number of units for of each treatment, and the cumulative value of all treatments.
• Number of couples under treatment
• Number of couples who have completed treatment
• Number of treatments that took place later than the booked date advised – with those
changed because of patient postponement or clinical factors noted
• Assessment of final outcome of treatment (number of clinical pregnancies and number of
live births per treatment)
• Progress with re-assessment of couples on your waiting list assessment against priority
access criteria
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• The number of patients booked for each type of treatment.
• The number of patients waiting, unbooked, for each type of treatment
• The cumulative value of travel and accommodation support, and of interpreting services
used.
• For the distribution of Authorised Pharmaceuticals, the cumulative number of:
• Cycles treated
• Patients treated
• Cycles to ovulation
• Cycles discontinued
• Adverse events
• Pregnancies
• The current price paid for each Authorised Pharmaceutical, and the cumulative value of
Authorised Pharmaceuticals distributed.
The following information should be reported annually to us:
• Medical complications from treatment, and how the rate compares internationally
• Multiple pregnancy rates for the key treatment programmes
• Incident reporting and action taken
• Analysis of the ethnicity of users of the service
• Emerging issues and how they will be dealt with
• The number of staff by type (Maori, total)
• Level of patient satisfaction with the service and its aspects
• Organisational plan for Maori including:
 Maori consumer satisfaction
 Services meet the needs of Maori
 Maori participation
 Quality plan
 Support for Maori
 Strategies to recruit and train Maori.
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Appendix N: 
NECAHR Membership 
 
Rosemary De Luca (Chair) 
 
Rosemary De Luca is a Senior Lecturer in the Department of Arts and Language Education at 
the University of Waikato. She was until recently the Chair of the Waikato Ethics Committee and 
was also a member of the Working Group revising the National Standard for Health and 
Disability Ethics Committees. She has twelve years' experience in health sector ethics, and 
teaches and has published widely in this field. Her current research interests include the 
language and procedures associated with informed consent to medical treatment in hospitals. 
 
Associate Professor Ken Daniels 
 
Ken Daniels is an Associate Professor in Social Work at the University of Canterbury. He teaches 
values and ethics and has taken advanced studies in bioethics. He has been researching and 
writing in the field of assisted human reproduction for twenty four years and has published over 
100 paper, chapters and books on this issue. He is currently involved in research in Sweden, 
Germany, the United Kingdom, Singapore, Argentina and New Zealand.  
 
Alison Douglass 
 
Alison Douglass is a partner in the law firm Tripe Matthews and Feist, specialising in civil 
litigation and health law. She is former Chairperson of the Wellington Ethics Committee and a 
member of the medical misadventure advisory panel to ACC. She has a Masters degree in 
Bioethics.  
 
Dr Alastair Gunn 
 
Alastair Gunn is an Associate Professor in the Department of Philosophy at the University of 
Waikato. He was a member of the Waikato Ethics Committee for a number of years. He has an 
interest in health ethics, in particular issues relating to assisted human reproduction.  
 
Dr Audrey Jarvis 
 
Dr Jarvis is a microbial geneticist, having retired from the position of Principal Scientist at the 
New Zealand Dairy Research Institute, Palmerston North. She has served on national and 
international scientific committees, and received New Zealand and international awards in 
recognition of her scientific achievements. She has been active on health ethics committees and 
at regional and national level, and is currently Chairperson of the Interchurch Commission on 
Genetic Engineering.  
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Dr Arlene Smyth 
 
Arlene Smyth is a general practitioner working at the Island Bay Medical Centre in Wellington. 
Her main interests are in the area of women’s and children’s health and she is a practicing GPO 
(General Practitioner Obstetrician). She is involved in undergraduate teaching for the University 
of Otago, regularly tutoring medical students in her general practice and also in the Department 
of Obstetrics at Wellington Women’s Hospital. She is also involved in the Wellington Doctors for 
Sexual Abuse Cases (DSAC) and is on the Quality Assurance Committee for MATPRO (the 
Wellington Maternity Project).  
 
Rose Smith 
 
Rose Smith is a registered general and obstetrics nurse and is currently employed as the senior 
staff nurse, General Surgical and Urology Unit, Health Waikato. She has been a Maori member 
on the Waikato Ethics Committee, and also serves on a number of other local marae and 
community committees. 
 
Dr Anne Robertson  
 
Anne Robertson is a consultant obstetrician and gynaecologist. She has an extensive 
background in obstetrics, gynaecology, sexual health, and ethics.  As a health professional 
member of the Manawatu-Whanganui Ethics Committee since 1996 she has developed 
significant experience in and knowledge of the area of ethical review in the health sector.  
 
Dr Barbara Nicholas – Director-General of Health’s Representative  
 
Barbara Nicholas is currently employed as Senior Advisor (Services Research), Health Services 
Policy and is located in the Christchurch office of the Ministry. She holds a PhD in bioethics. Her 
experience in the field of bioethics includes lecturing at the Otago Medical School in this 
subject, and research in the area of ethics and genetics. 
 
• Adapted from http://www.newhealth.govt.nz/necahr/membership.htm [18 February 2002] 
